<SEC-DOCUMENT>0001022079-21-000111.txt : 20210723
<SEC-HEADER>0001022079-21-000111.hdr.sgml : 20210723
<ACCEPTANCE-DATETIME>20210723160424
ACCESSION NUMBER:		0001022079-21-000111
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		65
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210723
DATE AS OF CHANGE:		20210723

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		211110920

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dgx-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:c0ef2d88-a53d-457b-ba3c-2a15db2c46ae,g:aea639b6-1560-47bd-8a23-0a619e498ffc,d:882bbfef3d8d4f5e83c65ae9785b734f--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dgx="http://questdiagnostics.com/20210630" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dgx-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV8xLTEtMS0xLTA_6dd5fdfe-6e6e-49bc-af01-abf94b196322">0001022079</ix:nonNumeric><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV8yLTEtMS0xLTA_ccdc6109-b322-485f-8c00-f5154c590401">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV8zLTEtMS0xLTA_d40ffea9-379a-4d8e-abba-f667b8803fe7">2021</ix:nonNumeric><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV80LTEtMS0xLTA_8473c0b0-684c-49b7-9489-ff30dece4d94">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV81LTEtMS0xLTA_ef0303af-d8ee-419e-a350-9ca7e5d4f751">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dgx-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib645763448a14b6d8a210f113e155fd7_I20210715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i561420fa41374455918b2b347d38a86c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i99a551f639d34e26b6107af0da64abe6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3656967af97247b1bbcb74c67d929381_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f1009ff18c488b8726927338c269af_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia74ca347035d47afab9af2863189a9af_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie409db7692b2496c84592ac0ae13ab4b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cdf70fc1e32411f987859d4ba3a4b93_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1234b393ecf446beb2d12b0db437882a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95131b6d75e44a49bc1fac55189ad1cc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d562072f0674b3ab9fbfd9437b9b623_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3f0b2f6f90d4e56a9e0c7eafef2d828_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d95e47035740e2be82b0b81c67afed_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0c0ed67c1eb40078423e9d062bb487f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f8251b106654d1c98108056fb012db9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfd6ba29f4e1492491f91836654d629f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefc874b9d0dd40489c1a7dcf6860f5a0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9214e898766d4e348c518cc861e2a6d6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idadbab3594fd43348d9b825585c50f1e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c07c80b26c24ce38628b41e10b0357e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe18efd7ba104ac9a5aa32571d8c6166_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i562a2de976ae4600bcfccf456de6283f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71c62f68e0b7484397a15c914fab24bc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4a7dcc35654302bd8e48f6068259be_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if708b3a322c142a896b74f2674affc33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0848c719bfa64a6997b49547abca2d7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9a1846b30804708b76daaf8e7313d54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i926d05e6d1164bceb1d1e6ee02daa1c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5b79ec0ef2348fdae4dc4f7e23a8c61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2775145b5b44ba595f9fd2c6019fffa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127f391cad8f454e934f06617f28068b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab17e5ada04d4e3f8418321f4fed5170_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45e6e7f9cf924fcfba4006108d77d2d7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i120d2d9a75ae49a78ce64d7e98309352_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2d14897dec64b1f93d805966f667a67_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c64b417754a41bf9cb5d032e7c7f1d2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i292f044a2a694be987cf1e050fc32158_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe0f2af904df4308974d0cfadbf6c95f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f22713e20cc4bba8a7d9e37885165ac_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0cdf7d6ee7c436a9d9d7ab4fe709a5e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida27930c41dd4f5a9e90d48ebfc0c9c4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f21b83c03584dc6924263f55d606a78_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic29fec842eda4d01b395c9c45167a267_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib46a16fab53a4ae68476a2fb7593280f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if819fd1fb51043378a435a56ad7b4b3c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2f9ac74121f49239c7f3983ae7bae36_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e4e7a78200d43478e75bd5cdd2d9c12_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic61245d5d6bf4ec6ac96d7e5d11d0de6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74a92cff8b5f4b7585d55a6b13176562_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26783a3b7dd249be9c28f89f9ffb93c8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6f8598006da47daaf4f264d1f79a720_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fa0525d2dc0497f928c8d6ab3456eb5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e56b1b204974d05a0f5e2c43eea7cbd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i546e403b15214524b8519bba76c4d0da_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d014e770945452f897511320c1c2b70_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d38a260d94c443d8eea143672b2cd72_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50aeb63e5efe48d99c044cfb52e07b48_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df3ecb6e73749a49030a463355f0fba_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7500943b3564489290004ac65ed7fccf_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc55a2801094ec0bc9f846effac87da_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62149b0b25564ab180137047be530824_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i533de8c040f5497f94c63d60c5e38efa_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ceb997147b42ebafa6e46d4f452d31_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iede8a4b7d31f4a908594d37d2d356dce_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic80123e8686446ea809da2ddaa1ffaea_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18670a49a70d49f8aeb8c2046b450952_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3af8b0558d7461c9027eaf168d159f3_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3be2c0db58246b7ba37ca73d78f5af0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:ForeignCurrencyTranslationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04611b3c394b4101bd96d6e4b765e44c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb4f5b2e63164cf29143b9d989289909_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i859aca831b984d80a0b94d96fc615aa2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2e3fa85839f4364b166f6fd6333403f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib638d54663d141b3b55a392010b4133c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4153cd4b719540d983239e906877df0e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a3f19649844f0b9777994eb7530457_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbe6cc9023dd4f6b925f3e4b803adba0_I20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfcc6d7cb7ac4f62b3b2a88f27e08e14_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c021b8753de48c7949085222e7a6139_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41845b250794af096b47fe4b8dcfef7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0928297813dc4017bf49f241cc643448_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i062d7e387e63446587683b565e79cc7c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62c6b6c329864ab3b58435cdeddd4726_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i243d7693a5f1415e850da25a647196b6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i080fe75a1bab496783d14dbde41a0ab7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b349580952a42daa37b46b6272cf25b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6867e614c34049c1a7f3aced88b5b8bc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5398a8c43e6c402d94b6baa7dbf0d6ee_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f627c6887ae40ecafd69b4688c9cc51_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i240c440483ce414d8bd8a947d07168e4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77a870ab4b284d47b78555d636f33091_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6261831038be4db5bd54afa80dbf7bd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4d571b8f74b4b3393f62cdbd449a4fa_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia38bbfcf307146078c97c1184f858dcd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c902ee777e4bfc97e2db0e0d3526be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i388db605d7fa414f925f9483e847602e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i158831a555d7459cbe9af1e66382b1d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11b6b69b0dc94269aeb47d2aa8b322c0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8d9f93c589f4849bf27e56a6e0c38c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04635c8c75144bd8a8ba0318721159e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e506a9924014d9bb1c2cfc78ca49c38_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9062ff9a1ae48d79906ea44e302c2e7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifef13a5c7cd74ff2af0e1affd9841703_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbac0da433664c12b78532c13c77e330_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id28577727d1648e484a07b8110249cb4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5227393e6940467e8dee71a1b9b51664_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3fbebc3bfe4304ba9e9eb9b1bba88c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aa5e0abeaed4700bdad18c66e5e59b9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i662c45865225464399b955e53cc70538_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd95473cf34947db9595e10c6d055373_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fa06c6f3bf140899d194e149d257ba9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic627ecff5fda4835a645a85a28ace8c5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03e1d81e938740ac958144ec1c77ded0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20d06c07440d4f66b5778443f9d59b7a_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08b3d9b382f42539d1313a3fc3d9152_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1daf0363ce34e388d9a621878fbf6c0_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326c009316994d11a6801f243ae0c3c5_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a71b4b1c174929a891375f3de116e1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea4626114bd94a1b8470c2ae9e6f26e2_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fbb220f78a341abb8f1709736881c15_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b25ce7f6ff24ed7bbb7af00c1bd27a7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4ea064d0de34ab9b6d853e2567d8e12_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44b2df1b377b46139f619a2f36e50ecf_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02f8071b495d4e6690e62d4d392886da_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a152b0fb1084caa902c4093da8d43db_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i556b98e351504ca9ab3b40b06f30f294_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82b7d6590d24533bdb4d454c3f65409_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6477236048c4c93b9a5e798f19e3fcc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5be56e298c3542a08d1a42235055721a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dgx:claim</xbrli:measure></xbrli:unit><xbrli:context id="icab7ab47a0de43f7bab61f509c638937_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d0fd1d47784fd697f3c49dd3ee9148_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fb24d8255674ea29c12a58a75a31c7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29a251826fef44b7a2f0a3c45547f1cf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i383af7e535cb4e1b91b38301026c3942_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90505fcb3b254cc1854ef977088118fc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb4af20d3554d7c929c5923a8579af2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3010233763bd4c139f2be9e14d283953_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6397d097e9541cd93b37f7f3793e996_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf9bb291bfed42dd8d3e3f6e51487a32_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb0cbdde947349c2a36c2d246eb753b3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0889a4285c0e4785b648e20f63f330f9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c3b5a5d28a4bd8ad953fad99e01101_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15a526c3a9c94237af3d47054f8b6d88_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcc4b8411f1549df9adea0e982455905_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97dbe548aae446e5b0a2d3af9581d04d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief4ea7051e25417fbffc0d616878520f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i624857d463ea42cba64821f6526c8f30_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9487c77290544536af9132f251d1f6ea_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cc8267b895c4a3f960332826d5a02a4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibebaf9b7d93d4b928c763156787f0e12_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7302c53e8d34d6f90c6b6355b0f4289_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide03df6794ec4f319643260a062544e3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b44cf9ddb7649a4b78b908d8d56915d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2434d7efd8540e98be5af167e3ed184_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fb502a9bf254ed190f3f05d0c743c9f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60bb75a4ffe942ad8f8ee7cc12887a86_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib040e682f6cd49fa8fcaeab6c9d181d8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0da175e34d54ca9bc607ec32504bb8c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b11f69b1f65429992a961faaccd7fd2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33bfedc0555f4b54a3fb6ed997bac076_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d1e8f63991474d991b6164216d4e30_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25ee037b0e524fc29dea8a393cc05548_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f9d9630be94d08b53f303e6841bda8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc42e2ae9df4d33a04a0b7b4ad4f4a5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia152bf35c30347d8873598f3162479e9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bdcdaca428a4c798866885a7bf83056_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide868a83c608446793a82a3dd54fa369_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd0e727fc05c4c8995fdb6239cf65e8b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffe84216348445a59b369c286ef7ea93_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78df85d445ba4c0db260659c0ff4938d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3415e92f142e4b66b223b653c1a52387_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c5637dc35e141ba997c638460a77408_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a7aade517b46ed8b5a72c6df38f8aa_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71015133b38c46c58c9f22d76e9138bf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e91a1c6442413ea75e76e2d1d3dfba_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d45b95ebfa54455b7a8148902aef07e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d1ae3e3c083422987b0fb7513f90028_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86c6e680c2644742bae6cf23bce0251e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3fd720e863c4f78bafdeb62b08b7f4f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd965423d424e19a504a6a42bb048c0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i247d47c1463a483386454a9395684d29_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25cda7d1389e444ea61b767b89bced02_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53e1743ac9e84f96b59d2add6ce6e13d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba66174bf50b4b8e989cb690f4f40491_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d8f167638d849ea9481c99bc9392ad0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5541bed47cc341dfbed89f1ffbc4662d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3656dc776fa3408393224dc1faa34145_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70684da285074a80b27a51d58ae0bb69_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib54ce13b5fa748fca4142752ebed0ace_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3456017b640b4ec79039ff09ce94613a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12c508b86ea2424cb0fd8f135fe41718_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29d70c753e104f2e9381d4c4d680e64e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i351bd30e85e24fbbb3960dc16939ff04_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb969f883d7f4514bce846057de29d5d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fb23c7e2fab487ba4834d786dea4bf7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3845502e9c3418fa7afe7f9e6d923f7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic74a4e69eaf749ee870747305583176f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17eefeebe6ed4e218bc255b2a54bc938_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52eab006215b4f08859dc4a709d65fa5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67c88c4d2eab4a3e92f6026392a577d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i673f602d80e04697ad707632c81bedc9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec294bc9c1544d1b91cea9e983a73d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie91fe1b790d2497fa2a96a583468755b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2fac1abae04410ca5aa5c55ced1c0d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7308d78e16804acdb197a6fe7389240b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc053e1f6804e8bad318c14a1840e34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5efcf88fa11e4c91a8d160f946aa751a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i498cb94f65974aa2812f578184595178_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0267b05c8fa74b65aae925e3bb8946a3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WASHINGTON, DC 20549</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTI4_f27e2b8e-9616-4a02-abb1-a74c1b0058b6">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One) </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTI5_02fbac45-eb7c-4615-b32b-7c6e982d80cf">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8yNzQ4Nzc5MDcxNDM2_6ab62e98-8600-4d6a-83a8-9acbcd7a6c9d">June 30, 2021</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Or</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTMw_fa899390-2b1b-4927-9dd8-5221f5ea234a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from          to</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTMx_2516b97e-2ef2-4085-9627-05156af276fe">001-12215</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTMy_d91fa084-2536-4502-b45a-7054d1862706">Quest Diagnostics Inc</ix:nonNumeric>orporated</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:519.00pt"><tr><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:201.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8wLTAtMS0xLTA_d699fee2-e0ae-4ea8-9ae4-12b8b84991b2">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8wLTUtMS0xLTA_cc2dda37-e105-473c-bf2d-37cd98598063">16-1387862</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8yLTAtMS0xLTA_2e6fb709-7ee6-43bd-9f1c-5128668d64e2">500 Plaza Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8zLTAtMS0xLTA_3ead50fb-d0ed-43f0-a78f-8feabcb6ac89">Secaucus,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8zLTEtMS0xLTA_82a66928-31df-49e8-8752-861fa90256ef">NJ</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8zLTItMS0xLTA_32731fd7-8366-4837-ac0f-82d6fea92d52">07094</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF80LTAtMS0xLTA_73856ab9-c732-4357-87c8-808a9dac5827">(973)</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF80LTEtMS0xLTA_2d17dd37-4dbb-41b2-9847-e84ab68ddef0">520-2700</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.055%"><tr><td style="width:1.0%"></td><td style="width:30.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6N2RhOGI0ZDQ5MmU0NDM4ODkzZjc5Zjc4YWFkNDNkZGYvdGFibGVyYW5nZTo3ZGE4YjRkNDkyZTQ0Mzg4OTNmNzlmNzhhYWQ0M2RkZl8xLTAtMS0xLTA_d90748ce-b5c0-4746-af28-88a7f2456eea">Common Stock, $0.01 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6N2RhOGI0ZDQ5MmU0NDM4ODkzZjc5Zjc4YWFkNDNkZGYvdGFibGVyYW5nZTo3ZGE4YjRkNDkyZTQ0Mzg4OTNmNzlmNzhhYWQ0M2RkZl8xLTEtMS0xLTA_03eb22b6-9399-4d12-90bd-091c551802ad">DGX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6N2RhOGI0ZDQ5MmU0NDM4ODkzZjc5Zjc4YWFkNDNkZGYvdGFibGVyYW5nZTo3ZGE4YjRkNDkyZTQ0Mzg4OTNmNzlmNzhhYWQ0M2RkZl8xLTItMS0xLTA_e3d02ed3-3a62-4acc-aa6e-00191f44f523">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTMz_ba6b8674-d630-47ad-99ea-cbb8706d6e89">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTI2_15fb8e6b-4ec2-4b0b-b98c-dc48e3bc03c9">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.166%"><tr><td style="width:1.0%"></td><td style="width:42.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MGMxNDk2OWI4ODUzNDRlNjg5NmE3M2I5ZDUzMDdlNmMvdGFibGVyYW5nZTowYzE0OTY5Yjg4NTM0NGU2ODk2YTczYjlkNTMwN2U2Y18wLTAtMS0xLTA_bb45b0a4-942a-464d-9e45-a1e6680a6e07">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MGMxNDk2OWI4ODUzNDRlNjg5NmE3M2I5ZDUzMDdlNmMvdGFibGVyYW5nZTowYzE0OTY5Yjg4NTM0NGU2ODk2YTczYjlkNTMwN2U2Y18xLTMtMS0xLTA_4ab78706-ec18-45b4-a531-8c27cf2104b8">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MGMxNDk2OWI4ODUzNDRlNjg5NmE3M2I5ZDUzMDdlNmMvdGFibGVyYW5nZTowYzE0OTY5Yjg4NTM0NGU2ODk2YTczYjlkNTMwN2U2Y18yLTMtMS0xLTA_58d4a011-316e-4470-850c-f00b3dbdb0fe">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTI3_3d4582ca-4337-4172-aa9c-cf870cb4f7cb">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July&#160;15, 2021, there were outstanding <ix:nonFraction unitRef="shares" contextRef="ib645763448a14b6d8a210f113e155fd7_I20210715" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xODY3_203e3ccc-4e81-40f3-8e79-77d986c9b49c">122,180,759</ix:nonFraction>  shares of the registrant&#8217;s common stock, $.01 par value.</span></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1. Financial Statements (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Index to unaudited consolidated financial statements filed as part of this report:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_13">Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_16">Consolidated Statements of Comprehensive Income for the Three and Six Months Ended June 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_19">Consolidated Balance Sheets as of June 30, 2021 and December 31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_22">Consolidated Statements of Cash Flows for the Six Months June 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_25">Consolidated Statements of Stockholders&#8217; Equity for the Three and Six Months Ended June 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_28">Notes to Consolidated Financial Statements</a> (unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_73">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_73">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_88">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_73">See Item 2. &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_88">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_91">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_91">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_91">36</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pag</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND SIX MONTHS ENDED JUNE&#160;30, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_13"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMi0xLTEtMS0w_fc1a95b9-5b36-446b-a520-35540da939d7">2,550</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMi0zLTEtMS0w_cd00fb5a-b1b6-4649-ab6f-94483fd194b1">1,827</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMi01LTEtMS0w_bcc7d142-047b-488d-b70a-03e150aa0001">5,270</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMi03LTEtMS0w_119fac11-51cb-4fd0-bf88-67b5c546cb40">3,649</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNS0xLTEtMS0w_831efc5a-e08c-48ea-87b5-c39666bc8d40">1,565</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNS0zLTEtMS0w_26a5b6b8-6c3e-4efd-a5be-0556396591a2">1,221</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNS01LTEtMS0w_618eeece-56f7-45ca-ab4f-d35296a692e6">3,191</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNS03LTEtMS0w_fe8ac189-f1f7-4e18-897b-2963db5024dd">2,491</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNi0xLTEtMS0w_aa2d429b-335e-44a1-b324-72d3688102af">429</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNi0zLTEtMS0w_02fdc74a-ac2f-4098-99a0-4d8634b3f552">360</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNi01LTEtMS0w_9b434130-3811-48d7-b34b-043a1373a557">836</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNi03LTEtMS0w_17cbd86b-3c1b-412c-a0c7-d3b8ec7c1b30">707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNy0xLTEtMS0w_6a0e6c95-0f93-471e-b9ba-fadec14c3fc7">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNy0zLTEtMS0w_e108fc8e-1b65-4b0c-a825-cecd3a3e5719">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNy01LTEtMS0w_92bad958-ecb0-4de4-907c-5609465bf3aa">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNy03LTEtMS0w_c69d877b-5c7d-4a09-a523-4981df2bc2b2">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfOS0xLTEtMS0w_dee132ac-1d3b-4a2f-89ba-278cd6a8888b">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfOS0zLTEtMS0w_20eefe42-7c86-4708-a540-46a79110a780">62</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfOS01LTEtMS0w_83e8cbaa-1e12-44fe-bd9f-07b276bd0579">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfOS03LTEtMS0w_74994036-27b5-42fc-8853-0e55077f8bcc">57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTAtMS0xLTEtMA_2e1e1fa8-fe4b-4016-8910-17e89865cc61">2,017</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTAtMy0xLTEtMA_c996a5e0-4ed2-4ce6-b4d0-ef5445fdd87b">1,544</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTAtNS0xLTEtMA_b3391794-b15c-49d6-b42d-917146c17300">4,077</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTAtNy0xLTEtMA_9ea69cf1-c9d7-4a5a-ad6d-a9f29a26fe2a">3,191</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTItMS0xLTEtMA_11d585e7-58c7-44bc-877d-336fa2cc849b">533</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTItMy0xLTEtMA_603367a3-7dda-4ba3-b82c-484e30ef32b6">283</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTItNS0xLTEtMA_e31eea8d-39ec-4cbc-8051-b82928873497">1,193</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTItNy0xLTEtMA_6e4e6b85-6f7a-4267-9554-834cee776c44">458</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTUtMS0xLTEtMA_99c391fb-6817-47d7-b920-e331da94b1a3">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTUtMy0xLTEtMA_7e9828a4-a695-4881-bf87-879f836d9aa4">41</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTUtNS0xLTEtMA_da3de060-e546-4363-bb49-c13b94b0505b">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTUtNy0xLTEtMA_a379d696-e044-4dbf-90e9-5c87a2170389">82</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTYtMS0xLTEtMA_05c69018-16ba-45e7-8e55-0bf5823533bb">322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTYtMy0xLTEtMA_62fcc405-cbee-49ba-bb09-89f4fba19611">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTYtNS0xLTEtMA_6c0ee8fc-006d-4a23-9571-2764d9dfedc9">326</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTYtNy0xLTEtMA_16e49fba-4c78-4adb-bd3f-c7422731dc24">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income (expense), net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTctMS0xLTEtMA_8640f65c-f044-4249-bc80-28c5d41aa6ff">284</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTctMy0xLTEtMA_3093e26f-c667-4b16-ac86-f1deb1475a45">28</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTctNS0xLTEtMA_7374c04c-486e-4abf-af2e-f02274bdf588">250</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTctNy0xLTEtMA_69fce8ec-6a42-4b2a-9e9b-8671f8363e0a">85</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTktMS0xLTEtMA_7e749051-d36f-45ad-b726-01b3c4aeee1d">817</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTktMy0xLTEtMA_2107968c-f893-4137-8360-9e0cef22aad9">255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTktNS0xLTEtMA_ce247608-152b-47a9-86af-c38f1a3e027a">1,443</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTktNy0xLTEtMA_8a866003-720f-4075-8b63-61db9c932e47">373</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjAtMS0xLTEtMA_68d4c507-6b50-4be3-9eed-988541251782">177</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjAtMy0xLTEtMA_e4976c99-b41f-4c99-89a6-8d196fe9c5d2">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjAtNS0xLTEtMA_a630ee36-57ab-481a-bfdf-8b3dffda8529">330</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjAtNy0xLTEtMA_295f0589-ff63-486e-85ec-e3e05bcfb00c">92</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtMS0xLTEtMA_b4a2d493-1de0-40a1-9c9a-483338a82029">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtMy0xLTEtMA_5edaa6f7-40a2-4a22-83fd-58329718ccda">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtNS0xLTEtMTMwMw_26775f79-a83e-4a65-a3d6-e78ca2531c13"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtNS0xLTEtMTMwMw_4b9b3006-bb2c-4b86-a969-bfb3041b1996"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtNS0xLTEtMTMwMw_6e888c36-402f-4100-91ed-93b703198ee0">27</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtNy0xLTEtMA_5e1a2882-3725-457b-a133-5d41150c2f6b">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjQtMS0xLTEtMA_a738bfbc-6c8e-4dd8-a301-dbcc051d4740">650</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjQtMy0xLTEtMA_0c2e4dfe-6198-47c9-ad46-789083e8e45e">193</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjQtNS0xLTEtMA_f3a85723-3609-44e8-8548-e532bbbac80c">1,140</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjQtNy0xLTEtMA_a494afc5-4bf0-4d2a-84a1-03edf69627a3">299</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjUtMS0xLTEtMA_ffe6f478-14ab-446f-9954-f6f4c0eae840">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjUtMy0xLTEtMA_2ad09ab2-879a-4382-9a1e-00e802b83535">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjUtNS0xLTEtMA_64f505bb-0ee4-488b-bb5c-be6ca8906851">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjUtNy0xLTEtMA_aabe4b27-36b4-4019-a032-e484f58c8aad">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjYtMS0xLTEtMA_02f6de2d-6a97-493b-bfb2-a53fb0526788">631</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjYtMy0xLTEtMA_064f0c87-2760-4057-8133-3312f5969fd5">185</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjYtNS0xLTEtMA_549be23e-8a12-4e87-a0b7-90c67573cc5f">1,100</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjYtNy0xLTEtMA_ac8f0836-20e2-4513-8528-77bc9f0c53a8">284</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMzYtMS0xLTEtMA_54510063-af48-4395-8246-7ffae0e10eeb">5.05</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMzYtMy0xLTEtMA_dd17af99-1810-4263-9494-b9ac1f6d8eb0">1.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMzYtNS0xLTEtMA_199f61ae-3ccd-4549-ac0a-6c64f7ef8bda">8.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMzYtNy0xLTEtMA_5bc44d1e-e8e7-48cd-9dd1-be9d1299cefc">2.12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDEtMS0xLTEtMA_c8d18fee-b4ac-43d6-8214-cfa21e433cd7">4.96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDEtMy0xLTEtMA_ab52cefc-82d5-495a-881b-ac49e1632b21">1.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDEtNS0xLTEtMA_0e310ed0-435a-4c8f-b82f-13965dad1d2b">8.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDEtNy0xLTEtMA_4431b110-ffeb-4d65-9c0c-6f269fd0abee">2.09</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDQtMS0xLTEtMA_e59068b8-f6e4-4557-83f9-dcd46e65a6d6">125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDQtMy0xLTEtMA_2571cb85-722a-42f3-b2c6-b7a9010dc47a">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDQtNS0xLTEtMA_414dbc7d-8aed-4768-976d-580e985cbf31">129</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDQtNy0xLTEtMA_1db536a0-0eb0-4d01-8549-dd6636661f52">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDYtMS0xLTEtMA_3addd579-c31f-4d02-a00d-bb5350c80b3d">127</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDYtMy0xLTEtMA_f5026ffd-8425-4838-a8b4-af969b048430">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDYtNS0xLTEtMA_6415670a-df5d-4f03-ad19-f6a3cdf1831c">131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDYtNy0xLTEtMA_e08a7b44-ca28-455e-89f1-d125fe0b0980">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND SIX MONTHS ENDED JUNE&#160;30, 2021 AND 2020</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMi0xLTEtMS0w_a738bfbc-6c8e-4dd8-a301-dbcc051d4740">650</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMi0zLTEtMS0w_0c2e4dfe-6198-47c9-ad46-789083e8e45e">193</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMi01LTEtMS0w_f3a85723-3609-44e8-8548-e532bbbac80c">1,140</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMi03LTEtMS0w_a494afc5-4bf0-4d2a-84a1-03edf69627a3">299</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNS0xLTEtMS0w_6c307b55-fcbb-44c6-9771-85d73f2bea94">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNS0zLTEtMS0w_49a3ecfb-146d-48d7-9022-528bf14e0768">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNS01LTEtMS0w_1f8e72dc-a255-455a-9f31-273425772864">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNS03LTEtMS0w_3b8e6356-58b3-48cd-9ca7-62ac72ce05cd">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in available-for-sale debt securities, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNi0xLTEtMS0w_acee0d32-3f70-40aa-800d-00ee8695e246">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNi0zLTEtMS0w_95ca5f28-9a0c-4db5-b32c-3c27c7639d87">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNi01LTEtMS0w_18363e45-3156-4496-896e-87490c2b04e5">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNi03LTEtMS0w_5f7ff597-8595-447a-bfb4-30a4a3c97a04">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfOS0xLTEtMS0w_f945583a-efc1-4bcf-ae5a-748e99ba07b0">21</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfOS0zLTEtMS0w_f3097aed-e76e-40d8-8d20-2ebada036c3f">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfOS01LTEtMS0w_fba526ec-b2d7-47c5-86bd-36d09cb5c65f">11</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfOS03LTEtMS0w_d0c92554-9d48-4566-b169-710f4b9c48e0">16</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTEtMS0xLTEtMA_5620b33c-4267-465e-b3f0-7558aae01c21">671</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTEtMy0xLTEtMA_3dc1f49e-9b63-4d93-b714-4c896fb2aab5">196</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTEtNS0xLTEtMA_5e0d45b1-50db-4b73-aecd-13d97542c443">1,151</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTEtNy0xLTEtMA_d3b0111e-6fe7-4223-95e4-4217c60e1657">283</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTItMS0xLTEtMA_2633e01d-abbb-47d1-a021-7d8147fd640f">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTItMy0xLTEtMA_9ad6eb9e-6939-4951-b539-bb7f361bf125">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTItNS0xLTEtMA_0bd66f73-fd8a-400d-ac37-e9196219e019">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTItNy0xLTEtMA_429a80e6-39f6-4e6a-88a6-8dd28a2106c9">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTMtMS0xLTEtMA_5820f051-5240-400a-9568-76c402bed1e7">652</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTMtMy0xLTEtMA_49f95b2c-47b0-48f9-9b23-10b91a09238f">188</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTMtNS0xLTEtMA_1ceacde0-290a-46ad-b195-a6e77c166647">1,111</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTMtNy0xLTEtMA_909f2484-7e9e-48d5-a17d-c6d2ca98abb3">268</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_19"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JUNE&#160;30, 2021 AND DECEMBER&#160;31, 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMy0xLTEtMS0w_1bafc3c0-f580-40ba-baa4-31f8fa128cf6">560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMy0zLTEtMS0w_d5144588-2d0f-4bdc-80a9-6b684d896e68">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNC0wLTEtMS0wL3RleHRyZWdpb246Y2I2YTM2NTBkNzVjNGI1N2I2OTlhYmRmNTYzZjRhNmZfNjM_661430d6-d57a-4012-83d0-34b61a71bfc9">29</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNC0wLTEtMS0wL3RleHRyZWdpb246Y2I2YTM2NTBkNzVjNGI1N2I2OTlhYmRmNTYzZjRhNmZfNzA_9cf61022-8c28-4c4f-9e4d-ee705e547aa9">28</ix:nonFraction> as of June 30, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNC0xLTEtMS0w_882e0050-5043-4fdb-bd61-a80fdb7998a8">1,255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNC0zLTEtMS0w_3db0d1af-e527-4a18-9da9-2bd94d7c6198">1,520</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNS0xLTEtMS0w_3382b614-3254-4d94-84f7-18f32f87a82f">199</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNS0zLTEtMS0w_1735cb35-8666-42b7-b1d7-7aecaa1ead06">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNi0xLTEtMS0w_9c4c2987-2435-447a-b3c5-a3232727cc95">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNi0zLTEtMS0w_ac5da6a5-ad06-4bd2-be9e-954ed5d8a06a">157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfOC0xLTEtMS0w_e68dc20e-9da5-4fdb-81ad-4b2d9c22820b">2,146</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfOC0zLTEtMS0w_f5a941b5-3151-40df-ae69-c658c5b00aef">3,058</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfOS0xLTEtMS0w_7f8afb4d-5e91-43c2-a2fe-f9a843c1fe35">1,622</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfOS0zLTEtMS0w_6ae5e412-747c-4036-bce7-ef3ec9200ed4">1,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTAtMS0xLTEtMA_f90ef775-c449-4fd1-936f-4a4600fc707c">589</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTAtMy0xLTEtMA_fd5c1549-dfb4-4542-b39c-ff21b6713ea2">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTEtMS0xLTEtMA_192e71f9-a935-4879-ae0f-df8b2aa4d7d6">7,045</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTEtMy0xLTEtMA_c4d3bd82-4d6f-4186-bb8b-6d15ddf53468">6,873</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTItMS0xLTEtMA_40750c3c-aee8-4952-b476-4c61f9dff947">1,172</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTItMy0xLTEtMA_c62a77df-df87-4a7f-af85-dde507c77589">1,167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments in equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTMtMS0xLTEtMA_53ac6749-76a5-4dad-a2b7-3114721e94bd">111</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTMtMy0xLTEtMA_24c19ecd-c0b3-42a8-ab63-52f2f5242ec4">521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTQtMS0xLTEtMA_ce4c35b4-f17a-481b-8bac-560f77a2529e">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTQtMy0xLTEtMA_b4d3ae3d-5c96-4cb7-952d-0ba61cd88b57">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTYtMS0xLTEtMA_c4af5866-9388-4bf7-9886-9e6a5559319e">12,861</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTYtMy0xLTEtMA_350e5a8d-b4cd-4c77-b67a-1d3c9417ea25">14,026</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjAtMS0xLTEtMA_23ae5740-3647-4aef-bb69-7213b7c0c3da">1,404</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjAtMy0xLTEtMA_82ab840a-d919-4f86-a265-a86a284e83da">1,633</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjEtMS0xLTEtMA_18ad9e6e-d29d-4ca4-b535-fdff7059a5c2">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjEtMy0xLTEtMA_95778e92-1e61-4dd1-854f-d1846292494a">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjItMS0xLTEtMA_be9d579f-9371-4d9b-9dff-83c840586bd0">145</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjItMy0xLTEtMA_14c74121-877a-4f32-aed5-bd0d51a82846">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjQtMS0xLTEtMA_e2214045-9581-4bba-af1f-771f95bb06dd">1,551</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjQtMy0xLTEtMA_a27445d5-8dd6-4095-a4c4-7c88c027dfb5">1,776</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjUtMS0xLTEtMA_f784d46c-12e3-4445-b5fd-f095eb9e1345">4,008</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjUtMy0xLTEtMA_aefafa56-7d4b-452a-8925-fbaa9381cbe0">4,013</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjYtMS0xLTEtMA_3edc94d6-8f72-4443-b981-99450407acb9">492</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjYtMy0xLTEtMA_4161b66c-be79-466f-aac8-9e924c6c9db2">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjctMS0xLTEtMA_81f73ce4-7eab-444f-a909-037604ca475a">792</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjctMy0xLTEtMA_73985cd2-50fb-48a2-be5c-6c90f174d69d">847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjktMS0xLTEtMA_01d04dad-9148-4697-9feb-5825712cbea5"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjktMy0xLTEtMA_468605b0-37d6-4cd2-beaf-7208ffb71805"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzAtMS0xLTEtMA_5eee4f02-c24e-48d9-8b83-5ef8cec75079">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzAtMy0xLTEtMA_c6a35229-2901-43d3-abc3-012c528d9830">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzI4_68daf4be-8993-4569-82de-aa0ce39ba0db"><ix:nonFraction unitRef="usdPerShare" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzI4_c10cf4ab-41f3-4236-b8ef-72893ba4be21">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzQy_add94852-7dbb-470f-8e29-371ed5b39697"><ix:nonFraction unitRef="shares" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzQy_e5ae28dc-1c61-4abb-ad5d-d759e03e80d6">600</ix:nonFraction></ix:nonFraction> shares authorized as of both June 30, 2021 and December 31, 2020; <ix:nonFraction unitRef="shares" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzExMg_b0e8edc1-685e-41f7-b16a-3e596cd9189b"><ix:nonFraction unitRef="shares" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzExMg_c9535d48-7c1f-48e0-8682-4b4c8877caa3">217</ix:nonFraction></ix:nonFraction> shares issued as of both June 30, 2021 and December 31, 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMS0xLTEtMA_7a3de849-5c72-4ed5-81d0-8cd3d1556a0f">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMy0xLTEtMA_0bae6181-a665-40bb-aaa8-fb7ce5913958">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzQtMS0xLTEtMA_ed9db5be-4836-40ed-9c22-ad39d6c3f0e9">2,555</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzQtMy0xLTEtMA_8fb34189-0c30-4af6-b519-6db52c7c75eb">2,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzUtMS0xLTEtMA_e8ac7042-8695-479e-9488-7bf2b7ff997f">10,246</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzUtMy0xLTEtMA_27fe70e1-854b-472d-9cb6-45682fbd6675">9,303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzYtMS0xLTEtMA_0702198a-800e-49bd-9562-02c187cf8e18">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzYtMy0xLTEtMA_9eb6ad0a-50da-4ee9-95a7-71cb95e56680">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2ZGYzNmY0ZjRlMzQ0Yjc5NTJlNTE2OTA5MjNlYWMyXzI5_9591c0fe-02b5-4cd5-8690-c8c03954d585">95</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2ZGYzNmY0ZjRlMzQ0Yjc5NTJlNTE2OTA5MjNlYWMyXzM2_cef01f75-0acb-491f-a664-58fc8f03f2c1">84</ix:nonFraction> shares as of June 30, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzctMS0xLTEtMA_557dcdaf-bf14-4678-aa4e-5568727c0c6b">6,894</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzctMy0xLTEtMA_d7fa207f-4055-4fa4-8e99-e04f39e62414">5,366</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Quest Diagnostics stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzgtMS0xLTEtMA_8958cde1-275a-4fd6-8df9-8efdcadd2d3e">5,899</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzgtMy0xLTEtMA_d30bf4b8-3811-4d16-ba5a-17cb1b45a40f">6,759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzktMS0xLTEtMA_88fb9af3-ce25-4af9-b96e-ff72be846c73">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzktMy0xLTEtMA_aa6ba480-a325-487a-8811-68eb06c6117f">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNDAtMS0xLTEtMA_50633860-cd1a-4642-99a6-7aa85ff04f80">5,940</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNDAtMy0xLTEtMA_a5a0fce3-391f-46c8-a322-af7d132e93c3">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNDEtMS0xLTEtMA_239af3c8-8975-4dca-ad35-7f9425aaf04b">12,861</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNDEtMy0xLTEtMA_36aaecb2-6d45-49cd-9013-3521e4e5aa36">14,026</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE SIX MONTHS ENDED JUNE&#160;30, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions) </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMy0xLTEtMS0w_f3a85723-3609-44e8-8548-e532bbbac80c">1,140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMy0zLTEtMS0w_a494afc5-4bf0-4d2a-84a1-03edf69627a3">299</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNS0xLTEtMS0w_de30d6f6-7dee-4265-af40-835d9c87c642">201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNS0zLTEtMS0w_751404aa-f639-4b9b-b855-2d21feef9039">174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNi0xLTEtMS0w_afe305de-66df-4061-826c-7c934208ea5d">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNi0zLTEtMS0w_04c08113-9223-4b58-88e1-d3ade55f9a99">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (benefit) provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNy0xLTEtMS0w_9d46c3a1-1472-46a7-9a34-b8192cfa5f27">89</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNy0zLTEtMS0w_d0c76939-bc60-45df-a05e-c62be3556e33">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfOC0xLTEtMS0w_0535e561-e04f-4c0c-b809-57f9d56f4d3d">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfOC0zLTEtMS0w_0f573602-9b40-4911-81f5-eb953085d7e3">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposition of investment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTAtMS0xLTEtMA_ea081166-f2cc-445a-86ab-fa33629e423d">314</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTAtMy0xLTEtMA_75e5560b-d3b4-4ebe-a824-08841c750301">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTEtMS0xLTEtMA_22a27fbe-25e0-4745-8327-487706dab316">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTEtMy0xLTEtMA_2e129075-f8fc-4578-941a-800eb1a20be1">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTMtMS0xLTEtMA_c7c53ee6-c7d5-447d-980e-835c43f160e7">265</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTMtMy0xLTEtMA_3906363c-376a-4ca3-80eb-87a138e220fb">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTQtMS0xLTEtMA_f7ebb71a-e066-4094-8c4a-6bbc28e12e73">199</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTQtMy0xLTEtMA_49befeb8-9b1f-4d12-ba9c-702cd13f2434">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTUtMS0xLTEtMA_9fba7dba-63c7-45aa-adff-99c9e3fce5cb">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTUtMy0xLTEtMA_bc62588a-c02c-473d-9033-820ad1eb0a80">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination of interest rate swap agreements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="dgx:TerminationOfInterestRateSwapAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTYtMS0xLTEtMTgwOA_614ca486-2656-43c3-8d73-266aa653eb88">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="dgx:TerminationOfInterestRateSwapAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTYtMy0xLTEtMTgwNg_27ad8910-d36a-4d9a-8b4c-aa11eab14572">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTctMS0xLTEtMA_664e766f-9a39-42df-801d-bffc2d86fc97">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTctMy0xLTEtMA_8737768b-34ef-4611-9582-a96500b5b3eb">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTgtMS0xLTEtMA_7a34ce59-df9f-4683-bf4c-dfba9510d2ec">1,191</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTgtMy0xLTEtMA_ef4d47bc-4855-4be7-9ffc-aa618eef9605">602</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjEtMS0xLTEtMA_4658db5c-57d5-4d4e-85b0-3defe1b2778c">231</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjEtMy0xLTEtMA_a1de82bb-066a-44e0-a910-59a3df732902">228</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjQtMS0xLTEtMA_6ef36a60-1feb-461a-98a7-2c9c9ecf2637">170</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjQtMy0xLTEtMA_7570436c-f408-4415-a981-b6546241060c">165</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from disposition of investment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjYtMS0xLTEtMzY3Ng_5d69de6c-9804-45af-bd41-193a265b2c12">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjYtMy0xLTEtMzY4MA_556e4077-e1d0-4920-b832-45d6d2d97a99">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in investments and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjYtMS0xLTEtMA_74253d1f-a73e-4da2-8c99-adbcb89e9b3c">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjYtMy0xLTEtMA_a9ce8083-b9a0-49f9-9ff3-c14c8f5177eb">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjctMS0xLTEtMA_e718ce93-ad39-4b95-a721-d81e0f1c6b97">344</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjctMy0xLTEtMA_f73c40b5-fb96-423c-b8a8-edaf0562b7bf">411</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzAtMS0xLTEtMA_93e0e8c1-6790-45de-83d6-3e3ffe438f5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzAtMy0xLTEtMA_84daba70-1318-43b7-b112-b6337b646d11">749</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzEtMS0xLTEtMA_8f2675be-6e9f-4bab-bbd7-7db9e53f4923">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzEtMy0xLTEtMA_901dc5ef-d69a-4d6b-bd0d-36c09847b4f2">1,001</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzItMS0xLTEtMA_afecf1d5-279a-46e9-b656-8eb27e7c6d4d">1,910</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzItMy0xLTEtMA_0b9d7657-e6a4-4b3d-8be9-c5b9cb7dc5ef">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzMtMS0xLTEtMA_d6525ba6-4de8-452b-9538-6fb4dbac00f3">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzMtMy0xLTEtMA_b631664e-b21a-4ecc-93b7-ceb5f3f65ebd">117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzQtMS0xLTEtMA_c81265ff-e158-4cee-9efb-c67d7594b87b">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzQtMy0xLTEtMA_e61813ed-08c0-45e0-8caf-4131c8029190">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzUtMS0xLTEtMA_e67515a4-f178-4987-9c48-0cab353e22e8">156</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzUtMy0xLTEtMA_b6bc443e-313e-4102-bd49-8eceb44372d6">146</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzYtMS0xLTEtMA_e0919b8d-c9a7-4899-8624-b9995559618d">53</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzYtMy0xLTEtMA_b5ce6ba4-64ee-45a5-8251-4186ca489bd3">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzktMS0xLTEtMA_0d27a50f-740e-45d9-ad93-2193f54758ab">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzktMy0xLTEtMA_458f2d8d-2827-420b-a2fc-0dcb76289645">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDAtMS0xLTEtMA_e0091a23-4dfa-46bf-ba5c-51419d219d08">2,133</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDAtMy0xLTEtMA_60de0676-98ce-446f-92a0-192db6c216a4">395</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDItMS0xLTEtMA_05c21d62-8dee-4e2b-8b59-5072974802ab">598</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDItMy0xLTEtMA_fcbf9935-f3ad-4512-a8e2-638df75bd445">204</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDQtMS0xLTEtMA_ba1d86c3-c8de-4e78-9ff8-60792259dde3">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f1009ff18c488b8726927338c269af_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDQtMy0xLTEtMA_a5160884-b24f-4f6d-8643-f218e6a27a60">1,192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDUtMS0xLTEtMA_8d4926ee-4862-4927-94c5-575f8028ca6b">560</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74ca347035d47afab9af2863189a9af_I20200630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDUtMy0xLTEtMA_a25a9cea-eaa3-406d-b10d-7ef2c5f34f98">988</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND SIX MONTHS ENDED JUNE&#160;30, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie409db7692b2496c84592ac0ae13ab4b_I20210331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xLTEtMS0w_9a59f597-8dd0-44c9-ae51-4ccb638c5877">131</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie409db7692b2496c84592ac0ae13ab4b_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0zLTEtMS0w_81e9cce0-c0fe-4ef4-ad80-11b5a217e934">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cdf70fc1e32411f987859d4ba3a4b93_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi01LTEtMS0w_00393dd5-c44a-4634-ba38-d3b2379d77d3">2,824</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1234b393ecf446beb2d12b0db437882a_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi03LTEtMS0w_68967a52-e4f0-4af6-9dfa-ea98ae51338c">9,690</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95131b6d75e44a49bc1fac55189ad1cc_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi05LTEtMS0w_2b89ab74-0534-4d91-9e2c-fdbcbb08bc0a">31</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d562072f0674b3ab9fbfd9437b9b623_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xMS0xLTEtMA_ff46f18c-faec-48d7-94bb-dc9c3a900c5f">5,740</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3f0b2f6f90d4e56a9e0c7eafef2d828_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xMy0xLTEtMA_61a7e193-d851-4c7e-a822-4a201eb26b96">45</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d95e47035740e2be82b0b81c67afed_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xNS0xLTEtMA_f51eecd0-005f-4cd7-a8da-139a051069c3">6,790</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d95e47035740e2be82b0b81c67afed_I20210331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xOC0xLTEtMA_00ef9f5c-257b-4b08-b671-4bb3fc852527">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c0ed67c1eb40078423e9d062bb487f_D20210401-20210630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMy03LTEtMS0w_ccc10ab3-905e-47d2-b41a-81bee0faa632">631</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f8251b106654d1c98108056fb012db9_D20210401-20210630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMy0xMy0xLTEtMA_4689bdda-8587-42a9-b01c-94edf41a214a">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMy0xNS0xLTEtMA_a27869fa-b744-42fe-8a36-c0f30af949a7">648</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMy0xOC0xLTEtMA_43276ac8-72c1-49fb-b275-91f0c8c7039b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfd6ba29f4e1492491f91836654d629f_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNC05LTEtMS0w_7958637f-a90b-40f1-8d58-f7b554983455">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNC0xNS0xLTEtMA_cf90bd8d-61fe-47e3-88cb-41155f8542aa">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0c0ed67c1eb40078423e9d062bb487f_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNS03LTEtMS0w_9f4c638c-012c-4958-ab60-eb622a9c5653">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNS0xNS0xLTEtMA_79dce035-2050-4d61-849f-067343fc7a00">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f8251b106654d1c98108056fb012db9_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNi0xMy0xLTEtMA_35c92bbc-d68a-4a82-b6d2-20dadb32fc39">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNi0xNS0xLTEtMA_7ad4dccd-6d92-41c8-983c-2ef373a04705">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNi0xOC0xLTEtMA_1f8a8833-c6e3-4ed1-8a7c-a7aa4eff37f0">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNy01LTEtMS0w_fc669419-b829-48a2-aad0-92c23c06978b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc874b9d0dd40489c1a7dcf6860f5a0_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNy0xMS0xLTEtMA_783ad149-e31a-4fd2-bf2e-940e0415cca8">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNy0xNS0xLTEtMA_24a5e42a-4536-462d-8599-9ed30a25e1cf">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOC01LTEtMS0w_d2be3940-1b48-478f-9eda-8e2b6ff1bc30">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOC0xNS0xLTEtMA_48a1b146-64fd-412e-b9d2-779f9131fc3f">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOS01LTEtMS0w_20f43ad1-60fa-4481-8105-e78d29d92185">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc874b9d0dd40489c1a7dcf6860f5a0_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOS0xMS0xLTEtMA_31310a35-7b27-4b81-89a2-5889749c40f0">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOS0xNS0xLTEtMA_9a15b0ab-69a7-4606-bb92-524294fa67a0">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTAtNS0xLTEtMA_a862eabe-293f-42e1-831d-30d6b5c461f9">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTAtMTUtMS0xLTA_cf024910-a1bc-44cb-8503-d66cb9e04434">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9214e898766d4e348c518cc861e2a6d6_D20210401-20210630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTEtMS0xLTEtMA_ee58d2e1-5235-4373-b902-b3098c278fdd">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTEtNS0xLTEtMzkwMQ_ce5a746d-733b-404b-ae2e-9d838bf5144a">300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefc874b9d0dd40489c1a7dcf6860f5a0_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTEtMTEtMS0xLTA_9344654a-cfc7-4a67-98b7-db0abe292241">1,200</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTEtMTUtMS0xLTA_30290390-ae24-4e87-8fe1-a2b1c04cba91">1,500</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idadbab3594fd43348d9b825585c50f1e_I20210630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMS0xLTEtMA_7ecfef95-7caf-46e1-9759-853890e9b450">122</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadbab3594fd43348d9b825585c50f1e_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMy0xLTEtMA_fe26e38a-15ad-4223-aa17-4bc5441d65e6">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c07c80b26c24ce38628b41e10b0357e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItNS0xLTEtMA_2fa154b2-7568-4f71-8721-94797213bc38">2,555</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe18efd7ba104ac9a5aa32571d8c6166_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItNy0xLTEtMA_2c6e6084-8165-4cc2-b632-8371083a4d76">10,246</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i562a2de976ae4600bcfccf456de6283f_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItOS0xLTEtMA_d189cbeb-0e73-47cd-a4d9-5aee61ea2576">10</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71c62f68e0b7484397a15c914fab24bc_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMTEtMS0xLTA_5d617cf0-c3eb-4397-b91d-88230819a113">6,894</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4a7dcc35654302bd8e48f6068259be_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMTMtMS0xLTA_9e117fb7-df28-475d-bde9-bf448b8edd18">41</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMTUtMS0xLTA_6be51167-423f-4ac7-9689-3ccc2d802846">5,940</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMTgtMS0xLTA_70b70375-e86a-41f7-b566-e94552713e30">78</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if708b3a322c142a896b74f2674affc33_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMS0xLTEtMTE4_aa29e3cf-0932-4d01-9baa-92070c4aabe1">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if708b3a322c142a896b74f2674affc33_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMy0xLTEtMTIx_55ebbfa3-7a35-4f7d-89d9-2ed66bad0bb0">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0848c719bfa64a6997b49547abca2d7c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtNS0xLTEtMTI0_64ab6abd-3328-4539-a255-82f1c32bbc12">2,841</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a1846b30804708b76daaf8e7313d54_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtNy0xLTEtMTI3_43a9267f-f0e9-46e7-9fdf-107747cf6d0c">9,303</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i926d05e6d1164bceb1d1e6ee02daa1c8_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtOS0xLTEtMTMx_9739aa70-0f50-4534-bd26-6f0a417ee773">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5b79ec0ef2348fdae4dc4f7e23a8c61_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMTEtMS0xLTEzNA_8cbd012d-a048-4fe5-a0cd-23e081e0d8cb">5,366</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2775145b5b44ba595f9fd2c6019fffa_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMTMtMS0xLTEzNw_49db37a4-ad9f-42e1-bdcc-4a4d58aff799">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMTUtMS0xLTA_5c3af7cb-5374-40ba-b705-e343e54452b5">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMTgtMS0xLTE0MA_d6624923-6fd6-4c06-b728-d7f95af05b8b">82</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127f391cad8f454e934f06617f28068b_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTctNy0xLTEtMA_30e0c9bf-b8a5-44b7-8dba-333521b8f5c5">1,100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab17e5ada04d4e3f8418321f4fed5170_D20210101-20210630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTctMTMtMS0xLTA_1248dd70-81cb-4636-b4c1-285c8339fe13">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTctMTUtMS0xLTA_aff36f45-b119-45c3-a1ea-08ec153df45e">1,134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTctMTgtMS0xLTA_c329f1cc-d31a-4fc5-b90e-778d569fbfc3">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e6e7f9cf924fcfba4006108d77d2d7_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTgtOS0xLTEtMA_ad08ea95-e7f5-426e-b848-e48fdbb91457">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTgtMTUtMS0xLTA_dc50c8e0-6aaf-478b-b966-b199fd071ed9">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127f391cad8f454e934f06617f28068b_D20210101-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTktNy0xLTEtMA_42b27a2f-0f65-48d1-9412-cb4157a5f228">157</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTktMTUtMS0xLTA_801a3bba-6772-426e-a064-2378c1fb2ea3">157</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab17e5ada04d4e3f8418321f4fed5170_D20210101-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjAtMTMtMS0xLTA_93bde61d-64ad-42ba-ab3f-2d15042ba63d">43</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjAtMTUtMS0xLTA_cc85da1e-41fa-41bf-a20f-12f03d47c044">43</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjAtMTgtMS0xLTA_edc51626-43cd-4e2d-a034-718144046c0a">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjEtNS0xLTEtMA_de05cad7-6540-4341-b48e-963f658b1bd2">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjEtMTEtMS0xLTA_10b89308-8f63-4c28-966f-5a69c8c3feea">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjEtMTUtMS0xLTA_db060163-d2b4-4a9a-adb5-3b602fa11d52">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjItNS0xLTEtMA_8379d958-b9db-4bf3-bf38-67e1f31a1833">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjItMTUtMS0xLTA_1946d161-28d3-475e-a10b-f39e7e0b5374">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i120d2d9a75ae49a78ce64d7e98309352_D20210101-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjMtMS0xLTEtMA_35d11b05-4a00-4289-9948-b422726a3b28">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjMtNS0xLTEtMA_3080b4ef-c7d8-4b69-8b1d-cd2a0a102e06">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjMtMTEtMS0xLTA_7ba38fb0-595f-4668-b886-a9a9e71ce749">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjMtMTUtMS0xLTA_af2d2180-7297-4ed3-b71d-ba8f749a10e6">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjQtNS0xLTEtMA_3db35d1c-2b04-4620-925c-a09277866658">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjQtMTEtMS0xLTM5OTk_336ee658-f01b-4588-95eb-249c5a0aaa8c">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjQtMTUtMS0xLTA_dabdf271-b08e-420e-a3c7-43bfd1b420b8">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i120d2d9a75ae49a78ce64d7e98309352_D20210101-20210630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjUtMS0xLTEtMA_294fd0a4-66fb-408f-91f5-78f0e379449c">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjUtNS0xLTEtMzg4Nw_10f046b4-287d-4654-b10c-46a1eda26e09">300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjUtMTEtMS0xLTA_8cec6b95-3609-4697-a17f-11ca49980fa0">1,610</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjUtMTUtMS0xLTA_2dabe043-9ff6-4814-bcc4-67807c6bf9d3">1,910</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idadbab3594fd43348d9b825585c50f1e_I20210630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMS0xLTEtMA_e8a8419c-e0f1-484b-b100-d48d5e89ba2b">122</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadbab3594fd43348d9b825585c50f1e_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMy0xLTEtMA_60b0f660-47ba-4ae0-93a7-398ee1b9d122">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c07c80b26c24ce38628b41e10b0357e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtNS0xLTEtMA_c7ecf512-c50b-45cd-a8ae-a25e2d8dd86c">2,555</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe18efd7ba104ac9a5aa32571d8c6166_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtNy0xLTEtMA_1defe77c-620c-4823-b4df-03cae7b9b99e">10,246</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i562a2de976ae4600bcfccf456de6283f_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtOS0xLTEtMA_0d0f4f55-96b5-4e3c-a5cd-631a405a6836">10</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71c62f68e0b7484397a15c914fab24bc_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMTEtMS0xLTA_1bd40254-b343-4494-a740-8a2cb0faed31">6,894</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4a7dcc35654302bd8e48f6068259be_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMTMtMS0xLTA_cb0516b3-6547-4426-9acc-84abf906cd09">41</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMTUtMS0xLTA_c1b305fd-02b1-4897-827f-37abd3393364">5,940</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMTgtMS0xLTA_7dec7f28-7060-4f80-8349-0b474056414e">78</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.025%"><tr><td style="width:1.0%"></td><td style="width:28.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND SIX MONTHS ENDED JUNE&#160;30, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2d14897dec64b1f93d805966f667a67_I20200331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xLTEtMS0w_aa711460-39fc-4002-ae65-0bd6095037ca">134</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2d14897dec64b1f93d805966f667a67_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0zLTEtMS0w_04617174-e25e-4431-bf41-2cb7e6bca0b6">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c64b417754a41bf9cb5d032e7c7f1d2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi01LTEtMS0w_c4f0dfa2-6c27-4281-817c-38ebcf68b7cf">2,738</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i292f044a2a694be987cf1e050fc32158_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi03LTEtMS0w_9b18e19c-b0b3-4165-acc6-270247fbd73f">8,197</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe0f2af904df4308974d0cfadbf6c95f_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi05LTEtMS0w_2281ee99-db25-4c21-ad03-ecf8280fc72f">58</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f22713e20cc4bba8a7d9e37885165ac_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xMS0xLTEtMA_d783c31e-f4a6-4993-bcd1-1a89a4c8f458">5,222</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0cdf7d6ee7c436a9d9d7ab4fe709a5e_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xMy0xLTEtMA_24dad66b-3926-4e3a-96c9-62ea7d8b1777">46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida27930c41dd4f5a9e90d48ebfc0c9c4_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xNS0xLTEtMA_6caf3637-163b-408d-8dab-4fadfb7d57b4">5,703</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida27930c41dd4f5a9e90d48ebfc0c9c4_I20200331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xOC0xLTEtMA_66187ecf-f442-469c-a44a-84b48fc6487c">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f21b83c03584dc6924263f55d606a78_D20200401-20200630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMy03LTEtMS0w_3d4455a3-d52e-436e-918b-2b9e914b35ee">185</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic29fec842eda4d01b395c9c45167a267_D20200401-20200630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMy0xMy0xLTEtMA_fb7975bb-7566-49fe-9c05-02033ad70c5f">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMy0xNS0xLTEtMA_8a400c0b-0278-46cf-8a69-fe67cf68fa8b">192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMy0xOC0xLTEtMA_07e569f9-08a5-498b-a206-1fa3f4f3f238">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46a16fab53a4ae68476a2fb7593280f_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNC05LTEtMS0w_fb92577e-8217-4795-bec6-24230b5223c4">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNC0xNS0xLTEtMA_19a1caa3-0fa2-40d5-8d13-ca89149db327">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f21b83c03584dc6924263f55d606a78_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNS03LTEtMS0w_6f828269-a434-4a78-9e70-898f36938c77">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNS0xNS0xLTEtMA_277c46c8-8360-41eb-80db-fc95017dddd4">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic29fec842eda4d01b395c9c45167a267_D20200401-20200630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNi0xMy0xLTEtMA_1ed118a6-636d-4ca3-82a2-b70f5cfe53a7">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNi0xNS0xLTEtMA_1dc5e8b7-95bc-493d-8429-4aaa1adfd261">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if819fd1fb51043378a435a56ad7b4b3c_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNy01LTEtMS0w_dbc4403b-11e4-4d83-877d-6f7d0430e0f0">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2f9ac74121f49239c7f3983ae7bae36_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNy0xMS0xLTEtMA_40337f01-cb5b-44de-8f86-2e0e8b0da7ba">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNy0xNS0xLTEtMA_0b5273a9-0da9-4c56-96db-d513bf51776f">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if819fd1fb51043378a435a56ad7b4b3c_D20200401-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOC01LTEtMS0w_805543f5-2b84-4886-a2f0-cb88fd1ac6b3">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOC0xNS0xLTEtMA_31a4dad0-5131-423b-8d01-eabdbc3ef8d5">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if819fd1fb51043378a435a56ad7b4b3c_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOS01LTEtMS0w_cc6c32e8-2540-42c2-8a93-72a6a04a6bd0">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2f9ac74121f49239c7f3983ae7bae36_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOS0xMS0xLTEtMA_10b83915-63ad-47a2-8bab-f93870814258">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOS0xNS0xLTEtMA_8659d49d-c50b-40dd-a1e1-22c4676d34a5">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMS0xLTEtMA_5be198f0-f918-401a-95ea-2c86a1d27f39">134</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMy0xLTEtMA_9dfca37d-488c-479d-a6fd-eae5f59a1651">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e4e7a78200d43478e75bd5cdd2d9c12_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItNS0xLTEtMA_20d2c764-0ab6-4e3a-bacc-b706f977dec7">2,764</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic61245d5d6bf4ec6ac96d7e5d11d0de6_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItNy0xLTEtMA_5e461e65-ecf0-42f1-bb43-1410164e25c3">8,307</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74a92cff8b5f4b7585d55a6b13176562_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItOS0xLTEtMA_3dfb3a29-b654-4ff6-b890-6e6a2c9f3409">55</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26783a3b7dd249be9c28f89f9ffb93c8_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMTEtMS0xLTA_01751891-5e3b-413d-a633-8bfa209f979c">5,187</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6f8598006da47daaf4f264d1f79a720_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMTMtMS0xLTA_c78368af-ab4d-4789-a3bd-8beb6879c636">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74ca347035d47afab9af2863189a9af_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMTUtMS0xLTA_4c3c248b-0cee-4865-ab2b-2f22a79028be">5,881</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74ca347035d47afab9af2863189a9af_I20200630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMTgtMS0xLTA_78d66a33-46ee-4290-b950-b03676b7daf8">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fa0525d2dc0497f928c8d6ab3456eb5_I20191231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMS0xLTEtMA_5ec9fd8e-33a6-4b71-b468-9ecc1d574b36">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa0525d2dc0497f928c8d6ab3456eb5_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMy0xLTEtMA_3fd256ca-dcb8-4afa-9562-340481c82612">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e56b1b204974d05a0f5e2c43eea7cbd_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtNS0xLTEtMA_d719b3d1-8973-41ad-a195-1898ae1ed945">2,722</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i546e403b15214524b8519bba76c4d0da_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtNy0xLTEtMA_91666225-62c9-4f7f-a1d0-ba0cf3640095">8,174</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d014e770945452f897511320c1c2b70_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtOS0xLTEtMA_520930dd-e27e-4c44-b5e8-4e5a76eefff1">39</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d38a260d94c443d8eea143672b2cd72_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMTEtMS0xLTA_85d0fbd8-4be5-4695-81c1-7a596cf7af66">5,218</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50aeb63e5efe48d99c044cfb52e07b48_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMTMtMS0xLTA_86c50a7b-c240-44df-ba5c-6fc963975a72">46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f1009ff18c488b8726927338c269af_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMTUtMS0xLTA_004b1a31-66c0-4000-a380-5c51d3a59433">5,687</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f1009ff18c488b8726927338c269af_I20191231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMTgtMS0xLTA_71518a51-7963-4104-b873-01f9bb425b31">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df3ecb6e73749a49030a463355f0fba_D20200101-20200630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTctNy0xLTEtMA_5b50b1b8-d760-4ef5-bdd7-48ff51f74027">284</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7500943b3564489290004ac65ed7fccf_D20200101-20200630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTctMTMtMS0xLTA_68da65cb-6887-4274-ac92-12dd8dcba427">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTctMTUtMS0xLTA_ca13e325-bfbb-4248-9036-77ca9e0da19b">297</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTctMTgtMS0xLTA_65a85509-4257-4441-98d5-00687d686990">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cc55a2801094ec0bc9f846effac87da_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTgtOS0xLTEtMA_a03fd4fc-9692-4429-aeea-6c2c6b696efe">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTgtMTUtMS0xLTA_ebd3999b-78a2-46a4-99b0-b1a3513910f7">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6df3ecb6e73749a49030a463355f0fba_D20200101-20200630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTktNy0xLTEtMA_d2588ad6-14cf-4c10-a63c-3e81310c1847">151</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTktMTUtMS0xLTA_b727faae-7f86-49ee-8f56-c318cff7ab9f">151</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7500943b3564489290004ac65ed7fccf_D20200101-20200630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjAtMTMtMS0xLTA_9e645ad3-5e0f-4133-9771-38fca1e40fcb">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjAtMTUtMS0xLTA_adf680bf-aaef-4963-96d8-d25d51fdbbf4">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjAtMTgtMS0xLTA_7bf84ecb-364d-4cc1-9d30-a3ed23c54bea">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjEtNS0xLTEtMA_7dfb8627-ba42-4969-967d-df75f492c067">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjEtMTEtMS0xLTA_27080d96-907c-42df-8687-a170ad3e5e3e">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjEtMTUtMS0xLTA_29070776-9a09-4c30-84e5-98a09a9fafbb">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjItNS0xLTEtMA_450f0343-5068-48b4-be91-98fc145180dc">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjItMTUtMS0xLTA_1ac1251c-e215-4b2c-8c52-38d063c5f999">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62149b0b25564ab180137047be530824_D20200101-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjMtMS0xLTEtMA_2fb5b9bf-30a5-4712-ae28-e7ab2176b58d">2</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjMtNS0xLTEtMA_00496f94-7a19-457b-a426-bb15fbf714e9">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjMtMTEtMS0xLTA_3dfbda7b-e6e8-4ddd-b105-672f110c74c1">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjMtMTUtMS0xLTA_be9b67ef-86e3-418e-91c8-d40b8bf0d107">117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjQtNS0xLTEtMA_ab00ff95-eb06-46e6-b429-286b79275f81">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjQtMTUtMS0xLTA_0e6b41ee-da2f-48cd-a7f1-fcf4b1c7a50e">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i62149b0b25564ab180137047be530824_D20200101-20200630" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjUtMS0xLTEtMA_3411cf7f-2e12-4f59-87b6-8da97997317f">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjUtMTEtMS0xLTA_b54896e9-6a6b-4154-8ab5-46f2abc160b3">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjUtMTUtMS0xLTA_fd51fa5c-bb1d-424e-a0ea-ce50497377bb">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMS0xLTEtMA_5ce77a33-bc70-45cb-ae4c-d4c0fb9277a2">134</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMy0xLTEtMA_abb9f7ca-6d74-4540-8e78-9768999712c8">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e4e7a78200d43478e75bd5cdd2d9c12_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtNS0xLTEtMA_6529aece-95fa-404a-864c-6efa5e84f8a1">2,764</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic61245d5d6bf4ec6ac96d7e5d11d0de6_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtNy0xLTEtMA_b57246a3-9e73-4ddc-b743-7bfbf1814888">8,307</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74a92cff8b5f4b7585d55a6b13176562_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtOS0xLTEtMA_33fab46e-321a-4e57-9dd9-8212f472ec38">55</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26783a3b7dd249be9c28f89f9ffb93c8_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMTEtMS0xLTA_5ec7814d-ac98-428f-a657-f3219d5362d7">5,187</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6f8598006da47daaf4f264d1f79a720_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMTMtMS0xLTA_4989b749-e98f-4c98-895b-bbb4f927bc5a">50</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74ca347035d47afab9af2863189a9af_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMTUtMS0xLTA_b33e138a-1be9-4318-a52c-20c6950468c0">5,881</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74ca347035d47afab9af2863189a9af_I20200630" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMTgtMS0xLTA_5a54150d-374c-4b4c-a3d2-fc6e7059dc3e">77</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_28"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zMS9mcmFnOmZiNmQ0NmMzNGE3NzQwNzlhOWE5ZmMxMWI4NGQ1ZDBjL3RleHRyZWdpb246ZmI2ZDQ2YzM0YTc3NDA3OWE5YTlmYzExYjg0ZDVkMGNfMTY5OQ_442cb7b6-20c8-4db4-900d-921e1b32c428" continuedAt="i1ce8bfcad0d44a70a51c8024a4cf2b57" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i1ce8bfcad0d44a70a51c8024a4cf2b57" continuedAt="ibb616447fef24b82acd5a25f5a207286"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibb616447fef24b82acd5a25f5a207286">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI3NQ_bb3b9bd2-f2d4-48eb-9277-05762c2c0e6f" continuedAt="i41f132278bd542cc9b23cff2e8dee9c0" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div style="text-indent:29.25pt"><span><br/></span></div><ix:continuation id="i41f132278bd542cc9b23cff2e8dee9c0" continuedAt="i05985c791d454aacb9784fe67a7e3f38"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI4Ng_af2a153e-e6ab-48db-bdaf-7b0e9bfd45d0" escape="true">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#8220;COVID-19&#8221;) continues to impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three and six months ended June&#160;30, 2021 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI2Ng_1be41e31-e021-4acb-91be-2d01cdc29f40" escape="true">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI4Mg_3d668b8b-5498-4f03-9cfc-92edff2d0e0c" continuedAt="i9da5e58c778b40699e49c2e68295202d" escape="true">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i05985c791d454aacb9784fe67a7e3f38"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9da5e58c778b40699e49c2e68295202d">common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI4NA_d793f3e1-39e2-4967-a1d7-aec4ebb21999" escape="true">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RleHRyZWdpb246ZWU2OWFkMDA2OWFmNDE5NjhmZWZmODQ5NGYyNTQwZTVfMjk1_c6d826cb-4b5a-461d-a6b3-24dc5e56b53c" continuedAt="i8e5294d1033a40678c5183051825b22f" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8e5294d1033a40678c5183051825b22f" continuedAt="i9e9bd4d3653449e98c419d7d363da395"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RleHRyZWdpb246ZWU2OWFkMDA2OWFmNDE5NjhmZWZmODQ5NGYyNTQwZTVfMzAx_98ae7bde-5787-4cd6-9347-1dfa48323c80" continuedAt="i2e74884a5deb4017a74ff4387422f347" escape="true">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i2e74884a5deb4017a74ff4387422f347"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfNy0xLTEtMS0w_bac1ef35-4eee-4306-877b-f895c69a44d3">631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfNy0zLTEtMS0w_8f7adcbf-7b93-42e2-8485-64f966fbe6c5">185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfNy01LTEtMS0w_3bd8ae88-585d-4823-88ff-d1c863d1477b">1,100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfNy03LTEtMS0w_1bc497c8-89b3-4c4f-aa5b-43a9ab95cdfd">284</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOC0xLTEtMS0w_7d57ad91-602d-49c9-bbda-7eb1812a45a2">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOC0zLTEtMS0w_a25c747b-c7cd-4021-a984-c424eaee7607">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOC01LTEtMS0w_ce8bb739-ee64-46fb-8a2c-f9578c65ae84">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOC03LTEtMS0w_405a3d90-ec8f-4ee7-9b0f-b46b31676062">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOS0xLTEtMS0w_b07b24e4-6862-4b46-a8e2-e12eddd7c52a">628</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOS0zLTEtMS0w_3ce586f9-0a20-4d8a-aca9-113eb0294f6e">184</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOS01LTEtMS0w_0497162a-ea3e-44b5-a021-569ce85eab0e">1,096</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOS03LTEtMS0w_581675dc-1b1b-4191-b742-8daf29b328dd">283</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTEtMS0xLTEtMA_e59068b8-f6e4-4557-83f9-dcd46e65a6d6">125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTEtMy0xLTEtMA_2571cb85-722a-42f3-b2c6-b7a9010dc47a">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTEtNS0xLTEtMA_414dbc7d-8aed-4768-976d-580e985cbf31">129</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTEtNy0xLTEtMA_1db536a0-0eb0-4d01-8549-dd6636661f52">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTMtMS0xLTEtMA_9c487cb6-8610-468a-9ee7-555a6342830a">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTMtMy0xLTEtMA_fd2825cb-3716-429a-8520-e7c8f21e57a5">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTMtNS0xLTEtMA_a1caa044-d76e-4c1b-ab62-5919ffe9e137">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTMtNy0xLTEtMA_2ef4dc0c-2225-4e1c-9b3d-f12b929f211d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTQtMS0xLTEtMA_3addd579-c31f-4d02-a00d-bb5350c80b3d">127</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTQtMy0xLTEtMA_f5026ffd-8425-4838-a8b4-af969b048430">136</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTQtNS0xLTEtMA_6415670a-df5d-4f03-ad19-f6a3cdf1831c">131</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTQtNy0xLTEtMA_e08a7b44-ca28-455e-89f1-d125fe0b0980">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTctMS0xLTEtMA_6e9086ac-19f2-46e5-9376-b6c931b67def">5.05</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTctMy0xLTEtMA_37ac15aa-3347-40f4-9dce-716aabde4edb">1.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTctNS0xLTEtMA_e056e47b-8f48-48b4-adc3-5d635457a335">8.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTctNy0xLTEtMA_2c2df394-d513-430d-b7fa-1db41880b5bf">2.12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMjItMS0xLTEtMA_ea240ddb-67f7-4ff4-b8f6-04eae1f9bf98">4.96</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMjItMy0xLTEtMA_56fb31a3-7395-41f8-8937-ed750fb254ac">1.36</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMjItNS0xLTEtMA_69e810ad-532e-412b-bd77-a0d9c1b8553d">8.38</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMjItNy0xLTEtMA_0c2958a7-0cdd-4fcd-8033-9b9482a8301f">2.09</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RleHRyZWdpb246ZWU2OWFkMDA2OWFmNDE5NjhmZWZmODQ5NGYyNTQwZTVfMjkx_d171ffc5-1bd2-4308-a860-c07d7d0d51bf" continuedAt="i5c230eb173654fb1b0a94812f78c7a39" escape="true">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i5c230eb173654fb1b0a94812f78c7a39"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmI5ZjMxNThjN2UwNjRjNWQ4ZGY0N2I5YWJjOWY2MWY4L3RhYmxlcmFuZ2U6YjlmMzE1OGM3ZTA2NGM1ZDhkZjQ3YjlhYmM5ZjYxZjhfMi0xLTEtMS0w_d2cf3dd1-90b4-4cd6-b15f-12eec6df9681">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmI5ZjMxNThjN2UwNjRjNWQ4ZGY0N2I5YWJjOWY2MWY4L3RhYmxlcmFuZ2U6YjlmMzE1OGM3ZTA2NGM1ZDhkZjQ3YjlhYmM5ZjYxZjhfMi0zLTEtMS0w_797feedf-ed36-45a5-bb5d-583fb66fa266">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmI5ZjMxNThjN2UwNjRjNWQ4ZGY0N2I5YWJjOWY2MWY4L3RhYmxlcmFuZ2U6YjlmMzE1OGM3ZTA2NGM1ZDhkZjQ3YjlhYmM5ZjYxZjhfMi01LTEtMS0w_5b4292c8-e2c3-4256-b68a-7bdf2063b141">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmI5ZjMxNThjN2UwNjRjNWQ4ZGY0N2I5YWJjOWY2MWY4L3RhYmxlcmFuZ2U6YjlmMzE1OGM3ZTA2NGM1ZDhkZjQ3YjlhYmM5ZjYxZjhfMi03LTEtMS0w_28873f78-67c1-43cb-b59f-a6b87ae95179">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9e9bd4d3653449e98c419d7d363da395"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $<ix:nonFraction unitRef="usd" contextRef="i533de8c040f5497f94c63d60c5e38efa_D20210401-20210430" decimals="-8" format="ixt:numdotdecimal" name="dgx:AcceleratedShareRepurchasesInitialPricePaid" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RleHRyZWdpb246ZWU2OWFkMDA2OWFmNDE5NjhmZWZmODQ5NGYyNTQwZTVfNDk0NzgwMjMyNTc1Mg_aabed288-d76c-47cb-be99-af3a0b89a94c">1.5</ix:nonFraction>&#160;billion of the Company's common stock as part of the Company's share repurchase program.  See Note 9 for further details.  The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first two quarters of 2021 did not equal the total for the six months ended June 30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of the ASRs.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfNTE5_c160c080-5a41-45cb-b12c-7550d3070e3d" continuedAt="i10154537f0f544aea42ab0c6fde68e4b" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i10154537f0f544aea42ab0c6fde68e4b" continuedAt="i959498b314e94b9ca674d41e6e4f39a5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i32ceb997147b42ebafa6e46d4f452d31_D20210601-20210601" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTc1NA_bd6bd55d-452a-4a3c-9f16-33cb3a6373db">225</ix:nonFraction>&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $<ix:nonFraction unitRef="usd" contextRef="iede8a4b7d31f4a908594d37d2d356dce_I20210601" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTc0MQ_7cca1f65-d295-49a7-ad47-39c68face5f5">54</ix:nonFraction>&#160;million of customer-related intangible assets and $<ix:nonFraction unitRef="usd" contextRef="ic80123e8686446ea809da2ddaa1ffaea_I20210601" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTcyNw_3b7b00c0-e36c-472e-b98f-dca03c8d88b4"><ix:nonFraction unitRef="usd" contextRef="ic80123e8686446ea809da2ddaa1ffaea_I20210601" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTcyNw_7773d110-6cce-4c8a-843a-a3d0c3f83b48">171</ix:nonFraction></ix:nonFraction>&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of <ix:nonNumeric contextRef="i18670a49a70d49f8aeb8c2046b450952_D20210601-20210601" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTcxMg_59cb3314-4877-4edd-bb03-a16e0a2fbb35">15</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i959498b314e94b9ca674d41e6e4f39a5">&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfODA0_660f54e7-67f0-41ba-a4c1-f3a6c53ba076" continuedAt="i42b4306f43fe4bfea00d021f863acdd2" escape="true">DISPOSITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i42b4306f43fe4bfea00d021f863acdd2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its <ix:nonFraction unitRef="number" contextRef="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNjc_9be9f08b-c0e2-4190-876f-41ea1227c269">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $<ix:nonFraction unitRef="usd" contextRef="ie3af8b0558d7461c9027eaf168d159f3_D20210401-20210401" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfMjUy_b501c5af-c8fe-4c51-a664-7f5cbb4a92f7">760</ix:nonFraction>&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the three months ended June 30, 2021, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMyNjczMA_c1dcc054-2461-45ed-ba62-69f8cf577e31">314</ix:nonFraction>&#160;million pre-tax gain in other income (expense), net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $<ix:nonFraction unitRef="usd" contextRef="ic3be2c0db58246b7ba37ca73d78f5af0_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMzMDEzNw_104c3026-e817-4c06-beb4-40f4dfcd4568">20</ix:nonFraction>&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the three months ended June 30, 2021, the Company also recorded $<ix:nonFraction unitRef="usd" contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMyODM3MA_cb661b76-73ee-4e23-a945-813fdedbb774">55</ix:nonFraction>&#160;million of income tax expense related to the gain, consisting of $<ix:nonFraction unitRef="usd" contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMzMDUwNQ_679bf563-473b-467d-814a-619892509e16">127</ix:nonFraction>&#160;million of current income tax expense, partially offset by $<ix:nonFraction unitRef="usd" contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMzMDQ5Mw_16abbc19-12f6-4d96-abaa-1fb15eb45782">72</ix:nonFraction>&#160;million of deferred income tax benefit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_43"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfNDg0NA_ef579edc-2eb5-4b5d-b880-f01a67e370a6" continuedAt="ie88405d13f684c2a9b69ea83f568ca7c" escape="true">FAIR VALUE MEASUREMENTS  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie88405d13f684c2a9b69ea83f568ca7c" continuedAt="i3e739b5e5baf4b239043d7ff8c35675e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfNDg0Nw_3f010716-f79e-4c52-bd8a-9e3194c4221a" continuedAt="i3fe70decc9a4423a9abc9b387bf97bf0" escape="true">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</ix:nonNumeric></span></div><ix:continuation id="i3fe70decc9a4423a9abc9b387bf97bf0"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNi0xLTEtMS0w_888e9283-3998-4eb6-acda-e3155bf4f5d5">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNi0zLTEtMS0w_11bdc377-4cc2-4bf6-aa72-978eacceb9e7">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNi01LTEtMS0w_b95586e2-0767-47c5-861a-434603dc555b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNi03LTEtMS0w_3f561656-c47d-4272-afc3-30e56bf262dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNy0xLTEtMS0w_6f8846bf-7037-4aef-8a7f-5b10fc0cb048">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNy0zLTEtMS0w_99bc23c9-5562-413d-9c30-13a8e6e2b1d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNy01LTEtMS0w_64f1ba13-4a1f-42f4-aed2-c29bb40ea15f">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNy03LTEtMS0w_954cc373-0659-45fd-be41-f8cb330b8e7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfOS0xLTEtMS0w_0a113f7b-686e-4647-864e-5df0e773c112">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfOS0zLTEtMS0w_a9f10f55-898e-49e0-8bd1-f8f32d6bb168">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfOS01LTEtMS0w_2003ad84-856a-477f-8506-db9242a89439">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfOS03LTEtMS0w_d764caaa-33de-41e2-ae11-5d2650394151">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTItMS0xLTEtMA_7989f8e0-ad6e-4adb-8bf1-46525d0e83d9">131</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTItMy0xLTEtMA_0d6fce71-f9b3-483c-9b84-e8675a63ecf5">75</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTItNS0xLTEtMA_56af5a95-2aa1-4a7e-b332-105448dc5efd">55</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTItNy0xLTEtMA_d3d83b82-bbf8-4201-9503-a02d6bd80329">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTUtMS0xLTEtMA_7318f8d9-8e50-4cd4-a578-2a7ab30bb6e7">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTUtMy0xLTEtMA_cf400cf0-3d4b-430f-8957-1fb85aa4bb2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTUtNS0xLTEtMA_e8efff42-a179-4e26-b2ea-f0ec2369f35f">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTUtNy0xLTEtMA_a3846ba9-0243-4d94-a847-939d408f32d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMjItMS0xLTEtMA_bba55f78-cb94-4fd3-8c32-b38aadafa61e">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMjItMy0xLTEtMA_757a63fc-40e4-4485-b986-2f3343cf8185">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMjItNy0xLTEtMA_4512afa1-35b8-42f0-a8fa-ebea7324095c">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMy0xLTEtMS0w_5b7e9327-0c20-4014-a2df-96d8dc3ea7d5">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib638d54663d141b3b55a392010b4133c_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMy0zLTEtMS0w_81b6fa36-2e62-4257-aa09-4999352500b2">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4153cd4b719540d983239e906877df0e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMy01LTEtMS0w_d7a2476d-c839-456c-8376-740fa56e7b30">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a3f19649844f0b9777994eb7530457_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMy03LTEtMS0w_6f20826e-2854-45a6-aa13-b615d3dee57d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNC0xLTEtMS0w_2980f97f-4808-41c6-bd8e-95f00e76ce7a">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib638d54663d141b3b55a392010b4133c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNC0zLTEtMS0w_3549eb69-55ac-4b8a-8cda-b22b8aee067d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4153cd4b719540d983239e906877df0e_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNC01LTEtMS0w_a0725de5-eff1-43c6-bd4e-4962e5c50aaf">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a3f19649844f0b9777994eb7530457_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNC03LTEtMS0w_05a329f9-6ce6-4d1c-bd38-818df60de18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNS0xLTEtMS0w_e3a5a6fb-268b-425a-aaa4-9018c789edf4">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib638d54663d141b3b55a392010b4133c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNS0zLTEtMS0w_82007153-f09c-4009-a2ff-951f3781542c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4153cd4b719540d983239e906877df0e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNS01LTEtMS0w_f31e76a5-3c92-4c87-92be-de6addb1231f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a3f19649844f0b9777994eb7530457_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNS03LTEtMS0w_21481957-48d4-404a-908f-f5bd902e6c7c">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTAtMS0xLTEtMA_099b87a7-490b-4587-9fb0-58e31733f57c">129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib638d54663d141b3b55a392010b4133c_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTAtMy0xLTEtMA_62e5d214-873a-44ba-8032-820111cf84ad">67</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4153cd4b719540d983239e906877df0e_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTAtNS0xLTEtMA_6e04feee-2c8d-4f2b-86b3-358644deb6cd">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a3f19649844f0b9777994eb7530457_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTAtNy0xLTEtMA_03570f07-737d-4efe-acc2-5a19a15d32bc">12</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTMtMS0xLTEtMA_646e722e-5d97-4c92-9475-0811fe1851df">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib638d54663d141b3b55a392010b4133c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTMtMy0xLTEtMA_1e8cf0dd-7bf1-4b0f-abad-2d271a86bc8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4153cd4b719540d983239e906877df0e_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTMtNS0xLTEtMA_040d5cb6-8c6e-484f-8c80-2433618777a1">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a3f19649844f0b9777994eb7530457_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTMtNy0xLTEtMA_d8f97bab-81b8-4623-a4b5-aa176d60844f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMjEtMS0xLTEtMA_ca43cdbd-7e43-4541-bead-82ea97524c65">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib638d54663d141b3b55a392010b4133c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMjEtMy0xLTEtMA_14e3e63b-73b4-4343-8516-6937daae41ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a3f19649844f0b9777994eb7530457_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMjEtNy0xLTEtMA_196dce9f-77d7-4821-99fa-e4167cdbef9d">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed investment options that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div></ix:continuation><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i3e739b5e5baf4b239043d7ff8c35675e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="idbe6cc9023dd4f6b925f3e4b803adba0_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfMjk2MA_42b8a66f-c3fe-4efc-a6a1-022af6180347">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of June&#160;30, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the six months ended June&#160;30, 2021, the Company recorded an $<ix:nonFraction unitRef="usd" contextRef="icfcc6d7cb7ac4f62b3b2a88f27e08e14_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfMzcyOQ_ed3d0710-f0a3-44c6-af1a-cd953c6705b6">8</ix:nonFraction>&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of June&#160;30, 2021 and December&#160;31, 2020, the fair value of the Company&#8217;s debt was estimated at $<ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfNDQ3NQ_a90bb97f-d679-4114-a53e-1779b9feaa09">4.5</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfNDQ4Mg_375a8ef1-c189-47ed-aa10-48b3e8d37719">4.6</ix:nonFraction> billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfMTEwNw_f511f074-923b-4daa-ae7e-9db9b8e22f33" continuedAt="i3d4508537fb843718cf7eab841d2aa8c" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3d4508537fb843718cf7eab841d2aa8c" continuedAt="i4e77bebcfc8149c1b924dbae80610709"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfMTA5OQ_37ce0fbd-d4f6-4664-ac37-217ba062ee7c" continuedAt="i0009326240ae48e397d8cd4601fad719" escape="true">The changes in goodwill for the six months ended June&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i0009326240ae48e397d8cd4601fad719"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:57.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMS0xLTEtMS0w_32ec0c5a-ccdd-4b4d-94c3-52f0da20ec7f">6,873</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f1009ff18c488b8726927338c269af_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMS0zLTEtMS0w_947680ab-69f1-4658-afac-b29903fffa12">6,619</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMi0xLTEtMS0w_5a029cca-80e9-4b69-88d7-ced6fa35e0ce">174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c021b8753de48c7949085222e7a6139_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMi0zLTEtMS0w_00fadea1-eb67-4339-98db-7c759a619657">247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMy0xLTEtMS0w_8fa65bef-d6b7-4be1-969e-eb36a72914ff">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c021b8753de48c7949085222e7a6139_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMy0zLTEtMS0w_b02bab4f-1466-4c02-b807-ef946d50618d">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfNy0xLTEtMS0w_20e1373f-43bf-4ebb-89de-10ab215446f5">7,045</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfNy0zLTEtMS0w_7abf42ab-0c73-4a0f-aaa4-fb03e9bdcd5d">6,873</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of June&#160;30, 2021 and December&#160;31, 2020 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, goodwill acquired was principally associated with the acquisition of the outreach laboratory services business of Mercy Health, and adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy; Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining <ix:nonFraction unitRef="number" contextRef="ia41845b250794af096b47fe4b8dcfef7_I20201231" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfNTg3_38b42b5f-92af-40fc-aac5-bffa1af70010">56</ix:nonFraction>% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i4e77bebcfc8149c1b924dbae80610709"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfMTA4Ng_464e39cc-e658-4134-b163-b1abf66fc3ce" continuedAt="ic6dafa06e94647a18dc12e60e2e097f5" escape="true">Intangible assets as of June&#160;30, 2021 and December&#160;31, 2020 consisted of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ic6dafa06e94647a18dc12e60e2e097f5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.727%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0928297813dc4017bf49f241cc643448_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy0xLTEtMS0w_778c7c4c-6749-4fc1-8a3f-c930f64acf1e">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i062d7e387e63446587683b565e79cc7c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy0zLTEtMS0w_3673ed92-75d7-47c4-b1f0-15b224c78130">1,535</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i062d7e387e63446587683b565e79cc7c_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy01LTEtMS0w_7879779e-f3f0-429d-b882-04d8a8cd0d0d">682</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i062d7e387e63446587683b565e79cc7c_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy03LTEtMS0w_d59bc5b5-ee44-4b62-84d7-f0d8db827e25">853</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c6b6c329864ab3b58435cdeddd4726_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy05LTEtMS0w_6577599c-a1e0-4b1c-bca8-efdcccd346b4">1,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62c6b6c329864ab3b58435cdeddd4726_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy0xMS0xLTEtMA_eea5fba6-68c1-4bd1-a201-403175c05b0a">638</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c6b6c329864ab3b58435cdeddd4726_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy0xMy0xLTEtMA_d6ce3a1e-6992-4b7d-b67d-31ee7ac798f2">841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i243d7693a5f1415e850da25a647196b6_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC0xLTEtMS0w_7dde5663-565b-4766-92d3-ffd703d39ec4">9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080fe75a1bab496783d14dbde41a0ab7_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC0zLTEtMS0w_815c46e3-cd20-46eb-aba7-3f16a6c57157">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i080fe75a1bab496783d14dbde41a0ab7_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC01LTEtMS0w_b389b7c1-df21-434e-b155-e4d09055ae6e">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080fe75a1bab496783d14dbde41a0ab7_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC03LTEtMS0w_238a2491-eb43-4105-823d-047cdec23b5f">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b349580952a42daa37b46b6272cf25b_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC05LTEtMS0w_fe5e2f16-c1b4-478e-9295-a3452fe95090">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b349580952a42daa37b46b6272cf25b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC0xMS0xLTEtMA_f813147b-17d5-451f-b0d3-f95c8e9db875">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b349580952a42daa37b46b6272cf25b_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC0xMy0xLTEtMA_e9743179-335d-4235-8bf9-ac361caf75be">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6867e614c34049c1a7f3aced88b5b8bc_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS0xLTEtMS0w_e0722f67-18cf-4bc1-b3bb-101dbbddaf30">14</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5398a8c43e6c402d94b6baa7dbf0d6ee_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS0zLTEtMS0w_b5ac9748-38ff-45f1-a51d-c5e7f99bd987">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5398a8c43e6c402d94b6baa7dbf0d6ee_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS01LTEtMS0w_40ef738d-5f1a-45b1-bb71-a348ad897784">70</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5398a8c43e6c402d94b6baa7dbf0d6ee_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS03LTEtMS0w_de34ba3e-44b0-4dd2-9444-0a3d96629ce4">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f627c6887ae40ecafd69b4688c9cc51_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS05LTEtMS0w_a2990c86-6230-449b-96a6-909c887e0a40">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f627c6887ae40ecafd69b4688c9cc51_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS0xMS0xLTEtMA_94b5ff0f-0b1b-4e95-822a-d83ad0cf15f1">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f627c6887ae40ecafd69b4688c9cc51_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS0xMy0xLTEtMA_6807aebf-3368-4967-9fb8-434cb64075d4">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i240c440483ce414d8bd8a947d07168e4_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi0xLTEtMS0w_9005489b-c5ba-468e-b8d0-db311f876746">5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a870ab4b284d47b78555d636f33091_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi0zLTEtMS0w_9bb369aa-892c-4a58-a97e-d67456e4352a">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a870ab4b284d47b78555d636f33091_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi01LTEtMS0w_0653b0d4-62b6-4cc7-b647-8d762be8e482">99</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a870ab4b284d47b78555d636f33091_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi03LTEtMS0w_b2bde92a-95dd-4ffa-80d6-5ae156628a2d">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6261831038be4db5bd54afa80dbf7bd1_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi05LTEtMS0w_ddb44c35-a1a8-4224-8078-23ea44a40207">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6261831038be4db5bd54afa80dbf7bd1_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi0xMS0xLTEtMA_eaea0d27-c4ce-4b09-8d9a-ba715b8ed344">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6261831038be4db5bd54afa80dbf7bd1_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi0xMy0xLTEtMA_2ab53dd6-359f-4014-a793-d2956acfb208">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie4d571b8f74b4b3393f62cdbd449a4fa_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy0xLTEtMS0w_e1eddd92-4b4c-447d-89bb-f1202635a300">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38bbfcf307146078c97c1184f858dcd_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy0zLTEtMS0w_275b187f-898e-4e7a-aebb-6cf2958f59c5">1,789</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia38bbfcf307146078c97c1184f858dcd_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy01LTEtMS0w_29f4b572-d054-4d19-a447-c9cfa6c8f5ef">853</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia38bbfcf307146078c97c1184f858dcd_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy03LTEtMS0w_06617bf2-4bc2-4508-87fe-dff088177746">936</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c902ee777e4bfc97e2db0e0d3526be_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy05LTEtMS0w_ec1f2a68-d5c7-4272-a325-4b58fc8f163e">1,731</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56c902ee777e4bfc97e2db0e0d3526be_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy0xMS0xLTEtMA_16a6d778-335f-42e5-8291-28819c9b4042">800</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c902ee777e4bfc97e2db0e0d3526be_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy0xMy0xLTEtMA_f150259a-1295-4907-ae22-7fb86526ac52">931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388db605d7fa414f925f9483e847602e_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTAtMy0xLTEtMA_0bbf5164-0d7c-43ec-b22b-a98db428ec7c">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388db605d7fa414f925f9483e847602e_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTAtNy0xLTEtMA_4137ba92-37e5-45ea-ba5f-db442df46bd5">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i158831a555d7459cbe9af1e66382b1d1_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTAtOS0xLTEtMA_5549e260-0ebf-4ae5-b814-d5aed88856e6">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i158831a555d7459cbe9af1e66382b1d1_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTAtMTMtMS0xLTA_89afbcd9-2b37-468d-b8dd-9bc4f3f8f750">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b6b69b0dc94269aeb47d2aa8b322c0_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTItMy0xLTEtMA_b969cf0a-22d6-4695-9fb8-4e74a4061f92">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b6b69b0dc94269aeb47d2aa8b322c0_I20210630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTItNy0xLTEtMA_5270afff-9d32-4b06-88f1-f3ae3c86cdad">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8d9f93c589f4849bf27e56a6e0c38c9_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTItOS0xLTEtMA_6a7b80eb-b398-408e-80dc-36c774b46325">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8d9f93c589f4849bf27e56a6e0c38c9_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTItMTMtMS0xLTA_cfd0d35c-e48f-4913-8381-b6ab31c36260">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtMy0xLTEtMA_773f40c8-9cae-4e09-9578-a4a800252f7b">2,025</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtNS0xLTEtMA_08ac0b92-b3be-48b9-bf57-c3ce18eb6e52">853</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtNy0xLTEtMA_6df4909f-bca4-4ae5-94e1-5945de98a475">1,172</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtOS0xLTEtMA_eaa6f8b2-f0f6-4fa7-bfc5-dabc73f15142">1,967</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtMTEtMS0xLTA_84d3931f-73ca-491e-9e48-7c0335aeb4ce">800</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtMTMtMS0xLTA_5412831b-0c32-4be9-bb52-6d3a6030065c">1,167</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfMTExMw_65bb4842-6709-43eb-9ac8-154946e4f306" continuedAt="i154161b0e64844b591e25d309459606e" escape="true">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of June&#160;30, 2021 is as follows:</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i154161b0e64844b591e25d309459606e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"></td><td style="width:72.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfMS0xLTEtMS0w_6ff70f1a-10b6-4787-bb8d-fcd791729ed3">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfMi0xLTEtMS0w_3663b0ba-044b-4246-99ad-5a4f3555f50d">102</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfMy0xLTEtMS0w_f8a0900e-97f6-48af-9b4c-aae6e79e7131">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfNC0xLTEtMS0w_395f3e67-262a-431b-b4c4-a449fdb1ba4a">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfNS0xLTEtMS0w_50a10baf-7181-46b6-96e7-fffb31fd9ed9">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfNi0xLTEtMS0w_4732ba12-06b6-41a9-ab1f-1fe04d0dd56f">91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfNy0xLTEtMS0w_cadc5fc1-c19e-46a3-a6ff-6f1ee78fe1e6">396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfOC0xLTEtMS0w_148a26b3-8d32-4afe-a676-5686a210631e">936</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMzgzOQ_573ef7bb-2042-4f5a-9399-bb81091f96f5" continuedAt="i6ecc379eb8644db1b56fb5fea48b83c2" escape="true">FINANCIAL INSTRUMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6ecc379eb8644db1b56fb5fea48b83c2" continuedAt="i6dbbeca942f942389feec2f8e9449adc">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMzgzMQ_312c7f90-4231-435c-a013-16665e22284c" continuedAt="i5dc5b445946c4a40b7554b16e4a930f8" escape="true">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </ix:nonNumeric></ix:continuation></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i6dbbeca942f942389feec2f8e9449adc" continuedAt="i5c9d045d6c6d488fbf49dfd02d18d5d1"><ix:continuation id="i5dc5b445946c4a40b7554b16e4a930f8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $<ix:nonFraction unitRef="usd" contextRef="i04635c8c75144bd8a8ba0318721159e8_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMjMyOQ_5dfa429c-2825-494e-8286-ccff4aa1fd08"><ix:nonFraction unitRef="usd" contextRef="i5e506a9924014d9bb1c2cfc78ca49c38_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMjMyOQ_fedaf100-b017-45b0-be35-490e8eae3731">1</ix:nonFraction></ix:nonFraction>&#160;million as of both June&#160;30, 2021 and December&#160;31, 2020.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMjU0Nw_6d5b2bb0-05f6-43a8-9b81-f0a1af9ee7cc">1</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMzgyMA_9e2af33d-5d72-4c15-9998-2a07ac20f581" continuedAt="ied38ceba54a64415be3ccc4432a8f659" escape="true">As of June&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</ix:nonNumeric></span></div><ix:continuation id="ied38ceba54a64415be3ccc4432a8f659"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9062ff9a1ae48d79906ea44e302c2e7_I20210630" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjljNDA0NTgzNTAxYTQ4YWViNTdlYTQ1MWM5ZWYzY2U4L3RhYmxlcmFuZ2U6OWM0MDQ1ODM1MDFhNDhhZWI1N2VhNDUxYzllZjNjZThfMi01LTEtMS0w_0326fcd8-f91a-4bc5-b6db-687df2d25b49">45</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifef13a5c7cd74ff2af0e1affd9841703_I20201231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjljNDA0NTgzNTAxYTQ4YWViNTdlYTQ1MWM5ZWYzY2U4L3RhYmxlcmFuZ2U6OWM0MDQ1ODM1MDFhNDhhZWI1N2VhNDUxYzllZjNjZThfMi05LTEtMS0w_4652ea48-a32e-4b63-b629-084fba8307b1">51</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both June&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i5c9d045d6c6d488fbf49dfd02d18d5d1" continuedAt="i6c6fbb71bc834247be12b774f1f024d3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMzgyMg_5d6de609-6f20-48b6-9acb-3a404c256c19" continuedAt="i6b00993ee67a4ac988802ab013fbd082" escape="true">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and six months ended June&#160;30, 2021 and 2020:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i6b00993ee67a4ac988802ab013fbd082"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfMy0zLTEtMS0w_05c69018-16ba-45e7-8e55-0bf5823533bb">322</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfMy01LTEtMS0w_62fcc405-cbee-49ba-bb09-89f4fba19611">13</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfMy03LTEtMS0w_6c0ee8fc-006d-4a23-9571-2764d9dfedc9">326</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfMy05LTEtMS0w_16e49fba-4c78-4adb-bd3f-c7422731dc24">3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbac0da433664c12b78532c13c77e330_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNi0zLTEtMS0w_46b2ad7e-7a1f-4450-9f04-b5b723bf2763">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28577727d1648e484a07b8110249cb4_D20200401-20200630" decimals="-6" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNi01LTEtMS0w_deb9492f-4c9b-4830-b004-396ed26e6417">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5227393e6940467e8dee71a1b9b51664_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNi03LTEtMS0w_9b3faa44-2bdc-410c-9a6f-401128ed90f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a3fbebc3bfe4304ba9e9eb9b1bba88c_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNi05LTEtMS0w_499e7085-9ce0-44c7-987b-fb8a2bff044a">68</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aa5e0abeaed4700bdad18c66e5e59b9_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNy0zLTEtMS0w_783cd94b-fab6-4d5e-a0c5-768ad630aeb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i662c45865225464399b955e53cc70538_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNy01LTEtMS0w_20115e15-43ff-4dd5-b823-d2f880e814cd">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd95473cf34947db9595e10c6d055373_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNy03LTEtMS0w_4361f9cd-55c1-4c72-a94f-5f58398f4d09">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa06c6f3bf140899d194e149d257ba9_D20200101-20200630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNy05LTEtMS0w_899cc365-2f8e-486d-8f0b-b4f8ea10308d">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i6c6fbb71bc834247be12b774f1f024d3" continuedAt="if954c71192854089ae595de3772301da">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if954c71192854089ae595de3772301da">A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</ix:continuation>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMzMyMg_8b1e1c3f-f5b0-4e00-b21f-db6f78e45c17" continuedAt="ie5ecce98600c4f1d9ee6b199eeb1b3f5" escape="true">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><ix:continuation id="ie5ecce98600c4f1d9ee6b199eeb1b3f5" continuedAt="i5c0ced3427444c0e85c115c4bef251d5"><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and six months ended June&#160;30, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its <ix:nonFraction unitRef="number" contextRef="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTA5OTUxMTYzMTM4NA_9be9f08b-c0e2-4190-876f-41ea1227c269">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the three months ended June 30, 2021, $<ix:nonFraction unitRef="usd" contextRef="ic3be2c0db58246b7ba37ca73d78f5af0_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNjI4MQ_af65aa34-7a8f-4ad2-8b00-7ef8f1d61628">20</ix:nonFraction>&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income (expense), net.  See Note 5 for further details. </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first and second quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic627ecff5fda4835a645a85a28ace8c5_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTA5OQ_cd0e91a5-aeee-46bd-8938-9e57657f1a2f"><ix:nonFraction unitRef="usdPerShare" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTA5OQ_f0560210-b954-4e1d-bed7-5ab64df8cfd7">0.62</ix:nonFraction></ix:nonFraction> per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i03e1d81e938740ac958144ec1c77ded0_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTIzMg_1afb92fe-01f2-4579-9ff4-05b3db2e74be"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTIzMg_714de203-12ce-4477-943b-9830f9647768"><ix:nonFraction unitRef="usdPerShare" contextRef="i20d06c07440d4f66b5778443f9d59b7a_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTIzMg_9c688e68-ae49-4dbe-9c2c-5305fd8928c4"><ix:nonFraction unitRef="usdPerShare" contextRef="ib08b3d9b382f42539d1313a3fc3d9152_D20200101-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTIzMg_c2efa9bf-bb67-45fb-90e3-5534dec19c69">0.56</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="ic1daf0363ce34e388d9a621878fbf6c0_D20210301-20210331" decimals="INF" format="ixt:numdotdecimal" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTQwOA_4e84ebc2-67ef-4742-b98f-5c0689b690c6"><ix:nonFraction unitRef="usd" contextRef="i326c009316994d11a6801f243ae0c3c5_D20210201-20210228" decimals="INF" format="ixt:numdotdecimal" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTQwOA_57b96286-327f-49be-bb0b-5322fc6c4d20">1</ix:nonFraction></ix:nonFraction>&#160;billion. As of June&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTQyMg_f0538db8-f73d-48b4-a0aa-87cb1d55deeb">1.3</ix:nonFraction> billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i5c0ced3427444c0e85c115c4bef251d5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNjU5NzA2OTc3ODE1MA_ae8f7274-3706-4e60-b890-2f239c07af96">12.5</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNjU5NzA2OTc3ODE1Nw_a92e9c9b-8de5-4ea8-8330-c01580d58edb">1.6</ix:nonFraction>&#160;billion, including <ix:nonFraction unitRef="shares" contextRef="ib5a71b4b1c174929a891375f3de116e1_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNjQ3Mg_6b52ecfa-e917-4700-8989-fa943e45b944">9.1</ix:nonFraction>&#160;million shares repurchased under ASRs as follows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $<ix:nonFraction unitRef="usd" contextRef="iea4626114bd94a1b8470c2ae9e6f26e2_I20210430" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTUzMQ_5b07554d-388f-49d6-afd8-8cac66827974">1.5</ix:nonFraction>&#160;billion of the Company's common stock as part of the Company's share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract. For the three months ended June 30, 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="iea4626114bd94a1b8470c2ae9e6f26e2_I20210430" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNjcxNQ_5b07554d-388f-49d6-afd8-8cac66827974">1.5</ix:nonFraction>&#160;billion to the financial institutions and received <ix:nonFraction unitRef="shares" contextRef="i3fbb220f78a341abb8f1709736881c15_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTU0Nw_005ef932-493b-48d0-9a8a-32dcf5f18ced">9.1</ix:nonFraction>&#160;million shares of its common stock, at an initial price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="INF" name="us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTU2MA_e25d9067-b6f5-423b-ace3-708f535e9c65">132.27</ix:nonFraction> per share for a value of $<ix:nonFraction unitRef="usd" contextRef="i1b25ce7f6ff24ed7bbb7af00c1bd27a7_D20210401-20210630" decimals="-8" format="ixt:numdotdecimal" name="dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTU3MQ_efc8660e-ad06-4c59-a74b-df0f5cb37302">1.2</ix:nonFraction>&#160;billion, which represents <ix:nonFraction unitRef="number" contextRef="i1b25ce7f6ff24ed7bbb7af00c1bd27a7_D20210401-20210630" decimals="2" name="dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTYzOA_6d830b3e-a39d-4b08-8b1a-5325883c8903">80</ix:nonFraction>% of the total value of shares to be repurchased under the ASRs. The ASR contracts will settle the remaining shares, based on the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, upon the completion of the ASRs over the third and fourth quarters of 2021. The Company recorded the transactions as an increase to treasury stock of $<ix:nonFraction unitRef="usd" contextRef="i3fbb220f78a341abb8f1709736881c15_D20210401-20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTU4Nw_4609b796-aca1-497e-936a-02ea8552e64e">1.2</ix:nonFraction>&#160;billion and it recorded the remaining $<ix:nonFraction unitRef="usd" contextRef="ie4ea064d0de34ab9b6d853e2567d8e12_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTYwMQ_d16c09ee-9bbc-43b2-8298-5f883053252a">300</ix:nonFraction>&#160;million as a decrease to additional paid-in capital in the Company&#8217;s consolidated balance sheet.  The $<ix:nonFraction unitRef="usd" contextRef="ie4ea064d0de34ab9b6d853e2567d8e12_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="dgx:AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTYxNQ_00852f80-4e68-44b7-9b79-a5fcade68dc0">300</ix:nonFraction>&#160;million recorded in additional paid-in capital will be included in treasury stock upon completion of the ASRs.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTc0Mw_a6553c4d-775f-4eeb-a450-b8a00da52360">0.7</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTc3Nw_f60df190-1b4a-4b3b-b8cb-9ec4ae4bda6b">75</ix:nonFraction> million.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the six months ended June&#160;30, 2021 and 2020, the Company reissued <ix:nonFraction unitRef="shares" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMjI2Nw_38ebf3b7-96b7-4866-851b-4169e012b9f6">1.2</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMjI4MQ_c4739abc-89a5-461d-8919-f9061ae9f0a5">1.7</ix:nonFraction> million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="idbe6cc9023dd4f6b925f3e4b803adba0_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMjU4Ng_42b8a66f-c3fe-4efc-a6a1-022af6180347">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of June&#160;30, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 6.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_55"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfMTUy_e0b47c86-b56c-47e5-a378-4060e816ee6d" continuedAt="i6a0e34793daa4148a12434597c165d6c" escape="true">SUPPLEMENTAL CASH FLOW AND OTHER DATA</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6a0e34793daa4148a12434597c165d6c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfMTU4_0e6e0457-854d-4338-a68e-ae22f34fcb09" continuedAt="icb2783d35fdb42fd8ad5365493c855f7" escape="true">Supplemental cash flow and other data for the three and six months ended June&#160;30, 2021 and 2020 was as follows:</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icb2783d35fdb42fd8ad5365493c855f7" continuedAt="ib2c3bf97e7ff4fa28732cb79916d2e52"> </ix:continuation></span></div><div style="margin-top:5pt"><ix:continuation id="ib2c3bf97e7ff4fa28732cb79916d2e52"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:56.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMi0xLTEtMS0w_66f7d99b-ca33-4043-b11a-11e43b4a32ad">75</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMi0zLTEtMS0w_7a9706bc-3f39-406d-9bf6-8ea312b55712">64</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMi01LTEtMS0w_0674bb4a-4b30-4893-86d4-36a20dcfe502">149</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMi03LTEtMS0w_99d2f804-bae8-4231-a224-0b9673c34237">124</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMy0xLTEtMS0w_6a0e6c95-0f93-471e-b9ba-fadec14c3fc7">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMy0zLTEtMS0w_b4b8b46e-7cfb-47c8-b68c-a26aeaa8b241">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMy01LTEtMS0w_92bad958-ecb0-4de4-907c-5609465bf3aa">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMy03LTEtMS0w_ce1b2e2d-778a-4e09-b2e4-c31c26a40645">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNC0xLTEtMS0w_a7cfe5cb-6536-4528-b811-b20e86fdf781">100</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNC0zLTEtMS0w_62a49b9e-c640-48ca-84f3-f4bdcd14c220">89</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNC01LTEtMS0w_a0f9989e-1577-4521-ac53-301bc9af8f7f">201</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNC03LTEtMS0w_23b0b6a2-c104-4a30-8486-77ebb23e3888">174</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNi0xLTEtMS0w_bca08391-db58-4d70-9a3a-1202999505c5">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNi0zLTEtMS0w_1712b02c-8f4d-4fa8-8ceb-8340c4d242a5">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNi01LTEtMS0w_e0c0c446-14a2-4dd2-be04-72f8588aa33e">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNi03LTEtMS0w_f65f5780-6970-4a4c-915c-44749b2c6487">84</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNy0xLTEtMS0w_0da8c90f-98aa-48bd-acf2-366746e74425">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNy0zLTEtMS0w_4055456e-a1c8-47ac-b9d7-483eb1d024e5">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNy01LTEtMS0w_d2826aef-9a9d-40d1-b175-ae9dee444640">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNy03LTEtMS0w_8d353115-adce-428f-937a-37c0a5e615d4">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfOC0xLTEtMS0w_4bf9f41d-e10d-4ba8-9936-65870f21cb05">38</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfOC0zLTEtMS0w_eb9c91a6-8e8a-4825-baab-c79fa58248e8">41</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfOC01LTEtMS0w_701f8867-6019-428f-85c7-aa08e74ba4b6">76</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfOC03LTEtMS0w_d72a54ab-4c12-47c2-8a39-e2f0a6d6b787">82</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTAtMS0xLTEtMA_57e32fd2-b254-41e9-a192-799f1d28b407">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTAtMy0xLTEtMA_8b53b49b-983d-4ebc-8cc9-0e4e7615ddec">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTAtNS0xLTEtMA_4bccc6a3-a487-4941-91cf-1fa500ae1d10">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTAtNy0xLTEtMA_c8c9fbb6-b63f-4dfc-8d3a-a14a46d1f146">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTEtMS0xLTEtMA_4d31bc51-14ae-4eaf-b258-01ec0932c1f8">328</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTEtMy0xLTEtMA_bd93cfeb-57d5-4682-b84d-bbcbfe2f5077">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTEtNS0xLTEtMA_c39e4af3-7361-47ec-9892-c6c51984275a">335</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTEtNy0xLTEtMA_3b844ccf-d302-42c9-b483-d5994d5d34aa">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTMtMS0xLTEtMA_2c34b2b2-4ea6-4d19-b894-393c052930c6">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTMtMy0xLTEtMA_28a3b73e-f5ff-4d25-94b3-6eaffb5726b5">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTMtNS0xLTEtMA_4f8a3a01-e0e4-4755-9a8d-585f153f9ac5">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTMtNy0xLTEtMA_d582f015-6d69-45b2-bb1f-59567cbb93f1">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTUtMS0xLTEtMA_906058ad-32ec-40cd-be70-4c95c3a3d3da">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74ca347035d47afab9af2863189a9af_I20200630" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTUtMy0xLTEtMA_4bee37bc-77c2-4297-ac04-bb2eca6f0f0f">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTUtNS0xLTEtMA_b09c3c85-e4f2-4237-80c8-bb258c0f6de6">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74ca347035d47afab9af2863189a9af_I20200630" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTUtNy0xLTEtMA_f1234ff6-6075-4fdd-be2f-e14fae600281">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTgtMS0xLTEtMA_61f4d57c-0d4d-4061-b203-9683f2d8961b">234</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTgtMy0xLTEtMA_f278e946-5a0e-4450-93d2-318a51b702c5">120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTgtNS0xLTEtMA_e97c4832-1ee3-49bd-a50f-30c6ae2e6e92">234</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTgtNy0xLTEtMA_95bf2d30-d687-4402-ba9f-1aec867dbe94">251</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTktMS0xLTEtMA_44c16f3b-352e-47e8-ac99-69276163987a">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTktMy0xLTEtMA_fbe58c9d-949a-48c4-845a-95a6ba3523e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTktNS0xLTEtMA_a2b58402-3e88-4fcd-99dd-f5b3b2817ab0">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTktNy0xLTEtMA_b67092d8-a12c-4e7b-b3c1-c7bc6e4d265d">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjAtMS0xLTEtMA_9fc70dbf-b0a8-4e26-a587-bad16d3146fd">231</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjAtMy0xLTEtMA_22d538c3-47df-4d7a-a093-4bccf82c7f36">120</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjAtNS0xLTEtMA_0b0c9a1e-8cbc-4969-9c60-28461e1566e3">231</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjAtNy0xLTEtMA_e7ff742a-260a-4bb5-9d18-7ee88f74a1fc">231</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjMtMS0xLTEtMA_1f0d9cc2-e6cf-49e5-a6ff-b06fd27deb96">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjMtMy0xLTEtMA_89962adb-2aff-43ac-a5e8-b66e90b8925e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjMtNS0xLTEtMA_18cf45a1-8fec-47ed-bd1d-d1514f5b019c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjMtNy0xLTEtMA_9a2e54ee-f4a2-4237-a11d-67fa16cafe0d">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjQtMS0xLTEtMA_de70fc4b-c0e7-46eb-880a-f045b7e7d0c9">231</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjQtMy0xLTEtMA_cc73d5eb-6f1d-45e6-8702-0f79d6e1f108">120</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjQtNS0xLTEtMA_0aaf0746-ab26-432b-a917-321a133952b0">231</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjQtNy0xLTEtMA_a6758561-bada-4490-9f32-b199b01f8c96">228</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMzEtMS0xLTEtMA_a7da8b4b-67b3-4a35-8dcb-464664efd353">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMzEtMy0xLTEtMA_41cbefab-8939-46aa-8c01-e13f5af3e540">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMzEtNS0xLTEtMA_cecb2d7b-eb9d-4c94-8b59-0c963a179d48">69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMzEtNy0xLTEtMA_5ee1179a-7b76-49f8-98e3-7beefba27168">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law.  In April 2020, the Company received approximately $<ix:nonFraction unitRef="usd" contextRef="i44b2df1b377b46139f619a2f36e50ecf_D20200401-20200430" decimals="-6" format="ixt:numdotdecimal" name="dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfNjA0NzMxMzk2MDQ4OA_e62f0cea-66b2-4ad2-8a34-cc4d7c3f3851">65</ix:nonFraction>&#160;million of funds that were distributed to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic under the CARES Act.  The Company accounted for the receipt of the funds under a gain contingency model. Accordingly, the amount was recognized when the funds were received and the Company had determined that it satisfied the associated terms and conditions. During the three months ended June 30, 2020, based on the terms and conditions that were in effect at such time, the Company concluded that it had satisfied such terms and conditions for the $<ix:nonFraction unitRef="usd" contextRef="i02f8071b495d4e6690e62d4d392886da_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="dgx:CARESActProceedsRecognizedInTheStatementOfOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfNjA0NzMxMzk2MDkzNw_3e0fc895-7095-4aeb-b577-dac44077dd45">65</ix:nonFraction>&#160;million of funds that were received in April 2020 and, therefore, the Company recognized such amount in other operating income, net during the second quarter of 2020.  During the three months ended September 30, 2020, the Company reversed the $<ix:nonFraction unitRef="usd" contextRef="i6a152b0fb1084caa902c4093da8d43db_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:ReversalOfRecognitionOfCARESActProceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfNjA0NzMxMzk2MTA1MA_1595ddf5-92fd-4edf-b3cc-949faab6f549">65</ix:nonFraction>&#160;million of funds that had previously been recognized and, during the three months ended December 31, 2020, the Company returned the funds.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_58"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfODkyNA_ac2c3316-9a75-4b2d-b3a7-e4b862799bf7" continuedAt="id2de0c2724b348ef8ac77924e238f5dd" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id2de0c2724b348ef8ac77924e238f5dd" continuedAt="i636839ac6e2b4c4eb4caf5278610db90"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i556b98e351504ca9ab3b40b06f30f294_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMTEx_07a3e32f-247c-4728-972d-800ce1d56807">100</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="ib82b7d6590d24533bdb4d454c3f65409_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMTI0_f7cce64e-9e2f-4895-8d69-4d668d659849">600</ix:nonFraction>&#160;million secured receivables credit facility and $<ix:nonFraction unitRef="usd" contextRef="if6477236048c4c93b9a5e798f19e3fcc_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMTY3_65b45033-d729-44f6-a35c-a52d5e6ee525">150</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i5be56e298c3542a08d1a42235055721a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMTgw_5f272bf7-058b-49f6-b903-cd08a1efccfd">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility.  See Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $<ix:nonFraction unitRef="usd" contextRef="ib82b7d6590d24533bdb4d454c3f65409_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfNTc5_1c840460-2aec-497d-9289-05ebbe04424c">70</ix:nonFraction> million in letters of credit under the secured receivables credit facility were outstanding as of June&#160;30, 2021, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, <ix:nonFraction unitRef="claim" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMjE0MQ_aef3edc6-c113-4bc1-a09f-a1f0996f4673">two</ix:nonFraction> putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="icab7ab47a0de43f7bab61f509c638937_I20201031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMjY4OQ_667dce09-ba6c-4551-bbe6-47a20e2b578a">two</ix:nonFraction> lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i636839ac6e2b4c4eb4caf5278610db90" continuedAt="i8eb3987050124aa6b9af8762352d9ac9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of June&#160;30, 2021, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $<ix:nonFraction unitRef="usd" contextRef="ie7d0fd1d47784fd697f3c49dd3ee9148_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfNzYyOA_61c9f60d-8276-4d6c-9904-2986d0cc4691">6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5fb24d8255674ea29c12a58a75a31c7c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfNzYzNQ_4c1927ed-7b7e-46b6-a4ed-fcd8181f8955">1</ix:nonFraction> million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8eb3987050124aa6b9af8762352d9ac9">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $<ix:nonFraction unitRef="usd" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfODc0Mw_5cef7c4d-db65-4738-b9d6-51b87df7862e">151</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfODc1MA_14b18d71-5e82-45b1-9bf8-3178f9be172d">138</ix:nonFraction> million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfMjQxNQ_219d2c44-fc3a-4e37-b238-8c2f8e3e4471" continuedAt="i8761dff1e8604202b2ceb8728b671257" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8761dff1e8604202b2ceb8728b671257" continuedAt="i41d089734eb642fc8360ef1a092ece13"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i29a251826fef44b7a2f0a3c45547f1cf_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfODA3_81c79ce3-6587-4e94-82e3-5bb55d44b44f"><ix:nonFraction unitRef="number" contextRef="i383af7e535cb4e1b91b38301026c3942_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfODA3_a74abeb3-1bdf-469d-929c-ed7672be57cc">95</ix:nonFraction></ix:nonFraction>% of net revenues in 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of June&#160;30, 2021, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfMjQxOA_cd10f9d7-d9fa-4c1b-821c-2c4e77a7265e" continuedAt="i00d7b96de143470e911683eb43d4c620" escape="true">The following table is a summary of segment information for the three and six months ended June&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i41d089734eb642fc8360ef1a092ece13"><div style="margin-top:5pt;text-align:center"><ix:continuation id="i00d7b96de143470e911683eb43d4c620"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.847%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90505fcb3b254cc1854ef977088118fc_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMy0xLTEtMS0w_3d30141b-eff6-4018-8d4a-8e6187a95cbd">2,474</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb4af20d3554d7c929c5923a8579af2_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMy0zLTEtMS0w_75ea7535-7cf9-4547-9755-46330b0a22aa">1,764</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3010233763bd4c139f2be9e14d283953_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMy01LTEtMS0w_fb48cfd6-5245-4c39-9b9e-d708fac842a2">5,117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6397d097e9541cd93b37f7f3793e996_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMy03LTEtMS0w_30420a93-b50d-4980-9abf-2f4fe4b5c8a2">3,508</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9bb291bfed42dd8d3e3f6e51487a32_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNC0xLTEtMS0w_e4eb7ba7-43de-48df-86d1-b246b4d1532c">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0cbdde947349c2a36c2d246eb753b3_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNC0zLTEtMS0w_25082193-9425-4f44-b2df-a4615bba6e43">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0889a4285c0e4785b648e20f63f330f9_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNC01LTEtMS0w_73df5fb6-4e28-40d0-85d5-e351945556a5">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c3b5a5d28a4bd8ad953fad99e01101_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNC03LTEtMS0w_3df7489b-1765-41d2-ae5f-5532cf90218c">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNS0xLTEtMS0w_6e331d9e-b58f-4f8c-a5cd-e6881c9c5e2c">2,550</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNS0zLTEtMS0w_4433f0e0-8512-4bad-87c6-762913b2ac69">1,827</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNS01LTEtMS0w_925903e5-a258-472f-8654-8a2bce154a0c">5,270</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNS03LTEtMS0w_7277701e-2745-40a0-8e69-fa24abd36b7b">3,649</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90505fcb3b254cc1854ef977088118fc_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOC0xLTEtMS0w_36a902e3-fce5-457c-83bd-28a94c904fed">601</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb4af20d3554d7c929c5923a8579af2_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOC0zLTEtMS0w_e354c316-041f-4e19-897e-291bc6fe3387">280</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3010233763bd4c139f2be9e14d283953_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOC01LTEtMS0w_911d185b-bcea-4a38-9bf9-fc71be6a9caf">1,313</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6397d097e9541cd93b37f7f3793e996_D20200101-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOC03LTEtMS0w_67c1d2ad-55b0-4f6a-bfca-78abbe777c33">485</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf9bb291bfed42dd8d3e3f6e51487a32_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOS0xLTEtMS0w_ea0b83fb-b93e-4088-a780-ebb5b74c71ca">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb0cbdde947349c2a36c2d246eb753b3_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOS0zLTEtMS0w_d749f0c1-333c-4e1a-b459-cb45cca10ce4">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0889a4285c0e4785b648e20f63f330f9_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOS01LTEtMS0w_d33d8285-9ee8-4b85-a3b5-128511a8c982">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9c3b5a5d28a4bd8ad953fad99e01101_D20200101-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOS03LTEtMS0w_494c068d-54bb-4e26-ac6e-9f9d098f43a4">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15a526c3a9c94237af3d47054f8b6d88_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTAtMS0xLTEtMA_5e73d491-914b-4d8c-bdc8-77e96686ecff">77</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcc4b8411f1549df9adea0e982455905_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTAtMy0xLTEtMA_41dfcf08-fbef-4ded-ba42-6c76b09da318">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97dbe548aae446e5b0a2d3af9581d04d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTAtNS0xLTEtMA_f3a97219-e85a-42f3-8366-63c12c8e0531">138</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief4ea7051e25417fbffc0d616878520f_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTAtNy0xLTEtMA_76e1c6d4-4b0c-4dee-a71c-89da34466200">40</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTEtMS0xLTEtMA_4aadee24-72b7-48bd-904f-3093e20408da">533</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTEtMy0xLTEtMA_614d8736-ada5-4785-97a2-0f3a9714c375">283</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTEtNS0xLTEtMA_93af02b9-6484-4101-aab1-d2bb84f8dfc7">1,193</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTEtNy0xLTEtMA_d5901606-23a1-49a7-bcce-644219984bc1">458</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTItMS0xLTEtMA_8640f65c-f044-4249-bc80-28c5d41aa6ff">284</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTItMy0xLTEtMA_3093e26f-c667-4b16-ac86-f1deb1475a45">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTItNS0xLTEtMA_7374c04c-486e-4abf-af2e-f02274bdf588">250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTItNy0xLTEtMA_69fce8ec-6a42-4b2a-9e9b-8671f8363e0a">85</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTMtMS0xLTEtMA_7e749051-d36f-45ad-b726-01b3c4aeee1d">817</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTMtMy0xLTEtMA_2107968c-f893-4137-8360-9e0cef22aad9">255</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTMtNS0xLTEtMA_ce247608-152b-47a9-86af-c38f1a3e027a">1,443</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTMtNy0xLTEtMA_8a866003-720f-4075-8b63-61db9c932e47">373</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTQtMS0xLTEtMA_68d4c507-6b50-4be3-9eed-988541251782">177</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTQtMy0xLTEtMA_e4976c99-b41f-4c99-89a6-8d196fe9c5d2">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTQtNS0xLTEtMA_a630ee36-57ab-481a-bfdf-8b3dffda8529">330</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTQtNy0xLTEtMA_295f0589-ff63-486e-85ec-e3e05bcfb00c">92</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtMS0xLTEtMA_b4a2d493-1de0-40a1-9c9a-483338a82029">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtMy0xLTEtMA_5edaa6f7-40a2-4a22-83fd-58329718ccda">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtNS0xLTEtMTMwNw_26775f79-a83e-4a65-a3d6-e78ca2531c13"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtNS0xLTEtMTMwNw_4b9b3006-bb2c-4b86-a969-bfb3041b1996"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtNS0xLTEtMTMwNw_6e888c36-402f-4100-91ed-93b703198ee0">27</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtNy0xLTEtMA_5e1a2882-3725-457b-a133-5d41150c2f6b">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTgtMS0xLTEtMA_a738bfbc-6c8e-4dd8-a301-dbcc051d4740">650</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTgtMy0xLTEtMA_0c2e4dfe-6198-47c9-ad46-789083e8e45e">193</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTgtNS0xLTEtMA_f3a85723-3609-44e8-8548-e532bbbac80c">1,140</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTgtNy0xLTEtMA_a494afc5-4bf0-4d2a-84a1-03edf69627a3">299</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTktMS0xLTEtMA_ffe6f478-14ab-446f-9954-f6f4c0eae840">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTktMy0xLTEtMA_2ad09ab2-879a-4382-9a1e-00e802b83535">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTktNS0xLTEtMA_64f505bb-0ee4-488b-bb5c-be6ca8906851">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTktNy0xLTEtMA_aabe4b27-36b4-4019-a032-e484f58c8aad">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMjAtMS0xLTEtMA_02f6de2d-6a97-493b-bfb2-a53fb0526788">631</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMjAtMy0xLTEtMA_064f0c87-2760-4057-8133-3312f5969fd5">185</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMjAtNS0xLTEtMA_549be23e-8a12-4e87-a0b7-90c67573cc5f">1,100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMjAtNy0xLTEtMA_ac8f0836-20e2-4513-8528-77bc9f0c53a8">284</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfMjQyMA_e55d5177-d8ed-45b8-af8c-c329d8df2e76" continuedAt="i42d4fa9ba0ab4002a9b625518119a865" escape="true">Net revenues by major service were as follows:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i42d4fa9ba0ab4002a9b625518119a865"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.788%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i624857d463ea42cba64821f6526c8f30_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfMy0xLTEtMS0w_0479f099-7ec7-4ce5-80ce-05778c769a5a">1,150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9487c77290544536af9132f251d1f6ea_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfMy0zLTEtMS0w_0b058b33-2a8f-4a1d-a16f-c69e5d303ea6">812</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc8267b895c4a3f960332826d5a02a4_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfMy01LTEtMS0zODI_83932470-2c4c-4846-a005-ac81dee5d32f">2,182</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibebaf9b7d93d4b928c763156787f0e12_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfMy03LTEtMS0zODU_06142437-869b-4c17-a401-963899cd8ff8">1,757</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7302c53e8d34d6f90c6b6355b0f4289_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNC0xLTEtMS0w_8df7baec-9896-4b47-9cef-7716f6e9f989">511</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide03df6794ec4f319643260a062544e3_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNC0zLTEtMS0w_a79ad8f5-8c87-4ce7-863e-5d971d1ae9ec">582</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b44cf9ddb7649a4b78b908d8d56915d_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNC01LTEtMS0zODI_d4749370-f630-467c-9148-39e94d47e456">1,339</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2434d7efd8540e98be5af167e3ed184_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNC03LTEtMS0zODU_34cffa89-e461-4465-bc4b-c0d8e53b380d">606</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fb502a9bf254ed190f3f05d0c743c9f_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNS0xLTEtMS0w_44a72536-c8c8-4442-9e43-fd617e79b07e">673</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60bb75a4ffe942ad8f8ee7cc12887a86_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNS0zLTEtMS0w_5d7446f1-cd0d-4eaf-9f96-5c2afc8038d9">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib040e682f6cd49fa8fcaeab6c9d181d8_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNS01LTEtMS0zODI_af00edb4-dea0-4fae-a926-5f90b891f694">1,326</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0da175e34d54ca9bc607ec32504bb8c_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNS03LTEtMS0zODU_0ff459cf-24a7-43ff-afab-8ba3ef9ab6c0">935</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b11f69b1f65429992a961faaccd7fd2_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNi0xLTEtMS0w_3641355b-201d-4d34-9071-ca254b1bfcc3">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33bfedc0555f4b54a3fb6ed997bac076_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNi0zLTEtMS0w_fc5b56a6-172b-4646-b8c3-2963d4279214">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74d1e8f63991474d991b6164216d4e30_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNi01LTEtMS0zODI_5c94d82b-be18-470f-ab6a-db6ab03ec74b">270</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25ee037b0e524fc29dea8a393cc05548_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNi03LTEtMS0zODU_959d010e-50f5-4e3b-8853-e0d859e044d3">210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f9d9630be94d08b53f303e6841bda8_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNy0xLTEtMS0w_59263974-0f97-4607-b05a-4ac1756dc2de">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc42e2ae9df4d33a04a0b7b4ad4f4a5_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNy0zLTEtMS0w_b0fc7932-481e-4105-baab-5736b06e54f4">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia152bf35c30347d8873598f3162479e9_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNy01LTEtMS0zODI_2f6ebe97-bfe6-4efe-b755-c4a5a3313ae5">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bdcdaca428a4c798866885a7bf83056_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNy03LTEtMS0zODU_36e6811d-439e-407d-ab99-b50446da5cf2">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfOC0xLTEtMS0w_9fd8c50b-06fa-427f-8b56-3f0e9fb87c83">2,550</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfOC0zLTEtMS0w_d9d6e96d-834e-4f35-a49a-d9d25dc8ce6a">1,827</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfOC01LTEtMS0zODI_0c762a78-5aa5-49e8-90f6-958acab4e624">5,270</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfOC03LTEtMS0zODU_7c5ba0d4-90fe-4ebc-8c61-352bdf2def1e">3,649</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTU0OQ_bfb33d9c-985c-4b44-a739-faed89c21552" continuedAt="i8ec39b51b2eb471aa7890b3bfb64e377" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8ec39b51b2eb471aa7890b3bfb64e377" continuedAt="ib8f651fc2eb84b97a42e291cfb506562"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over <ix:nonFraction unitRef="number" contextRef="ide868a83c608446793a82a3dd54fa369_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTA5OTUxMTYyOTM2Mg_71037b66-bbad-402c-b528-6ff16ebd8075"><ix:nonFraction unitRef="number" contextRef="i383af7e535cb4e1b91b38301026c3942_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTA5OTUxMTYyOTM2Mg_b11d5b5b-19a9-4102-958d-12fefbfe0057"><ix:nonFraction unitRef="number" contextRef="i29a251826fef44b7a2f0a3c45547f1cf_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTA5OTUxMTYyOTM2Mg_fb073dd2-6f32-4d66-a803-61bc5f55cf47"><ix:nonFraction unitRef="number" contextRef="idd0e727fc05c4c8995fdb6239cf65e8b_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTA5OTUxMTYyOTM2Mg_fdd5dca3-d106-4832-9a47-fbd884b4e7c9">95</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total net revenues for the three and six months ended June&#160;30, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib8f651fc2eb84b97a42e291cfb506562" continuedAt="ifad92397f13a4bab90d6a55a6509b9e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTU1Mw_1baddeb8-1355-4ab3-81ab-3cc4eb1dc5fc" continuedAt="i72fd7531f3b24990a0c3b3db93136b8b" escape="true">The approximate percentage of net revenue by type of customer was as follows:</ix:nonNumeric></span></div><ix:continuation id="i72fd7531f3b24990a0c3b3db93136b8b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iffe84216348445a59b369c286ef7ea93_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMy0xLTEtMS0w_06ba8d48-9cdf-4ed6-84f8-37f97bf06a17">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i78df85d445ba4c0db260659c0ff4938d_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMy0zLTEtMS0w_e578ac1a-617d-4a55-9491-53341cdb60f9">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3415e92f142e4b66b223b653c1a52387_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMy01LTEtMS0w_3b8bb8da-a9bf-4a1f-806a-3b72c6336a4a">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c5637dc35e141ba997c638460a77408_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMy03LTEtMS0w_b04b6592-4cfb-4eeb-92f4-0fe72ad2a30b">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0a7aade517b46ed8b5a72c6df38f8aa_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNC0xLTEtMS0w_fbbff670-91aa-4f94-84b8-ac7a294cd50f">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71015133b38c46c58c9f22d76e9138bf_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNC0zLTEtMS0w_b49b5e9c-5a0b-437c-952a-e532bacad563">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61e91a1c6442413ea75e76e2d1d3dfba_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNC01LTEtMS0w_de4f3033-5bdb-4db3-bc90-1959f0ea41ce">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9d45b95ebfa54455b7a8148902aef07e_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNC03LTEtMS0w_3d7edbc6-b0bf-43c6-8060-587e4a53b0b9">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d1ae3e3c083422987b0fb7513f90028_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNS0xLTEtMS0w_a65e0310-dc8f-45d1-a45e-bdb2f9bcdf1a">41</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86c6e680c2644742bae6cf23bce0251e_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNS0zLTEtMS0w_b7a47eb7-d81d-496c-833a-75e7a789dbca">35</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3fd720e863c4f78bafdeb62b08b7f4f_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNS01LTEtMS0w_ee07e8c0-eaa0-420c-baa3-d4db4d283fc0">41</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9dd965423d424e19a504a6a42bb048c0_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNS03LTEtMS0w_23b2297f-08b0-44a0-bf7b-9806ba27431f">35</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i247d47c1463a483386454a9395684d29_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNi0xLTEtMS0w_e5649cba-ef9d-4d31-983d-cadaddf7d799">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25cda7d1389e444ea61b767b89bced02_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNi0zLTEtMS0w_40516614-cfdb-49b9-9270-eba9852bde8c">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53e1743ac9e84f96b59d2add6ce6e13d_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNi01LTEtMS0w_8ae38fae-a866-4d0c-acd7-7bd506d3420c">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba66174bf50b4b8e989cb690f4f40491_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNi03LTEtMS0w_e14b86e8-1923-4e63-8516-48eb7c786e8c">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d8f167638d849ea9481c99bc9392ad0_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNy0xLTEtMS0w_5b29aa9a-5772-4776-a2b1-efb783c916cd">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5541bed47cc341dfbed89f1ffbc4662d_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNy0zLTEtMS0w_92837c50-6f4a-486c-beac-0848fb2c89df">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3656dc776fa3408393224dc1faa34145_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNy01LTEtMS0w_d1bbd67e-fed5-4ed3-b49a-ac4dab3823fa">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70684da285074a80b27a51d58ae0bb69_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNy03LTEtMS0w_b161a895-e8e0-4cd2-be0d-7204cb2a1a35">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib54ce13b5fa748fca4142752ebed0ace_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOC0xLTEtMS0w_ec2f8e6d-622c-4692-bcfa-91c2804eb6c1">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3456017b640b4ec79039ff09ce94613a_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOC0zLTEtMS0w_1a8fca1e-ec42-41f1-b80f-833f474e29c8">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12c508b86ea2424cb0fd8f135fe41718_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOC01LTEtMS0w_35e61e64-6841-49d8-a48b-9a7b697c3a19">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29d70c753e104f2e9381d4c4d680e64e_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOC03LTEtMS0w_02db8bac-fe6a-4851-b4a8-2a751e48936d">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90505fcb3b254cc1854ef977088118fc_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOS0xLTEtMS0w_be3558d8-eccf-443d-b0e4-f4c04b5e238f">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bb4af20d3554d7c929c5923a8579af2_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOS0zLTEtMS0w_8f82c174-bc7e-4070-ad2d-2bd8f5b1e844">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3010233763bd4c139f2be9e14d283953_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOS01LTEtMS0w_382b31e0-2fa4-4d09-b10d-8d41071da73e">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib6397d097e9541cd93b37f7f3793e996_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOS03LTEtMS0w_e3a5d983-9c30-4358-a765-4b5be323708b">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i351bd30e85e24fbbb3960dc16939ff04_D20210401-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTAtMS0xLTEtMA_1ac2d3b9-3b8a-4e93-9cff-b83013aeec09">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb969f883d7f4514bce846057de29d5d_D20200401-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTAtMy0xLTEtMA_cc1462dd-4d45-4048-b274-823f1717c02c">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fb23c7e2fab487ba4834d786dea4bf7_D20210101-20210630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTAtNS0xLTEtMA_e2ede340-d155-4ee7-8ba2-a48d64a21360">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia3845502e9c3418fa7afe7f9e6d923f7_D20200101-20200630" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTAtNy0xLTEtMA_ea8bfea9-cd74-4687-a265-12a1d67add21">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTEtMS0xLTEtMA_770ca5b8-5a0c-4009-863e-697fbffed913">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTEtMy0xLTEtMA_d109c80a-3b3f-4912-968e-a1279adef9c9">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTEtNS0xLTEtMA_178e27a5-a79e-4424-8e8a-553dfd4ab751">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTEtNy0xLTEtMA_b8828957-2715-48c6-970f-3c22b96b7e50">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="dgx:AccountsReceivableDisaggregationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTU1NQ_37aeb8c1-624a-4f69-be98-dfe4cdaddf0f" continuedAt="i7172a9396caf41579188bfafdadf78a7" escape="true">The approximate percentage of net accounts receivable by type of customer was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="margin-top:5pt;text-align:center"><ix:continuation id="ifad92397f13a4bab90d6a55a6509b9e2"><ix:continuation id="i7172a9396caf41579188bfafdadf78a7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic74a4e69eaf749ee870747305583176f_I20210630" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfMi0xLTEtMS0w_a43f7681-ab7e-4372-bbab-83685416b23d">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17eefeebe6ed4e218bc255b2a54bc938_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfMi0zLTEtMS0w_cad61725-d2dd-40fc-b7ae-dd33d22d6f1c">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52eab006215b4f08859dc4a709d65fa5_I20210630" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfMy0xLTEtMS0w_7800c93c-669f-47df-9782-fd48ca9f0c41">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67c88c4d2eab4a3e92f6026392a577d6_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfMy0zLTEtMS0w_b97fe5f1-3b63-48a6-ac2b-df0d1c293072">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i673f602d80e04697ad707632c81bedc9_I20210630" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNC0xLTEtMS0w_202c2d91-6e6f-4859-8194-422fc6cadf51">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ec294bc9c1544d1b91cea9e983a73d2_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNC0zLTEtMS0w_469f95d4-0f47-43e8-bf83-5f80c8420e6d">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie91fe1b790d2497fa2a96a583468755b_I20210630" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNS0xLTEtMS0w_3c57fa9d-6fb0-4e33-8d64-b257afdb2015">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2fac1abae04410ca5aa5c55ced1c0d7_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNS0zLTEtMS0w_b5c2618c-c28a-4529-ab0b-14c1aff92ba0">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7308d78e16804acdb197a6fe7389240b_I20210630" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNi0xLTEtMS0w_46d557a4-0e5c-4e7a-970d-f03f6c4e8758">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icbc053e1f6804e8bad318c14a1840e34_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNi0zLTEtMS0w_6ccc0722-43e5-49e0-b701-019b52c1098b">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5efcf88fa11e4c91a8d160f946aa751a_I20210630" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNy0xLTEtMS0w_bdfdf32b-620a-4639-9859-466e1812ef5b">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i498cb94f65974aa2812f578184595178_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNy0zLTEtMS0w_2ac32ae2-389b-43b1-8a54-b451c872cd62">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfOC0xLTEtMS0w_75e62f07-5ef4-4d9a-9ca8-309aef7b673e">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3656967af97247b1bbcb74c67d929381_I20201231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfOC0zLTEtMS0w_ff5d7238-dfc5-4b0b-a143-7c755f58c306">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_1206"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjU5OTUz_833f42c0-817d-4a01-863e-3e87bbfa2362" continuedAt="iff08656c967d4df0b30e5ab57dad011f" escape="true">TAXES ON INCOME</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iff08656c967d4df0b30e5ab57dad011f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended June&#160;30, 2021 and 2020, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxMTc5_f5e997bc-8507-4778-a311-48a2b5505bd6">21.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxMTg3_1a889d8d-25a5-4172-8172-6632895e0152">25.5</ix:nonFraction>%, respectively.  For the three months ended June&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, <ix:nonFraction unitRef="number" contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjYyNTY1_cecc5e6f-f8d5-48fd-8d54-cd0d5cfb85d3">17.6</ix:nonFraction>%, on the gain on the sale of the Company's <ix:nonFraction unitRef="number" contextRef="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjYyNTcy_47746927-873e-4e2c-a5cf-7af53c1e7267">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions (see Note 5).  In addition, the effective income tax rate benefited from $<ix:nonFraction unitRef="usd" contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxNDU0_a05821b1-711b-4469-9ae7-5095b22dc261">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxNDYy_36bc4055-2b2f-4dda-b594-a9d0828f3354">4</ix:nonFraction> million of excess tax benefits associated with stock-based compensation arrangements for the three months ended June&#160;30, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021 and 2020, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxOTc2_bfc33700-acf3-41f9-ad81-f05d446e4f24">22.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxOTg0_90b0587c-e37f-4eb6-a372-e457ffd97c26">24.4</ix:nonFraction>%, respectively.  For the six months ended June&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, <ix:nonFraction unitRef="number" contextRef="i0267b05c8fa74b65aae925e3bb8946a3_D20210101-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjYyNTc3_d632741c-66bb-437d-a81d-d544c443d638">17.6</ix:nonFraction>%, on the gain on the sale of the Company's <ix:nonFraction unitRef="number" contextRef="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjYyNTg0_faa87407-e798-4ce9-9e5e-bb20929426ce">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions (see Note 5). In addition, the effective income tax rate benefited from $<ix:nonFraction unitRef="usd" contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcyMjUw_6747f884-2c23-4402-b9c9-0b9c7acb4d45">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcyMjU4_7a543607-b533-47b5-bf6d-49f7674ca935">12</ix:nonFraction> million of excess tax benefits associated with stock-based compensation arrangements for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Information Services</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics empowers people to take action to improve health outcomes.  We use our extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  Our diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We provide services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  We offer the broadest access in the United States to diagnostic information services through our nationwide network of laboratories, patient service centers and phlebotomists in physician offices and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  We are the world's leading provider of diagnostic information services.  We provide interpretive consultation with one of the largest medical and scientific staffs in the industry.  Our DIS business makes up greater than 95% of our consolidated net revenues.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our revenue performance for the DIS business based upon, among other factors, volume (measured by test requisitions) and revenue per requisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each requisition accompanies patient specimens, indicating the test(s) to be performed and the party to be billed for the test(s).   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue per requisition is impacted by various factors, including, among other items, the impact of fee schedule changes (i.e., unit price), test mix, payer mix, and the number of tests per requisition. Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix.  Therefore, we believe that information related to changes in these metrics from period to period are useful information for investors as it allows them to assess the performance of the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Diagnostic Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Diagnostic Solutions ("DS") businesses, which represent the balance of our consolidated net revenues, we offer a variety of solutions for life insurers and healthcare organizations and clinicians.  We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Second Quarter Highlights</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:60.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,550</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,827</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,474</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,764</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per requisition change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.6)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">45.2%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.7)%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40.1%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.2)%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$76</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$63</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$631</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$185</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.96</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.36</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$460</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$355</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further discussion of the year-over-year changes for the three months ended June&#160;30, 2021 compared to the three months ended June&#160;30, 2020, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID - 19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a novel strain of coronavirus (COVID-19) continues to impact the economy of the United States and other countries around the world, we are committed to being a part of the coordinated public and private sector response to this unprecedented challenge. We have made substantial investments to expand the amount of COVID-19 testing available to the country and are currently capable of performing approximately 300,000 COVID-19 molecular diagnostic tests per day to aid in the diagnosis of COVID-19 and approximately 350,000 COVID-19 antibody tests per day to aid in the detection of immune response. We have been effectively managing challenges in the global supply chain; and, at this point, we have sufficient supplies to conduct our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2020 and the first half of 2021, our testing volume and revenues were materially impacted by the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During January and February 2020, we experienced growth in DIS revenues and volume compared to the prior year period. However, in March 2020, we experienced a material decline in testing volume due to the COVID-19 pandemic.  During May and June 2020, we began to experience a recovery in base testing volume (which excludes COVID-19 testing), which continued in the second half of 2020 and the first half of 2021 driven by people returning to the healthcare system as well as contributions from new Professional Laboratory Services offerings.  For the first and second quarters of 2021, our base testing volume, excluding volume associated with recent acquisitions, was 2.8% below and 1.9% above our historical first and second quarter of 2019 levels, respectively.  Recent agreements associated with our Professional Laboratory Services offerings contributed 5.2% and 5.8% volume growth compared to 2019 for the first and second quarters of 2021, respectively.  Unless there is a change in the severity of the COVID-19 pandemic, we believe that there will be a continued return to healthcare throughout 2021 with, in some cases, patients pursuing care delayed during the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in base testing volume was driven by federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19, a significant reduction in physician office visits, the cancellation of elective medical procedures, customers closing or severely curtailing their operations (voluntarily or in response to government orders), and the adoption of work-from-home policies, all of which have had, and may continue to have, an impact on our operating results, financial position and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning during the second quarter of 2020, we experienced growing demand for COVID-19 testing services and we expanded our capacity throughout 2020 in order to satisfy the demand, which has had a significant impact on our testing volumes.  Since the fourth quarter of 2020, demand for COVID-19 testing has decreased reflecting an industry-wide trend.  Compared to the fourth quarter of 2020, our net revenues associated with COVID-19 testing in the first and second quarters of 2021 declined by 27.9% and 55.7%, respectively.  Given the significant progress of vaccinations in the U.S., we continue to expect a decline in demand for COVID-19 molecular testing in the second half of 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our revenue per requisition has been positively impacted by COVID-19 molecular testing. In April 2020 the Centers for Medicare and Medicaid Services ("CMS") announced that it would increase the reimbursement for certain COVID-19 molecular tests making use of high-throughput technologies developed by the private sector that allow for increased testing capacity, faster results, and more effective means of combating the spread of the virus to $100 per test, effective April 14, 2020. Beginning January 1, 2021, Medicare changed the base reimbursement rate for COVID-19 diagnostic tests run on high-throughput technologies to $75 per test with an additional payment of $25 per test if the laboratory (1) completes the test in two calendar days or less and (2) completes the majority of its COVID-19 tests that use high throughput technology in two calendar days or less for all of its patients in the previous month.  Certain healthcare insurers have now moved to a similar reimbursement model for COVID-19 molecular tests.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the COVID-19 pandemic&#8217;s impact on our consolidated results of operations, financial position and cash flows will be primarily driven by: the severity and duration of the COVID-19 pandemic; healthcare insurer, government, and client payer reimbursement rates for COVID-19 molecular testing; the COVID-19 pandemic&#8217;s impact on the U.S. healthcare system and the U.S. economy; and the timing, scope and effectiveness of federal, state and local governmental responses to the COVID-19 pandemic, including the impact of vaccination efforts. We may also be impacted by changes in the severity of the COVID-19 pandemic at different times in the various cities and regions where we operate and offer services. Even as the COVID-19 pandemic continues to moderate and the business and social distancing restrictions continue to ease, we may continue to experience similar effects to our businesses, consolidated results of operations, financial position and cash flows.  In the longer term, given the many challenges that hospitals will face, we may have more opportunities to partner with hospitals to help achieve their laboratory strategies, and the COVID-19 pandemic may also be a further catalyst for consolidation in the laboratory testing industry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of the Outreach Laboratory Services Business of Mercy Health</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 1, 2021, we completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225 million.  The acquired business is included in our DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Note 4 to the interim unaudited consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Ownership Interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Solutions") to IQVIA Holdings, Inc. ("IQVIA")</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, we sold our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, our clinical trials central laboratory services joint venture, to IQVIA, our joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, we accounted for our minority interest as an equity method investment.  As a result of the transaction, during the three months ended June 30, 2021, we recorded a $314&#160;million pre-tax gain in other income (expense), net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the three months ended June 30, 2021, we also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, we will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details, see Note 5 to the interim unaudited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accelerated Share Repurchase Agreements ("ASRs")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;In April 2021, we entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of our common stock as part of our share repurchase program.  Each of the ASRs was structured to permit us to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of our common stock during the repurchase period, less a fixed discount. For the second quarter of 2021, we paid $1.5&#160;billion to the financial institutions and received 9.1&#160;million shares of our common stock, at an initial price of $132.27 per share for a value of $1.2&#160;billion, which represents 80% of the total value of shares to be repurchased under the ASRs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;For further details regarding the ASRs and our repurchases of our common stock, see Note 9 to the interim unaudited consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Sequestration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the suspension of Medicare sequestration, which has resulted in a small benefit to us in the form of higher reimbursement rates for diagnostic testing services performed on behalf of Medicare beneficiaries, was extended through the end of 2021.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Invigorate Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are engaged in a multi-year program called Invigorate, which is designed to reduce our cost structure and improve our performance.  We currently aim annually to deliver savings of approximately 3% of our costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invigorate has consisted of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, we have identified key themes to change how we operate including reducing denials and patient price concessions; further digitizing our business; standardization and automation; and optimization initiatives in our lab network and patient service center network.  We believe that our efforts to standardize our information technology systems, equipment and data also foster our efforts to strengthen our foundation for growth and support the value creation initiatives of our clinical franchises by enhancing our operational flexibility, empowering and enhancing the customer experience, facilitating the delivery of actionable insights and bolstering our large data platform.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, we incurred $34&#160;million of pre-tax charges under our Invigorate program primarily consisting of systems conversion and integration costs, all of which result in cash expenditures. Additional restructuring charges may be incurred in future periods as we identify additional opportunities to achieve further cost savings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There have been no significant changes to our critical accounting policies from those disclosed in our 2020 Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of new accounting standards, if any, is discussed in Note 2 to the interim unaudited consolidated financial statements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The impact of recent accounting pronouncements not yet effective on our consolidated financial statements is also discussed in Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables set forth certain results of operations data for the periods presented:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,621&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,565&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,491&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,017&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,077&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,191&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating income (expense), net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share attributable to Quest Diagnostics' common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM - Not Meaningful</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table sets forth certain results of operations data as a percentage of net revenues for the periods presented:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:56.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended June&#160;30, 2021 were affected by certain items that on a net basis increased diluted earnings per share by $1.78 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain recorded in other income (expense), net of $314 million, or $2.04 per diluted share, on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $5 million, or $0.04 per diluted share, recorded in income tax expense; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $25 million in amortization of intangible assets or $0.15 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $21 million ($12 million in cost of services and $9&#160;million in selling, general and administrative expenses), or $0.12 per diluted share, primarily associated with workforce reductions, systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $5 million, or $0.03 per diluted share, associated with donations, contributions and other financial support through Quest for Health Equity, our initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities, recorded in selling, general and administrative expenses.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results for the six months ended June&#160;30, 2021 were affected by certain items that on a net basis increased diluted earnings per share by $1.42 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain recorded in other income (expense), net of $314 million, or $1.98 per diluted share, on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $9 million, or $0.07 per diluted share, recorded in income tax expense; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $54 million ($52 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes) or $0.31 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $38 million ($19 million in cost of services and $19 million in selling, general and administrative expenses), or $0.22 per diluted share, primarily associated with workforce reductions, systems conversions and integration incurred in connection with further restructuring and integrating our business; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $13 million, or $0.07 per diluted share, including $5 million associated with donations, contributions and other financial support through Quest for Health Equity recorded in selling, general and administrative expenses, and a pre-tax non-cash impairment to the carrying value of an equity method investment, recorded in equity in earnings of equity method investees, net of taxes of $8 million; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $4 million in cost of services, or $0.03 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic including incremental costs incurred to protect the health and safety of our employees and customers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six months ended June&#160;30, 2021, diluted earnings per share benefited from the impact of the ASRs on our weighted average shares outstanding as compared to the prior year periods.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended June 30, 2020 were affected by certain items that on a net basis reduced diluted earnings per share by $0.06 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $28 million ($25 million in amortization of intangible assets and $3 million in equity in earnings of equity method investees, net of taxes) or $0.16 per diluted share; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $9 million ($3 million in cost of services and $6 million in selling, general and administrative expenses), or $0.06 per diluted share, representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax net gain of $26 million (a $62 million gain in other operating income, net and a $3 million gain in equity in earnings of equity method investees, net of taxes, partially offset by $34 million of charges in cost of services and $5 million of charges in selling, general and administrative expenses), or $0.13 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic including $65 million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), partially offset by expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19, certain asset impairment charges, and incremental costs incurred primarily to protect the health and safety of our employees and customers; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $4 million, or $0.03 per diluted share, recorded in income tax expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the six months ended June 30, 2020 were affected by certain items that on a net basis reduced diluted earnings per share by $0.27 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $56 million ($50 million in amortization of intangible assets and $6 million in equity in earnings of equity method investees, net of taxes) or $0.31 per diluted share; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $25 million ($10 million in cost of services and $15 million in selling, general and administrative expenses), or $0.15 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax net gain of $17 million (a $57 million gain in other operating income, net and a $3 million gain in equity in earnings of equity method investees, net of taxes, partially offset by $35 million of charges in cost of services, and $8 million of charges in selling, general and administrative expenses), or $0.10 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic including $65 million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the CARES Act, partially offset by expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19, certain asset impairment charges, and incremental costs incurred primarily to protect the health and safety of our employees and customers; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $12&#160;million, or $0.09 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For both the three and six months ended June&#160;30, 2020, results include $65&#160;million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the CARES Act.  During the three months ended September 30, 2020, we reversed the $65&#160;million of income and the funds were returned during the three months ended December 31, 2020.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the three months ended June&#160;30, 2021 increased by 39.5% compared to the prior year period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the three months ended June&#160;30, 2021 increased by 40.2% compared to the prior year period.  For the three months ended June&#160;30, 2021:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Organic revenue and acquisitions contributed approximately 37.6% and 2.6%, respectively, to DIS revenue growth compared to the prior year period.  Organic revenue growth was driven by growth in the base business, partially offset by a decrease in COVID-19 antibody testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 66.1% compared to the prior year period, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in the second quarter of 2019, revenues in the base business, excluding revenue associated with recent acquisitions, increased by 1.4%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 2.1% revenue growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume increased by 45.2% with organic volume and acquisitions contributing approximately 40.1% and 5.1%, respectively.  Organic volume growth was driven by growth in the base business, partially offset by a decrease in volume associated with COVID-19 antibody testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) continued to recover and was up 60.7% compared to the prior year period, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in the second quarter of 2019, testing volume in the base business, excluding volume associated with recent acquisitions, increased 1.9%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 5.8% volume growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition decreased by 3.6% compared to the prior year period primarily due to growth in our Professional Laboratory Services engagements, which carry a lower revenue per requisition than the average for the remainder of the DIS business, and due to the impact of recent acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the six months ended June&#160;30, 2021 increased by 44.4% compared to the prior year period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the six months ended June&#160;30, 2021 increased by 45.9% compared to the prior year period.  For the six months ended June&#160;30, 2021:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Organic revenue and acquisitions contributed approximately 43.0% and 2.9%, respectively, to DIS revenue growth compared to the prior year period.  Organic revenue growth was driven by growth in the base business and demand for COVID-19 molecular testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 30.2% compared to the prior year period, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in the first half of 2019, revenues in the base business, excluding revenue associated with recent acquisitions, decreased by 0.7%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 2.3% revenue growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume increased by 34.7% with organic volume and acquisitions contributing approximately 30.0% and 4.7%, respectively.  Organic volume growth was driven by growth in the base business and, to a lesser extent, demand for COVID-19 molecular testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) continued to recover and was up 28.0% compared to the prior year period, which was negatively impacted as a result of the COVID-19 pandemic.  Compared to historical levels in the first half of 2019, testing volume in the base business, excluding volume associated with recent acquisitions, decreased by 0.4%.  Recent agreements associated with our Professional Laboratory Services offerings contributed 5.5% volume growth compared to 2019.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition increased by 8.1% compared to the prior year period driven in large part by COVID-19 molecular testing, partially offset by growth in our Professional Laboratory Services engagements, which carry a lower revenue per requisition than the average for the remainder of the DIS business.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services consists principally of costs for obtaining, transporting and testing specimens as well as facility costs used for the delivery of our services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended June&#160;30, 2021, cost of services increased by $344 million compared to the prior year period.  The increase was primarily driven by higher variable expenses related to increased testing volumes and, to a lesser extent, additional operating costs associated with our acquisitions, partially offset by higher incremental costs incurred in the prior year period related to the COVID-19 pandemic including expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, cost of services increased by $700 million compared to the prior year period.  The increase was primarily driven by higher variable expenses related to increased testing volumes as well as test mix and a higher supply cost associated with COVID-19 testing, and, to a lesser extent, additional operating costs associated with our acquisitions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses ("SG&amp;A")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A consist principally of the costs associated with our sales and marketing efforts, billing operations, credit loss expense and general management and administrative support as well as administrative facility costs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $69 million for the three months ended June&#160;30, 2021, compared to the prior year period, primarily driven by higher variable expenses to support our increase in testing volumes as well as higher performance-based compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $129 million for the six months ended June&#160;30, 2021, compared to the prior year period, primarily driven by higher variable expenses to support our increase in testing volumes, higher performance-based compensation, and higher costs associated with changes in the value of our deferred compensation obligations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The change in the value of our deferred compensation obligations is largely offset by gains or losses due to the changes in the value of the associated investments, which are recorded in other income (expense), net.  For further details regarding our deferred compensation plans, see Note 17 to the audited consolidated financial statements in our 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Amortization Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021, amortization expense increased by $2 million compared to the prior year period as a result of recent acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Operating Income, Net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income, net includes miscellaneous income and expense items and other charges related to operating activities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six months ended June&#160;30, 2020, other operating income, net primarily represents $65 million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the CARES Act.  During the three months ended September 30, 2020, we reversed the $65 million of income and the funds were returned during the three months ended December 31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest expense, net decreased for the three months ended June&#160;30, 2021 compared to the prior year period, primarily due to lower average outstanding indebtedness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest expense, net decreased for the six months ended June&#160;30, 2021 compared to the prior year period, primarily driven by lower interest rates due to recent refinancing transactions, including the termination of our interest rate swap agreements in April 2020, which resulted in a deferred gain that is being amortized as a reduction of interest expense, net over the remaining term of the associated debt, combined with lower average outstanding indebtedness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Income (Expense), Net </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other income (expense), net represents miscellaneous income and expense items related to non-operating activities, such as gains and losses associated with investments and other non-operating assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended June&#160;30, 2021, other income (expense), net increased by $309 million compared to the prior year period primarily due to a $314&#160;million pre-tax gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, our clinical trials central laboratory services joint venture, to IQVIA, our joint venture partner, partially offset by changes in the value of investments associated with our deferred compensation plans.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, other income (expense), net increased by $329 million compared to the prior year period primarily due to the pre-tax gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions and, to a lesser extent, changes in the value of investments associated with our deferred compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Income Tax Expense </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the three months ended June&#160;30, 2021 and 2020 was $177 million and $66 million, respectively.  The increase in income tax expense for the three months ended June&#160;30, 2021 compared to the prior year period was primarily driven by an increase in income before income taxes and equity in earnings of equity method investees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended June&#160;30, 2021 and 2020, the effective income tax rate was 21.6% and 25.5%, respectively.  For the three months ended June&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions.  In addition, the effective income tax rate benefited from $5 million and $4 million of excess tax benefits associated with stock-based compensation arrangements for the three months ended June&#160;30, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the six months ended June&#160;30, 2021 and 2020 was $330 million and $92 million, respectively.  The increase in income tax expense for the six months ended June&#160;30, 2021 compared to the prior year period was primarily driven by an increase in income before income taxes and equity in earnings of equity method investees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021 and 2020, the effective income tax rate was 22.9% and 24.4%, respectively.  For the six months ended June&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions. In addition, the effective income tax rate benefited from $9 million and $12 million of excess tax benefits associated with stock-based compensation arrangements for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Equity Method Investees, Net of Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes increased for the three months ended June&#160;30, 2021 by $6 million compared to the prior year period primarily due to recovery in the base business (which excludes COVID-19 testing) of the investees, which was negatively impacted in 2020 as a result of the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes increased for the six months ended June&#160;30, 2021 by $9 million compared to the prior year period primarily due to the demand for COVID-19 testing services, partially offset by an $8 million non-cash impairment to the carrying value of an equity method investment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We address our exposure to market risks, principally the risk of changes in interest rates, through a controlled program of risk management that includes the use of derivative financial instruments.  We do not hold or issue derivative financial instruments for speculative purposes.  We seek to mitigate the variability in cash outflows that result from changes in interest rates by maintaining a balanced mix of fixed-rate and variable-rate debt obligations.  In order to achieve this objective, we have historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements are recognized as an adjustment to interest expense, net.  We believe that our exposures to foreign exchange impacts and changes in commodity prices are not material to our consolidated results of operations, financial position or cash flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of June&#160;30, 2021 and December&#160;31, 2020, the fair value of our debt was estimated at approximately $4.5&#160;billion and $4.6&#160;billion, respectively, principally using quoted prices in active markets and yields for the same or similar types of borrowings, taking into account the underlying terms of the debt instruments.  As of June&#160;30, 2021 and December&#160;31, 2020, the estimated fair value exceeded the carrying value of the debt by $463&#160;million and $597&#160;million, respectively.  A hypothetical 10% increase in interest rates (representing 21 basis points as of June&#160;30, 2021 and 17 basis points as of December&#160;31, 2020) would potentially reduce the estimated fair value of our debt by approximately $87&#160;million and $82&#160;million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our secured receivables credit facility and our senior unsecured revolving credit facility are subject to variable interest rates.  Interest on our secured receivables credit facility is based on either commercial paper rates for highly rated issuers, or LIBOR, plus a spread.  As of June&#160;30, 2021, interest on our senior unsecured revolving credit facility is based on certain published rates plus an applicable margin based on changes in our public debt ratings and our leverage ratio. As such, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our borrowing cost under this credit arrangement is subject to fluctuations in interest rates, our leverage ratio and changes in our public debt ratings.  As of June&#160;30, 2021, the borrowing rates under these debt instruments were: for our secured receivables credit facility, commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.825% to 0.950%; and for our senior unsecured revolving credit facility, LIBOR plus 1.125%.  As of June&#160;30, 2021, there were no borrowings outstanding under either our $600&#160;million secured receivables credit facility or our $750&#160;million senior unsecured revolving credit facility.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A hypothetical 10% change to the variable rate component of our variable rate indebtedness would not materially change our annual interest expense. &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our outstanding debt, see Note 13 to the audited consolidated financial statements included in our 2020 Annual Report on Form 10-K.  For details regarding our financial instruments and hedging activities, see Note 8 to the interim unaudited consolidated financial statements and Note 15 to the audited consolidated financial statements included in our 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Associated with Investment Portfolio</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investment portfolio primarily includes equity investments comprised mostly of strategic holdings in privately and publicly held companies.  These securities are exposed to price fluctuations and are generally concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value with changes in fair value recognized in net income. Equity investments that do not have readily determinable fair values are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  We regularly evaluate these equity investments to determine if there are any indicators that the investment is impaired.  The carrying value of our equity investments that do not have readily determinable fair values was $26&#160;million as of June&#160;30, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not hedge our equity price risk.  The impact of an adverse movement in equity prices on our holdings in privately held companies cannot be easily quantified, as our ability to realize returns on investments depends on, among other things, the enterprises&#8217; ability to raise additional capital or derive cash inflows from continuing operations or through liquidity events such as initial public offerings, mergers or private sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our June&#160;30, 2021 financial statements, we considered whether the carrying values of our investments were impaired and concluded that no such impairment existed. </span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.263%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,133)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(395)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,738)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents consist of cash and highly-liquid short-term investments.  Cash and cash equivalents as of June&#160;30, 2021 totaled $560 million, compared to $1,158 million as of December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of June&#160;30, 2021, approximately 7% of our $560 million of consolidated cash and cash equivalents were held outside of the United States.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by operating activities for the six months ended June&#160;30, 2021 and 2020 was $1,191 million and $602 million, respectively.  The $589 million increase in net cash provided by operating activities for the six months ended June&#160;30, 2021, compared to the prior year period was primarily a result of:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher operating income in 2021 as compared to 2020; and, to a lesser extent,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of movements in our working capital accounts; partially offset by </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $315 million increase in income tax payments due to higher operating income in 2021 as compared to 2020 combined with lower payments in the 2020 period as a result of the extension of various payment deadlines into the second half of 2020; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher performance-based compensation payments in 2021 compared to 2020, and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$65 million in proceeds in the 2020 period that we received from the initial tranche of funds that were appropriated to healthcare providers under the CARES Act, which funds were returned during the fourth quarter of 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Days sales outstanding ("DSO"), a measure of billing and collection efficiency, was 46 days as of June&#160;30, 2021, 46 days as of December&#160;31, 2020 and 44 days as of June&#160;30, 2020.  Recent changes in our DSO is partially due to fluctuations in our monthly revenue due to the impact of the COVID-19 pandemic.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by (used in) investing activities for the six months ended June&#160;30, 2021 and 2020 was $344 million and $(411) million, respectively.  This $755 million change in cash provided by (used in) investing activities for the six months ended June&#160;30, 2021, compared to the prior year period was primarily a result of net cash proceeds received from the sale of our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in financing activities for the six months ended June&#160;30, 2021 and 2020 was $2,133 million and $395 million, respectively.  This $1,738 million increase in cash used in financing activities for the six months ended June&#160;30, 2021, compared to the prior year period was primarily a result of: </span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $1,835 million increase in repurchases of our common stock (see "Share Repurchase Program" for further details); and, to a lesser extent,</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $49 million decrease in proceeds from the exercise of stock options, which was a result of a decrease in the volume of stock options exercised compared to the prior year; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $43 million increase in distributions to noncontrolling interest partners; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$252 million of net debt repayments (repayments of debt less proceeds from borrowings) in 2020 compared to $1 million of net debt repayments in 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the six months ended June&#160;30, 2021, there were no borrowings or repayments under our secured receivables credit facility or senior unsecured revolving credit facility.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the six months ended June&#160;30, 2020, we completed the issuance of the 2.80% senior notes due June 2031. Additionally, during the six months ended June&#160;30, 2020, we redeemed in full the outstanding indebtedness under our senior notes due January 2020 and senior notes due March 2020 using proceeds from the issuance, in December 2019, of the 2.95% senior notes due June 2030, along with cash on hand.  During the six months ended June&#160;30, 2020, we borrowed $100&#160;million under our secured receivables credit facility and $100&#160;million under our senior unsecured revolving credit facility, which were repaid prior to June&#160;30, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first and second quarters of 2021, our Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, our Board of Directors declared a quarterly cash dividend of $0.56 per common share. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February and March 2021, our Board of Directors increased the size of our share repurchase program by $1&#160;billion.  As of June&#160;30, 2021, $1.3 billion remained available under our share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, we repurchased 12.5 million shares of our common stock for $1.6 billion, including 9.1&#160;million shares repurchased under ASRs.  See "Second Quarter Highlights" above for further details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2020, we repurchased 0.7 million shares of our common stock for $75 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investees</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our equity method investees primarily consist of a diagnostic information services joint venture and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  Such investees are accounted for under the equity method of accounting.  Our investment in equity method investees is less than 5% of our consolidated total assets.  Our proportionate share of income before income taxes associated with our equity method investees is less than 5% of our consolidated income before income taxes and equity in earnings of equity method investees.  We have no material unconditional obligations or guarantees to, or in support of, our equity method investees and their operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our June&#160;30, 2021 financial statements, we considered whether the carrying values of our equity method investments were impaired and, during the six months ended June&#160;30, 2021, we recorded an $8&#160;million impairment charge for one of the investments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding related party transactions with our equity method investees, see Note 20 to the audited consolidated financial statements in our 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements and Capital Resources </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We estimate that we will invest approximately $400 million during 2021 for capital expenditures, to support and grow our existing operations, principally related to investments in information technology, laboratory equipment and facilities, including COVID-19 testing equipment and completion of our new multi-year laboratory construction in New Jersey, and investments in our advanced diagnostics and consumer growth strategies.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Together with the Quest Diagnostics Foundation, during 2020 we launched a multi-year initiative to reduce health disparities in underserved communities, including those impacted by the COVID-19 pandemic.  As part of this initiative, we plan to offer testing services and fund a range of initiatives estimated to total more than $100 million aimed at improving access to testing and awareness of the value of diagnostic insights in managing overall health, a significant portion of which will occur in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of June&#160;30, 2021, we had $1.3 billion of borrowing capacity available under our existing credit facilities, including $530&#160;million available under our secured receivables credit facility and $750 million available under our senior unsecured revolving credit facility.  There were no borrowings under these credit facilities as of June&#160;30, 2021.   In support of our risk management program, $70&#160;million in letters of credit under the secured receivables credit facility were outstanding as of June&#160;30, 2021.  The secured receivables credit facility includes a $250 million loan commitment which matures in October 2021, and a $250 million loan commitment and a $100 million letter of credit facility which mature in October 2022.  The senior unsecured revolving credit facility matures in March 2023. For further details regarding the credit facilities, see Note 13 to the audited consolidated financial statements in our 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our secured receivables credit facility is subject to customary affirmative and negative covenants, and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility. Our senior unsecured revolving credit facility is also subject to certain financial covenants and limitations on indebtedness.  As of June&#160;30, 2021, we were in compliance with all such applicable financial covenants.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our cash and cash equivalents and cash from operations, together with our borrowing capacity under our credit facilities, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares, share repurchases and additional growth opportunities for the foreseeable future.  However, should it become necessary, we believe that our credit profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_85"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some statements and disclosures in this document are forward-looking statements.  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan&#8221; or &#8220;continue.&#8221;  These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking statements.  Risks and uncertainties that may affect our future results include, but are not limited to, impacts of the COVID-19 pandemic and measures taken in response, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in our most recently filed Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; &#8220;Cautionary Factors that May Affect Future Results&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of those reports.</span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).  Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the second quarter of 2021, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_94"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART II - OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 11 to the interim unaudited consolidated financial statements for information regarding the status of legal proceedings involving the Company.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_103"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the second quarter of 2021.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.435%"><tr><td style="width:1.0%"></td><td style="width:43.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.170%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yet Be Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Under the Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">or Programs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2021 &#8211; April 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,072,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,072,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2021 &#8211; May 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2021 &#8211; June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,072,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,072,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,053&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Since the share repurchase program&#8217;s inception in May 2003, our Board of Directors has authorized $11 billion of share repurchases of our common stock through June&#160;30, 2021.  The share repurchase authorization has no set expiration or termination date.  In each of February and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1 billion.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Includes: (1) shares delivered or attested to in satisfaction of the exercise price and/or tax withholding obligations by holders of stock options (granted under the Company&#8217;s Amended and Restated Employee Long-Term Incentive Plan) who exercised options; and (2) shares withheld (under the terms of grants under the Amended and Restated Employee Long-Term Incentive Plan) to offset tax withholding obligations that occur upon the delivery of outstanding common shares underlying restricted stock units and performance share units.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Does not include $300&#160;million of the $1.5 billion second quarter 2021 payment associated with the April 2021 accelerated share repurchase agreements ("ASRs"), which represents 20% percent of the total value of shares expected to be repurchased under the ASRs over the third and fourth quarters of 2021. See Note 9 to the interim unaudited consolidated financial statements for further information regarding the ASRs.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="-sec-extract:summary;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Exhibits </span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibits:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx06302021ex22.htm">Subsidiary Guarantors</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx06302021ex311.htm">Rule 13a-14(a) Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx06302021ex312.htm">Rule 13a-14(a) Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx06302021ex321.htm">Section 1350 Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx06302021ex322.htm">Section 1350 Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx06302021ex101.htm">Amendment No. 8 to The Profit Sharing Plan of Quest Diagnostics Incorporated</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document  - dgx-20210630.xsd</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20210630_cal.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20210630_def.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20210630_lab.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20210630_pre.xml</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i882bbfef3d8d4f5e83c65ae9785b734f_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July&#160;23, 2021 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.087%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and President</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark J. Guinan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div id="i882bbfef3d8d4f5e83c65ae9785b734f_112"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>dgx06302021ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie0e6dc241f1f4e3d8e15c0ddf412aa10_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit 10.1</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">AMENDMENT NO. 8 TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">THE PROFIT SHARING PLAN OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">QUEST DIAGNOSTICS INCORPORATED</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Profit Sharing Plan of Quest Diagnostics Incorporated, as presently maintained under an amendment and restatement effective as of January 1, 2016 (the &#8220;Plan&#8221;), is hereby amended in the following respects, effective as of January 1, 2021&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.&#160;&#160;&#160;&#160;Paragraph (b) of Section 6.1 (&#8220;Loans to Participants&#8221;) is amended as follows&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">(b)        Except with respect to pre-existing loans transferred to or merged into this Plan under subsection (k), or as set forth in the last sentence of this subsection (b), a Participant may have only one (1) loan outstanding at any time. For purposes of this subsection (b), a loan that is in default under subsection (e) is treated as outstanding. There must be a minimum of fourteen (14) days (or such other period determined by the Plan Administrator) between the payoff of one Plan loan and the issuance of a new loan, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%"> that the minimum-day restriction may be waived under procedures established by the Plan Administrator. Notwithstanding the foregoing, during the period from March 27, 2020, through January 31, 2021, a Participant may receive a loan even if the Participant already has a loan outstanding, and the maximum number of loans shall be increased to two (2) for so long as both such loans are outstanding.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.&#160;&#160;&#160;&#160;Appendix A to the Plan is amended and restated in the form appended to this Amendment.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">As evidence of its adoption of this Amendment, Quest Diagnostics Incorporated has caused this Amendment to be executed by its Senior Vice President and Chief Human Resources Officer on May 27, 2021.</font></div><div style="text-align:justify;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">QUEST DIAGNOSTICS INCORPORATED</font></div><div style="text-align:justify;text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#47;s&#47; Cecilia K. McKenney&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font></div><div style="padding-left:36pt;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Cecilia K. McKenney</font></div><div style="padding-left:36pt;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">SVP and Chief Human Resources Officer</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:150%">APPENDIX A PARTICIPATING EMPLOYERS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:200%">The Plan allows Employers other than the Company to adopt its provisions.  The names (and jurisdictions of organization) of Quest Diagnostics and the other Employers, as of January 1, 2021, in the Plan are&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Members of the Quest Controlled Group</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Terracotta LLC (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Medical Laboratories, Incorporated (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Ventures, LLC (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Athena Diagnostics, Inc. (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Reprosource Fertility Diagnostics, Inc. (MA)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Blueprint Genetics Inc. (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Specialty Laboratories, Inc. (CA)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Reference Services, Inc. (MD)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Health &#38; Wellness, LLC (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne LLC (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unilab Corporation (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide, Inc. (PA)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Cincinnati, Inc. (OH)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide of NJ, Inc. (NJ)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Cleveland, Inc. (OH)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne, LLC (MO)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriPath Consolidated Labs, Inc. (FL)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne of Ohio, Inc. (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Florida, LLC (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mid America Clinical Laboratories, LLC (IN)*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Hospital Services Florida, LLC (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest HealthConnect, LLC (CA)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath, Inc. (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nomad Massachusetts, Inc. (MA)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Indianapolis, P.C. (IN)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pathology Building Partnership (MD)  </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Kentucky, Inc. (KY)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PhenoPath Laboratories, PLLC (WA)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Lubbock 5.01(a) Corporation (TX)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Clinical Laboratories, Inc. (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath New York, LLC (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Domestic Holder LLC (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Texas Inc. (TX)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Holdings Incorporated (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Tucson, Inc. (AZ)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clearpoint Diagnostic Laboratories, LLC (TX)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated (MD)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cleveland Heartlab, Inc. (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated (NV)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Colorado Pathology Consultants, P.C. (CO)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Infectious Disease, Inc. (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consolidated DermPath, Inc. (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics International LLC (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dermatopathology of Wisconsin, S.C. (WI)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Investments LLC (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">DFW 5.01(a) Corporation (TX)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC (CT)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Pathology Services, Inc. (OK)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC (IL)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Institute for Dermatopathology, P.C. (PA)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC (MA)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kailash B. Sharma, M.D., Inc. (GA)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Massachusetts LLC (MA)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kilpatrick Pathology, P.A. (NC)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute (CA)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Med Fusion, LLC (TX)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute, Inc. (VA)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nuclear Medicine and Pathology Associates (GA)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics of Pennsylvania Inc. (DE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ocmulgee Medical Pathology Association, Inc. (GA)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Receivables Inc. (DE)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics TB, LLC (DE)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*          The vesting service as of January 1, 2021, of a Participant who was a participant in the Mid America Clinical Laboratories Retirement Savings Plan on January 1, 2021, shall be equal to the total period of time commencing on such Participant&#8217;s Benefit Service Date, as communicated to the Company by Mid America Clinical Laboratories, LLC, which amount shall be final and conclusive as to the number of years of vesting service to which such Participant was entitled as of January 1, 2021.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>3
<FILENAME>dgx06302021ex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7ecb7a250a9c4d68b6e34c3e3cc2e0b7_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit 22</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Subsidiary Guarantors of Securities</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of July 23, 2021, the following subsidiaries of Quest Diagnostics Incorporated provided, subject to the terms of such senior notes, unconditional and irrevocable guarantees to the senior notes listed below that were issued by Quest Diagnostics Incorporated pursuant to an offering registered under the Securities Act of 1933, as amended&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:27.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Securities</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Issuer</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsidiary Guarantor</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">State of Organization</font></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="32" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.95% Senior Notes due 2037</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.75% Senior Notes due 2040</font></div></td><td colspan="3" rowspan="32" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">American Medical Laboratories, Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Consolidated Labs, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Hospital Services Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Kentucky, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kentucky</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath New York, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Texas, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Athena Diagnostics, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Pathology Services, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Oklahoma</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Reference Services, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Maryland</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pennsylvania</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide of NJ, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New Jersey</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kailash B. Sharma, M.D., Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Missouri</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne of Ohio, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ocmulgee Medical Pathology Association, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pathology Building Partnership</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Maryland</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Clinical Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Holdings Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Maryland</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nevada</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Infectious Disease, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Investments LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Connecticut</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Illinois</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Massachusetts</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Virginia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics of Pennsylvania Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Specialty Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unilab Corporation</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>dgx06302021ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2a2f6d684ca040869e1c059e7f97bf79_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen H. Rusckowski, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July&#160;23, 2021 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.134%"><tr><td style="width:1.0%"></td><td style="width:11.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>dgx06302021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id2d927fcf9664983a8a5936def9ad164_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark J. Guinan, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July&#160;23, 2021 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.140%"><tr><td style="width:1.0%"></td><td style="width:14.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>dgx06302021ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i21ac1299844b4cbe9c5e5be3dd40151d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended June&#160;30, 2021 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 23, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>dgx06302021ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iaf61fc449bf54bc2a87095d167e485bd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended June&#160;30, 2021 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 23, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>dgx-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c0ef2d88-a53d-457b-ba3c-2a15db2c46ae,g:aea639b6-1560-47bd-8a23-0a619e498ffc-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dgx="http://questdiagnostics.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://questdiagnostics.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://questdiagnostics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE">
        <link:definition>2104103 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables">
        <link:definition>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails">
        <link:definition>2406401 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS">
        <link:definition>2107104 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISPOSITION" roleURI="http://questdiagnostics.com/role/DISPOSITION">
        <link:definition>2109105 - Disclosure - DISPOSITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISPOSITIONDetails" roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails">
        <link:definition>2410403 - Disclosure - DISPOSITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2111106 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2115107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSGoodwillDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails">
        <link:definition>2417406 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSSchedulesDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
        <link:definition>2418407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2119108 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>2421408 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSBalanceSheetsDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails">
        <link:definition>2422409 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSIncomeStatementDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails">
        <link:definition>2423410 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>2124109 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
        <link:definition>2425411 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATA" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA">
        <link:definition>2126110 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATATables" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables">
        <link:definition>2327305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails">
        <link:definition>2428412 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails">
        <link:definition>2429413 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2130111 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2431414 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>2132112 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>2333306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>2434415 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION">
        <link:definition>2135113 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables">
        <link:definition>2336307 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails">
        <link:definition>2437416 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOME" roleURI="http://questdiagnostics.com/role/TAXESONINCOME">
        <link:definition>2138114 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMEDetails" roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails">
        <link:definition>2439417 - Disclosure - TAXES ON INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dgx_COVID19TestingServicesMember" abstract="true" name="COVID19TestingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_RoutineclinicaltestingservicesMember" abstract="true" name="RoutineclinicaltestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ClientPayersMember" abstract="true" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" abstract="false" name="CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" abstract="false" name="EquityMethodInvestmentOwnershipPercentDisposedOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" abstract="false" name="PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataLineItems" abstract="true" name="SupplementalCashFlowAndOtherDataLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_GovernmentPayersMember" abstract="true" name="GovernmentPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataTable" abstract="true" name="SupplementalCashFlowAndOtherDataTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_AcceleratedShareRepurchasesInitialPricePaid" abstract="false" name="AcceleratedShareRepurchasesInitialPricePaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_UMassJointVentureMember" abstract="true" name="UMassJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_Q2SolutionsMember" abstract="true" name="Q2SolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FairValueOfNetAssetsAcquired" abstract="false" name="FairValueOfNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ReversalOfRecognitionOfCARESActProceeds" abstract="false" name="ReversalOfRecognitionOfCARESActProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PatientsMember" abstract="true" name="PatientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AnatomicpathologytestingservicesMember" abstract="true" name="AnatomicpathologytestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" abstract="false" name="ScheduleOfRevenuesByMajorServiceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_AccountsReceivableDisaggregationTableTextBlock" abstract="false" name="AccountsReceivableDisaggregationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_CapitatedMember" abstract="true" name="CapitatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" abstract="true" name="ExcludesgeneralandprofessionalliabilityclaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AcceleratedShareRepurchaseAgreementsMember" abstract="true" name="AcceleratedShareRepurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_StockRepurchaseProgramAdditionalAmountAuthorized" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AllotherservicesMember" abstract="true" name="AllotherservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DescriptionOfBusinessAbstract" abstract="true" name="DescriptionOfBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ForeignCurrencyTranslationMember" abstract="true" name="ForeignCurrencyTranslationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TotalAmortizingIntangibleAssetsMember" abstract="true" name="TotalAmortizingIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PercentageofNetAccountsReceivable" abstract="false" name="PercentageofNetAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_DiagnosticInformationServicesBusinessMember" abstract="true" name="DiagnosticInformationServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DSBusinessesMember" abstract="true" name="DSBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" abstract="false" name="AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_SeniorunsecuredrevolvingcreditfacilityMember" abstract="true" name="SeniorunsecuredrevolvingcreditfacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PercentageofNetRevenues" abstract="false" name="PercentageofNetRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_TerminationOfInterestRateSwapAgreements" abstract="false" name="TerminationOfInterestRateSwapAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" abstract="true" name="MidAmericaClinicalLaboratoriesLLCMACLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" abstract="false" name="ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" abstract="false" name="ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_FeeforserviceMember" abstract="true" name="FeeforserviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_HealthcareInsurersMember" abstract="true" name="HealthcareInsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_GenebasedandesoterictestingservicesMember" abstract="true" name="GenebasedandesoterictestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_MercyHealthMember" abstract="true" name="MercyHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_CARESActProceedsRecognizedInTheStatementOfOperations" abstract="false" name="CARESActProceedsRecognizedInTheStatementOfOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>dgx-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c0ef2d88-a53d-457b-ba3c-2a15db2c46ae,g:aea639b6-1560-47bd-8a23-0a619e498ffc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a8ef7d1a-63ac-4d09-8c03-4e19d76f0ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1ff496ea-931b-4a14-986e-459511c57bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a8ef7d1a-63ac-4d09-8c03-4e19d76f0ac4" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1ff496ea-931b-4a14-986e-459511c57bc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f247a01b-29cb-4ade-878f-df7a9d4e3e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a8ef7d1a-63ac-4d09-8c03-4e19d76f0ac4" xlink:to="loc_us-gaap_OperatingIncomeLoss_f247a01b-29cb-4ade-878f-df7a9d4e3e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ee0d1de1-351f-4e87-b640-355a28a7492d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_62502f68-f3ad-4daf-98f7-82d21785f651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ee0d1de1-351f-4e87-b640-355a28a7492d" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_62502f68-f3ad-4daf-98f7-82d21785f651" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_be609829-0009-463d-8215-163344209757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ee0d1de1-351f-4e87-b640-355a28a7492d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_be609829-0009-463d-8215-163344209757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3fb4009c-08a3-4728-a1b4-6239746e582e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3802973f-401d-4f82-bdd5-fdeffd245aff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3fb4009c-08a3-4728-a1b4-6239746e582e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_3802973f-401d-4f82-bdd5-fdeffd245aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2578558b-f111-4f67-84bf-a39f961b5727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3fb4009c-08a3-4728-a1b4-6239746e582e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2578558b-f111-4f67-84bf-a39f961b5727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3cb9ec57-f821-478a-80a1-e5ae2d3fc0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_3fb4009c-08a3-4728-a1b4-6239746e582e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3cb9ec57-f821-478a-80a1-e5ae2d3fc0a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2c188e09-a26c-4827-beb5-4ee3f0c2eb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e9c2d3da-0c33-41e3-9972-d62e2fe04d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c188e09-a26c-4827-beb5-4ee3f0c2eb5f" xlink:to="loc_us-gaap_CostsAndExpenses_e9c2d3da-0c33-41e3-9972-d62e2fe04d4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6196b774-8bb8-4d0a-9765-a5e8568ee1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c188e09-a26c-4827-beb5-4ee3f0c2eb5f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6196b774-8bb8-4d0a-9765-a5e8568ee1ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f92e7a52-1e47-4634-870b-6d1aa94979d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6953cedc-0398-40cf-a174-b80e201b2a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f92e7a52-1e47-4634-870b-6d1aa94979d7" xlink:to="loc_us-gaap_ProfitLoss_6953cedc-0398-40cf-a174-b80e201b2a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_91d7b580-ec23-4371-9b25-ba7a2f229bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f92e7a52-1e47-4634-870b-6d1aa94979d7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_91d7b580-ec23-4371-9b25-ba7a2f229bdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_342a96a2-a5f5-4762-bfcf-2977327391fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_76434164-c706-4514-9b14-97236b4760f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_342a96a2-a5f5-4762-bfcf-2977327391fb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_76434164-c706-4514-9b14-97236b4760f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_158f227b-c50f-432d-b510-1560e9deb278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_342a96a2-a5f5-4762-bfcf-2977327391fb" xlink:to="loc_us-gaap_CostOfRevenue_158f227b-c50f-432d-b510-1560e9deb278" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_21213001-5335-433f-ae4c-3f3c8aabfbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_342a96a2-a5f5-4762-bfcf-2977327391fb" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_21213001-5335-433f-ae4c-3f3c8aabfbfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7abad108-d6f4-413a-b870-ef048b7fe97a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_342a96a2-a5f5-4762-bfcf-2977327391fb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7abad108-d6f4-413a-b870-ef048b7fe97a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3917fd8f-5977-4033-a999-c0e18bc6a132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_025757bb-ee53-489e-8539-83f443d91d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3917fd8f-5977-4033-a999-c0e18bc6a132" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_025757bb-ee53-489e-8539-83f443d91d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ab31c9e7-07e2-4f1a-a4dc-4cdc98e1c872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3917fd8f-5977-4033-a999-c0e18bc6a132" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_ab31c9e7-07e2-4f1a-a4dc-4cdc98e1c872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d00ffb37-1f80-40ec-9e39-d989c1188de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_058ffb8d-e6d8-47de-9020-f2ce83739c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d00ffb37-1f80-40ec-9e39-d989c1188de1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_058ffb8d-e6d8-47de-9020-f2ce83739c7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e9c1398d-2c59-4761-b008-9b531278c43c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d00ffb37-1f80-40ec-9e39-d989c1188de1" xlink:to="loc_us-gaap_ProfitLoss_e9c1398d-2c59-4761-b008-9b531278c43c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d8a31ce6-b907-4dfa-9a74-f6b5cd589920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_75c5748b-8fe1-4931-ab18-11473fa6b6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d8a31ce6-b907-4dfa-9a74-f6b5cd589920" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_75c5748b-8fe1-4931-ab18-11473fa6b6ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2421b796-4280-4287-a74a-3bf4ff224018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d8a31ce6-b907-4dfa-9a74-f6b5cd589920" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2421b796-4280-4287-a74a-3bf4ff224018" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_22b6ec10-e6a7-4fe8-8925-d499857431cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3d639854-4c05-4d93-bfe6-e580b319688d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22b6ec10-e6a7-4fe8-8925-d499857431cd" xlink:to="loc_us-gaap_CommonStockValue_3d639854-4c05-4d93-bfe6-e580b319688d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_43e08587-18dc-4939-9eec-e15da4d15463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22b6ec10-e6a7-4fe8-8925-d499857431cd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_43e08587-18dc-4939-9eec-e15da4d15463" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0719faed-7e48-48e3-a9c2-affeead40ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22b6ec10-e6a7-4fe8-8925-d499857431cd" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0719faed-7e48-48e3-a9c2-affeead40ca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4716b620-3fb5-4187-8392-b69216e917db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22b6ec10-e6a7-4fe8-8925-d499857431cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4716b620-3fb5-4187-8392-b69216e917db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_7c249a2b-f975-41b8-b4b3-1c250c571a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22b6ec10-e6a7-4fe8-8925-d499857431cd" xlink:to="loc_us-gaap_TreasuryStockValue_7c249a2b-f975-41b8-b4b3-1c250c571a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a0823cb2-3ab5-41f9-ac2e-fc7ab6a05339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1cdc730a-36fd-4dc9-a6aa-10956ce5ac39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a0823cb2-3ab5-41f9-ac2e-fc7ab6a05339" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1cdc730a-36fd-4dc9-a6aa-10956ce5ac39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_14a1c9c3-d5be-4931-b529-63c13f6de450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a0823cb2-3ab5-41f9-ac2e-fc7ab6a05339" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_14a1c9c3-d5be-4931-b529-63c13f6de450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_273ba733-dbd3-4fd6-aa09-44d2fde9ae68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a0823cb2-3ab5-41f9-ac2e-fc7ab6a05339" xlink:to="loc_us-gaap_InventoryNet_273ba733-dbd3-4fd6-aa09-44d2fde9ae68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3a847a95-8458-4811-ba45-1bd7abeeef65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a0823cb2-3ab5-41f9-ac2e-fc7ab6a05339" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3a847a95-8458-4811-ba45-1bd7abeeef65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ce190a4-b304-473c-afb3-b3b00ab04459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_92af3163-fc74-44fc-9281-431ddc3669c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ce190a4-b304-473c-afb3-b3b00ab04459" xlink:to="loc_us-gaap_StockholdersEquity_92af3163-fc74-44fc-9281-431ddc3669c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_405337af-1efc-46e2-8868-849c73a2565f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0ce190a4-b304-473c-afb3-b3b00ab04459" xlink:to="loc_us-gaap_MinorityInterest_405337af-1efc-46e2-8868-849c73a2565f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e327ce8a-18ba-4356-a8fe-7f5a32cb89d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cf2f85de-4f50-48dd-83f9-24851f84d417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e327ce8a-18ba-4356-a8fe-7f5a32cb89d4" xlink:to="loc_us-gaap_AssetsCurrent_cf2f85de-4f50-48dd-83f9-24851f84d417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_775738a5-bb24-4fdf-9035-496627f6352f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e327ce8a-18ba-4356-a8fe-7f5a32cb89d4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_775738a5-bb24-4fdf-9035-496627f6352f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_aab26602-63c7-4ddd-a394-3eb58df56964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e327ce8a-18ba-4356-a8fe-7f5a32cb89d4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_aab26602-63c7-4ddd-a394-3eb58df56964" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b4c57b71-3452-4257-8d2f-f8d1a4f08313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e327ce8a-18ba-4356-a8fe-7f5a32cb89d4" xlink:to="loc_us-gaap_Goodwill_b4c57b71-3452-4257-8d2f-f8d1a4f08313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0b794759-37bb-41c5-b0a5-266b45a601e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e327ce8a-18ba-4356-a8fe-7f5a32cb89d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0b794759-37bb-41c5-b0a5-266b45a601e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_46342bb0-08c1-4fce-be10-4e3024d1fd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e327ce8a-18ba-4356-a8fe-7f5a32cb89d4" xlink:to="loc_us-gaap_EquityMethodInvestments_46342bb0-08c1-4fce-be10-4e3024d1fd4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_09ce8699-f5f6-451a-84a0-7b71054e1de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e327ce8a-18ba-4356-a8fe-7f5a32cb89d4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_09ce8699-f5f6-451a-84a0-7b71054e1de4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a0a8001-28f1-4250-908c-36d92c8a27a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1ef7523c-f08e-4bfc-9a05-ca83835a46b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a0a8001-28f1-4250-908c-36d92c8a27a1" xlink:to="loc_us-gaap_LiabilitiesCurrent_1ef7523c-f08e-4bfc-9a05-ca83835a46b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5d556bc1-a0cb-4685-8511-d7c0e704485d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a0a8001-28f1-4250-908c-36d92c8a27a1" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5d556bc1-a0cb-4685-8511-d7c0e704485d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_69ee2afd-d978-44b7-a256-7340368a41bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a0a8001-28f1-4250-908c-36d92c8a27a1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_69ee2afd-d978-44b7-a256-7340368a41bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c2de838-a177-42f0-8cc7-ef02655e0be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a0a8001-28f1-4250-908c-36d92c8a27a1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9c2de838-a177-42f0-8cc7-ef02655e0be2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_7fc500de-cb2a-4ce5-8c10-6f8801485678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a0a8001-28f1-4250-908c-36d92c8a27a1" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_7fc500de-cb2a-4ce5-8c10-6f8801485678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_50f2f6e2-557c-4ec2-b626-b319203bf307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a0a8001-28f1-4250-908c-36d92c8a27a1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_50f2f6e2-557c-4ec2-b626-b319203bf307" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6fe5d881-81d3-4625-924c-6834639483c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a0a8001-28f1-4250-908c-36d92c8a27a1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6fe5d881-81d3-4625-924c-6834639483c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0c219c4c-3b03-4dc9-a670-821219b0b25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4b0f7618-7961-46e3-bf72-94fdbb0986f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c219c4c-3b03-4dc9-a670-821219b0b25b" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4b0f7618-7961-46e3-bf72-94fdbb0986f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ca483e2f-7da3-40c2-9910-35849b97537c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c219c4c-3b03-4dc9-a670-821219b0b25b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ca483e2f-7da3-40c2-9910-35849b97537c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_87d1de3d-7e2a-481c-ae4c-5f596e284480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c219c4c-3b03-4dc9-a670-821219b0b25b" xlink:to="loc_us-gaap_LongTermDebtCurrent_87d1de3d-7e2a-481c-ae4c-5f596e284480" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_17c7cb93-5324-4912-a92f-3f3f8f81bbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_17c7cb93-5324-4912-a92f-3f3f8f81bbd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_9ad63146-5dac-4668-87ee-d07e706214a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:to="loc_us-gaap_RepaymentsOfDebt_9ad63146-5dac-4668-87ee-d07e706214a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d097610e-1ce3-4799-b035-d3afebe5ea5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d097610e-1ce3-4799-b035-d3afebe5ea5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d68d5b60-b3ba-4d36-959c-cc180840744e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d68d5b60-b3ba-4d36-959c-cc180840744e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_19409cb1-f04d-4a42-9ef0-0cd63dd01ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_19409cb1-f04d-4a42-9ef0-0cd63dd01ac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_57af6b96-9e89-4b5e-8442-fe2c84599ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_57af6b96-9e89-4b5e-8442-fe2c84599ffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_5c460b97-f164-4984-b786-52f230fedf3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_5c460b97-f164-4984-b786-52f230fedf3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d12dbe21-b5ce-4713-90eb-320992ba7077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_38827cb7-6b4a-405e-8938-af2208a0ab56" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d12dbe21-b5ce-4713-90eb-320992ba7077" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_66ae33d0-141e-4b57-b6db-85ca79c0c51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_17f5bdab-820f-4035-823b-4cd9dfcba616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_66ae33d0-141e-4b57-b6db-85ca79c0c51f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_17f5bdab-820f-4035-823b-4cd9dfcba616" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_113fd058-6768-46b7-ab02-3fb515609303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_66ae33d0-141e-4b57-b6db-85ca79c0c51f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_113fd058-6768-46b7-ab02-3fb515609303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_3e8eb393-c85b-4bb8-9e46-6575de4ad315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_66ae33d0-141e-4b57-b6db-85ca79c0c51f" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_3e8eb393-c85b-4bb8-9e46-6575de4ad315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_98eaa74d-c89c-4b62-b255-329ffabc8c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_66ae33d0-141e-4b57-b6db-85ca79c0c51f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_98eaa74d-c89c-4b62-b255-329ffabc8c30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f1745e01-7670-4c6c-9736-a4d915c0d998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_ProfitLoss_f1745e01-7670-4c6c-9736-a4d915c0d998" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_de4eb300-d8ac-41d6-be8e-bb95d3338246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_de4eb300-d8ac-41d6-be8e-bb95d3338246" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_71bdf21b-ca02-449f-b741-22851314b786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_71bdf21b-ca02-449f-b741-22851314b786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_9edb2b40-7979-4f9b-978f-1b5260cd8f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_9edb2b40-7979-4f9b-978f-1b5260cd8f8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_20467b49-e121-49e3-8968-52a49b1e5f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_20467b49-e121-49e3-8968-52a49b1e5f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_38a97b30-3f75-447c-b304-c6d04ec26d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_ShareBasedCompensation_38a97b30-3f75-447c-b304-c6d04ec26d71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_5e4ea18d-7632-4b69-a698-13aca618f950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_5e4ea18d-7632-4b69-a698-13aca618f950" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_73f2dfb1-ffdc-446b-b3e7-cb489c30e410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_73f2dfb1-ffdc-446b-b3e7-cb489c30e410" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements_830a53f5-fab3-47c0-88d3-392bbd159058" xlink:href="dgx-20210630.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_dgx_TerminationOfInterestRateSwapAgreements_830a53f5-fab3-47c0-88d3-392bbd159058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f026fc15-1ed6-45dc-a54b-49fe5c42265a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f026fc15-1ed6-45dc-a54b-49fe5c42265a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_761ff865-4fb8-4242-8e5e-a91b12fddf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_761ff865-4fb8-4242-8e5e-a91b12fddf3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_73d40775-5176-4811-ab39-98c84649e242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfb89dc1-57ec-46c7-8147-288171e4606a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_73d40775-5176-4811-ab39-98c84649e242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb14bf17-fef1-4760-aee2-7d8254985b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d363a80-746e-4dd9-87d3-32d521d4f7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb14bf17-fef1-4760-aee2-7d8254985b1c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d363a80-746e-4dd9-87d3-32d521d4f7b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ae614a87-ba70-494f-b58d-a32d5290a5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb14bf17-fef1-4760-aee2-7d8254985b1c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ae614a87-ba70-494f-b58d-a32d5290a5c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b7a9ab3-3a0d-42f0-96d2-408234f2abe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb14bf17-fef1-4760-aee2-7d8254985b1c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b7a9ab3-3a0d-42f0-96d2-408234f2abe2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_7d58f257-efc4-4cdb-8c93-aff31daa9c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3db94839-d1f5-4589-badd-35c1b7bda5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_7d58f257-efc4-4cdb-8c93-aff31daa9c5e" xlink:to="loc_us-gaap_NetIncomeLoss_3db94839-d1f5-4589-badd-35c1b7bda5a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_2965c206-d946-4a63-bdd0-3a9c157a0adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_7d58f257-efc4-4cdb-8c93-aff31daa9c5e" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_2965c206-d946-4a63-bdd0-3a9c157a0adf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fb2d69ac-7567-40fb-8ea7-0f3c023b7415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9bb8c192-21f4-4fe1-8677-99c2a5472a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fb2d69ac-7567-40fb-8ea7-0f3c023b7415" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9bb8c192-21f4-4fe1-8677-99c2a5472a85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ad8886b5-fc63-4917-ba61-74a1b31f1714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fb2d69ac-7567-40fb-8ea7-0f3c023b7415" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ad8886b5-fc63-4917-ba61-74a1b31f1714" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f5d2b9b2-3d59-4a5b-9017-f582f15c91bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_257e8b78-6f48-43a2-b737-86724a6d96a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f5d2b9b2-3d59-4a5b-9017-f582f15c91bd" xlink:to="loc_us-gaap_TradingSecurities_257e8b78-6f48-43a2-b737-86724a6d96a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_d74d0bf9-840c-4dd7-9371-a8d153f7e0b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f5d2b9b2-3d59-4a5b-9017-f582f15c91bd" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_d74d0bf9-840c-4dd7-9371-a8d153f7e0b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c48c4d9-a81c-4bab-a83f-608dca191d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_f5d2b9b2-3d59-4a5b-9017-f582f15c91bd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4c48c4d9-a81c-4bab-a83f-608dca191d6b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_50c134fd-94bd-488c-b453-3cf5d544b5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_84a00f79-d044-41b2-a5e9-b8ba4b285f36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_50c134fd-94bd-488c-b453-3cf5d544b5a6" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_84a00f79-d044-41b2-a5e9-b8ba4b285f36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_905487ac-f104-44ac-81b3-347428ba1c63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_50c134fd-94bd-488c-b453-3cf5d544b5a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_905487ac-f104-44ac-81b3-347428ba1c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_aabcd3d2-d868-42f7-9ee2-a3cbb6ff90df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_70990e8d-5477-436b-a64d-057c65b6dc8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_aabcd3d2-d868-42f7-9ee2-a3cbb6ff90df" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_70990e8d-5477-436b-a64d-057c65b6dc8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_cdb1cbd2-5392-4bd4-a155-9f21d6326086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_aabcd3d2-d868-42f7-9ee2-a3cbb6ff90df" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_cdb1cbd2-5392-4bd4-a155-9f21d6326086" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2b5e1e36-155f-4856-a9cf-fb0b01729d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_aabcd3d2-d868-42f7-9ee2-a3cbb6ff90df" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2b5e1e36-155f-4856-a9cf-fb0b01729d5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_082a1838-c9c2-447c-91e5-70f68d401488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_aabcd3d2-d868-42f7-9ee2-a3cbb6ff90df" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_082a1838-c9c2-447c-91e5-70f68d401488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6a9c6dd1-48f5-44ed-ad36-b14c1ae94f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_aabcd3d2-d868-42f7-9ee2-a3cbb6ff90df" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_6a9c6dd1-48f5-44ed-ad36-b14c1ae94f62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_23d59bc4-0f7a-4348-8c1b-426fc282e644" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_aabcd3d2-d868-42f7-9ee2-a3cbb6ff90df" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_23d59bc4-0f7a-4348-8c1b-426fc282e644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0c7a872f-1ceb-41d1-8b7e-00aed0cdad94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_aabcd3d2-d868-42f7-9ee2-a3cbb6ff90df" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0c7a872f-1ceb-41d1-8b7e-00aed0cdad94" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_86af3025-517f-4c1a-a03b-811001c5e18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6f3d9d9a-8d75-4b96-a624-ec2aeba175cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_86af3025-517f-4c1a-a03b-811001c5e18d" xlink:to="loc_us-gaap_Depreciation_6f3d9d9a-8d75-4b96-a624-ec2aeba175cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_da8a54fe-a78c-4d51-b288-daeb23d26bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_86af3025-517f-4c1a-a03b-811001c5e18d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_da8a54fe-a78c-4d51-b288-daeb23d26bf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_eb3e99d3-fbc9-47ca-bed0-5901b86c5f27" xlink:href="dgx-20210630.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_497193dd-c4a8-42e8-84bb-59aba5fcbab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_eb3e99d3-fbc9-47ca-bed0-5901b86c5f27" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_497193dd-c4a8-42e8-84bb-59aba5fcbab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_8b57cd71-2d74-443e-95a2-e924cb6a730a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_eb3e99d3-fbc9-47ca-bed0-5901b86c5f27" xlink:to="loc_us-gaap_LiabilitiesAssumed1_8b57cd71-2d74-443e-95a2-e924cb6a730a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ed94f5b4-c6c0-4407-9557-21d6232ebbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_68fe9c65-dc3b-4b03-b438-e46d397a93a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_ed94f5b4-c6c0-4407-9557-21d6232ebbd1" xlink:to="loc_us-gaap_InterestExpense_68fe9c65-dc3b-4b03-b438-e46d397a93a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_86270076-a3ea-424f-be73-84079fbe04ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_ed94f5b4-c6c0-4407-9557-21d6232ebbd1" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_86270076-a3ea-424f-be73-84079fbe04ce" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>dgx-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c0ef2d88-a53d-457b-ba3c-2a15db2c46ae,g:aea639b6-1560-47bd-8a23-0a619e498ffc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i52a3a420704240e0b5ab9fd96bf064ae_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5c2515ef-80ab-4207-95ad-7863e28ed58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5c2515ef-80ab-4207-95ad-7863e28ed58c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c9e07a30-de32-46d5-9c79-8ec903676000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c9e07a30-de32-46d5-9c79-8ec903676000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694b8956-d646-4099-8968-60de320f4871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694b8956-d646-4099-8968-60de320f4871" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_7529f430-38c7-4f26-a57c-ad0b48caf494" xlink:href="dgx-20210630.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_7529f430-38c7-4f26-a57c-ad0b48caf494" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fbe06a95-0e0d-4f50-a4ec-18d3d9cfe22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fbe06a95-0e0d-4f50-a4ec-18d3d9cfe22b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_3c53d30b-5a1a-4a6f-9d29-19836f68b150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_DividendsCommonStockCash_3c53d30b-5a1a-4a6f-9d29-19836f68b150" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_75c14751-c6f3-483c-bb79-7c2ef459d191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_75c14751-c6f3-483c-bb79-7c2ef459d191" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ba11c529-f64c-4a5b-8876-3b801458b98f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ba11c529-f64c-4a5b-8876-3b801458b98f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ab3c6469-5683-4a65-8bd1-1734a5fd9e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ab3c6469-5683-4a65-8bd1-1734a5fd9e6b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0e144614-d5c1-47a0-9187-a860ebd15985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0e144614-d5c1-47a0-9187-a860ebd15985" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_175ae2e0-4ef7-46f1-9017-8445fd83ac25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_175ae2e0-4ef7-46f1-9017-8445fd83ac25" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_34edbf57-aafb-415e-ae08-c665bc29664f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_34edbf57-aafb-415e-ae08-c665bc29664f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e864faf8-555e-41f1-b1d5-e2cb99a2f087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e864faf8-555e-41f1-b1d5-e2cb99a2f087" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_160f889a-757f-4023-b5c5-a82583bc0ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_160f889a-757f-4023-b5c5-a82583bc0ec7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8d3164db-c474-4535-aef6-5b1cafc9cfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d1c8d82-d6dc-4343-bd28-38a0e29f8110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5c2515ef-80ab-4207-95ad-7863e28ed58c" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0b581f6e-7670-4f33-bf9b-fd03d01edf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0b581f6e-7670-4f33-bf9b-fd03d01edf3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_1d04c349-4f32-468f-9803-a09479bc4a06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_1d04c349-4f32-468f-9803-a09479bc4a06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_02239d72-b1f0-4c62-8b80-8677c5b11454" xlink:href="dgx-20210630.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_02239d72-b1f0-4c62-8b80-8677c5b11454" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_5c418cfd-b943-4199-b85d-e2819e2e7b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e410ef27-73a5-4cf6-9adf-e216080db3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5c2515ef-80ab-4207-95ad-7863e28ed58c" xlink:to="loc_us-gaap_StatementTable_e410ef27-73a5-4cf6-9adf-e216080db3dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5577bb54-95c8-4676-a07e-f5dc2df2af72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e410ef27-73a5-4cf6-9adf-e216080db3dc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5577bb54-95c8-4676-a07e-f5dc2df2af72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5577bb54-95c8-4676-a07e-f5dc2df2af72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5577bb54-95c8-4676-a07e-f5dc2df2af72" xlink:to="loc_us-gaap_EquityComponentDomain_5577bb54-95c8-4676-a07e-f5dc2df2af72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5577bb54-95c8-4676-a07e-f5dc2df2af72" xlink:to="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2b2578aa-ac0b-4605-8ca1-e153a83de782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_CommonStockMember_2b2578aa-ac0b-4605-8ca1-e153a83de782" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ad3abbb4-057c-4111-9823-3035b632a5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ad3abbb4-057c-4111-9823-3035b632a5e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7f8cd022-357f-46f3-a0e4-96233fe79395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_RetainedEarningsMember_7f8cd022-357f-46f3-a0e4-96233fe79395" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93437a9e-7971-4adf-84ef-dd9c3cd6a5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93437a9e-7971-4adf-84ef-dd9c3cd6a5d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_86510d61-ba7b-4372-817b-802467fc4fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_TreasuryStockMember_86510d61-ba7b-4372-817b-802467fc4fc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_dc936309-7ba1-4d93-a488-c786ea412068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_dc936309-7ba1-4d93-a488-c786ea412068" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#EARNINGSPERSHAREDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended" id="i10ca71ff46b54b278d57e33eed9f182d_EARNINGSPERSHAREDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b20594c0-a5ea-4cbd-a940-4d8a65719bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid_8e61c895-040f-44b7-93d9-018b7b34677a" xlink:href="dgx-20210630.xsd#dgx_AcceleratedShareRepurchasesInitialPricePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b20594c0-a5ea-4cbd-a940-4d8a65719bac" xlink:to="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid_8e61c895-040f-44b7-93d9-018b7b34677a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_ff92c320-3451-48e1-b366-71ec86d116b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b20594c0-a5ea-4cbd-a940-4d8a65719bac" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_ff92c320-3451-48e1-b366-71ec86d116b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e7d91411-6504-44a8-95d6-e4940f65c75f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_ff92c320-3451-48e1-b366-71ec86d116b4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e7d91411-6504-44a8-95d6-e4940f65c75f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e7d91411-6504-44a8-95d6-e4940f65c75f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e7d91411-6504-44a8-95d6-e4940f65c75f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e7d91411-6504-44a8-95d6-e4940f65c75f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_9cc02006-c278-4b01-adeb-c26b5dd232b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e7d91411-6504-44a8-95d6-e4940f65c75f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_9cc02006-c278-4b01-adeb-c26b5dd232b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_50057aa6-c5ea-4836-8c2c-9363f3cafeea" xlink:href="dgx-20210630.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_9cc02006-c278-4b01-adeb-c26b5dd232b9" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_50057aa6-c5ea-4836-8c2c-9363f3cafeea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="ie03b290d15634de5b2a9f78e2c1e904f_BUSINESSACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1166936e-607a-4d8e-a950-d82f40f849f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1166936e-607a-4d8e-a950-d82f40f849f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_47c50caf-787d-4766-8d2f-f7de8d0de34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_47c50caf-787d-4766-8d2f-f7de8d0de34f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0625d94c-249f-4f63-b991-da5d168d016b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_Goodwill_0625d94c-249f-4f63-b991-da5d168d016b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f5ed08fc-78e3-4d19-86e0-c1406de7093c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f5ed08fc-78e3-4d19-86e0-c1406de7093c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_deddba3d-b5db-4382-9838-c64b2b4d69a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_deddba3d-b5db-4382-9838-c64b2b4d69a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_09da23cd-34e8-4bd4-b0dc-ad81d25fe178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_09da23cd-34e8-4bd4-b0dc-ad81d25fe178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09da23cd-34e8-4bd4-b0dc-ad81d25fe178_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09da23cd-34e8-4bd4-b0dc-ad81d25fe178" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09da23cd-34e8-4bd4-b0dc-ad81d25fe178_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1e4cd2a-ace9-4d2d-8108-2e9c06e051c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09da23cd-34e8-4bd4-b0dc-ad81d25fe178" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1e4cd2a-ace9-4d2d-8108-2e9c06e051c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember_9350c3fa-0bc2-4e7f-867a-5a6c358ab504" xlink:href="dgx-20210630.xsd#dgx_MercyHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1e4cd2a-ace9-4d2d-8108-2e9c06e051c5" xlink:to="loc_dgx_MercyHealthMember_9350c3fa-0bc2-4e7f-867a-5a6c358ab504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb114415-a7ac-4e55-ab22-e5fe5f2aea65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb114415-a7ac-4e55-ab22-e5fe5f2aea65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eb114415-a7ac-4e55-ab22-e5fe5f2aea65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb114415-a7ac-4e55-ab22-e5fe5f2aea65" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_eb114415-a7ac-4e55-ab22-e5fe5f2aea65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ffb6f5ac-13bc-4083-9194-c30c357525a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb114415-a7ac-4e55-ab22-e5fe5f2aea65" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ffb6f5ac-13bc-4083-9194-c30c357525a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f5029cbd-1d51-46ba-911f-fc785135fb27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ffb6f5ac-13bc-4083-9194-c30c357525a5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f5029cbd-1d51-46ba-911f-fc785135fb27" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#DISPOSITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="extended" id="i1025bc9e02054689a7407e212f606454_DISPOSITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_238c0eaf-9610-4a49-bdc0-cfc3b8681a77" xlink:href="dgx-20210630.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_238c0eaf-9610-4a49-bdc0-cfc3b8681a77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_65a699dd-12a5-4979-8bf1-a0d24d7fa0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_65a699dd-12a5-4979-8bf1-a0d24d7fa0fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_99e3cd84-08df-44ad-b631-c59324949eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_99e3cd84-08df-44ad-b631-c59324949eb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c8ab4078-b2a3-436c-bf2e-86930f656549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c8ab4078-b2a3-436c-bf2e-86930f656549" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_040c3d60-907c-485f-b91e-bb897d85ec34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_040c3d60-907c-485f-b91e-bb897d85ec34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e9ddee24-5aa0-4899-80b2-f3fbc3dc15cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e9ddee24-5aa0-4899-80b2-f3fbc3dc15cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a5c763bf-d76a-4e0c-89c8-3ad732ae285a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a5c763bf-d76a-4e0c-89c8-3ad732ae285a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_197a48ed-b897-4565-bcef-b8ea371baaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_197a48ed-b897-4565-bcef-b8ea371baaa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_197a48ed-b897-4565-bcef-b8ea371baaa8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_197a48ed-b897-4565-bcef-b8ea371baaa8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_197a48ed-b897-4565-bcef-b8ea371baaa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b606fde-e8c1-451c-a2a8-309f4e0d82ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_197a48ed-b897-4565-bcef-b8ea371baaa8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b606fde-e8c1-451c-a2a8-309f4e0d82ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_ba97c0b9-b27c-4732-b79b-0c15855cf7fb" xlink:href="dgx-20210630.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b606fde-e8c1-451c-a2a8-309f4e0d82ec" xlink:to="loc_dgx_Q2SolutionsMember_ba97c0b9-b27c-4732-b79b-0c15855cf7fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d90d75ab-bc29-4669-9096-8289706ee2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d90d75ab-bc29-4669-9096-8289706ee2b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d90d75ab-bc29-4669-9096-8289706ee2b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d90d75ab-bc29-4669-9096-8289706ee2b1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d90d75ab-bc29-4669-9096-8289706ee2b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e7f10777-d605-40a4-abdb-881f0360cd34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d90d75ab-bc29-4669-9096-8289706ee2b1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e7f10777-d605-40a4-abdb-881f0360cd34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_da97051d-1f35-4e47-bf00-9a9950bba647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e7f10777-d605-40a4-abdb-881f0360cd34" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_da97051d-1f35-4e47-bf00-9a9950bba647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4ac7257f-033b-4b21-bff5-70ed43f8ff30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4ac7257f-033b-4b21-bff5-70ed43f8ff30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4ac7257f-033b-4b21-bff5-70ed43f8ff30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4ac7257f-033b-4b21-bff5-70ed43f8ff30" xlink:to="loc_us-gaap_EquityComponentDomain_4ac7257f-033b-4b21-bff5-70ed43f8ff30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fdb580ff-102b-4625-9e93-6d26c7e287b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4ac7257f-033b-4b21-bff5-70ed43f8ff30" xlink:to="loc_us-gaap_EquityComponentDomain_fdb580ff-102b-4625-9e93-6d26c7e287b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_b3875655-ac30-4a9a-b2e9-49dd19426bc2" xlink:href="dgx-20210630.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fdb580ff-102b-4625-9e93-6d26c7e287b9" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_b3875655-ac30-4a9a-b2e9-49dd19426bc2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i029124d20a584134a8d20eae8bbbabc4_FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_b452dd11-317d-44fd-873f-bd882b3d5ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_TradingSecurities_b452dd11-317d-44fd-873f-bd882b3d5ff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_b66d1329-df1f-415a-a080-eb7f8a619e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_b66d1329-df1f-415a-a080-eb7f8a619e4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_39e44f5a-8c5c-415f-b3b3-061df7029231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_39e44f5a-8c5c-415f-b3b3-061df7029231" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d1922007-1e52-4039-a126-e0fd20364a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d1922007-1e52-4039-a126-e0fd20364a8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_cee93da5-579b-4e85-8e9a-9f9f17c1a5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_cee93da5-579b-4e85-8e9a-9f9f17c1a5ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_117d900b-c603-496d-a22e-94fd2e813a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_117d900b-c603-496d-a22e-94fd2e813a7b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ec340a-418d-4ba2-b925-8318177d73d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ec340a-418d-4ba2-b925-8318177d73d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_73ec340a-418d-4ba2-b925-8318177d73d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ec340a-418d-4ba2-b925-8318177d73d0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_73ec340a-418d-4ba2-b925-8318177d73d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bb7b089e-1d6b-49fb-925d-90c8926e172b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ec340a-418d-4ba2-b925-8318177d73d0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bb7b089e-1d6b-49fb-925d-90c8926e172b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_3a00a25a-bfc2-4f02-b407-0e107f03ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_bb7b089e-1d6b-49fb-925d-90c8926e172b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_3a00a25a-bfc2-4f02-b407-0e107f03ab90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_350841f3-f2ed-4548-9d7c-7464548d3023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_350841f3-f2ed-4548-9d7c-7464548d3023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_350841f3-f2ed-4548-9d7c-7464548d3023_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_350841f3-f2ed-4548-9d7c-7464548d3023" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_350841f3-f2ed-4548-9d7c-7464548d3023_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_350841f3-f2ed-4548-9d7c-7464548d3023" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_baaa8671-fbb6-4601-8ca0-871ec0ee7ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_baaa8671-fbb6-4601-8ca0-871ec0ee7ac1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_daf4c1cd-3e63-4095-abb9-303e66768687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_daf4c1cd-3e63-4095-abb9-303e66768687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5acd29f8-b35f-4e8d-bfb8-77442e0ba8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5acd29f8-b35f-4e8d-bfb8-77442e0ba8c7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i1464505f1a0c4c1097a042777ca2430e_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0e0ee3e-1ca4-43c5-bcfc-a2d25c062e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_daf4cbd9-b000-4d1b-915b-f29551c3e129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0e0ee3e-1ca4-43c5-bcfc-a2d25c062e5e" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_daf4cbd9-b000-4d1b-915b-f29551c3e129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_26027bc1-fde6-4a8e-aa4a-405d35b4ef15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0e0ee3e-1ca4-43c5-bcfc-a2d25c062e5e" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_26027bc1-fde6-4a8e-aa4a-405d35b4ef15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0e0ee3e-1ca4-43c5-bcfc-a2d25c062e5e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_073d7d71-165d-4959-91c7-7a1ad9d793b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:to="loc_srt_OwnershipAxis_073d7d71-165d-4959-91c7-7a1ad9d793b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_073d7d71-165d-4959-91c7-7a1ad9d793b9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_073d7d71-165d-4959-91c7-7a1ad9d793b9" xlink:to="loc_srt_OwnershipDomain_073d7d71-165d-4959-91c7-7a1ad9d793b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_bc2cfdea-3dfc-40a3-8239-b2498712ebe4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_073d7d71-165d-4959-91c7-7a1ad9d793b9" xlink:to="loc_srt_OwnershipDomain_bc2cfdea-3dfc-40a3-8239-b2498712ebe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_dead2c93-a7c2-4a34-a11c-fa3f8c93d5ef" xlink:href="dgx-20210630.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_bc2cfdea-3dfc-40a3-8239-b2498712ebe4" xlink:to="loc_dgx_UMassJointVentureMember_dead2c93-a7c2-4a34-a11c-fa3f8c93d5ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9a8c005-e29f-40f5-961c-5b05b29bb00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9a8c005-e29f-40f5-961c-5b05b29bb00e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8c005-e29f-40f5-961c-5b05b29bb00e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9a8c005-e29f-40f5-961c-5b05b29bb00e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9a8c005-e29f-40f5-961c-5b05b29bb00e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ec7fa6a-7cd7-4283-b98b-38daa8527e65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9a8c005-e29f-40f5-961c-5b05b29bb00e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ec7fa6a-7cd7-4283-b98b-38daa8527e65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_38a286a5-c739-4c74-b30f-7d526c3de170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ec7fa6a-7cd7-4283-b98b-38daa8527e65" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_38a286a5-c739-4c74-b30f-7d526c3de170" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended" id="i76d3f8d88ce74caf8f6e36dfefe58c9a_GOODWILLANDINTANGIBLEASSETSGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b14318a9-37a7-4ad7-add0-56655c238f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_24c45cb9-7401-4c6d-b623-4ba2387fff13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b14318a9-37a7-4ad7-add0-56655c238f22" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_24c45cb9-7401-4c6d-b623-4ba2387fff13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fbb7f023-3a3a-4e10-a8ba-bb27af734496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b14318a9-37a7-4ad7-add0-56655c238f22" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fbb7f023-3a3a-4e10-a8ba-bb27af734496" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d39eec84-ed5b-415d-9d81-f10a2038cd02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fbb7f023-3a3a-4e10-a8ba-bb27af734496" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d39eec84-ed5b-415d-9d81-f10a2038cd02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d39eec84-ed5b-415d-9d81-f10a2038cd02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d39eec84-ed5b-415d-9d81-f10a2038cd02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d39eec84-ed5b-415d-9d81-f10a2038cd02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5603796c-d510-45f2-8cdd-e3fc6cea1dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d39eec84-ed5b-415d-9d81-f10a2038cd02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5603796c-d510-45f2-8cdd-e3fc6cea1dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_3e684f45-da86-4d3c-a177-0ae3abe8345f" xlink:href="dgx-20210630.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5603796c-d510-45f2-8cdd-e3fc6cea1dc3" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_3e684f45-da86-4d3c-a177-0ae3abe8345f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended" id="i7f4affb6fc4a4c13a6eb28b2048c8efe_GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:href="dgx-20210630.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fd35f283-59e1-449a-aa3f-d0bea1ce1bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fd35f283-59e1-449a-aa3f-d0bea1ce1bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b60c0439-7c26-41c0-89c0-9ef7d9e8cfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b60c0439-7c26-41c0-89c0-9ef7d9e8cfd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6f4a693a-07e3-48ac-bb8b-6be8636fe4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6f4a693a-07e3-48ac-bb8b-6be8636fe4cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3653e1ae-64f2-4d41-96d3-995e2744dfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3653e1ae-64f2-4d41-96d3-995e2744dfe0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f93df880-0176-474e-b593-676b789cbfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f93df880-0176-474e-b593-676b789cbfb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_38ec99bd-e013-4aff-bb2d-e8f334f84cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_38ec99bd-e013-4aff-bb2d-e8f334f84cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f770b546-10a2-484d-9aba-7bf93dca45bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f770b546-10a2-484d-9aba-7bf93dca45bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ece9334e-ff49-4141-a419-428ea7c3c981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ece9334e-ff49-4141-a419-428ea7c3c981" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_92066800-dc07-4100-8c2a-5fd4baeaa593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_92066800-dc07-4100-8c2a-5fd4baeaa593" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cb13b868-6f5e-4c90-855d-2f29cf8fad09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cb13b868-6f5e-4c90-855d-2f29cf8fad09" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc1b3ee3-13a2-444a-a208-be382dbfac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc1b3ee3-13a2-444a-a208-be382dbfac8a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5b60a833-f3fa-45da-959e-5671bef556c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5b60a833-f3fa-45da-959e-5671bef556c3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_35a8c8c8-40f4-4ef5-aaf8-257d991497dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_35a8c8c8-40f4-4ef5-aaf8-257d991497dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:href="dgx-20210630.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa4444af-e64c-4d60-973e-67c60bde1f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa4444af-e64c-4d60-973e-67c60bde1f7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa4444af-e64c-4d60-973e-67c60bde1f7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa4444af-e64c-4d60-973e-67c60bde1f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fa4444af-e64c-4d60-973e-67c60bde1f7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa4444af-e64c-4d60-973e-67c60bde1f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b9e1b8fc-897b-458d-965e-41fcdeb4f533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b9e1b8fc-897b-458d-965e-41fcdeb4f533" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_3a202bf9-05dc-4881-ae23-447b0b61d758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_3a202bf9-05dc-4881-ae23-447b0b61d758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_b172a52c-8648-49b9-b164-74eb69c6f9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_b172a52c-8648-49b9-b164-74eb69c6f9ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_aca43a96-682b-4223-ae13-360da6eab88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_aca43a96-682b-4223-ae13-360da6eab88d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_80b46af4-5614-4e83-9f16-27efbdb0859f" xlink:href="dgx-20210630.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_80b46af4-5614-4e83-9f16-27efbdb0859f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce03f58a-4137-4e5e-ad09-a59840c7ba5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce03f58a-4137-4e5e-ad09-a59840c7ba5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_6ada3a17-3065-4ae9-820c-25a129fa4ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce03f58a-4137-4e5e-ad09-a59840c7ba5d" xlink:to="loc_us-gaap_TradeNamesMember_6ada3a17-3065-4ae9-820c-25a129fa4ff1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_4f00a64b-eeaa-43a9-a255-a274982a87b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce03f58a-4137-4e5e-ad09-a59840c7ba5d" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_4f00a64b-eeaa-43a9-a255-a274982a87b4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended" id="i8e924ed4b41e40ae97dd935e091cda3d_FINANCIALINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ff8baf6b-f815-4419-a319-1bb81fa4eece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c92cdd3c-4b59-496f-98a3-3b2454f609e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ff8baf6b-f815-4419-a319-1bb81fa4eece" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c92cdd3c-4b59-496f-98a3-3b2454f609e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_351d999d-25cd-4054-880c-7c679a833bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ff8baf6b-f815-4419-a319-1bb81fa4eece" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_351d999d-25cd-4054-880c-7c679a833bba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ff8baf6b-f815-4419-a319-1bb81fa4eece" xlink:to="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d90bee79-8bbd-4af2-b4ea-755064da0565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d90bee79-8bbd-4af2-b4ea-755064da0565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d90bee79-8bbd-4af2-b4ea-755064da0565_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d90bee79-8bbd-4af2-b4ea-755064da0565" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d90bee79-8bbd-4af2-b4ea-755064da0565_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_371a8859-cea3-42c7-a667-b0a3ff88f11b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d90bee79-8bbd-4af2-b4ea-755064da0565" xlink:to="loc_us-gaap_HedgingRelationshipDomain_371a8859-cea3-42c7-a667-b0a3ff88f11b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_46015ff6-d5c0-4a81-9412-6855dd56c07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_371a8859-cea3-42c7-a667-b0a3ff88f11b" xlink:to="loc_us-gaap_CashFlowHedgingMember_46015ff6-d5c0-4a81-9412-6855dd56c07f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_cd552026-de07-406d-bedf-94c803038763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_371a8859-cea3-42c7-a667-b0a3ff88f11b" xlink:to="loc_us-gaap_FairValueHedgingMember_cd552026-de07-406d-bedf-94c803038763" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e08883f-007a-4b7e-83fd-62baac5c377f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:to="loc_srt_RangeAxis_6e08883f-007a-4b7e-83fd-62baac5c377f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e08883f-007a-4b7e-83fd-62baac5c377f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6e08883f-007a-4b7e-83fd-62baac5c377f" xlink:to="loc_srt_RangeMember_6e08883f-007a-4b7e-83fd-62baac5c377f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_23bcc53d-ee01-484c-a2a2-2526e9c34d46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6e08883f-007a-4b7e-83fd-62baac5c377f" xlink:to="loc_srt_RangeMember_23bcc53d-ee01-484c-a2a2-2526e9c34d46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f6226c0d-9fb2-4244-accd-667e875e467e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_23bcc53d-ee01-484c-a2a2-2526e9c34d46" xlink:to="loc_srt_MinimumMember_f6226c0d-9fb2-4244-accd-667e875e467e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended" id="i1fc349e01de347de9fd49998e567f7c6_FINANCIALINSTRUMENTSBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b12b079d-20f7-4a12-804b-43cd4bd84375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_f766a42d-f036-4fef-bac0-71bf6bf5f1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b12b079d-20f7-4a12-804b-43cd4bd84375" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_f766a42d-f036-4fef-bac0-71bf6bf5f1ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b12b079d-20f7-4a12-804b-43cd4bd84375" xlink:to="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c18732ea-ca6a-4082-bfba-122ec610d305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c18732ea-ca6a-4082-bfba-122ec610d305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c18732ea-ca6a-4082-bfba-122ec610d305_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c18732ea-ca6a-4082-bfba-122ec610d305" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c18732ea-ca6a-4082-bfba-122ec610d305_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_72ad7426-7341-4bb5-8693-af699ff0788e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c18732ea-ca6a-4082-bfba-122ec610d305" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_72ad7426-7341-4bb5-8693-af699ff0788e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_1c2e4d31-7990-4be4-b26c-c9949c48547f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_72ad7426-7341-4bb5-8693-af699ff0788e" xlink:to="loc_us-gaap_LongTermDebtMember_1c2e4d31-7990-4be4-b26c-c9949c48547f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_afff5771-c566-4b31-8858-75119034f14f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_afff5771-c566-4b31-8858-75119034f14f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_afff5771-c566-4b31-8858-75119034f14f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_afff5771-c566-4b31-8858-75119034f14f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_afff5771-c566-4b31-8858-75119034f14f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bc40e1d8-5233-473c-ae5c-3ce821af712f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_afff5771-c566-4b31-8858-75119034f14f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bc40e1d8-5233-473c-ae5c-3ce821af712f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_7748f61e-594f-4616-ae09-5f642571a849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bc40e1d8-5233-473c-ae5c-3ce821af712f" xlink:to="loc_us-gaap_FairValueHedgingMember_7748f61e-594f-4616-ae09-5f642571a849" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended" id="id8155d79bc1d42fbab0d2a1fafd2e44c_FINANCIALINSTRUMENTSIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a9c9c1bf-ab4e-4560-94fb-51fe0192372e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a9c9c1bf-ab4e-4560-94fb-51fe0192372e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c5a61441-29ca-41d6-8138-ab2b2b87c8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c5a61441-29ca-41d6-8138-ab2b2b87c8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_07858cd6-c574-483e-bb62-5f77b61167f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_07858cd6-c574-483e-bb62-5f77b61167f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:to="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e6ad928f-f470-40cb-a9de-042bf004a1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e6ad928f-f470-40cb-a9de-042bf004a1c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e6ad928f-f470-40cb-a9de-042bf004a1c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e6ad928f-f470-40cb-a9de-042bf004a1c7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e6ad928f-f470-40cb-a9de-042bf004a1c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5860437a-ffdc-478b-b47e-0cc16e3e857e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e6ad928f-f470-40cb-a9de-042bf004a1c7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5860437a-ffdc-478b-b47e-0cc16e3e857e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9314f476-ddda-490b-9509-2281019ccffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5860437a-ffdc-478b-b47e-0cc16e3e857e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9314f476-ddda-490b-9509-2281019ccffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cbbfacb5-742f-4b92-a44d-fd8809c50d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cbbfacb5-742f-4b92-a44d-fd8809c50d25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cbbfacb5-742f-4b92-a44d-fd8809c50d25_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cbbfacb5-742f-4b92-a44d-fd8809c50d25" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cbbfacb5-742f-4b92-a44d-fd8809c50d25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4d1f618c-1ffa-4181-9bce-df71844ff396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cbbfacb5-742f-4b92-a44d-fd8809c50d25" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4d1f618c-1ffa-4181-9bce-df71844ff396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_786d8956-6eb6-4588-b580-12b15413220d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4d1f618c-1ffa-4181-9bce-df71844ff396" xlink:to="loc_us-gaap_FairValueHedgingMember_786d8956-6eb6-4588-b580-12b15413220d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended" id="ia18152858f4f4985950ae0e38a6ed281_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:href="dgx-20210630.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_4ea5a232-dd2b-4fd6-be3d-dfcae41e43d6" xlink:href="dgx-20210630.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_4ea5a232-dd2b-4fd6-be3d-dfcae41e43d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_01ea269d-d4d4-4068-98c3-957cd6676bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_01ea269d-d4d4-4068-98c3-957cd6676bbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e85dcc08-e58f-438d-b442-cf31e2ae6e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e85dcc08-e58f-438d-b442-cf31e2ae6e9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_52a5bdcb-17eb-4e4b-9a90-a99f311b56b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_52a5bdcb-17eb-4e4b-9a90-a99f311b56b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_3c94a025-6053-44ba-9200-253478b0e042" xlink:href="dgx-20210630.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_3c94a025-6053-44ba-9200-253478b0e042" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8f4617eb-9a3f-4453-894f-e2002834d2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8f4617eb-9a3f-4453-894f-e2002834d2de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1b9ba180-0090-462e-bcf1-cd2dadfe5bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1b9ba180-0090-462e-bcf1-cd2dadfe5bae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_cd06da78-4796-44bf-bc0e-4e2b369f01d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_cd06da78-4796-44bf-bc0e-4e2b369f01d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_359f0a13-4823-42b0-827f-3eb53d08f65c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_359f0a13-4823-42b0-827f-3eb53d08f65c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_7e4852a1-ffc8-4b3e-85d1-ca027696c7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_7e4852a1-ffc8-4b3e-85d1-ca027696c7b3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_4bb95111-e059-404c-8240-409d924ee3e9" xlink:href="dgx-20210630.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_4bb95111-e059-404c-8240-409d924ee3e9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_42d4e468-295b-4abe-9046-87391aacbbe4" xlink:href="dgx-20210630.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_42d4e468-295b-4abe-9046-87391aacbbe4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_116f557a-3b53-4d4b-9860-997ee62ec9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_116f557a-3b53-4d4b-9860-997ee62ec9d6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_c9ef0876-ca36-4e81-b370-6a30da751f82" xlink:href="dgx-20210630.xsd#dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_c9ef0876-ca36-4e81-b370-6a30da751f82" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_07423bc4-221b-4a2b-b9ef-76fc7fb8e32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_07423bc4-221b-4a2b-b9ef-76fc7fb8e32a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8760d4f2-87f0-4521-9daf-126ba62b1c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8760d4f2-87f0-4521-9daf-126ba62b1c8a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:href="dgx-20210630.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2c9e1f9-e6b2-4245-8638-a840b9a92998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2c9e1f9-e6b2-4245-8638-a840b9a92998" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2c9e1f9-e6b2-4245-8638-a840b9a92998_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2c9e1f9-e6b2-4245-8638-a840b9a92998" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e2c9e1f9-e6b2-4245-8638-a840b9a92998_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_671a2720-1c0d-4d7a-b432-e8e87cc89cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2c9e1f9-e6b2-4245-8638-a840b9a92998" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_671a2720-1c0d-4d7a-b432-e8e87cc89cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_7f4a09f8-b594-4820-b874-840b2514a55a" xlink:href="dgx-20210630.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_671a2720-1c0d-4d7a-b432-e8e87cc89cd0" xlink:to="loc_dgx_Q2SolutionsMember_7f4a09f8-b594-4820-b874-840b2514a55a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_eed6fd76-ee69-4d39-adc3-ac951ef35fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_eed6fd76-ee69-4d39-adc3-ac951ef35fc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_eed6fd76-ee69-4d39-adc3-ac951ef35fc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_eed6fd76-ee69-4d39-adc3-ac951ef35fc9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_eed6fd76-ee69-4d39-adc3-ac951ef35fc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_523ac73e-b179-4fbe-bf1c-43fc095cbd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_eed6fd76-ee69-4d39-adc3-ac951ef35fc9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_523ac73e-b179-4fbe-bf1c-43fc095cbd9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_71e7a103-de81-4792-8edd-f7df0b12ef4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_523ac73e-b179-4fbe-bf1c-43fc095cbd9f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_71e7a103-de81-4792-8edd-f7df0b12ef4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cf379fe2-13b1-461d-9be2-fd7557516f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cf379fe2-13b1-461d-9be2-fd7557516f83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cf379fe2-13b1-461d-9be2-fd7557516f83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cf379fe2-13b1-461d-9be2-fd7557516f83" xlink:to="loc_us-gaap_EquityComponentDomain_cf379fe2-13b1-461d-9be2-fd7557516f83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cf379fe2-13b1-461d-9be2-fd7557516f83" xlink:to="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_137c7df8-2c3a-488a-b24e-1043ff0debd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:to="loc_us-gaap_TreasuryStockMember_137c7df8-2c3a-488a-b24e-1043ff0debd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e0b55d31-ecee-40ec-9b71-298e406cd64f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e0b55d31-ecee-40ec-9b71-298e406cd64f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_9c8e2215-3c50-454d-bb67-4a6816475447" xlink:href="dgx-20210630.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_9c8e2215-3c50-454d-bb67-4a6816475447" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_a07ca18e-8eda-463e-8fef-942c95ddb635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_a07ca18e-8eda-463e-8fef-942c95ddb635" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_a07ca18e-8eda-463e-8fef-942c95ddb635_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_a07ca18e-8eda-463e-8fef-942c95ddb635" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_a07ca18e-8eda-463e-8fef-942c95ddb635_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_01252a42-3998-4c16-a883-967ebc003480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_a07ca18e-8eda-463e-8fef-942c95ddb635" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_01252a42-3998-4c16-a883-967ebc003480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_6dd016d6-e586-4057-b011-13fd3a64fff7" xlink:href="dgx-20210630.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_01252a42-3998-4c16-a883-967ebc003480" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_6dd016d6-e586-4057-b011-13fd3a64fff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_15980737-166c-429f-8b71-e7507f9f6cf1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_srt_OwnershipAxis_15980737-166c-429f-8b71-e7507f9f6cf1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_15980737-166c-429f-8b71-e7507f9f6cf1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_15980737-166c-429f-8b71-e7507f9f6cf1" xlink:to="loc_srt_OwnershipDomain_15980737-166c-429f-8b71-e7507f9f6cf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_fd79bdb9-a862-4b30-97fa-1089af2bdc50" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_15980737-166c-429f-8b71-e7507f9f6cf1" xlink:to="loc_srt_OwnershipDomain_fd79bdb9-a862-4b30-97fa-1089af2bdc50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_831c8dfd-b012-45b5-9d8a-8481945854df" xlink:href="dgx-20210630.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_fd79bdb9-a862-4b30-97fa-1089af2bdc50" xlink:to="loc_dgx_UMassJointVentureMember_831c8dfd-b012-45b5-9d8a-8481945854df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="extended" id="i966790d923754d84a8e890ac675aacc0_SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:href="dgx-20210630.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_62d2382c-a266-4da6-b4a7-1b11d80ee9c5" xlink:href="dgx-20210630.xsd#dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:to="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_62d2382c-a266-4da6-b4a7-1b11d80ee9c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_2328853d-cb38-4e1b-97ad-30e1c9da6725" xlink:href="dgx-20210630.xsd#dgx_CARESActProceedsRecognizedInTheStatementOfOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:to="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_2328853d-cb38-4e1b-97ad-30e1c9da6725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfRecognitionOfCARESActProceeds_6fbfc14d-4029-42ad-820a-bacc8a9058f9" xlink:href="dgx-20210630.xsd#dgx_ReversalOfRecognitionOfCARESActProceeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:to="loc_dgx_ReversalOfRecognitionOfCARESActProceeds_6fbfc14d-4029-42ad-820a-bacc8a9058f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_c30f86d7-095f-4045-a09c-ae5db5c56625" xlink:href="dgx-20210630.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_c30f86d7-095f-4045-a09c-ae5db5c56625" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2e717155-cf24-409c-ace0-3edf6d9ad105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_c30f86d7-095f-4045-a09c-ae5db5c56625" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2e717155-cf24-409c-ace0-3edf6d9ad105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2e717155-cf24-409c-ace0-3edf6d9ad105_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e717155-cf24-409c-ace0-3edf6d9ad105" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2e717155-cf24-409c-ace0-3edf6d9ad105_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_854c6a4e-7879-4191-b7bf-c1b04b022b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e717155-cf24-409c-ace0-3edf6d9ad105" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_854c6a4e-7879-4191-b7bf-c1b04b022b53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_b912f148-3ed0-4324-8a10-8da1bfb4809c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_854c6a4e-7879-4191-b7bf-c1b04b022b53" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_b912f148-3ed0-4324-8a10-8da1bfb4809c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ic6d1e2a3212c4291952f9b0456f1c1f0_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_991f49fc-5a8e-442a-b1b3-424552c21860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_f2d8d08c-bd8b-45ce-beea-c22de920eb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_991f49fc-5a8e-442a-b1b3-424552c21860" xlink:to="loc_us-gaap_LitigationReserve_f2d8d08c-bd8b-45ce-beea-c22de920eb31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_a4514860-8369-4cbe-a7d5-e288247f0526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_991f49fc-5a8e-442a-b1b3-424552c21860" xlink:to="loc_us-gaap_LossContingenciesTable_a4514860-8369-4cbe-a7d5-e288247f0526" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a9a9df04-718b-47c0-b99e-6aa092a889e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_a4514860-8369-4cbe-a7d5-e288247f0526" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a9a9df04-718b-47c0-b99e-6aa092a889e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a9a9df04-718b-47c0-b99e-6aa092a889e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a9a9df04-718b-47c0-b99e-6aa092a889e6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_a9a9df04-718b-47c0-b99e-6aa092a889e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9159901a-00ea-4235-b4d0-283ea25d9bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a9a9df04-718b-47c0-b99e-6aa092a889e6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9159901a-00ea-4235-b4d0-283ea25d9bcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5bea76f6-1008-4167-805d-39f8a5845d70" xlink:href="dgx-20210630.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9159901a-00ea-4235-b4d0-283ea25d9bcb" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5bea76f6-1008-4167-805d-39f8a5845d70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b4edb75c-5ef7-459c-9597-59940d57ee76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d6569340-041d-47ef-a9c3-8385fa09dc47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4edb75c-5ef7-459c-9597-59940d57ee76" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d6569340-041d-47ef-a9c3-8385fa09dc47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4e9a7b1b-3841-4a87-a11e-a3bddf274b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4edb75c-5ef7-459c-9597-59940d57ee76" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4e9a7b1b-3841-4a87-a11e-a3bddf274b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4edb75c-5ef7-459c-9597-59940d57ee76" xlink:to="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_da22ae23-52cd-4d34-af65-21d2a274b080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_da22ae23-52cd-4d34-af65-21d2a274b080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_da22ae23-52cd-4d34-af65-21d2a274b080_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_da22ae23-52cd-4d34-af65-21d2a274b080" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_da22ae23-52cd-4d34-af65-21d2a274b080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_be8a6bb3-9b2a-40cc-a90a-d6f2cfd926f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_da22ae23-52cd-4d34-af65-21d2a274b080" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_be8a6bb3-9b2a-40cc-a90a-d6f2cfd926f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_1eecaee0-f15b-4294-9b68-a0e83908d03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_be8a6bb3-9b2a-40cc-a90a-d6f2cfd926f5" xlink:to="loc_us-gaap_SecuredDebtMember_1eecaee0-f15b-4294-9b68-a0e83908d03b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_5db7d966-ca34-4e44-8e51-0d5cdcfee628" xlink:href="dgx-20210630.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_be8a6bb3-9b2a-40cc-a90a-d6f2cfd926f5" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_5db7d966-ca34-4e44-8e51-0d5cdcfee628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_56642a4c-cf7b-43cd-b51e-d292026766ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:to="loc_us-gaap_CreditFacilityAxis_56642a4c-cf7b-43cd-b51e-d292026766ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_56642a4c-cf7b-43cd-b51e-d292026766ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_56642a4c-cf7b-43cd-b51e-d292026766ae" xlink:to="loc_us-gaap_CreditFacilityDomain_56642a4c-cf7b-43cd-b51e-d292026766ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bf155394-5894-4b9b-88fc-426481002e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_56642a4c-cf7b-43cd-b51e-d292026766ae" xlink:to="loc_us-gaap_CreditFacilityDomain_bf155394-5894-4b9b-88fc-426481002e82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d098306d-c6eb-4b26-99b5-4bec12a8c0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_bf155394-5894-4b9b-88fc-426481002e82" xlink:to="loc_us-gaap_LetterOfCreditMember_d098306d-c6eb-4b26-99b5-4bec12a8c0a7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="i49a977c048ec4db089595dab1f35e887_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_1e64c590-1a06-46d2-8f2c-8116f435590a" xlink:href="dgx-20210630.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_dgx_PercentageofNetRevenues_1e64c590-1a06-46d2-8f2c-8116f435590a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25f160a8-0a3e-416c-b715-ce7e9e027eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25f160a8-0a3e-416c-b715-ce7e9e027eec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dbbd3554-52ae-4e14-ae29-e0b3d2cc84ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_OperatingIncomeLoss_dbbd3554-52ae-4e14-ae29-e0b3d2cc84ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_923dc601-8c07-48ce-bfd9-098939b3b10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_923dc601-8c07-48ce-bfd9-098939b3b10c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c631664a-602c-4f9e-a53f-32f6b6887978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c631664a-602c-4f9e-a53f-32f6b6887978" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1e755b66-5494-4753-9301-d0e5a646abec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1e755b66-5494-4753-9301-d0e5a646abec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5edb0d85-6049-46c6-8b73-0cd2ffe2af95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5edb0d85-6049-46c6-8b73-0cd2ffe2af95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a1c3c7cd-7300-4f28-86a3-8279b191a79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_ProfitLoss_a1c3c7cd-7300-4f28-86a3-8279b191a79c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb08c1b8-d011-4f68-b3a6-8eaf9d53ef10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb08c1b8-d011-4f68-b3a6-8eaf9d53ef10" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eac705c2-bb2e-406e-9818-6eeeaedc6cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_NetIncomeLoss_eac705c2-bb2e-406e-9818-6eeeaedc6cdd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cd66cc73-59e0-400f-8640-65481a9478c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cd66cc73-59e0-400f-8640-65481a9478c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd66cc73-59e0-400f-8640-65481a9478c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cd66cc73-59e0-400f-8640-65481a9478c9" xlink:to="loc_us-gaap_SegmentDomain_cd66cc73-59e0-400f-8640-65481a9478c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cd66cc73-59e0-400f-8640-65481a9478c9" xlink:to="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_5303bc35-8358-462f-afe5-e7518b62b3a5" xlink:href="dgx-20210630.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_5303bc35-8358-462f-afe5-e7518b62b3a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_96f60d2b-d836-4fc7-8619-d369cb1780c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:to="loc_us-gaap_AllOtherSegmentsMember_96f60d2b-d836-4fc7-8619-d369cb1780c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_af474e7e-d581-4714-b592-9c154ff3f314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:to="loc_us-gaap_CorporateMember_af474e7e-d581-4714-b592-9c154ff3f314" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ac408f70-9341-41f5-8409-3dffa59a33b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:to="loc_srt_RangeAxis_ac408f70-9341-41f5-8409-3dffa59a33b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ac408f70-9341-41f5-8409-3dffa59a33b6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ac408f70-9341-41f5-8409-3dffa59a33b6" xlink:to="loc_srt_RangeMember_ac408f70-9341-41f5-8409-3dffa59a33b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9531ac6-5631-4878-9877-e01d90ec0a94" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ac408f70-9341-41f5-8409-3dffa59a33b6" xlink:to="loc_srt_RangeMember_d9531ac6-5631-4878-9877-e01d90ec0a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6f5cd028-2340-4a54-9f5d-d522a962e738" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d9531ac6-5631-4878-9877-e01d90ec0a94" xlink:to="loc_srt_MinimumMember_6f5cd028-2340-4a54-9f5d-d522a962e738" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ee789994-b3e5-4395-88ef-a29f4fa01b42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:to="loc_srt_ProductOrServiceAxis_ee789994-b3e5-4395-88ef-a29f4fa01b42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee789994-b3e5-4395-88ef-a29f4fa01b42_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ee789994-b3e5-4395-88ef-a29f4fa01b42" xlink:to="loc_srt_ProductsAndServicesDomain_ee789994-b3e5-4395-88ef-a29f4fa01b42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ee789994-b3e5-4395-88ef-a29f4fa01b42" xlink:to="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_80e8b52e-2ebd-447a-a1bb-598cf7c35bf0" xlink:href="dgx-20210630.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_80e8b52e-2ebd-447a-a1bb-598cf7c35bf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_d6136af5-e35a-4873-8b79-1c865b05b76b" xlink:href="dgx-20210630.xsd#dgx_COVID19TestingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_COVID19TestingServicesMember_d6136af5-e35a-4873-8b79-1c865b05b76b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_76f57ab7-88bf-48a5-8892-86a7782358a0" xlink:href="dgx-20210630.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_76f57ab7-88bf-48a5-8892-86a7782358a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_79f012d2-6b8b-442b-9a7b-c49c8c30343b" xlink:href="dgx-20210630.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_79f012d2-6b8b-442b-9a7b-c49c8c30343b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_c75afd92-4ce8-4d82-b4f3-7a8d094f6414" xlink:href="dgx-20210630.xsd#dgx_AllotherservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_AllotherservicesMember_c75afd92-4ce8-4d82-b4f3-7a8d094f6414" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="iff1394399b8347f6b2acecfeae1322a8_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_87b0e54f-6fa5-40a5-88b6-634fd3cf33c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_0cfea775-bee6-4723-b449-52ae6c1d3c39" xlink:href="dgx-20210630.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87b0e54f-6fa5-40a5-88b6-634fd3cf33c3" xlink:to="loc_dgx_PercentageofNetRevenues_0cfea775-bee6-4723-b449-52ae6c1d3c39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_fd9508b4-d28d-4014-8df9-1ac9a5299690" xlink:href="dgx-20210630.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87b0e54f-6fa5-40a5-88b6-634fd3cf33c3" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_fd9508b4-d28d-4014-8df9-1ac9a5299690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87b0e54f-6fa5-40a5-88b6-634fd3cf33c3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_25246928-7993-4b05-ac7b-d02f484dd8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_25246928-7993-4b05-ac7b-d02f484dd8a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_25246928-7993-4b05-ac7b-d02f484dd8a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25246928-7993-4b05-ac7b-d02f484dd8a7" xlink:to="loc_us-gaap_SegmentDomain_25246928-7993-4b05-ac7b-d02f484dd8a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d58a5e1-e12b-4873-ba0f-e0de7474999f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25246928-7993-4b05-ac7b-d02f484dd8a7" xlink:to="loc_us-gaap_SegmentDomain_9d58a5e1-e12b-4873-ba0f-e0de7474999f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_7bf82e44-1bfd-4521-80b0-4c41a04df967" xlink:href="dgx-20210630.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d58a5e1-e12b-4873-ba0f-e0de7474999f" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_7bf82e44-1bfd-4521-80b0-4c41a04df967" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_0274e774-1d76-4fdb-8e95-8ebbabc9d422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d58a5e1-e12b-4873-ba0f-e0de7474999f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_0274e774-1d76-4fdb-8e95-8ebbabc9d422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0e3d1f5f-1dc8-4603-8168-bc808907a4f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_srt_RangeAxis_0e3d1f5f-1dc8-4603-8168-bc808907a4f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0e3d1f5f-1dc8-4603-8168-bc808907a4f0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0e3d1f5f-1dc8-4603-8168-bc808907a4f0" xlink:to="loc_srt_RangeMember_0e3d1f5f-1dc8-4603-8168-bc808907a4f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e96ceec-583a-43c5-ad7b-21ae0f8218db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0e3d1f5f-1dc8-4603-8168-bc808907a4f0" xlink:to="loc_srt_RangeMember_6e96ceec-583a-43c5-ad7b-21ae0f8218db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c18ee01d-a9ec-4d4b-ab58-89108fb8add9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6e96ceec-583a-43c5-ad7b-21ae0f8218db" xlink:to="loc_srt_MinimumMember_c18ee01d-a9ec-4d4b-ab58-89108fb8add9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_652830b9-3d62-4e53-a485-3236e31cd358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_us-gaap_SubsegmentsAxis_652830b9-3d62-4e53-a485-3236e31cd358" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_652830b9-3d62-4e53-a485-3236e31cd358_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_652830b9-3d62-4e53-a485-3236e31cd358" xlink:to="loc_us-gaap_SubsegmentsDomain_652830b9-3d62-4e53-a485-3236e31cd358_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_652830b9-3d62-4e53-a485-3236e31cd358" xlink:to="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_3ebb7d4b-2e69-40d5-a3a0-e57da60de6df" xlink:href="dgx-20210630.xsd#dgx_HealthcareInsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_HealthcareInsurersMember_3ebb7d4b-2e69-40d5-a3a0-e57da60de6df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_65143acb-015d-4e1e-9beb-2d15bcf2ac32" xlink:href="dgx-20210630.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_GovernmentPayersMember_65143acb-015d-4e1e-9beb-2d15bcf2ac32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_f4a9070f-a53e-4386-b044-7fb7c14fe32f" xlink:href="dgx-20210630.xsd#dgx_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_ClientPayersMember_f4a9070f-a53e-4386-b044-7fb7c14fe32f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_960ce8ce-e061-4bbb-96a8-8a7a2d98a64c" xlink:href="dgx-20210630.xsd#dgx_PatientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_PatientsMember_960ce8ce-e061-4bbb-96a8-8a7a2d98a64c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_044fb4c5-73d8-4f94-91c4-db80a40bbd7f" xlink:href="dgx-20210630.xsd#dgx_DSBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_DSBusinessesMember_044fb4c5-73d8-4f94-91c4-db80a40bbd7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3c279b6e-17aa-4939-85c5-a3a3b3b699eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_srt_ProductOrServiceAxis_3c279b6e-17aa-4939-85c5-a3a3b3b699eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3c279b6e-17aa-4939-85c5-a3a3b3b699eb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3c279b6e-17aa-4939-85c5-a3a3b3b699eb" xlink:to="loc_srt_ProductsAndServicesDomain_3c279b6e-17aa-4939-85c5-a3a3b3b699eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_99b14c37-ad71-4bf9-8e28-585d7550cacc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3c279b6e-17aa-4939-85c5-a3a3b3b699eb" xlink:to="loc_srt_ProductsAndServicesDomain_99b14c37-ad71-4bf9-8e28-585d7550cacc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_6ac2af86-c1e1-451c-998a-67627224c24a" xlink:href="dgx-20210630.xsd#dgx_FeeforserviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_99b14c37-ad71-4bf9-8e28-585d7550cacc" xlink:to="loc_dgx_FeeforserviceMember_6ac2af86-c1e1-451c-998a-67627224c24a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_d415a691-56fb-4cf5-bfed-fbef06deaf7f" xlink:href="dgx-20210630.xsd#dgx_CapitatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_99b14c37-ad71-4bf9-8e28-585d7550cacc" xlink:to="loc_dgx_CapitatedMember_d415a691-56fb-4cf5-bfed-fbef06deaf7f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#TAXESONINCOMEDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended" id="iaddd50acd8644039b84c510fe245bcc3_TAXESONINCOMEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e887b8cf-5b15-4175-90eb-8980641a8d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e887b8cf-5b15-4175-90eb-8980641a8d8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_e12e39fd-62eb-495b-93c3-8d5e378cf28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_e12e39fd-62eb-495b-93c3-8d5e378cf28f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_6a2d206b-8c84-46c4-a742-a5c1896fae4e" xlink:href="dgx-20210630.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_6a2d206b-8c84-46c4-a742-a5c1896fae4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_59732518-ecc5-4677-be39-8868baf723f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_59732518-ecc5-4677-be39-8868baf723f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_59732518-ecc5-4677-be39-8868baf723f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_59732518-ecc5-4677-be39-8868baf723f2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_59732518-ecc5-4677-be39-8868baf723f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_424d0200-e6fe-431b-be49-af5b2994d742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_59732518-ecc5-4677-be39-8868baf723f2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_424d0200-e6fe-431b-be49-af5b2994d742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_94d0d0b9-2dfa-452e-ad2b-b574fe290a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_424d0200-e6fe-431b-be49-af5b2994d742" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_94d0d0b9-2dfa-452e-ad2b-b574fe290a7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_198f4cf9-4dbc-4f55-aaba-97ffb9559c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_198f4cf9-4dbc-4f55-aaba-97ffb9559c88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_198f4cf9-4dbc-4f55-aaba-97ffb9559c88_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_198f4cf9-4dbc-4f55-aaba-97ffb9559c88" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_198f4cf9-4dbc-4f55-aaba-97ffb9559c88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_67e6e2c2-b271-4c0f-8ff0-8b900eaf1e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_198f4cf9-4dbc-4f55-aaba-97ffb9559c88" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_67e6e2c2-b271-4c0f-8ff0-8b900eaf1e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_575f652b-d4e0-4a8a-8d7f-a328b00fbb25" xlink:href="dgx-20210630.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_67e6e2c2-b271-4c0f-8ff0-8b900eaf1e72" xlink:to="loc_dgx_Q2SolutionsMember_575f652b-d4e0-4a8a-8d7f-a328b00fbb25" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>dgx-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c0ef2d88-a53d-457b-ba3c-2a15db2c46ae,g:aea639b6-1560-47bd-8a23-0a619e498ffc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_LetterOfCreditMember_df634e5e-dc00-4596-9140-964477b241c8_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_435daf79-4ed6-4907-840d-def1b35287da_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aaacfcbf-152d-4f45-940f-90355a50acd3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_3696dcfb-b9a9-4211-bc42-c711c8db33f0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_63d61d8b-f20e-4df2-bb86-989794a33387_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6b9fe56f-b3a7-4767-b102-d68a4b5c4311_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_777ee947-4ee3-46f0-9b00-1139f8ee9606_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8fc4ee79-0de7-48fe-b00a-a075a612c5fa_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of investment, before tax</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7799364b-c591-401c-9c7b-ef65e7077bd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of investment, before tax</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_8606e19e-fbe2-4b83-871b-da1148f9553b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_59f2e915-3f3f-45e0-a9cd-2884550a5dab_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_04305e20-bd2d-49c8-bcf7-dd7b890e7fd2_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c24a1407-45bf-4144-83e5-4d6cb22a647f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_abfdcc80-b977-4805-aece-a35a251b3b06_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_e370ffef-bb1c-4aa2-92b4-064b13883e38_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_adfffa25-18f2-4ffe-b952-ce2f8c01c07b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_002c47f3-bf22-4c51-b698-cbeee02e71d7_terseLabel_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_label_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_documentation_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:href="dgx-20210630.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:to="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_395e68ea-5ce1-40da-807d-4360747b2f17_terseLabel_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_label_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_documentation_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:href="dgx-20210630.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:to="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_7f10c379-d255-468c-a979-c8dffccdb35b_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_66535859-e6b7-4eb2-81c3-d243a364fcf1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_8a1774b7-2085-4714-85fd-31c1cbba72ca_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_28b8ebcb-1b85-4185-a975-12c3b9cd5829_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d0823c1c-c8aa-41c3-9528-36e2dce184da_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_aa6c1962-c818-4bd6-81a9-97ff74c0ef74_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_a2473705-cbd8-4dcc-a5ca-9d95bc703214_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a04b896f-e302-4870-a84f-6151f9c03d36_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_f091f80d-df5b-4aff-a6d4-d3196edc8dc1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposition of investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_442afa9d-27dc-450a-a407-15ad0ab01432_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_41e80721-0d7c-4d1a-9381-b3f7f390aa52_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3392d61b-3ca8-4367-a8bc-35b9f07be7eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_5642e912-88e6-490d-b9a3-df8ab86d529f_netLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISPOSITION</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_f948002e-2062-425e-a805-a97b27f7042d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f8cae448-0509-4efb-b489-b5c6256b5c7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedge Accounting on the Statement of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f7f505ff-1677-4511-8207-b2c9dcb81dc4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UMassJointVentureMember_3b5c9f8a-fcec-423b-937e-a748fd37279a_terseLabel_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_label_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_documentation_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember" xlink:href="dgx-20210630.xsd#dgx_UMassJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UMassJointVentureMember" xlink:to="lab_dgx_UMassJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_f2032dab-43b0-4e87-a6aa-5077aa3d8796_terseLabel_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:href="dgx-20210630.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:to="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0a2adc2f-a568-4c2b-a98a-db3e8e9d6e48_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_99d58985-a392-422b-806d-9ff0dc993f5d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_463e7685-b2fa-4030-a9eb-da1bdaf4d1a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization remaining available</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_bb78e630-f1cd-4bd3-a5e9-5c4b2c4ba849_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Other</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_50e68307-8b0c-4511-8303-9cdfb8c84b14_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9e4c1c62-e5c5-4265-a952-a7bc860bb8ad_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_b0fda92a-bed8-4ddc-96cf-5377978ae9d9_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Accounting Basis Adjustment</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_a09cb717-e935-42f5-b7d3-b9656871c5d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_be615a55-e6cc-4913-87ba-f26a448bdad8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_f3157b5b-1f99-45c1-942b-f15528906e2d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_93d3e914-8750-40e0-9bbd-c5455d4cd5f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_d57779e4-73e9-454c-a99d-95ce89d9eadd_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d32ce7b8-fab4-439f-b81a-6c90429448d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_9a5b00ff-ea97-4665-b48b-c2fa2af0f1e8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetRevenues_92b9d087-40bf-41d1-afcb-a1d624235074_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_label_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_documentation_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues" xlink:href="dgx-20210630.xsd#dgx_PercentageofNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetRevenues" xlink:to="lab_dgx_PercentageofNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_2d7f31d2-ad9e-4483-a916-bf8a056e7f0b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_f8998365-5b87-4c7d-943a-60fcc820820b_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_f1957e45-693f-4259-9ca2-1685ed91a04c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposition of investment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0e388301-e624-4fee-b97e-56d4383ab370_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_c0e62f8a-68e5-4776-860a-554f45f6104e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ReversalOfRecognitionOfCARESActProceeds_9341d076-f197-4d97-8516-04ebe625793b_terseLabel_en-US" xlink:label="lab_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of recognition of CARES Act proceeds</link:label>
    <link:label id="lab_dgx_ReversalOfRecognitionOfCARESActProceeds_label_en-US" xlink:label="lab_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of recognition of CARES Act proceeds</link:label>
    <link:label id="lab_dgx_ReversalOfRecognitionOfCARESActProceeds_documentation_en-US" xlink:label="lab_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of recognition of CARES Act proceeds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:href="dgx-20210630.xsd#dgx_ReversalOfRecognitionOfCARESActProceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:to="lab_dgx_ReversalOfRecognitionOfCARESActProceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_47d26615-0088-4391-9748-bf446f4acc31_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ccaadeea-fe85-44bc-b04c-975039ba7338_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_530878ff-2e4c-4a6a-a4e4-b6afc02c6108_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c67ad0cd-1130-4e4c-ab47-9dde7fe5ec0e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapitatedMember_e036949d-4bd3-48a9-bcf7-eae38b8a94e0_terseLabel_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated</link:label>
    <link:label id="lab_dgx_CapitatedMember_label_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:label id="lab_dgx_CapitatedMember_documentation_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember" xlink:href="dgx-20210630.xsd#dgx_CapitatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapitatedMember" xlink:to="lab_dgx_CapitatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_89955b1a-86c7-4293-b6bd-7fde465706ae_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_cfa65058-0cf3-4e4d-a1d1-d6a7e14a899e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_a1f6c054-42b5-4409-9edf-f98b5c0ed35f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_995a56d7-78da-4831-a431-bee584428947_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_6e60e006-1b48-495b-abda-0092964b0b18_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Receivables Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_ccc13edc-2fde-495a-965d-d1f3ed8c4f53_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1384e6b3-5e40-48c9-85a4-c1574d3b0e58_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7156b1c1-37f8-4f7e-9665-f821fd3248cb_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_3c2021ee-f916-455a-99dc-f3ea852e4939_terseLabel_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_label_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_documentation_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:href="dgx-20210630.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:to="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_46a8f76b-e92c-4e59-860a-f1110a4a88bf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_daa56b91-c94c-476a-85fc-b2e9717751f5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9b95ea4a-b92a-4310-a87a-7298ee0353be_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf062013-4160-49b6-ad6d-8f6b9c325c39_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_458f00f4-431c-4d1c-b6f2-8ddecb326992_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_b39159ff-cba4-4aa6-8631-1705577a6c3a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ae55e37b-9f8c-4b59-9876-eace86bd3ead_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic(in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_d798f5ad-806b-48f7-aa16-3e467fc46af1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action lawsuits</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_734009a3-0fbf-4a55-a45f-0be255c3e145_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_c26cc219-436b-44a5-b6aa-172d0bc90c0e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_da111e86-bf45-4a3e-b505-392e24a088e6_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2b542e38-643c-4be7-b7d8-c11a40471ddd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_74202994-13e5-4997-8bbb-f7f6ff32e01b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_f8e9e5b8-6ce5-488c-9f3b-037785deaebb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_ae5e11cd-fa55-45a6-a3ea-213dc14a55c3_terseLabel_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of ownership interest sold</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_label_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_documentation_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:href="dgx-20210630.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:to="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_61b17b84-4b85-4d01-9a95-9e5d173466ff_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_04304c98-b1b5-46ac-a4ec-b72a846dbec1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7eb476e8-f842-42fc-8960-8a355bc09359_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_33f59856-0bff-4a4e-8d98-0db513857093_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_90d8f465-75fc-47ac-9125-59d1c6815489_netLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_426caf9d-4d79-43ad-bc2b-f3fa1be98b91_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:href="dgx-20210630.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:to="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_e39635b9-0342-45b1-92d8-8b76441ef995_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2efb2064-ee47-4627-b714-e90760354d4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_bda5049f-af77-4300-ac96-0ea17e1d495d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Q2SolutionsMember_c42b24de-bc4e-49b7-865a-ea7fb2696bae_terseLabel_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_label_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions [Member]</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_documentation_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember" xlink:href="dgx-20210630.xsd#dgx_Q2SolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Q2SolutionsMember" xlink:to="lab_dgx_Q2SolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_484449a7-c78e-4c3f-b238-a5540c5b6c0d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6a5ac6ce-90e5-40f4-979c-b33a9c02c2d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_44ccdb62-a64c-4704-bd6c-75e7fccaf678_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_1b6fe920-b9a0-401c-98c5-83958ae14435_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accounts receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_label_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_documentation_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable" xlink:href="dgx-20210630.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetAccountsReceivable" xlink:to="lab_dgx_PercentageofNetAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ced1c6f6-fa1b-4e0d-948c-36bf7123a2a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0c3fdfe0-45e9-45c0-ae79-cdba6824811d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_be19f8bc-e080-427c-b648-0e88083cb3ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_252d4b4d-094d-4cd9-baef-34453ec131bb_terseLabel_en-US" xlink:label="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act proceeds recognized in the statement of operations</link:label>
    <link:label id="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_label_en-US" xlink:label="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act proceeds recognized in the statement of operations</link:label>
    <link:label id="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_documentation_en-US" xlink:label="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act proceeds recognized in the statement of operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:href="dgx-20210630.xsd#dgx_CARESActProceedsRecognizedInTheStatementOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:to="lab_dgx_CARESActProceedsRecognizedInTheStatementOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AllotherservicesMember_2acf51b3-34ad-4427-9e8f-959ebee7099c_terseLabel_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_label_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_documentation_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember" xlink:href="dgx-20210630.xsd#dgx_AllotherservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AllotherservicesMember" xlink:to="lab_dgx_AllotherservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1dd3b6bf-3a8c-4653-8c68-d72e90ab1e3d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_a484d61f-df33-40e7-b6eb-93e781327359_terseLabel_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase, percent of total value to be repurchased</link:label>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_label_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</link:label>
    <link:label id="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_documentation_en-US" xlink:label="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:href="dgx-20210630.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:to="lab_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_b9c69379-499e-4fa5-bc23-b41d1640cc84_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PatientsMember_7ba15a7d-9ebc-4597-a848-79f89a552014_terseLabel_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients</link:label>
    <link:label id="lab_dgx_PatientsMember_label_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:label id="lab_dgx_PatientsMember_documentation_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember" xlink:href="dgx-20210630.xsd#dgx_PatientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PatientsMember" xlink:to="lab_dgx_PatientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_ac5a6418-b58c-4d32-a55f-7dcaf41a13fd_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, period Increase (decrease)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_91758f63-3615-40d0-aa68-c335578b9b25_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_061f8680-8357-4692-a9fb-e22f3ffcf489_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_b6054804-2a03-4d75-8ea9-fe156f1bcb41_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_031006d2-2700-4453-9033-c839ad286c86_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_1fc76d2b-7286-49d8-bdca-2bd1db6102ed_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_7bd192d8-f229-4d44-821c-cb95d5f44f21_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_49a4cb61-b5e1-4128-b591-8af1c0686fb0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_a23aa250-4176-4030-990d-84873b0637ba_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_17cdb2ff-ac4a-4f97-a9ab-c877385edbd2_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_47211657-c66b-49da-8d19-dae75e0b15c7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ea424cd1-139f-446f-9ec1-baf3e4090080_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_794d1b3d-20b6-40b5-b646-f17ba74094cd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_31c6ecdb-7c87-4ae7-939f-078b002c841d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_f0fbbbee-c42a-429b-9576-f29386d785c7_terseLabel_en-US" xlink:label="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</link:label>
    <link:label id="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_label_en-US" xlink:label="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</link:label>
    <link:label id="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_documentation_en-US" xlink:label="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:href="dgx-20210630.xsd#dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:to="lab_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_643b6226-bc76-48ca-84df-274aad40502c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_5c2d31ec-7bb0-4994-9214-931b4d32da2b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_395425f0-11aa-4158-a998-4fd95cfe0837_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DSBusinessesMember_ce3e9319-8fb4-406e-8d79-f7dc2f996863_terseLabel_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_label_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_documentation_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember" xlink:href="dgx-20210630.xsd#dgx_DSBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DSBusinessesMember" xlink:to="lab_dgx_DSBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_f5de85c7-c137-4e2a-a123-c374399d96d5_terseLabel_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_label_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_documentation_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract" xlink:href="dgx-20210630.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DescriptionOfBusinessAbstract" xlink:to="lab_dgx_DescriptionOfBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_490c6adf-2540-436c-a87e-3c03b9c6993e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in earnings of equity method investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_7984f623-23f8-4985-9391-cfe9bf163500_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a6e2629e-6809-41e2-9d93-08341cdbfb10_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_f3f74ca9-470c-47f6-af52-f21318a47be6_terseLabel_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIS business</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_label_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_documentation_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:href="dgx-20210630.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:to="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_60d69e2f-0d0f-40a7-92ca-8d3e29002284_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_881a96c6-f220-4dc0-afa4-44a8d2bdf7e0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_01a8a910-e44d-4b76-b57a-8d3007bf8520_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_76fd98fb-0db9-464b-a5ed-0d36819c199b_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8b04316f-2fc4-4523-9cf1-b6271b915591_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_653dd738-abff-4b16-9a4c-5cb31fbf8b3b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_62ad9cc9-c28a-405d-851f-72bdfa474eae_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="dgx-20210630.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_bfd77303-70cd-41d5-a4dd-f055ae5928c7_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_ee259416-c662-4e6f-a454-976168e62cda_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_9049e9ca-e563-4106-9592-3177a38d456b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_9bb59b97-7258-45ee-8eeb-11dbe7cca7e0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_45dc8557-057d-40e7-b398-f7ad5fba40db_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:href="dgx-20210630.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_6708b34e-8771-4859-ac26-35b1c395802d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses and other operating income:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_f4e355ae-c281-4e88-9b31-b9b2105986de_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_249b57b0-1b2f-4b81-b9ca-8ffc0f132842_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_5e708a5f-3b6c-405e-9b2f-a494355d6109_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_2df51a88-2418-4332-a63d-535379e13de2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 600 shares authorized as of both June 30, 2021 and December 31, 2020; 217 shares issued as of both June 30, 2021 and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d700b49c-c79c-4170-818a-5d9ac8ef8084_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-operating income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_55cc05b6-8d5c-4628-9ba2-a42e0b9503f2_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_4bd846c1-be04-492b-b599-a94863881522_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during the period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f37fbe16-6c9e-4ce4-b86a-122efdbe2d9e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_677eecac-635d-4420-b96c-2a6414c89318_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ClientPayersMember_5b39e561-9e69-4dfc-8e72-d9e1c591e530_terseLabel_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers</link:label>
    <link:label id="lab_dgx_ClientPayersMember_label_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_dgx_ClientPayersMember_documentation_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember" xlink:href="dgx-20210630.xsd#dgx_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ClientPayersMember" xlink:to="lab_dgx_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7a495477-807d-4832-8435-e691c5c4caa2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cba657af-71e6-493f-ae05-fcd36223c3bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_5d30ba4a-a6e6-41ca-ab66-9df53584b61f_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_9614edfb-89c3-4956-b64c-678183d9be15_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_05eb8000-2d08-43e5-be36-2b876502892b_terseLabel_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, amount received from initial tranche</link:label>
    <link:label id="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_label_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche</link:label>
    <link:label id="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_documentation_en-US" xlink:label="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:href="dgx-20210630.xsd#dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:to="lab_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_3c58d2de-6008-416a-9342-69fb6a6aa6c1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_96e6a128-5446-4d5b-87cf-f324ea6441ee_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_f6b918b4-d857-4e10-a2ae-147140e38075_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_092ed007-fc6b-44a3-9bc1-948e4e10beb7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21471172-e47a-4361-8a39-7f729f0217c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_deb81984-207a-446d-8f67-75a44da9549a_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses, net</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_fa84ad5a-e6aa-4595-a530-62922695962b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_2717b63c-8978-4041-b791-a0515b551fc0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_1eca20e8-6bfe-4e84-bcac-924bd99845c4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_9d4b8a1f-720f-4fdd-9cce-a4a1220411dc_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_af3eeb64-2033-4450-adea-2a313a97f529_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_b7a57e8f-2600-4351-a3f3-870e4e837a6e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_859cc2ab-ec8d-4b49-baca-667df0f0b745_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3ea1dd23-2eb5-44ab-a2a6-44fe23a02d67_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_e8b213f8-ce3a-4976-9e02-fc5f477f0438_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9d8ae909-2947-4b6d-b7c2-9a1c967bdf2a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_272b27b7-8b04-4f3b-84d2-aae899526b31_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_26328824-e309-4bc8-8046-df45fadde16f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9e737102-dd42-45c3-8c6d-9c2cac4d53a0_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_0fa8d97e-8b68-4328-9fcf-bb37df648b0e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_176271d2-94b3-4681-abd0-cfe21820c189_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e89a4e2c-4a85-4325-82a8-613a3b8a11d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_c5204b35-8eba-46bf-aafa-07b05c16d600_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_d62d2f6d-42fa-4988-a7d0-97f711551f14_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_a946c2ec-c160-4ec1-a4e9-fb8652d04037_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d81c183-982b-4936-ae6b-ed25a3c77f88_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_8411832b-2758-4b34-ab64-5d609791d97e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_6c518dc2-1b01-48aa-a4fe-1b4341e2a986_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a6c9bf31-92fd-4e6b-93d2-6293cdbf845e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_d332d152-b802-47b8-9add-bbe47cd68a35_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_18497851-f4a8-44a9-a588-1d4c1841ce49_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_c12a6b40-bb22-4819-8993-c645e01f8c7c_totalLabel_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_label_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_documentation_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired" xlink:href="dgx-20210630.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired" xlink:to="lab_dgx_FairValueOfNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_de4b117b-4b6b-4d25-bde7-7f663bfcbf61_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e4f98649-bf38-4e61-8da7-0fb9d0955434_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_1d0a3443-d1e0-4fa6-8356-4217705f3391_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:href="dgx-20210630.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_655d6c64-d1c2-4354-a861-d285629779d3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in investments and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_938bb731-b28b-4d86-bad9-0c4c438f1b9b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_e75de6a7-9470-4cd0-a9c1-4fa69b8ae638_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_81135d71-f76e-4678-ac10-a66f0dd61774_terseLabel_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of interest rate swap agreements</link:label>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_label_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of interest rate swap agreements</link:label>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_documentation_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of interest rate swap agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements" xlink:href="dgx-20210630.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TerminationOfInterestRateSwapAgreements" xlink:to="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_f94d5aee-edde-45d2-97bb-264b71ec366c_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_COVID19TestingServicesMember_52a32b6c-2a72-4660-addb-a8fdb1ef20cb_terseLabel_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_label_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services [Member]</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_documentation_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember" xlink:href="dgx-20210630.xsd#dgx_COVID19TestingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_COVID19TestingServicesMember" xlink:to="lab_dgx_COVID19TestingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e16078d3-ef81-4eef-89ba-44c20f5ac852_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_07270714-f078-4cc3-bc50-74f3e456df10_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_06ea9c45-5016-4ef7-badb-c3817798ae4a_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4706312e-33ac-4309-9df5-1a33c047a152_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d89bae58-d9e8-43fa-8146-e0d37ec3d126_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Quest Diagnostics stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_d0357fcd-fc86-4efb-a95e-78c17b37e52f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_f2d4c511-b7ab-4246-a877-e7d14a2232e3_terseLabel_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MACL</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_label_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL) [Member]</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_documentation_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:href="dgx-20210630.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:to="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b79a927c-a7ff-4cc5-bebf-185616f57429_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_d211ac51-153f-4e86-aca1-8f131d0a03b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6f975552-56d1-4601-8dd2-b3bf9635e478_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:href="dgx-20210630.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b58aa6f0-795e-45a6-852c-3bb1e47b0726_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_fd847f65-1d45-4faf-987f-98846cfadfef_terseLabel_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_label_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_documentation_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember" xlink:href="dgx-20210630.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AnatomicpathologytestingservicesMember" xlink:to="lab_dgx_AnatomicpathologytestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_3ca70ef4-f02a-4bc0-ab86-c4a41785558f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Excluding Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_df2c7d4f-35b9-4863-acc6-2cdf19cb0e14_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_acf4d60f-bdb5-4152-8ba1-3c9854aeab31_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quest Diagnostics stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_45609f70-1704-450b-b1f9-2e4c7fa61191_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_4b2813c4-d4a0-4841-a48d-f17f3796a927_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_94c79cb3-4809-4387-8fae-379603163c84_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_ed22d69a-0454-4514-9b65-e2f51dfff096_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_cf07e930-911c-4852-8097-f4581b7b3c05_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_4ab7731c-1ba9-48e8-b7a3-d67af37b90f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_f740b625-dba5-4c22-9927-0c7a72941336_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_a5ba97ba-7cab-45f8-af78-4f44b68c0ce1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_71e36153-bd37-4dca-b0df-5686cdc2db5a_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_74be0501-76f5-4889-8221-01dd9959c528_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3746293f-b7a0-4b89-ad29-70602ad4d844_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_b06b9681-1ef3-4682-97f5-0e7b497f726f_terseLabel_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_label_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services [Member]</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_documentation_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember" xlink:href="dgx-20210630.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RoutineclinicaltestingservicesMember" xlink:to="lab_dgx_RoutineclinicaltestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_e872ee99-dc3a-4740-8e88-5310b34eb01e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_01e3cd19-22bc-4baa-9fb6-1ba2f0d050fa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_d0b6823a-8010-4713-a093-87344ee109c5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_33113859-b570-45fa-8d63-33ff762b6f2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_cc94378e-7d19-4c37-9800-9bc55a158812_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_324069d4-9434-4c59-a52b-05fbd4ab0a4d_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_d64ff45c-2c7b-4d77-9039-46ce468cffce_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_b15d58c9-bc6d-46c5-af91-ee2f08a5314d_terseLabel_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_label_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_documentation_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:href="dgx-20210630.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:to="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_944f6f75-807a-49c0-a5ca-d36c17e6f838_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2b271545-2e81-49d7-a532-d5b241000d35_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_626c7b08-e111-4b7a-9732-fdb536071959_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_03a919f2-21f8-4919-a4e0-e41dacd4a9fe_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ba1361da-8abc-4c8a-8532-89afb113ef8f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0ce184da-1700-462e-b7e3-9cc929f4a847_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d2ca63f7-70be-4987-8820-1140cd4ceb92_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $29 and $28 as of June 30, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_aed9ce6f-4578-42eb-b390-b41e58a36ae2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a7a7495d-7e74-4a49-9abe-c9c23a269339_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_89d7d0d6-cbe0-4545-a835-c685728d99c3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_cf07e1c4-2f5a-4ae1-bdc4-ad220bd0572d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c82b0edb-39a3-4306-932d-fda0e7a9fb09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Reporting Information by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8689e520-4d59-4447-8e2b-3f8140464ccb_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2195ed27-2f3a-4f2b-a63f-7ed18487d9a2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_51dd7f88-210e-4a69-9713-a75cfd7df883_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_fe77eaf2-abf8-4ec8-b307-91bc84d0204b_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_f89c741b-53b8-4981-aa32-0eb5452e131e_terseLabel_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpatentedTechnologyMember" xlink:to="lab_us-gaap_UnpatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_f7fc0271-4c03-4058-bb4a-e4e8bf84b26e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d89f8a5b-ab86-4a66-9f3a-b015f9d3f970_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e71fbb46-e441-45c3-8423-b6269017e543_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f11ee0b4-973a-4956-ba98-4c4cdb1fde72_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_728e0dfd-dd54-4760-9383-33b2e8a37ce2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1884cb89-dbaf-4872-b675-7bf2388b4f72_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MercyHealthMember_7d56b57b-0072-4d88-9224-e12ad28b18bb_terseLabel_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health</link:label>
    <link:label id="lab_dgx_MercyHealthMember_label_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health [Member]</link:label>
    <link:label id="lab_dgx_MercyHealthMember_documentation_en-US" xlink:label="lab_dgx_MercyHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mercy Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember" xlink:href="dgx-20210630.xsd#dgx_MercyHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MercyHealthMember" xlink:to="lab_dgx_MercyHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_096d3376-d4a6-4044-b7a4-a2645dff60c3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3a288fbf-6e65-40ee-8243-a07870f9f783_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_a74b30d4-caee-46fe-9951-8f2c3a096981_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2b1d7c40-b6bd-4697-96f4-5f2930237221_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_9b2104fb-af0b-49a7-b53e-819321271212_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_1c41f1d0-2fe4-487f-8102-294c90892e83_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_1aac8d7e-e36a-4076-861f-94a1f71f5c2a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_aa4a5a63-c670-4e0d-a9b8-3eb9bc9cde2d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_b3003a86-fc33-4e30-943a-056130630968_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_44aefe27-3db1-4a6f-87c2-9fd9fd1ec275_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3b01020d-9cbd-4bfa-a89a-154102a07da8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1ba4967d-fa46-440d-8ff0-9d779a37a8e3_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GovernmentPayersMember_a8111c3a-3d46-4a2a-8a98-6abc682dd78c_terseLabel_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_label_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_documentation_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember" xlink:href="dgx-20210630.xsd#dgx_GovernmentPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GovernmentPayersMember" xlink:to="lab_dgx_GovernmentPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_ee425076-33f4-4403-9232-0c50e4ab5b5d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6279ec06-3665-4f6f-93ed-c61f923ebaa7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d60638b1-3e14-4f74-8d8d-070465324c88_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ff75721c-3d28-4492-8c00-54fdc6f80e0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4d13ab84-0035-4a50-9cef-cd59ac5f3d6f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b47673b9-7768-4c48-acfd-921881dcac98_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_714dca77-24c7-4494-8f3e-444c875f51e9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4a760a55-d59f-498a-a8a6-8655338f43d9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1887f87d-4ef1-4127-a3f9-4e3fe204c60f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_615a763e-b89f-430a-9152-9f693d697b68_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_b43c3c65-cd61-4b58-9604-cbd8a66c9dcd_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_96d1b645-7b2c-436f-9a21-080b43f80698_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_962fc682-81c3-49a2-a317-762a3e728a60_terseLabel_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_label_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_documentation_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:href="dgx-20210630.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:to="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_3479ce7b-d648-46ba-b0c9-8fe84c49dbb4_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:href="dgx-20210630.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:to="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_470759bd-a433-4c10-a9c5-20a645bbf457_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_eac21a1d-00c0-42c3-a89e-e593f62cf5ad_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_ede6ef30-5993-42c2-991e-2335c56a2c4a_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_154b2d41-41d9-43a2-ae14-f6202a0b28dc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8c67763a-fab5-4dea-b2fc-b7dbb8cac648_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_de962059-d615-467c-827a-55a9c882bc07_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other operating segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_ea58a28d-0487-49d5-b038-cfbc4e10e1a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_cb4328ae-f9e4-4cd2-905d-3e3ef9298b27_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2b053d59-7ae3-46ac-b1a8-b9424326a400_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2c3245e3-9319-48e2-9725-9dcffd210fca_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ab87b313-e1a9-4e97-8b1d-422de81a4169_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_dfc2179d-2523-41bb-b43b-3f40d7415a0d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HealthcareInsurersMember_aca7b24e-fdba-4b18-82a7-40f416c9de52_terseLabel_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_label_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_documentation_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember" xlink:href="dgx-20210630.xsd#dgx_HealthcareInsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HealthcareInsurersMember" xlink:to="lab_dgx_HealthcareInsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_40869525-60c9-4fb7-8812-d00c6946cf9e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_b7e9e625-2e4c-4d09-9d00-6a6d0896d347_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reissuance of shares for employee benefit plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_cacc5bae-b502-4caf-a3d7-dc5e0e9e202b_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_94c2f472-d9f7-419d-8a16-7c46afe19247_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_39439cbc-5c2e-4278-b85a-79ab3b88d63e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6bc8804c-4c6d-4ff6-86ba-2191c1aec519_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_f2e1bacc-03e1-46ea-9954-8e488fb0b5df_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_38d21c2e-61b7-48da-9e34-3afd944aa49f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_0a692542-4442-4518-a20d-23d7a600597f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate activities</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_38f95ca4-3fb5-425c-aeb4-70a9808e9690_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_5a66b16a-b5fb-48b3-b9c9-4795dfc5610a_terseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Earnings allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_529d94ed-816c-422a-b272-478ea863b1a1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_977295d8-7465-4370-93e7-3142f7645248_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 95 and 84 shares as of June 30, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_05454123-a084-4cec-a4a0-3d4b25e6a86f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_aab6107d-efcc-421e-8acd-8bc708320e8c_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance reserves</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_e6445aca-b698-4629-887f-52cdbbfffd09_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of equity method investees, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_b272502e-ce5e-4616-b509-ceb8d6b25931_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_8137562e-1153-421c-b925-06cdbfcdeab0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_8fdb23a3-87ad-4ac4-92c4-6e7f34730abd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a5787919-8390-4624-89cc-682a9e5e2765_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f40e96a1-c3be-4977-ac23-0f1364c07cff_totalLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_019eec38-a590-40b7-8e34-daaf4605536e_verboseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase, initial purchase price, per share</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Initial Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_55140650-684d-4bc4-b5e2-9353d28b8d4e_negatedTerseLabel_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dgx-20210630.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6c24fd81-8c10-43db-a8e4-9e80ae7ba9a5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_96aa2728-d893-492d-9ee8-69e1925cf488_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:href="dgx-20210630.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_22857827-5188-4dc9-b370-65c8281b3285_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_76ab6d6e-841d-49f0-8d28-52ea0f0ac000_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_ea029a7e-12be-49c2-bbe7-67ebfd7abff4_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6f44e38a-68aa-4263-9539-bf5e5c68ed77_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_67d6a690-17a3-4362-be28-7673c6998019_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_33d596ad-303c-40fd-ac2d-cbac569d0961_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_0b9e1e45-a16b-4198-ae27-a96f5c490b7f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_93aae481-63a9-400c-936f-0a52aee05524_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_4f07eb4c-53d2-42e4-b1d9-e78a879f238b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_724713a0-3113-47bc-8183-6a2babb653d2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in available-for-sale debt securities, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_072afa8a-efac-4a22-a954-f4adf205939e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_2b9c4c07-ee60-495d-8399-62b287b45e28_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4fc9642c-2323-48ec-94a1-39338ed44b5d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_8e1fdd3f-7842-43e4-b0e5-ce9719dfdd88_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_4d7aadb5-02e6-4220-828e-626dd6077933_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-related intangibles</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_38376965-b0d9-42c1-a91f-6b65e0359d15_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e705f013-dcfd-4abd-851a-6a0d6ccdac95_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6ab33882-c50c-4a86-a69f-cdd1f0e44717_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_12d95c47-5f9f-45ae-be99-9c6616170755_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_c6753d37-d266-45ee-a286-a1746a9b6985_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_369529ff-da09-4ec1-95e1-bcce2671d9a9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock- shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_a9837b1b-4ee5-42e5-84a6-f3791fcd2dd4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_32c5a626-52ff-493c-ac85-4fe46e171968_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_b44c9bfa-6995-4aa8-9dca-ea31a4b4e4ad_terseLabel_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares to be received under accelerated share repurchase agreements at execution</link:label>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_label_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</link:label>
    <link:label id="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_documentation_en-US" xlink:label="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:href="dgx-20210630.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:to="lab_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_695f3b73-9183-4c94-83b0-74afe3a44958_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_40f7c622-f55c-46b8-86d7-1ef1c5e85c71_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FeeforserviceMember_b99209f3-5508-41f5-8f7c-f67fcf39da18_terseLabel_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_label_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_documentation_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember" xlink:href="dgx-20210630.xsd#dgx_FeeforserviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FeeforserviceMember" xlink:to="lab_dgx_FeeforserviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_e8deb432-7cdd-423f-9599-73b8e4728cc8_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc06559-4e83-48e9-a794-c4dbf4c542c8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_75c256b8-c539-46fd-9d94-adba9fd2d0c7_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_01230dd7-99ca-49f1-acf9-a1ed1abe8d37_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_117891ea-6265-4c84-9ff1-89be57275e67_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_47513229-9235-4cf5-9e22-26c5f25e52ed_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_f12fa1d7-7281-4c9b-863d-192e4f398872_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_fffd34e2-afd2-41cd-9ca4-9952766f893d_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c671f99b-db1b-4a5b-933f-83c32d03692c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c23e9132-352a-41ad-b9cf-7e9ca6e2963c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_044b9eac-d280-4b09-bc08-495ae4a74950_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_bbde45f7-80c6-4e8e-96c1-0efaaa0dfce5_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:href="dgx-20210630.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:to="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5ccfef09-9b88-4e34-bbff-b737612a780b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_42305bd7-2750-4798-9cc4-d8188d4e869a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_46567973-cc2f-4fd7-b83e-6781f6387fb0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e31ad748-2180-47cf-8a23-b5368a79abfb_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_4756838e-2c1d-434d-8583-b8f572b5bfd5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b70af889-b2c5-4628-81da-79bbbf3d70db_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_40befcee-1ae9-4f1f-a6df-b8bdb50c4569_terseLabel_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_label_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation [Member]</link:label>
    <link:label id="lab_dgx_ForeignCurrencyTranslationMember_documentation_en-US" xlink:label="lab_dgx_ForeignCurrencyTranslationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember" xlink:href="dgx-20210630.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ForeignCurrencyTranslationMember" xlink:to="lab_dgx_ForeignCurrencyTranslationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8758f5f1-e4f3-411d-b37e-13f96b353132_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f4526cc3-97e9-4928-b1fe-e323e2c4a461_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c3c27922-b579-403b-9a35-e4066372bd42_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c3bec378-a450-46d4-8ca6-6de3a3e47553_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d949cbdc-5ac0-4ea5-b034-363bb2b85973_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_56acbcfc-a833-4355-a500-a15040d3c02d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f342bac4-ee70-41c5-9022-6905042fd5d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAXES ON INCOME</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_9c5af0c4-170b-4bfb-bd85-d0fd6aec999c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_02310dfa-f3c6-49c4-ab85-4b831c5f6601_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1696cf67-fed1-4eb2-8122-1669e0a233be_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8cccb474-e301-4ab1-8856-a8635aacda04_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_f90f7e66-c8d5-434b-9a98-8b5f648be040_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2892d729-2237-46b1-9486-870610848a46_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_64328218-e1f8-4750-9e27-f30233dce525_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_43ed9a56-dd98-4781-90bc-8a93dfa5327d_terseLabel_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASRs</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_label_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements [Member]</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchaseAgreementsMember_documentation_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:href="dgx-20210630.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:to="lab_dgx_AcceleratedShareRepurchaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_3c44a25c-f13c-49bd-a1af-e7f0a70d6c46_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd70f638-90c2-486e-bdec-bf3dcee3e134_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f870670d-9a1b-461d-9ddf-982330611326_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_cf80a7f4-b3d1-4aa9-bed3-e21a8b10e54b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0d7ca18e-ddba-4e20-8103-965b44263b86_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6562f2c4-8bae-4c9e-8d01-daf72fe343da_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_317b75c9-d5d9-4da6-b423-ac813e44e259_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_b9e6ba8f-e70c-4089-84f2-77288c8f0220_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items (Long-term debt)</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid_9eb88371-c2ba-40a1-97e0-4e9d9fded798_terseLabel_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchases price paid</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid_label_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Initial Price Paid</link:label>
    <link:label id="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid_documentation_en-US" xlink:label="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Initial Price Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:href="dgx-20210630.xsd#dgx_AcceleratedShareRepurchasesInitialPricePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:to="lab_dgx_AcceleratedShareRepurchasesInitialPricePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ef2cc944-c143-468e-8bfc-292d1e9f3363_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_ad9a7b8a-57aa-447b-9473-24a9e5f01d4c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_688d5686-5638-4ff5-b0bb-b9d33aab5056_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_64ad3f45-f9c6-415a-864d-cb9f744cdfdf_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_dd7cf727-af90-4fa4-8838-994ce5ef9eca_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_ef85f71f-bb01-445b-9d66-cbffc60c283d_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8737c6bf-3dee-4844-a430-45960474a58a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d0194cd0-d9ab-456f-bea3-4b6e1656a834_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_dd8ba421-4a34-4c4c-9790-77aea8dfd22a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d85134bf-3cce-435d-8934-3ffe6372a614_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards to be Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_5d0adfde-0a7f-4e6b-9113-8d8b163bfd0c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_05d551b0-2fd7-4bdb-a648-6c63eb02624f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_170e5c5f-974e-4641-8494-0a8fe213d0b6_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:href="dgx-20210630.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_f69b9afb-5bf4-42ad-aacf-8f482ed7e7e4_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_9b99bf89-8ed6-4a17-9c65-afb208bab396_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_ccd3d42b-fb80-4065-b7dc-834ac7a3b7da_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_9cb2af22-cead-45b8-aa89-4e01d256b12b_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_57c104ca-35a3-46c8-9e87-63c5b507371f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_d19112a8-ead9-4251-9010-2e73c3181dd7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_7e018df4-bc2f-4b99-a880-4f5df56bf783_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_7d889bff-73eb-49bb-9f96-87689ff2c344_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f83b6c5a-e82d-492a-8f2e-90185b73bcc3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>dgx-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c0ef2d88-a53d-457b-ba3c-2a15db2c46ae,g:aea639b6-1560-47bd-8a23-0a619e498ffc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20210630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_64ca7389-6ad3-4a44-83c5-6f00f4fa6754" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_DocumentType_64ca7389-6ad3-4a44-83c5-6f00f4fa6754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_20dc8e7b-669a-432c-8b48-af52cc3d2e21" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_DocumentQuarterlyReport_20dc8e7b-669a-432c-8b48-af52cc3d2e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_89b6c9be-1a6d-4b4b-92d0-202f8a2ade8b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_DocumentPeriodEndDate_89b6c9be-1a6d-4b4b-92d0-202f8a2ade8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b49f0f9e-ea92-4f8b-a0c7-9fdbb616de3e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_DocumentTransitionReport_b49f0f9e-ea92-4f8b-a0c7-9fdbb616de3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b59f5352-9dfa-42be-87a9-d5bc6edb2559" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityFileNumber_b59f5352-9dfa-42be-87a9-d5bc6edb2559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_90228825-6b65-421d-b5a0-321f4dce31b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityRegistrantName_90228825-6b65-421d-b5a0-321f4dce31b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7a93e0b6-0e3a-46f2-8335-2316cca275fe" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityCentralIndexKey_7a93e0b6-0e3a-46f2-8335-2316cca275fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_73b75f85-9f13-4c4a-8df7-e2fedc40a9b0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_CurrentFiscalYearEndDate_73b75f85-9f13-4c4a-8df7-e2fedc40a9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_50a854c7-fed9-4503-8340-81f2b87c169d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_DocumentFiscalYearFocus_50a854c7-fed9-4503-8340-81f2b87c169d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_64ca8a70-ac1f-4876-a32c-fe55f160f72a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_64ca8a70-ac1f-4876-a32c-fe55f160f72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0c164a1e-f909-49e0-a3d4-851e344722ca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_AmendmentFlag_0c164a1e-f909-49e0-a3d4-851e344722ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_63a8b33e-1bea-4721-abdd-63cbe0a49a75" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_63a8b33e-1bea-4721-abdd-63cbe0a49a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_924948c7-103d-47dc-990f-6590388824d8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityTaxIdentificationNumber_924948c7-103d-47dc-990f-6590388824d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6825da52-e727-47c6-b9f7-d6ff83d63c54" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityAddressAddressLine1_6825da52-e727-47c6-b9f7-d6ff83d63c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a1cc1dce-2a4d-4fd2-a2dc-3d7539b11b50" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityAddressCityOrTown_a1cc1dce-2a4d-4fd2-a2dc-3d7539b11b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ae43fa80-ab8d-4ccf-ac14-2b1975ff5f92" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityAddressStateOrProvince_ae43fa80-ab8d-4ccf-ac14-2b1975ff5f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e032dff9-0636-472f-b297-187d4cc420ea" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityAddressPostalZipCode_e032dff9-0636-472f-b297-187d4cc420ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bb7e142e-2081-46b8-b299-90043b0dbb5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_CityAreaCode_bb7e142e-2081-46b8-b299-90043b0dbb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f82be379-1325-484b-a5f0-3e8fc5933527" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_LocalPhoneNumber_f82be379-1325-484b-a5f0-3e8fc5933527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d5ae4623-950a-4f2a-8ee2-743a67458add" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_Security12bTitle_d5ae4623-950a-4f2a-8ee2-743a67458add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cf4bcece-db9e-4217-9399-4f992ece6437" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_TradingSymbol_cf4bcece-db9e-4217-9399-4f992ece6437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_94e6278d-d173-4b22-a4cb-0d0883faa8ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_SecurityExchangeName_94e6278d-d173-4b22-a4cb-0d0883faa8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_abeba10d-c74b-48f8-8a66-ece3cc1587fe" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityCurrentReportingStatus_abeba10d-c74b-48f8-8a66-ece3cc1587fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_bcf84594-04b3-4672-811c-9c1eb35ef1a8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityInteractiveDataCurrent_bcf84594-04b3-4672-811c-9c1eb35ef1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_cbcd92e4-9a4f-49cc-97f2-2fae0bd03610" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityFilerCategory_cbcd92e4-9a4f-49cc-97f2-2fae0bd03610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8823c382-cd1f-4322-bd36-d47f571e80cb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntitySmallBusiness_8823c382-cd1f-4322-bd36-d47f571e80cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_085e6035-50b2-4ad9-901c-6fd2153c08b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityEmergingGrowthCompany_085e6035-50b2-4ad9-901c-6fd2153c08b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c7220d3d-4444-4f74-ab8c-37434d36ca8e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityShellCompany_c7220d3d-4444-4f74-ab8c-37434d36ca8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d39f7db1-5c2d-4f3c-bfe8-c7cb34ad0d2c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_aef46bb7-dfb1-483e-8171-c2397abcb3c9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d39f7db1-5c2d-4f3c-bfe8-c7cb34ad0d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f34818f-6b61-4509-81f3-b18a67c7acd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f34818f-6b61-4509-81f3-b18a67c7acd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_7c58974b-0039-4b41-bda4-6104d300e900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_CostOfRevenueAbstract_7c58974b-0039-4b41-bda4-6104d300e900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f51e7dcf-ec68-42da-b066-90e4a40e0af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_7c58974b-0039-4b41-bda4-6104d300e900" xlink:to="loc_us-gaap_CostOfRevenue_f51e7dcf-ec68-42da-b066-90e4a40e0af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ed956ee0-7eca-41de-b793-9b2cf83916ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_7c58974b-0039-4b41-bda4-6104d300e900" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ed956ee0-7eca-41de-b793-9b2cf83916ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b5444097-b5ee-4118-8ba8-36987a8a2520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_7c58974b-0039-4b41-bda4-6104d300e900" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b5444097-b5ee-4118-8ba8-36987a8a2520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_a32c5716-c351-4d46-8533-b824464034d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_7c58974b-0039-4b41-bda4-6104d300e900" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_a32c5716-c351-4d46-8533-b824464034d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7edf2cb0-4b69-4650-94d3-9e4f6dac2cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_CostsAndExpenses_7edf2cb0-4b69-4650-94d3-9e4f6dac2cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ac59e2fc-8f46-4bf9-8a5a-a6abf0630394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_OperatingIncomeLoss_ac59e2fc-8f46-4bf9-8a5a-a6abf0630394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4c2cd4c-8c35-42a4-a135-02cdb78cd6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4c2cd4c-8c35-42a4-a135-02cdb78cd6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_5199dc3a-f8ae-4b0c-a818-1ab1bb57827c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4c2cd4c-8c35-42a4-a135-02cdb78cd6b9" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_5199dc3a-f8ae-4b0c-a818-1ab1bb57827c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_040515c8-a938-466b-a843-61dd0a4f8e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4c2cd4c-8c35-42a4-a135-02cdb78cd6b9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_040515c8-a938-466b-a843-61dd0a4f8e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_01170790-7420-49a7-be59-9f90bac12efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4c2cd4c-8c35-42a4-a135-02cdb78cd6b9" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_01170790-7420-49a7-be59-9f90bac12efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d2f20438-0da6-433d-98b6-979f5073b3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d2f20438-0da6-433d-98b6-979f5073b3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4259bf9c-3c2a-442e-99c9-abe4257358d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4259bf9c-3c2a-442e-99c9-abe4257358d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e2695d94-4e69-4b29-ba2d-a975fe1f1cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e2695d94-4e69-4b29-ba2d-a975fe1f1cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7119e1e3-bda6-4930-93e4-31fe98b314d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_ProfitLoss_7119e1e3-bda6-4930-93e4-31fe98b314d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3786d216-35f7-421b-a6f8-349ff59bdba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3786d216-35f7-421b-a6f8-349ff59bdba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_399905fa-5b4a-4be9-a8b8-d2b0da3bb696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_NetIncomeLoss_399905fa-5b4a-4be9-a8b8-d2b0da3bb696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e84d8815-30db-4cda-a999-90045ccaa959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e84d8815-30db-4cda-a999-90045ccaa959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8d7fb750-dce8-43b5-a411-2a3df2ddde75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e84d8815-30db-4cda-a999-90045ccaa959" xlink:to="loc_us-gaap_EarningsPerShareBasic_8d7fb750-dce8-43b5-a411-2a3df2ddde75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_359aeeac-5446-4102-9ac5-53cbabe5347c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e84d8815-30db-4cda-a999-90045ccaa959" xlink:to="loc_us-gaap_EarningsPerShareDiluted_359aeeac-5446-4102-9ac5-53cbabe5347c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8d04a018-b695-4d15-9fb5-8cb393f569a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d03d59c4-2dea-4d6b-bc30-bcb5de2f20d6" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8d04a018-b695-4d15-9fb5-8cb393f569a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dbc5a3fb-4c8b-4156-9fce-e35c377dffa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d04a018-b695-4d15-9fb5-8cb393f569a2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dbc5a3fb-4c8b-4156-9fce-e35c377dffa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6a9595f-1067-460b-b0b7-2647f980063e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8d04a018-b695-4d15-9fb5-8cb393f569a2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a6a9595f-1067-460b-b0b7-2647f980063e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5818211-46a4-4584-a1e7-06178a237bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1087639b-7145-4843-b144-06fa1ce09df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5818211-46a4-4584-a1e7-06178a237bd0" xlink:to="loc_us-gaap_ProfitLoss_1087639b-7145-4843-b144-06fa1ce09df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3be18f1f-1dc5-462f-aed2-e5116df57bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5818211-46a4-4584-a1e7-06178a237bd0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3be18f1f-1dc5-462f-aed2-e5116df57bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aea5f2f-f4e7-49a3-b475-4ea7d578a768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3be18f1f-1dc5-462f-aed2-e5116df57bd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4aea5f2f-f4e7-49a3-b475-4ea7d578a768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_425bef24-b2bf-46c0-8047-f78771940663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3be18f1f-1dc5-462f-aed2-e5116df57bd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_425bef24-b2bf-46c0-8047-f78771940663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c1b0fe16-e634-48b3-a3fc-2c8b96229db8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3be18f1f-1dc5-462f-aed2-e5116df57bd2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c1b0fe16-e634-48b3-a3fc-2c8b96229db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e1e7e7f7-7e56-4649-8ad3-3fb5bdfac547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5818211-46a4-4584-a1e7-06178a237bd0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e1e7e7f7-7e56-4649-8ad3-3fb5bdfac547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5a67d4fb-b908-4294-93b4-b83da1d9bee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5818211-46a4-4584-a1e7-06178a237bd0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5a67d4fb-b908-4294-93b4-b83da1d9bee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d107e3e3-a957-4346-adec-d473967891ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b5818211-46a4-4584-a1e7-06178a237bd0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d107e3e3-a957-4346-adec-d473967891ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a90f39fa-aa9c-4afa-b762-0c3e4ba8868e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a90f39fa-aa9c-4afa-b762-0c3e4ba8868e" xlink:to="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a5963bbf-fbc3-448f-ae21-5600011f1d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a5963bbf-fbc3-448f-ae21-5600011f1d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_31e8195c-53a8-40da-880b-8dbfb1125dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_31e8195c-53a8-40da-880b-8dbfb1125dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1a672985-018a-40e7-aa1b-26f0b84d5d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_InventoryNet_1a672985-018a-40e7-aa1b-26f0b84d5d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_79a48eaf-f5bb-4229-b784-8c8880b2a3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_79a48eaf-f5bb-4229-b784-8c8880b2a3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_22f6ce98-72df-45dc-8196-ed83a86398cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_AssetsCurrent_22f6ce98-72df-45dc-8196-ed83a86398cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8c5c45ae-886f-46a1-8eb8-0bfc872f9c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8c5c45ae-886f-46a1-8eb8-0bfc872f9c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_27b419e3-03bb-4093-b08a-da269c28767a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_27b419e3-03bb-4093-b08a-da269c28767a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ac7330c6-ad0c-4b8d-b2cc-c59762a9ae2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_Goodwill_ac7330c6-ad0c-4b8d-b2cc-c59762a9ae2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6ab2d361-8e08-4a85-8638-7c35a1c15e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6ab2d361-8e08-4a85-8638-7c35a1c15e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_5ddb1616-7488-426a-93b0-0cb889c883bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_EquityMethodInvestments_5ddb1616-7488-426a-93b0-0cb889c883bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_70542d96-0d77-4310-9115-caa8e08fdfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_70542d96-0d77-4310-9115-caa8e08fdfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d86f1522-6895-4cc4-965d-7d4738175af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_df65ae32-bb00-40e4-9a2b-41c54a66fa1b" xlink:to="loc_us-gaap_Assets_d86f1522-6895-4cc4-965d-7d4738175af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a90f39fa-aa9c-4afa-b762-0c3e4ba8868e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9791205c-69c6-4d14-a31f-5c173cc54d41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9791205c-69c6-4d14-a31f-5c173cc54d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1f468520-843f-4e85-bc3c-864964e3d483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_LongTermDebtCurrent_1f468520-843f-4e85-bc3c-864964e3d483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3133d402-4f1d-4d49-946c-1ad8847e756c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3133d402-4f1d-4d49-946c-1ad8847e756c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1a634bbc-ed49-4712-b63c-b911d0425d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_LiabilitiesCurrent_1a634bbc-ed49-4712-b63c-b911d0425d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6774c11a-9f90-4d51-aad6-68cdde33432d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6774c11a-9f90-4d51-aad6-68cdde33432d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_26f84091-8feb-4a3e-bc35-610295827e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_26f84091-8feb-4a3e-bc35-610295827e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_be2bae25-932a-44e3-b4b9-f497536c3f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_be2bae25-932a-44e3-b4b9-f497536c3f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_dc8d352c-08f2-4f7e-95e5-4511863f9a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_CommitmentsAndContingencies_dc8d352c-08f2-4f7e-95e5-4511863f9a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_19ddc65e-025f-4cf0-8eb7-fd52b9bd6d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_19ddc65e-025f-4cf0-8eb7-fd52b9bd6d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_313686cc-5dc8-48dc-a3ce-6df1752f7c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_313686cc-5dc8-48dc-a3ce-6df1752f7c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_eb246ab5-654a-4188-8578-0c28e342fcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_313686cc-5dc8-48dc-a3ce-6df1752f7c11" xlink:to="loc_us-gaap_StockholdersEquityAbstract_eb246ab5-654a-4188-8578-0c28e342fcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_34624228-ef1f-4627-a28a-c9722634bfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_eb246ab5-654a-4188-8578-0c28e342fcd7" xlink:to="loc_us-gaap_CommonStockValue_34624228-ef1f-4627-a28a-c9722634bfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5c3ff60b-a096-4039-aa55-47ea309ba5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_eb246ab5-654a-4188-8578-0c28e342fcd7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5c3ff60b-a096-4039-aa55-47ea309ba5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7bd43fcf-0734-4853-86d1-faeafc6fc536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_eb246ab5-654a-4188-8578-0c28e342fcd7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7bd43fcf-0734-4853-86d1-faeafc6fc536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_53493b84-526e-4a7c-a8af-74c13b7ee5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_eb246ab5-654a-4188-8578-0c28e342fcd7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_53493b84-526e-4a7c-a8af-74c13b7ee5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_02d516a2-0c56-40b1-8cab-7feaaebc5866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_eb246ab5-654a-4188-8578-0c28e342fcd7" xlink:to="loc_us-gaap_TreasuryStockValue_02d516a2-0c56-40b1-8cab-7feaaebc5866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f7412331-998f-4f79-bf0a-1abde48098f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_eb246ab5-654a-4188-8578-0c28e342fcd7" xlink:to="loc_us-gaap_StockholdersEquity_f7412331-998f-4f79-bf0a-1abde48098f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b52ad34f-19af-493c-bcd0-9a285fa63764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_313686cc-5dc8-48dc-a3ce-6df1752f7c11" xlink:to="loc_us-gaap_MinorityInterest_b52ad34f-19af-493c-bcd0-9a285fa63764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f53cd37a-0ab3-42f0-93ac-e56f62cc2742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_313686cc-5dc8-48dc-a3ce-6df1752f7c11" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f53cd37a-0ab3-42f0-93ac-e56f62cc2742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9833ca29-2024-4b57-a4b6-ca753195247a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_71fc06ae-6196-4678-8c07-b1b8a4d87beb" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9833ca29-2024-4b57-a4b6-ca753195247a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_094695d6-da5b-4d86-bbe1-3f9628a48dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cd0d7adc-ec55-47ee-9b1d-b60d41543d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_094695d6-da5b-4d86-bbe1-3f9628a48dd9" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_cd0d7adc-ec55-47ee-9b1d-b60d41543d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e28342b8-6b0e-4f19-8975-42adb9e47c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_094695d6-da5b-4d86-bbe1-3f9628a48dd9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e28342b8-6b0e-4f19-8975-42adb9e47c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_04bec78d-da66-4885-a5bf-77a2b533f51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_094695d6-da5b-4d86-bbe1-3f9628a48dd9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_04bec78d-da66-4885-a5bf-77a2b533f51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9e159a49-3133-434d-b455-34b479cd50e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_094695d6-da5b-4d86-bbe1-3f9628a48dd9" xlink:to="loc_us-gaap_CommonStockSharesIssued_9e159a49-3133-434d-b455-34b479cd50e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_3938f32e-bf0c-49fb-b4f2-1390b05ad035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_094695d6-da5b-4d86-bbe1-3f9628a48dd9" xlink:to="loc_us-gaap_TreasuryStockShares_3938f32e-bf0c-49fb-b4f2-1390b05ad035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_e0c0d2e3-829d-42aa-82ee-79274a07ec45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_29b8f67b-1edc-457d-97b5-031bfcdf7c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e0c0d2e3-829d-42aa-82ee-79274a07ec45" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_29b8f67b-1edc-457d-97b5-031bfcdf7c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_75b56322-d9f6-448d-8679-1afda3084abc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_29b8f67b-1edc-457d-97b5-031bfcdf7c5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_75b56322-d9f6-448d-8679-1afda3084abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a741677b-e007-403a-b23f-ded1926dd967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_75b56322-d9f6-448d-8679-1afda3084abc" xlink:to="loc_us-gaap_ProfitLoss_a741677b-e007-403a-b23f-ded1926dd967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_10fecdca-596c-488a-8318-5668d36ce3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_75b56322-d9f6-448d-8679-1afda3084abc" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_10fecdca-596c-488a-8318-5668d36ce3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d4ebd84f-cb94-4b43-8393-34e498f60eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_10fecdca-596c-488a-8318-5668d36ce3c6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d4ebd84f-cb94-4b43-8393-34e498f60eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_2c73d379-dcd0-424f-84ad-9aa40a3e58db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_10fecdca-596c-488a-8318-5668d36ce3c6" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_2c73d379-dcd0-424f-84ad-9aa40a3e58db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4e9adbc9-8d19-4982-abf6-70d1d8796c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_10fecdca-596c-488a-8318-5668d36ce3c6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4e9adbc9-8d19-4982-abf6-70d1d8796c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_42996012-05bd-4b5d-a975-f43a41a653f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_10fecdca-596c-488a-8318-5668d36ce3c6" xlink:to="loc_us-gaap_ShareBasedCompensation_42996012-05bd-4b5d-a975-f43a41a653f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_91fc08f2-94cd-428a-9e50-c21949de2ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_10fecdca-596c-488a-8318-5668d36ce3c6" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_91fc08f2-94cd-428a-9e50-c21949de2ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_fca0cffc-7b0c-46cc-89aa-ab61c2bb1732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_10fecdca-596c-488a-8318-5668d36ce3c6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_fca0cffc-7b0c-46cc-89aa-ab61c2bb1732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e9e0bd2b-998b-4ee5-9677-8bec0238c15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_75b56322-d9f6-448d-8679-1afda3084abc" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e9e0bd2b-998b-4ee5-9677-8bec0238c15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5a0b6357-f549-43d5-aee5-efbae640d977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e9e0bd2b-998b-4ee5-9677-8bec0238c15c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5a0b6357-f549-43d5-aee5-efbae640d977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0eaed2e0-5668-453c-a90d-eadca3ffebf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e9e0bd2b-998b-4ee5-9677-8bec0238c15c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0eaed2e0-5668-453c-a90d-eadca3ffebf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3d7d724b-096f-4380-80d6-0d2ebd9d8823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e9e0bd2b-998b-4ee5-9677-8bec0238c15c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3d7d724b-096f-4380-80d6-0d2ebd9d8823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements_47ae06d5-0ec9-441c-8f90-9158f9f2a7bd" xlink:href="dgx-20210630.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e9e0bd2b-998b-4ee5-9677-8bec0238c15c" xlink:to="loc_dgx_TerminationOfInterestRateSwapAgreements_47ae06d5-0ec9-441c-8f90-9158f9f2a7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_45a9ced0-40d4-4270-8511-f612c2c1dc67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e9e0bd2b-998b-4ee5-9677-8bec0238c15c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_45a9ced0-40d4-4270-8511-f612c2c1dc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f8541d88-137a-4972-becf-79f1205a542c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_75b56322-d9f6-448d-8679-1afda3084abc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f8541d88-137a-4972-becf-79f1205a542c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_814b1675-f1fd-4c7f-80f9-135daa315f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_29b8f67b-1edc-457d-97b5-031bfcdf7c5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_814b1675-f1fd-4c7f-80f9-135daa315f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_18142bd7-577b-4f68-bee6-fd19151f2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_814b1675-f1fd-4c7f-80f9-135daa315f0a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_18142bd7-577b-4f68-bee6-fd19151f2b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb5f6a7a-67a8-4d1a-9043-084a7229034d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_814b1675-f1fd-4c7f-80f9-135daa315f0a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb5f6a7a-67a8-4d1a-9043-084a7229034d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_fe0c8cd5-27cf-475e-b05c-409714bb0a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_814b1675-f1fd-4c7f-80f9-135daa315f0a" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_fe0c8cd5-27cf-475e-b05c-409714bb0a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4e2c9840-d903-4e54-b00d-4479d2b7c930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_814b1675-f1fd-4c7f-80f9-135daa315f0a" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4e2c9840-d903-4e54-b00d-4479d2b7c930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93ea302f-400c-408f-a2b8-dc5bca5ce19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_814b1675-f1fd-4c7f-80f9-135daa315f0a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93ea302f-400c-408f-a2b8-dc5bca5ce19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_29b8f67b-1edc-457d-97b5-031bfcdf7c5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_57b41086-6843-434d-baf2-92bb119a4c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_57b41086-6843-434d-baf2-92bb119a4c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_d905944e-f77b-4b69-8b4f-eb2408e6120f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_RepaymentsOfDebt_d905944e-f77b-4b69-8b4f-eb2408e6120f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_08d5b01f-866f-4917-9a4a-3beff32e2a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_08d5b01f-866f-4917-9a4a-3beff32e2a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9b9cb28f-67b0-47dc-88b9-81aec9a12c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9b9cb28f-67b0-47dc-88b9-81aec9a12c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3558b905-f420-457a-a33c-77c1198232c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3558b905-f420-457a-a33c-77c1198232c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_3566c6bf-f716-4809-9b8e-9c5a605e030d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_3566c6bf-f716-4809-9b8e-9c5a605e030d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0a6b39c4-ea87-45d2-ae18-6cb240606a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0a6b39c4-ea87-45d2-ae18-6cb240606a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b42d3acd-b1e3-43a1-a561-1069926f03ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b42d3acd-b1e3-43a1-a561-1069926f03ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d92b05c4-8051-4ad7-aa78-51514b7c083e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0dee01ed-8e34-422b-94e6-1f2646d97093" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d92b05c4-8051-4ad7-aa78-51514b7c083e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1febd103-66b4-4955-802f-138fa245d4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_29b8f67b-1edc-457d-97b5-031bfcdf7c5a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1febd103-66b4-4955-802f-138fa245d4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_730654ae-b4c5-48cd-8db5-b684d77233b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_29b8f67b-1edc-457d-97b5-031bfcdf7c5a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_730654ae-b4c5-48cd-8db5-b684d77233b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d1d7c1f0-ce28-48ec-9856-fb7ba71d0d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_29b8f67b-1edc-457d-97b5-031bfcdf7c5a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d1d7c1f0-ce28-48ec-9856-fb7ba71d0d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20210630.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4c98635-e118-4ab2-84b9-a0f1ace68921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e410ef27-73a5-4cf6-9adf-e216080db3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4c98635-e118-4ab2-84b9-a0f1ace68921" xlink:to="loc_us-gaap_StatementTable_e410ef27-73a5-4cf6-9adf-e216080db3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5577bb54-95c8-4676-a07e-f5dc2df2af72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e410ef27-73a5-4cf6-9adf-e216080db3dc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5577bb54-95c8-4676-a07e-f5dc2df2af72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5577bb54-95c8-4676-a07e-f5dc2df2af72" xlink:to="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2b2578aa-ac0b-4605-8ca1-e153a83de782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_CommonStockMember_2b2578aa-ac0b-4605-8ca1-e153a83de782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ad3abbb4-057c-4111-9823-3035b632a5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ad3abbb4-057c-4111-9823-3035b632a5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7f8cd022-357f-46f3-a0e4-96233fe79395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_RetainedEarningsMember_7f8cd022-357f-46f3-a0e4-96233fe79395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93437a9e-7971-4adf-84ef-dd9c3cd6a5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93437a9e-7971-4adf-84ef-dd9c3cd6a5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_86510d61-ba7b-4372-817b-802467fc4fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_TreasuryStockMember_86510d61-ba7b-4372-817b-802467fc4fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_dc936309-7ba1-4d93-a488-c786ea412068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_eb26b3ea-717d-44a4-85a5-2759ea804a7f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_dc936309-7ba1-4d93-a488-c786ea412068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5c2515ef-80ab-4207-95ad-7863e28ed58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e410ef27-73a5-4cf6-9adf-e216080db3dc" xlink:to="loc_us-gaap_StatementLineItems_5c2515ef-80ab-4207-95ad-7863e28ed58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5c2515ef-80ab-4207-95ad-7863e28ed58c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c9e07a30-de32-46d5-9c79-8ec903676000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c9e07a30-de32-46d5-9c79-8ec903676000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694b8956-d646-4099-8968-60de320f4871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_694b8956-d646-4099-8968-60de320f4871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_7529f430-38c7-4f26-a57c-ad0b48caf494" xlink:href="dgx-20210630.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_7529f430-38c7-4f26-a57c-ad0b48caf494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fbe06a95-0e0d-4f50-a4ec-18d3d9cfe22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fbe06a95-0e0d-4f50-a4ec-18d3d9cfe22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_3c53d30b-5a1a-4a6f-9d29-19836f68b150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_DividendsCommonStockCash_3c53d30b-5a1a-4a6f-9d29-19836f68b150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_75c14751-c6f3-483c-bb79-7c2ef459d191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_75c14751-c6f3-483c-bb79-7c2ef459d191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ba11c529-f64c-4a5b-8876-3b801458b98f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ba11c529-f64c-4a5b-8876-3b801458b98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ab3c6469-5683-4a65-8bd1-1734a5fd9e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ab3c6469-5683-4a65-8bd1-1734a5fd9e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0e144614-d5c1-47a0-9187-a860ebd15985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0e144614-d5c1-47a0-9187-a860ebd15985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_175ae2e0-4ef7-46f1-9017-8445fd83ac25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_175ae2e0-4ef7-46f1-9017-8445fd83ac25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_34edbf57-aafb-415e-ae08-c665bc29664f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_34edbf57-aafb-415e-ae08-c665bc29664f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e864faf8-555e-41f1-b1d5-e2cb99a2f087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e864faf8-555e-41f1-b1d5-e2cb99a2f087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_160f889a-757f-4023-b5c5-a82583bc0ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_160f889a-757f-4023-b5c5-a82583bc0ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8d3164db-c474-4535-aef6-5b1cafc9cfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8d3164db-c474-4535-aef6-5b1cafc9cfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d1c8d82-d6dc-4343-bd28-38a0e29f8110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c1f451b4-24d5-4388-9ac4-29c6dfeedf78" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4d1c8d82-d6dc-4343-bd28-38a0e29f8110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5c2515ef-80ab-4207-95ad-7863e28ed58c" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0b581f6e-7670-4f33-bf9b-fd03d01edf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0b581f6e-7670-4f33-bf9b-fd03d01edf3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_1d04c349-4f32-468f-9803-a09479bc4a06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_1d04c349-4f32-468f-9803-a09479bc4a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_02239d72-b1f0-4c62-8b80-8677c5b11454" xlink:href="dgx-20210630.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_02239d72-b1f0-4c62-8b80-8677c5b11454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_5c418cfd-b943-4199-b85d-e2819e2e7b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5f5fef7e-161c-4ca0-8ed4-2df20e311e78" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_5c418cfd-b943-4199-b85d-e2819e2e7b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20210630.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract_58030cff-f2af-486b-ba3c-f288366ae136" xlink:href="dgx-20210630.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_f124a180-8c44-4233-ae2b-497f96c8bc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_DescriptionOfBusinessAbstract_58030cff-f2af-486b-ba3c-f288366ae136" xlink:to="loc_us-gaap_NatureOfOperations_f124a180-8c44-4233-ae2b-497f96c8bc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20210630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_94cf4235-7170-4f4b-a4b1-96a98344b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1b7ccaa7-5e50-4776-8342-8fbd984adff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_94cf4235-7170-4f4b-a4b1-96a98344b7f2" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1b7ccaa7-5e50-4776-8342-8fbd984adff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20210630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5565d225-ed34-47d3-aa69-b8f6c1705b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_38cad9a5-f9eb-473b-9d43-bdf250e12425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5565d225-ed34-47d3-aa69-b8f6c1705b63" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_38cad9a5-f9eb-473b-9d43-bdf250e12425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_517c20c2-8363-48fb-91e9-56ea4164dfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5565d225-ed34-47d3-aa69-b8f6c1705b63" xlink:to="loc_us-gaap_UseOfEstimates_517c20c2-8363-48fb-91e9-56ea4164dfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_fc0edcc4-2e92-4e24-94e0-20e990720b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5565d225-ed34-47d3-aa69-b8f6c1705b63" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_fc0edcc4-2e92-4e24-94e0-20e990720b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1023346f-4e58-4853-9ef4-a10fc3d7502c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5565d225-ed34-47d3-aa69-b8f6c1705b63" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1023346f-4e58-4853-9ef4-a10fc3d7502c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_689424c7-f741-4c66-ba63-5e958cea6fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5565d225-ed34-47d3-aa69-b8f6c1705b63" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_689424c7-f741-4c66-ba63-5e958cea6fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20210630.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5aa43be9-8453-45c7-9d5f-78e301b6b0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7690f17b-df75-4f01-be86-323ed14d67fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5aa43be9-8453-45c7-9d5f-78e301b6b0a7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7690f17b-df75-4f01-be86-323ed14d67fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="dgx-20210630.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5fbacb62-ace2-4d23-ae4c-6756655ed519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_60174084-4dc4-45a4-8e6a-480d595e72ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5fbacb62-ace2-4d23-ae4c-6756655ed519" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_60174084-4dc4-45a4-8e6a-480d595e72ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3409f601-aaac-46da-bd7f-fdfb2f559aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5fbacb62-ace2-4d23-ae4c-6756655ed519" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3409f601-aaac-46da-bd7f-fdfb2f559aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_dfc91b01-ff66-4788-8181-b1b073987711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_dfc91b01-ff66-4788-8181-b1b073987711" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_47613b31-a2d3-42ab-8c1c-ee16b335c17e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:to="loc_us-gaap_NetIncomeLoss_47613b31-a2d3-42ab-8c1c-ee16b335c17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_9e1d968e-6403-4592-8b24-551d0ec9b44d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_9e1d968e-6403-4592-8b24-551d0ec9b44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_f0bdfda3-f610-4f50-a78a-f22aa0897e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_f0bdfda3-f610-4f50-a78a-f22aa0897e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_81d2bf3c-347d-4300-a14e-9411a49052a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_81d2bf3c-347d-4300-a14e-9411a49052a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9531998d-7c24-4c42-bbec-243a7bcbbca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9531998d-7c24-4c42-bbec-243a7bcbbca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_709fc616-6067-4271-b92a-ab61fb57d663" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_709fc616-6067-4271-b92a-ab61fb57d663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_03a6757e-46e5-43a3-ae4c-58b5d087fc31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:to="loc_us-gaap_EarningsPerShareBasic_03a6757e-46e5-43a3-ae4c-58b5d087fc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9cc3d7fd-46cc-4c66-b737-c3606d48bfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_a9fe5e51-ff17-4f7a-b170-55a3be10c1ca" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9cc3d7fd-46cc-4c66-b737-c3606d48bfc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1fc8cc3d-f23e-4fb6-a4a4-ffacf56b09a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_dfc91b01-ff66-4788-8181-b1b073987711" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1fc8cc3d-f23e-4fb6-a4a4-ffacf56b09a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_ff92c320-3451-48e1-b366-71ec86d116b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_dfc91b01-ff66-4788-8181-b1b073987711" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_ff92c320-3451-48e1-b366-71ec86d116b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e7d91411-6504-44a8-95d6-e4940f65c75f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_ff92c320-3451-48e1-b366-71ec86d116b4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e7d91411-6504-44a8-95d6-e4940f65c75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_9cc02006-c278-4b01-adeb-c26b5dd232b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_e7d91411-6504-44a8-95d6-e4940f65c75f" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_9cc02006-c278-4b01-adeb-c26b5dd232b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_50057aa6-c5ea-4836-8c2c-9363f3cafeea" xlink:href="dgx-20210630.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_9cc02006-c278-4b01-adeb-c26b5dd232b9" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_50057aa6-c5ea-4836-8c2c-9363f3cafeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b20594c0-a5ea-4cbd-a940-4d8a65719bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_ff92c320-3451-48e1-b366-71ec86d116b4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b20594c0-a5ea-4cbd-a940-4d8a65719bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid_8e61c895-040f-44b7-93d9-018b7b34677a" xlink:href="dgx-20210630.xsd#dgx_AcceleratedShareRepurchasesInitialPricePaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_b20594c0-a5ea-4cbd-a940-4d8a65719bac" xlink:to="loc_dgx_AcceleratedShareRepurchasesInitialPricePaid_8e61c895-040f-44b7-93d9-018b7b34677a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20210630.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8999b79a-edcf-42b5-9771-742001ea351d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_eb33ddb2-2cad-4197-94cf-68c5853460be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8999b79a-edcf-42b5-9771-742001ea351d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_eb33ddb2-2cad-4197-94cf-68c5853460be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_01bd71c1-cecf-4869-b88b-b1c4fc261bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_01bd71c1-cecf-4869-b88b-b1c4fc261bd8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_09da23cd-34e8-4bd4-b0dc-ad81d25fe178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_09da23cd-34e8-4bd4-b0dc-ad81d25fe178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1e4cd2a-ace9-4d2d-8108-2e9c06e051c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09da23cd-34e8-4bd4-b0dc-ad81d25fe178" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1e4cd2a-ace9-4d2d-8108-2e9c06e051c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MercyHealthMember_9350c3fa-0bc2-4e7f-867a-5a6c358ab504" xlink:href="dgx-20210630.xsd#dgx_MercyHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f1e4cd2a-ace9-4d2d-8108-2e9c06e051c5" xlink:to="loc_dgx_MercyHealthMember_9350c3fa-0bc2-4e7f-867a-5a6c358ab504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb114415-a7ac-4e55-ab22-e5fe5f2aea65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb114415-a7ac-4e55-ab22-e5fe5f2aea65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ffb6f5ac-13bc-4083-9194-c30c357525a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb114415-a7ac-4e55-ab22-e5fe5f2aea65" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ffb6f5ac-13bc-4083-9194-c30c357525a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f5029cbd-1d51-46ba-911f-fc785135fb27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ffb6f5ac-13bc-4083-9194-c30c357525a5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f5029cbd-1d51-46ba-911f-fc785135fb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9fa1846b-e79d-4316-848d-a35f9274c6d2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1166936e-607a-4d8e-a950-d82f40f849f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1166936e-607a-4d8e-a950-d82f40f849f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_47c50caf-787d-4766-8d2f-f7de8d0de34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_47c50caf-787d-4766-8d2f-f7de8d0de34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0625d94c-249f-4f63-b991-da5d168d016b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_Goodwill_0625d94c-249f-4f63-b991-da5d168d016b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f5ed08fc-78e3-4d19-86e0-c1406de7093c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f5ed08fc-78e3-4d19-86e0-c1406de7093c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_deddba3d-b5db-4382-9838-c64b2b4d69a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c2a80d8e-0c75-4d38-be34-7d3e1b9d93b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_deddba3d-b5db-4382-9838-c64b2b4d69a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITION" xlink:type="simple" xlink:href="dgx-20210630.xsd#DISPOSITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISPOSITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_503afa59-ce2c-4ed7-a940-9091e9f366ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_a6844193-4216-4686-8d2e-ed85e0cb8bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_503afa59-ce2c-4ed7-a940-9091e9f366ce" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_a6844193-4216-4686-8d2e-ed85e0cb8bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#DISPOSITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISPOSITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4ae75b6f-5a3d-4929-bec3-7072e0dcc0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_4ae75b6f-5a3d-4929-bec3-7072e0dcc0d0" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_197a48ed-b897-4565-bcef-b8ea371baaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_197a48ed-b897-4565-bcef-b8ea371baaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b606fde-e8c1-451c-a2a8-309f4e0d82ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_197a48ed-b897-4565-bcef-b8ea371baaa8" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b606fde-e8c1-451c-a2a8-309f4e0d82ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_ba97c0b9-b27c-4732-b79b-0c15855cf7fb" xlink:href="dgx-20210630.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b606fde-e8c1-451c-a2a8-309f4e0d82ec" xlink:to="loc_dgx_Q2SolutionsMember_ba97c0b9-b27c-4732-b79b-0c15855cf7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_d90d75ab-bc29-4669-9096-8289706ee2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_d90d75ab-bc29-4669-9096-8289706ee2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e7f10777-d605-40a4-abdb-881f0360cd34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_d90d75ab-bc29-4669-9096-8289706ee2b1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e7f10777-d605-40a4-abdb-881f0360cd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_da97051d-1f35-4e47-bf00-9a9950bba647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e7f10777-d605-40a4-abdb-881f0360cd34" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_da97051d-1f35-4e47-bf00-9a9950bba647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4ac7257f-033b-4b21-bff5-70ed43f8ff30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4ac7257f-033b-4b21-bff5-70ed43f8ff30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fdb580ff-102b-4625-9e93-6d26c7e287b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4ac7257f-033b-4b21-bff5-70ed43f8ff30" xlink:to="loc_us-gaap_EquityComponentDomain_fdb580ff-102b-4625-9e93-6d26c7e287b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_b3875655-ac30-4a9a-b2e9-49dd19426bc2" xlink:href="dgx-20210630.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fdb580ff-102b-4625-9e93-6d26c7e287b9" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_b3875655-ac30-4a9a-b2e9-49dd19426bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_31dc7ef8-1775-4534-9745-a718461f0743" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_238c0eaf-9610-4a49-bdc0-cfc3b8681a77" xlink:href="dgx-20210630.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_238c0eaf-9610-4a49-bdc0-cfc3b8681a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_65a699dd-12a5-4979-8bf1-a0d24d7fa0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_65a699dd-12a5-4979-8bf1-a0d24d7fa0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_99e3cd84-08df-44ad-b631-c59324949eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_99e3cd84-08df-44ad-b631-c59324949eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c8ab4078-b2a3-436c-bf2e-86930f656549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c8ab4078-b2a3-436c-bf2e-86930f656549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_040c3d60-907c-485f-b91e-bb897d85ec34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_040c3d60-907c-485f-b91e-bb897d85ec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e9ddee24-5aa0-4899-80b2-f3fbc3dc15cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e9ddee24-5aa0-4899-80b2-f3fbc3dc15cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a5c763bf-d76a-4e0c-89c8-3ad732ae285a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2dcb7e16-876f-4a81-9ef9-69dea1f229c6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a5c763bf-d76a-4e0c-89c8-3ad732ae285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20210630.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_92caa51e-3ef8-485d-8d91-64ac476a9cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_720d7175-6ef2-4bdf-9a5e-ffc81963924b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_92caa51e-3ef8-485d-8d91-64ac476a9cd0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_720d7175-6ef2-4bdf-9a5e-ffc81963924b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20210630.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c70d2f52-3e03-4816-980a-14c481ce6211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_ad4feafc-af6b-4e92-807f-267caa8621fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c70d2f52-3e03-4816-980a-14c481ce6211" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_ad4feafc-af6b-4e92-807f-267caa8621fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2e3bbfbc-fcf2-47f8-9f42-7d3ab2bcf952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2e3bbfbc-fcf2-47f8-9f42-7d3ab2bcf952" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ec340a-418d-4ba2-b925-8318177d73d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ec340a-418d-4ba2-b925-8318177d73d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bb7b089e-1d6b-49fb-925d-90c8926e172b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73ec340a-418d-4ba2-b925-8318177d73d0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bb7b089e-1d6b-49fb-925d-90c8926e172b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_3a00a25a-bfc2-4f02-b407-0e107f03ab90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_bb7b089e-1d6b-49fb-925d-90c8926e172b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_3a00a25a-bfc2-4f02-b407-0e107f03ab90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_350841f3-f2ed-4548-9d7c-7464548d3023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_350841f3-f2ed-4548-9d7c-7464548d3023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_350841f3-f2ed-4548-9d7c-7464548d3023" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_baaa8671-fbb6-4601-8ca0-871ec0ee7ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_baaa8671-fbb6-4601-8ca0-871ec0ee7ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_daf4c1cd-3e63-4095-abb9-303e66768687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_daf4c1cd-3e63-4095-abb9-303e66768687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5acd29f8-b35f-4e8d-bfb8-77442e0ba8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8440dea7-18b2-4019-9721-1824ca25b3b9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5acd29f8-b35f-4e8d-bfb8-77442e0ba8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c036d7dd-54a9-47b1-8a31-7873319aff28" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_b452dd11-317d-44fd-873f-bd882b3d5ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_TradingSecurities_b452dd11-317d-44fd-873f-bd882b3d5ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_b66d1329-df1f-415a-a080-eb7f8a619e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_b66d1329-df1f-415a-a080-eb7f8a619e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_39e44f5a-8c5c-415f-b3b3-061df7029231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_39e44f5a-8c5c-415f-b3b3-061df7029231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d1922007-1e52-4039-a126-e0fd20364a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d1922007-1e52-4039-a126-e0fd20364a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_cee93da5-579b-4e85-8e9a-9f9f17c1a5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_cee93da5-579b-4e85-8e9a-9f9f17c1a5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_117d900b-c603-496d-a22e-94fd2e813a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3f5aa995-d27a-4721-a373-7a6895f4a30f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_117d900b-c603-496d-a22e-94fd2e813a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2770276f-245b-4edb-a578-c37e8c0d60c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2770276f-245b-4edb-a578-c37e8c0d60c9" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_073d7d71-165d-4959-91c7-7a1ad9d793b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:to="loc_srt_OwnershipAxis_073d7d71-165d-4959-91c7-7a1ad9d793b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_bc2cfdea-3dfc-40a3-8239-b2498712ebe4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_073d7d71-165d-4959-91c7-7a1ad9d793b9" xlink:to="loc_srt_OwnershipDomain_bc2cfdea-3dfc-40a3-8239-b2498712ebe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_dead2c93-a7c2-4a34-a11c-fa3f8c93d5ef" xlink:href="dgx-20210630.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_bc2cfdea-3dfc-40a3-8239-b2498712ebe4" xlink:to="loc_dgx_UMassJointVentureMember_dead2c93-a7c2-4a34-a11c-fa3f8c93d5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9a8c005-e29f-40f5-961c-5b05b29bb00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9a8c005-e29f-40f5-961c-5b05b29bb00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ec7fa6a-7cd7-4283-b98b-38daa8527e65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9a8c005-e29f-40f5-961c-5b05b29bb00e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ec7fa6a-7cd7-4283-b98b-38daa8527e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_38a286a5-c739-4c74-b30f-7d526c3de170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4ec7fa6a-7cd7-4283-b98b-38daa8527e65" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_38a286a5-c739-4c74-b30f-7d526c3de170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0e0ee3e-1ca4-43c5-bcfc-a2d25c062e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_f8205708-018d-4bdf-a9aa-152d2bd1e2ab" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0e0ee3e-1ca4-43c5-bcfc-a2d25c062e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_daf4cbd9-b000-4d1b-915b-f29551c3e129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0e0ee3e-1ca4-43c5-bcfc-a2d25c062e5e" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_daf4cbd9-b000-4d1b-915b-f29551c3e129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_26027bc1-fde6-4a8e-aa4a-405d35b4ef15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0e0ee3e-1ca4-43c5-bcfc-a2d25c062e5e" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_26027bc1-fde6-4a8e-aa4a-405d35b4ef15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_b16bfff6-81a1-42b9-9eb6-face7ec26c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2770276f-245b-4edb-a578-c37e8c0d60c9" xlink:to="loc_us-gaap_DebtInstrumentFairValue_b16bfff6-81a1-42b9-9eb6-face7ec26c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20210630.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f815e10e-6afb-4ddf-b65c-0674ff780e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_fc5b44ec-e94a-4c28-aae7-218e81bd6945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f815e10e-6afb-4ddf-b65c-0674ff780e1a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_fc5b44ec-e94a-4c28-aae7-218e81bd6945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20210630.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9856bff0-60ec-495b-aaca-9352be746a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_ed85f938-8df4-4e3d-8759-0d228958e7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9856bff0-60ec-495b-aaca-9352be746a73" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_ed85f938-8df4-4e3d-8759-0d228958e7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a9d670c4-0d5c-4d90-b908-d3904a05348d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9856bff0-60ec-495b-aaca-9352be746a73" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a9d670c4-0d5c-4d90-b908-d3904a05348d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c30fb856-e786-45ee-bdeb-35b72f337858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9856bff0-60ec-495b-aaca-9352be746a73" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c30fb856-e786-45ee-bdeb-35b72f337858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e9a4fe8a-e12d-431c-b6d6-22d5ffe0a456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0666bd16-2c60-4e19-ad24-4cc91ed9b3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e9a4fe8a-e12d-431c-b6d6-22d5ffe0a456" xlink:to="loc_us-gaap_GoodwillRollForward_0666bd16-2c60-4e19-ad24-4cc91ed9b3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5f3eb132-b240-4282-a385-e27df11bffb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0666bd16-2c60-4e19-ad24-4cc91ed9b3d5" xlink:to="loc_us-gaap_Goodwill_5f3eb132-b240-4282-a385-e27df11bffb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_210dcc3b-6cd3-44aa-9a2e-449cf6a5ac02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0666bd16-2c60-4e19-ad24-4cc91ed9b3d5" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_210dcc3b-6cd3-44aa-9a2e-449cf6a5ac02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_7c6bbedf-21d1-4c68-8ea3-6147c37efd34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0666bd16-2c60-4e19-ad24-4cc91ed9b3d5" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_7c6bbedf-21d1-4c68-8ea3-6147c37efd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8f0b7b09-ecec-4d73-a6b0-09cb927f96a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0666bd16-2c60-4e19-ad24-4cc91ed9b3d5" xlink:to="loc_us-gaap_Goodwill_8f0b7b09-ecec-4d73-a6b0-09cb927f96a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fbb7f023-3a3a-4e10-a8ba-bb27af734496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e9a4fe8a-e12d-431c-b6d6-22d5ffe0a456" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fbb7f023-3a3a-4e10-a8ba-bb27af734496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d39eec84-ed5b-415d-9d81-f10a2038cd02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fbb7f023-3a3a-4e10-a8ba-bb27af734496" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d39eec84-ed5b-415d-9d81-f10a2038cd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5603796c-d510-45f2-8cdd-e3fc6cea1dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d39eec84-ed5b-415d-9d81-f10a2038cd02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5603796c-d510-45f2-8cdd-e3fc6cea1dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_3e684f45-da86-4d3c-a177-0ae3abe8345f" xlink:href="dgx-20210630.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5603796c-d510-45f2-8cdd-e3fc6cea1dc3" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_3e684f45-da86-4d3c-a177-0ae3abe8345f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b14318a9-37a7-4ad7-add0-56655c238f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fbb7f023-3a3a-4e10-a8ba-bb27af734496" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b14318a9-37a7-4ad7-add0-56655c238f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_24c45cb9-7401-4c6d-b623-4ba2387fff13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b14318a9-37a7-4ad7-add0-56655c238f22" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_24c45cb9-7401-4c6d-b623-4ba2387fff13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0ee8184a-79c1-46b5-8f29-f12fce9632cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:href="dgx-20210630.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0ee8184a-79c1-46b5-8f29-f12fce9632cc" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa4444af-e64c-4d60-973e-67c60bde1f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa4444af-e64c-4d60-973e-67c60bde1f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fa4444af-e64c-4d60-973e-67c60bde1f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b9e1b8fc-897b-458d-965e-41fcdeb4f533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b9e1b8fc-897b-458d-965e-41fcdeb4f533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_3a202bf9-05dc-4881-ae23-447b0b61d758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_3a202bf9-05dc-4881-ae23-447b0b61d758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_b172a52c-8648-49b9-b164-74eb69c6f9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_b172a52c-8648-49b9-b164-74eb69c6f9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_aca43a96-682b-4223-ae13-360da6eab88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_aca43a96-682b-4223-ae13-360da6eab88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_80b46af4-5614-4e83-9f16-27efbdb0859f" xlink:href="dgx-20210630.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_979f3e64-33ba-4891-931c-cd7e41f6c89e" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_80b46af4-5614-4e83-9f16-27efbdb0859f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce03f58a-4137-4e5e-ad09-a59840c7ba5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f00ae13c-8cb7-43bd-9eee-0db5e6ae32bc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce03f58a-4137-4e5e-ad09-a59840c7ba5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_6ada3a17-3065-4ae9-820c-25a129fa4ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce03f58a-4137-4e5e-ad09-a59840c7ba5d" xlink:to="loc_us-gaap_TradeNamesMember_6ada3a17-3065-4ae9-820c-25a129fa4ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_4f00a64b-eeaa-43a9-a255-a274982a87b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ce03f58a-4137-4e5e-ad09-a59840c7ba5d" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_4f00a64b-eeaa-43a9-a255-a274982a87b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:href="dgx-20210630.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_40572fec-4ad8-418a-99d0-fb19b21c185a" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fd35f283-59e1-449a-aa3f-d0bea1ce1bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fd35f283-59e1-449a-aa3f-d0bea1ce1bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b60c0439-7c26-41c0-89c0-9ef7d9e8cfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b60c0439-7c26-41c0-89c0-9ef7d9e8cfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6f4a693a-07e3-48ac-bb8b-6be8636fe4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6f4a693a-07e3-48ac-bb8b-6be8636fe4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3653e1ae-64f2-4d41-96d3-995e2744dfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3653e1ae-64f2-4d41-96d3-995e2744dfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f93df880-0176-474e-b593-676b789cbfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f93df880-0176-474e-b593-676b789cbfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_fe5cdbee-386d-4d0c-b9b6-0c6779aa5852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_38ec99bd-e013-4aff-bb2d-e8f334f84cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_38ec99bd-e013-4aff-bb2d-e8f334f84cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f770b546-10a2-484d-9aba-7bf93dca45bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f770b546-10a2-484d-9aba-7bf93dca45bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ece9334e-ff49-4141-a419-428ea7c3c981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ece9334e-ff49-4141-a419-428ea7c3c981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_92066800-dc07-4100-8c2a-5fd4baeaa593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_92066800-dc07-4100-8c2a-5fd4baeaa593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cb13b868-6f5e-4c90-855d-2f29cf8fad09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cb13b868-6f5e-4c90-855d-2f29cf8fad09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc1b3ee3-13a2-444a-a208-be382dbfac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc1b3ee3-13a2-444a-a208-be382dbfac8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5b60a833-f3fa-45da-959e-5671bef556c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5b60a833-f3fa-45da-959e-5671bef556c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_35a8c8c8-40f4-4ef5-aaf8-257d991497dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_18cb5c4e-84b9-4e94-99df-b424f8c52ad6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_35a8c8c8-40f4-4ef5-aaf8-257d991497dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20210630.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5f482e78-beb1-4bb7-9bb6-ffca81c42841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_40a9a96a-f203-406e-a94a-c8adf87d0851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5f482e78-beb1-4bb7-9bb6-ffca81c42841" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_40a9a96a-f203-406e-a94a-c8adf87d0851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20210630.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_29e32f7e-d855-4225-b13c-7c942637d2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_0b20e8b4-3396-401f-b672-873a9a24d106" xlink:href="dgx-20210630.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_29e32f7e-d855-4225-b13c-7c942637d2f5" xlink:to="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_0b20e8b4-3396-401f-b672-873a9a24d106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a546d24c-1ee2-4948-81a0-919b292e3c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_29e32f7e-d855-4225-b13c-7c942637d2f5" xlink:to="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_a546d24c-1ee2-4948-81a0-919b292e3c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ef115613-1157-436e-8336-83c7cabb905f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ef115613-1157-436e-8336-83c7cabb905f" xlink:to="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d90bee79-8bbd-4af2-b4ea-755064da0565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d90bee79-8bbd-4af2-b4ea-755064da0565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_371a8859-cea3-42c7-a667-b0a3ff88f11b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d90bee79-8bbd-4af2-b4ea-755064da0565" xlink:to="loc_us-gaap_HedgingRelationshipDomain_371a8859-cea3-42c7-a667-b0a3ff88f11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_46015ff6-d5c0-4a81-9412-6855dd56c07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_371a8859-cea3-42c7-a667-b0a3ff88f11b" xlink:to="loc_us-gaap_CashFlowHedgingMember_46015ff6-d5c0-4a81-9412-6855dd56c07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_cd552026-de07-406d-bedf-94c803038763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_371a8859-cea3-42c7-a667-b0a3ff88f11b" xlink:to="loc_us-gaap_FairValueHedgingMember_cd552026-de07-406d-bedf-94c803038763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e08883f-007a-4b7e-83fd-62baac5c377f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:to="loc_srt_RangeAxis_6e08883f-007a-4b7e-83fd-62baac5c377f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_23bcc53d-ee01-484c-a2a2-2526e9c34d46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6e08883f-007a-4b7e-83fd-62baac5c377f" xlink:to="loc_srt_RangeMember_23bcc53d-ee01-484c-a2a2-2526e9c34d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f6226c0d-9fb2-4244-accd-667e875e467e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_23bcc53d-ee01-484c-a2a2-2526e9c34d46" xlink:to="loc_srt_MinimumMember_f6226c0d-9fb2-4244-accd-667e875e467e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ff8baf6b-f815-4419-a319-1bb81fa4eece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1492afad-a1a8-454b-b64f-100e1f71e05d" xlink:to="loc_us-gaap_DerivativeLineItems_ff8baf6b-f815-4419-a319-1bb81fa4eece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c92cdd3c-4b59-496f-98a3-3b2454f609e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ff8baf6b-f815-4419-a319-1bb81fa4eece" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c92cdd3c-4b59-496f-98a3-3b2454f609e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_351d999d-25cd-4054-880c-7c679a833bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ff8baf6b-f815-4419-a319-1bb81fa4eece" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_351d999d-25cd-4054-880c-7c679a833bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8dda7c18-da88-4e8b-bbdc-7b221038ff05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8dda7c18-da88-4e8b-bbdc-7b221038ff05" xlink:to="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c18732ea-ca6a-4082-bfba-122ec610d305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c18732ea-ca6a-4082-bfba-122ec610d305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_72ad7426-7341-4bb5-8693-af699ff0788e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c18732ea-ca6a-4082-bfba-122ec610d305" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_72ad7426-7341-4bb5-8693-af699ff0788e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_1c2e4d31-7990-4be4-b26c-c9949c48547f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_72ad7426-7341-4bb5-8693-af699ff0788e" xlink:to="loc_us-gaap_LongTermDebtMember_1c2e4d31-7990-4be4-b26c-c9949c48547f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_afff5771-c566-4b31-8858-75119034f14f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_afff5771-c566-4b31-8858-75119034f14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_bc40e1d8-5233-473c-ae5c-3ce821af712f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_afff5771-c566-4b31-8858-75119034f14f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_bc40e1d8-5233-473c-ae5c-3ce821af712f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_7748f61e-594f-4616-ae09-5f642571a849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_bc40e1d8-5233-473c-ae5c-3ce821af712f" xlink:to="loc_us-gaap_FairValueHedgingMember_7748f61e-594f-4616-ae09-5f642571a849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b12b079d-20f7-4a12-804b-43cd4bd84375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_228b916f-ffe5-49df-befb-e9c0367167a6" xlink:to="loc_us-gaap_DerivativeLineItems_b12b079d-20f7-4a12-804b-43cd4bd84375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_f766a42d-f036-4fef-bac0-71bf6bf5f1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b12b079d-20f7-4a12-804b-43cd4bd84375" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_f766a42d-f036-4fef-bac0-71bf6bf5f1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7c39211-8ba3-46e3-8337-8e72fbb9d830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7c39211-8ba3-46e3-8337-8e72fbb9d830" xlink:to="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e6ad928f-f470-40cb-a9de-042bf004a1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e6ad928f-f470-40cb-a9de-042bf004a1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5860437a-ffdc-478b-b47e-0cc16e3e857e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e6ad928f-f470-40cb-a9de-042bf004a1c7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5860437a-ffdc-478b-b47e-0cc16e3e857e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9314f476-ddda-490b-9509-2281019ccffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5860437a-ffdc-478b-b47e-0cc16e3e857e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_9314f476-ddda-490b-9509-2281019ccffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cbbfacb5-742f-4b92-a44d-fd8809c50d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cbbfacb5-742f-4b92-a44d-fd8809c50d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4d1f618c-1ffa-4181-9bce-df71844ff396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cbbfacb5-742f-4b92-a44d-fd8809c50d25" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4d1f618c-1ffa-4181-9bce-df71844ff396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_786d8956-6eb6-4588-b580-12b15413220d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4d1f618c-1ffa-4181-9bce-df71844ff396" xlink:to="loc_us-gaap_FairValueHedgingMember_786d8956-6eb6-4588-b580-12b15413220d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_9acdebe9-a33d-472b-a78b-a13a3c2d7274" xlink:to="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a9c9c1bf-ab4e-4560-94fb-51fe0192372e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a9c9c1bf-ab4e-4560-94fb-51fe0192372e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c5a61441-29ca-41d6-8138-ab2b2b87c8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_c5a61441-29ca-41d6-8138-ab2b2b87c8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_07858cd6-c574-483e-bb62-5f77b61167f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b6aa7981-d750-4231-932a-77228d27e4b0" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_07858cd6-c574-483e-bb62-5f77b61167f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20210630.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_44af3121-9535-41b9-8abe-50731aad3c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_91e5ce82-1a40-4758-bd63-ac11812a7bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44af3121-9535-41b9-8abe-50731aad3c5a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_91e5ce82-1a40-4758-bd63-ac11812a7bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_41e8b84d-e4b4-4d65-8cd7-7a97b2452c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:href="dgx-20210630.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_41e8b84d-e4b4-4d65-8cd7-7a97b2452c00" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2c9e1f9-e6b2-4245-8638-a840b9a92998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2c9e1f9-e6b2-4245-8638-a840b9a92998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_671a2720-1c0d-4d7a-b432-e8e87cc89cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e2c9e1f9-e6b2-4245-8638-a840b9a92998" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_671a2720-1c0d-4d7a-b432-e8e87cc89cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_7f4a09f8-b594-4820-b874-840b2514a55a" xlink:href="dgx-20210630.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_671a2720-1c0d-4d7a-b432-e8e87cc89cd0" xlink:to="loc_dgx_Q2SolutionsMember_7f4a09f8-b594-4820-b874-840b2514a55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_eed6fd76-ee69-4d39-adc3-ac951ef35fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_eed6fd76-ee69-4d39-adc3-ac951ef35fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_523ac73e-b179-4fbe-bf1c-43fc095cbd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_eed6fd76-ee69-4d39-adc3-ac951ef35fc9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_523ac73e-b179-4fbe-bf1c-43fc095cbd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_71e7a103-de81-4792-8edd-f7df0b12ef4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_523ac73e-b179-4fbe-bf1c-43fc095cbd9f" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_71e7a103-de81-4792-8edd-f7df0b12ef4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cf379fe2-13b1-461d-9be2-fd7557516f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cf379fe2-13b1-461d-9be2-fd7557516f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cf379fe2-13b1-461d-9be2-fd7557516f83" xlink:to="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_137c7df8-2c3a-488a-b24e-1043ff0debd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:to="loc_us-gaap_TreasuryStockMember_137c7df8-2c3a-488a-b24e-1043ff0debd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_e0b55d31-ecee-40ec-9b71-298e406cd64f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_e0b55d31-ecee-40ec-9b71-298e406cd64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForeignCurrencyTranslationMember_9c8e2215-3c50-454d-bb67-4a6816475447" xlink:href="dgx-20210630.xsd#dgx_ForeignCurrencyTranslationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9b9c7d09-a669-4aac-935c-6775640101c5" xlink:to="loc_dgx_ForeignCurrencyTranslationMember_9c8e2215-3c50-454d-bb67-4a6816475447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_a07ca18e-8eda-463e-8fef-942c95ddb635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_a07ca18e-8eda-463e-8fef-942c95ddb635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_01252a42-3998-4c16-a883-967ebc003480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_a07ca18e-8eda-463e-8fef-942c95ddb635" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_01252a42-3998-4c16-a883-967ebc003480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_6dd016d6-e586-4057-b011-13fd3a64fff7" xlink:href="dgx-20210630.xsd#dgx_AcceleratedShareRepurchaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_01252a42-3998-4c16-a883-967ebc003480" xlink:to="loc_dgx_AcceleratedShareRepurchaseAgreementsMember_6dd016d6-e586-4057-b011-13fd3a64fff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_15980737-166c-429f-8b71-e7507f9f6cf1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_srt_OwnershipAxis_15980737-166c-429f-8b71-e7507f9f6cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_fd79bdb9-a862-4b30-97fa-1089af2bdc50" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_15980737-166c-429f-8b71-e7507f9f6cf1" xlink:to="loc_srt_OwnershipDomain_fd79bdb9-a862-4b30-97fa-1089af2bdc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_831c8dfd-b012-45b5-9d8a-8481945854df" xlink:href="dgx-20210630.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_fd79bdb9-a862-4b30-97fa-1089af2bdc50" xlink:to="loc_dgx_UMassJointVentureMember_831c8dfd-b012-45b5-9d8a-8481945854df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:href="dgx-20210630.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_88dfcdcd-b8c3-4c77-aee6-2ddfa4a4c76b" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_4ea5a232-dd2b-4fd6-be3d-dfcae41e43d6" xlink:href="dgx-20210630.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_4ea5a232-dd2b-4fd6-be3d-dfcae41e43d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_01ea269d-d4d4-4068-98c3-957cd6676bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_01ea269d-d4d4-4068-98c3-957cd6676bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e85dcc08-e58f-438d-b442-cf31e2ae6e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e85dcc08-e58f-438d-b442-cf31e2ae6e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_52a5bdcb-17eb-4e4b-9a90-a99f311b56b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_52a5bdcb-17eb-4e4b-9a90-a99f311b56b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_3c94a025-6053-44ba-9200-253478b0e042" xlink:href="dgx-20210630.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_3c94a025-6053-44ba-9200-253478b0e042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8f4617eb-9a3f-4453-894f-e2002834d2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8f4617eb-9a3f-4453-894f-e2002834d2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1b9ba180-0090-462e-bcf1-cd2dadfe5bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1b9ba180-0090-462e-bcf1-cd2dadfe5bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_cd06da78-4796-44bf-bc0e-4e2b369f01d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_cd06da78-4796-44bf-bc0e-4e2b369f01d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_359f0a13-4823-42b0-827f-3eb53d08f65c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_359f0a13-4823-42b0-827f-3eb53d08f65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_7e4852a1-ffc8-4b3e-85d1-ca027696c7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare_7e4852a1-ffc8-4b3e-85d1-ca027696c7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_4bb95111-e059-404c-8240-409d924ee3e9" xlink:href="dgx-20210630.xsd#dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution_4bb95111-e059-404c-8240-409d924ee3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_42d4e468-295b-4abe-9046-87391aacbbe4" xlink:href="dgx-20210630.xsd#dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements_42d4e468-295b-4abe-9046-87391aacbbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_116f557a-3b53-4d4b-9860-997ee62ec9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_116f557a-3b53-4d4b-9860-997ee62ec9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_c9ef0876-ca36-4e81-b370-6a30da751f82" xlink:href="dgx-20210630.xsd#dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements_c9ef0876-ca36-4e81-b370-6a30da751f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_07423bc4-221b-4a2b-b9ef-76fc7fb8e32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_07423bc4-221b-4a2b-b9ef-76fc7fb8e32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8760d4f2-87f0-4521-9daf-126ba62b1c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_6c745b56-9698-42c6-8e77-2bc87456e987" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_8760d4f2-87f0-4521-9daf-126ba62b1c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="simple" xlink:href="dgx-20210630.xsd#SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_396f59a5-58c8-4256-87a4-e0f1afb35a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_f989e7ff-441c-40d4-a549-1fcd48d1c8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_396f59a5-58c8-4256-87a4-e0f1afb35a98" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_f989e7ff-441c-40d4-a549-1fcd48d1c8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="simple" xlink:href="dgx-20210630.xsd#SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_74d34094-91a7-43f9-8004-d29924ee33bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_e36f544c-1fbc-46ea-bd96-a8e0a60dd242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_74d34094-91a7-43f9-8004-d29924ee33bb" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_e36f544c-1fbc-46ea-bd96-a8e0a60dd242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_faee1692-58ab-4dcb-8a3c-3ac8982c7af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_Depreciation_faee1692-58ab-4dcb-8a3c-3ac8982c7af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9dde7c30-bf59-41da-8268-2efa14aba96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9dde7c30-bf59-41da-8268-2efa14aba96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6381935c-6140-4b7c-91e5-cff7dc8327fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6381935c-6140-4b7c-91e5-cff7dc8327fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e51bdb22-acc5-438d-b930-f774c4d626b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_InterestExpense_e51bdb22-acc5-438d-b930-f774c4d626b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_85b56550-ebfb-41f5-8920-46884784a4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_85b56550-ebfb-41f5-8920-46884784a4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_004d9577-c268-46d6-b4d9-ef189d73484e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_004d9577-c268-46d6-b4d9-ef189d73484e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_c0d01bc3-1d7c-467c-a12d-1546033b870e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_InterestPaid_c0d01bc3-1d7c-467c-a12d-1546033b870e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_9fa3f618-7b6c-443d-af9b-6254fbbad34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_IncomeTaxesPaid_9fa3f618-7b6c-443d-af9b-6254fbbad34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_335e2cca-0396-47bb-b604-944212b202f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_335e2cca-0396-47bb-b604-944212b202f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_a74b146a-112a-431f-b20a-9af58331ef0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_a74b146a-112a-431f-b20a-9af58331ef0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_8818f036-1319-4db7-af63-b98c34d3c154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_8818f036-1319-4db7-af63-b98c34d3c154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_09c79fb3-8096-417d-92db-08e94f319e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_LiabilitiesAssumed1_09c79fb3-8096-417d-92db-08e94f319e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_275dc6db-bace-4171-860d-d9105150e302" xlink:href="dgx-20210630.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_dgx_FairValueOfNetAssetsAcquired_275dc6db-bace-4171-860d-d9105150e302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_f4e2af35-db9e-425c-8e4e-4fa9c5f164b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_f4e2af35-db9e-425c-8e4e-4fa9c5f164b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c310f2e1-7238-4a22-be2d-b18835e7c4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c310f2e1-7238-4a22-be2d-b18835e7c4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_d665d57e-f983-4094-bfa4-14f0d80569c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2858bf7e-155b-4748-ae8e-e6f944513376" xlink:to="loc_us-gaap_LeaseCostAbstract_d665d57e-f983-4094-bfa4-14f0d80569c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d53143f8-8b1c-4264-bcf3-002d7a3caaae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_d665d57e-f983-4094-bfa4-14f0d80569c1" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d53143f8-8b1c-4264-bcf3-002d7a3caaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_9a9a8dd1-1b25-4976-a5ad-4d09f885c543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_c30f86d7-095f-4045-a09c-ae5db5c56625" xlink:href="dgx-20210630.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9a9a8dd1-1b25-4976-a5ad-4d09f885c543" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_c30f86d7-095f-4045-a09c-ae5db5c56625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2e717155-cf24-409c-ace0-3edf6d9ad105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_c30f86d7-095f-4045-a09c-ae5db5c56625" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2e717155-cf24-409c-ace0-3edf6d9ad105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_854c6a4e-7879-4191-b7bf-c1b04b022b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2e717155-cf24-409c-ace0-3edf6d9ad105" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_854c6a4e-7879-4191-b7bf-c1b04b022b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_b912f148-3ed0-4324-8a10-8da1bfb4809c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_854c6a4e-7879-4191-b7bf-c1b04b022b53" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_b912f148-3ed0-4324-8a10-8da1bfb4809c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:href="dgx-20210630.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_c30f86d7-095f-4045-a09c-ae5db5c56625" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_62d2382c-a266-4da6-b4a7-1b11d80ee9c5" xlink:href="dgx-20210630.xsd#dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:to="loc_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche_62d2382c-a266-4da6-b4a7-1b11d80ee9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_2328853d-cb38-4e1b-97ad-30e1c9da6725" xlink:href="dgx-20210630.xsd#dgx_CARESActProceedsRecognizedInTheStatementOfOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:to="loc_dgx_CARESActProceedsRecognizedInTheStatementOfOperations_2328853d-cb38-4e1b-97ad-30e1c9da6725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfRecognitionOfCARESActProceeds_6fbfc14d-4029-42ad-820a-bacc8a9058f9" xlink:href="dgx-20210630.xsd#dgx_ReversalOfRecognitionOfCARESActProceeds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_ed1abb67-07b8-4fb2-8745-96005c24f181" xlink:to="loc_dgx_ReversalOfRecognitionOfCARESActProceeds_6fbfc14d-4029-42ad-820a-bacc8a9058f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20210630.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08c8f4f8-fdf8-47f8-a5fd-fd75ac1eef6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_40b60665-2ae8-45a2-91bc-5928cacdb1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_08c8f4f8-fdf8-47f8-a5fd-fd75ac1eef6a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_40b60665-2ae8-45a2-91bc-5928cacdb1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a66c4f8f-aece-4ea8-bfb8-901cfc638c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_a4514860-8369-4cbe-a7d5-e288247f0526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a66c4f8f-aece-4ea8-bfb8-901cfc638c3f" xlink:to="loc_us-gaap_LossContingenciesTable_a4514860-8369-4cbe-a7d5-e288247f0526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_a9a9df04-718b-47c0-b99e-6aa092a889e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a4514860-8369-4cbe-a7d5-e288247f0526" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_a9a9df04-718b-47c0-b99e-6aa092a889e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9159901a-00ea-4235-b4d0-283ea25d9bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_a9a9df04-718b-47c0-b99e-6aa092a889e6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9159901a-00ea-4235-b4d0-283ea25d9bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5bea76f6-1008-4167-805d-39f8a5845d70" xlink:href="dgx-20210630.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_9159901a-00ea-4235-b4d0-283ea25d9bcb" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_5bea76f6-1008-4167-805d-39f8a5845d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_991f49fc-5a8e-442a-b1b3-424552c21860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_a4514860-8369-4cbe-a7d5-e288247f0526" xlink:to="loc_us-gaap_LossContingenciesLineItems_991f49fc-5a8e-442a-b1b3-424552c21860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_f2d8d08c-bd8b-45ce-beea-c22de920eb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_991f49fc-5a8e-442a-b1b3-424552c21860" xlink:to="loc_us-gaap_LitigationReserve_f2d8d08c-bd8b-45ce-beea-c22de920eb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a66c4f8f-aece-4ea8-bfb8-901cfc638c3f" xlink:to="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_da22ae23-52cd-4d34-af65-21d2a274b080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_da22ae23-52cd-4d34-af65-21d2a274b080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_be8a6bb3-9b2a-40cc-a90a-d6f2cfd926f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_da22ae23-52cd-4d34-af65-21d2a274b080" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_be8a6bb3-9b2a-40cc-a90a-d6f2cfd926f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_1eecaee0-f15b-4294-9b68-a0e83908d03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_be8a6bb3-9b2a-40cc-a90a-d6f2cfd926f5" xlink:to="loc_us-gaap_SecuredDebtMember_1eecaee0-f15b-4294-9b68-a0e83908d03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_5db7d966-ca34-4e44-8e51-0d5cdcfee628" xlink:href="dgx-20210630.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_be8a6bb3-9b2a-40cc-a90a-d6f2cfd926f5" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_5db7d966-ca34-4e44-8e51-0d5cdcfee628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_56642a4c-cf7b-43cd-b51e-d292026766ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:to="loc_us-gaap_CreditFacilityAxis_56642a4c-cf7b-43cd-b51e-d292026766ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bf155394-5894-4b9b-88fc-426481002e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_56642a4c-cf7b-43cd-b51e-d292026766ae" xlink:to="loc_us-gaap_CreditFacilityDomain_bf155394-5894-4b9b-88fc-426481002e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d098306d-c6eb-4b26-99b5-4bec12a8c0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_bf155394-5894-4b9b-88fc-426481002e82" xlink:to="loc_us-gaap_LetterOfCreditMember_d098306d-c6eb-4b26-99b5-4bec12a8c0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b4edb75c-5ef7-459c-9597-59940d57ee76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_84f8945c-37a6-4b69-ab32-7da63753213c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b4edb75c-5ef7-459c-9597-59940d57ee76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d6569340-041d-47ef-a9c3-8385fa09dc47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4edb75c-5ef7-459c-9597-59940d57ee76" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d6569340-041d-47ef-a9c3-8385fa09dc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4e9a7b1b-3841-4a87-a11e-a3bddf274b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4edb75c-5ef7-459c-9597-59940d57ee76" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4e9a7b1b-3841-4a87-a11e-a3bddf274b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_0b5e0e8a-89d7-4a69-bf0b-0e795064544b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a66c4f8f-aece-4ea8-bfb8-901cfc638c3f" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_0b5e0e8a-89d7-4a69-bf0b-0e795064544b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_73abe5a5-ac8f-4977-9b83-ed88551bfe95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a66c4f8f-aece-4ea8-bfb8-901cfc638c3f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_73abe5a5-ac8f-4977-9b83-ed88551bfe95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20210630.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_140ed525-3ccd-49ee-95db-cfae7c381d54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_fbf53d38-d02a-41c7-ade4-d6bb1e5d3f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_140ed525-3ccd-49ee-95db-cfae7c381d54" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_fbf53d38-d02a-41c7-ade4-d6bb1e5d3f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20210630.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_87358297-139b-4648-98a7-d1edcf226901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_911c2058-6d21-4035-90a9-83022b461f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_87358297-139b-4648-98a7-d1edcf226901" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_911c2058-6d21-4035-90a9-83022b461f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_fa16f957-d0ce-4d86-a395-e4f056aeb3a1" xlink:href="dgx-20210630.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_87358297-139b-4648-98a7-d1edcf226901" xlink:to="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_fa16f957-d0ce-4d86-a395-e4f056aeb3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4c515540-87b7-409c-b12b-a47fd04f8ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4c515540-87b7-409c-b12b-a47fd04f8ccf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cd66cc73-59e0-400f-8640-65481a9478c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cd66cc73-59e0-400f-8640-65481a9478c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cd66cc73-59e0-400f-8640-65481a9478c9" xlink:to="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_5303bc35-8358-462f-afe5-e7518b62b3a5" xlink:href="dgx-20210630.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_5303bc35-8358-462f-afe5-e7518b62b3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_96f60d2b-d836-4fc7-8619-d369cb1780c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:to="loc_us-gaap_AllOtherSegmentsMember_96f60d2b-d836-4fc7-8619-d369cb1780c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_af474e7e-d581-4714-b592-9c154ff3f314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5f7adfa9-3eb1-4346-9816-857c9843c672" xlink:to="loc_us-gaap_CorporateMember_af474e7e-d581-4714-b592-9c154ff3f314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ac408f70-9341-41f5-8409-3dffa59a33b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:to="loc_srt_RangeAxis_ac408f70-9341-41f5-8409-3dffa59a33b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d9531ac6-5631-4878-9877-e01d90ec0a94" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ac408f70-9341-41f5-8409-3dffa59a33b6" xlink:to="loc_srt_RangeMember_d9531ac6-5631-4878-9877-e01d90ec0a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6f5cd028-2340-4a54-9f5d-d522a962e738" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d9531ac6-5631-4878-9877-e01d90ec0a94" xlink:to="loc_srt_MinimumMember_6f5cd028-2340-4a54-9f5d-d522a962e738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ee789994-b3e5-4395-88ef-a29f4fa01b42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:to="loc_srt_ProductOrServiceAxis_ee789994-b3e5-4395-88ef-a29f4fa01b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ee789994-b3e5-4395-88ef-a29f4fa01b42" xlink:to="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_80e8b52e-2ebd-447a-a1bb-598cf7c35bf0" xlink:href="dgx-20210630.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_80e8b52e-2ebd-447a-a1bb-598cf7c35bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_d6136af5-e35a-4873-8b79-1c865b05b76b" xlink:href="dgx-20210630.xsd#dgx_COVID19TestingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_COVID19TestingServicesMember_d6136af5-e35a-4873-8b79-1c865b05b76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_76f57ab7-88bf-48a5-8892-86a7782358a0" xlink:href="dgx-20210630.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_76f57ab7-88bf-48a5-8892-86a7782358a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_79f012d2-6b8b-442b-9a7b-c49c8c30343b" xlink:href="dgx-20210630.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_79f012d2-6b8b-442b-9a7b-c49c8c30343b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_c75afd92-4ce8-4d82-b4f3-7a8d094f6414" xlink:href="dgx-20210630.xsd#dgx_AllotherservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_08eb63bd-b851-4a26-bafa-87ad32674d97" xlink:to="loc_dgx_AllotherservicesMember_c75afd92-4ce8-4d82-b4f3-7a8d094f6414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c7f1ac00-f2d9-49f1-91f2-c1722d12d7af" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_1e64c590-1a06-46d2-8f2c-8116f435590a" xlink:href="dgx-20210630.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_dgx_PercentageofNetRevenues_1e64c590-1a06-46d2-8f2c-8116f435590a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25f160a8-0a3e-416c-b715-ce7e9e027eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_25f160a8-0a3e-416c-b715-ce7e9e027eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dbbd3554-52ae-4e14-ae29-e0b3d2cc84ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_OperatingIncomeLoss_dbbd3554-52ae-4e14-ae29-e0b3d2cc84ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_923dc601-8c07-48ce-bfd9-098939b3b10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_923dc601-8c07-48ce-bfd9-098939b3b10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c631664a-602c-4f9e-a53f-32f6b6887978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c631664a-602c-4f9e-a53f-32f6b6887978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1e755b66-5494-4753-9301-d0e5a646abec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1e755b66-5494-4753-9301-d0e5a646abec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5edb0d85-6049-46c6-8b73-0cd2ffe2af95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5edb0d85-6049-46c6-8b73-0cd2ffe2af95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a1c3c7cd-7300-4f28-86a3-8279b191a79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_ProfitLoss_a1c3c7cd-7300-4f28-86a3-8279b191a79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb08c1b8-d011-4f68-b3a6-8eaf9d53ef10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_eb08c1b8-d011-4f68-b3a6-8eaf9d53ef10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eac705c2-bb2e-406e-9818-6eeeaedc6cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1ca2ac91-8b38-49a8-9f5c-3e319581fc54" xlink:to="loc_us-gaap_NetIncomeLoss_eac705c2-bb2e-406e-9818-6eeeaedc6cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20210630.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5ca69b6c-40f0-468b-ace8-7b1f9513eb90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5d25b8fa-b01b-40dd-8b9b-90b3170aef6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5ca69b6c-40f0-468b-ace8-7b1f9513eb90" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5d25b8fa-b01b-40dd-8b9b-90b3170aef6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20210630.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e4dd3af-58a8-4961-a88a-8b6df8a67a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_760d3e2d-7f42-40de-9aa7-a8ab753ffb73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e4dd3af-58a8-4961-a88a-8b6df8a67a89" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_760d3e2d-7f42-40de-9aa7-a8ab753ffb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_d210770f-e904-41b4-833f-a3dfde33f309" xlink:href="dgx-20210630.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e4dd3af-58a8-4961-a88a-8b6df8a67a89" xlink:to="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_d210770f-e904-41b4-833f-a3dfde33f309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4a61bb0a-7b31-435e-86ce-901dab0ed6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4a61bb0a-7b31-435e-86ce-901dab0ed6f4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_25246928-7993-4b05-ac7b-d02f484dd8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_25246928-7993-4b05-ac7b-d02f484dd8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d58a5e1-e12b-4873-ba0f-e0de7474999f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_25246928-7993-4b05-ac7b-d02f484dd8a7" xlink:to="loc_us-gaap_SegmentDomain_9d58a5e1-e12b-4873-ba0f-e0de7474999f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_7bf82e44-1bfd-4521-80b0-4c41a04df967" xlink:href="dgx-20210630.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d58a5e1-e12b-4873-ba0f-e0de7474999f" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_7bf82e44-1bfd-4521-80b0-4c41a04df967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_0274e774-1d76-4fdb-8e95-8ebbabc9d422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d58a5e1-e12b-4873-ba0f-e0de7474999f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_0274e774-1d76-4fdb-8e95-8ebbabc9d422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0e3d1f5f-1dc8-4603-8168-bc808907a4f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_srt_RangeAxis_0e3d1f5f-1dc8-4603-8168-bc808907a4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e96ceec-583a-43c5-ad7b-21ae0f8218db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0e3d1f5f-1dc8-4603-8168-bc808907a4f0" xlink:to="loc_srt_RangeMember_6e96ceec-583a-43c5-ad7b-21ae0f8218db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c18ee01d-a9ec-4d4b-ab58-89108fb8add9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6e96ceec-583a-43c5-ad7b-21ae0f8218db" xlink:to="loc_srt_MinimumMember_c18ee01d-a9ec-4d4b-ab58-89108fb8add9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_652830b9-3d62-4e53-a485-3236e31cd358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_us-gaap_SubsegmentsAxis_652830b9-3d62-4e53-a485-3236e31cd358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_652830b9-3d62-4e53-a485-3236e31cd358" xlink:to="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_3ebb7d4b-2e69-40d5-a3a0-e57da60de6df" xlink:href="dgx-20210630.xsd#dgx_HealthcareInsurersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_HealthcareInsurersMember_3ebb7d4b-2e69-40d5-a3a0-e57da60de6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_65143acb-015d-4e1e-9beb-2d15bcf2ac32" xlink:href="dgx-20210630.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_GovernmentPayersMember_65143acb-015d-4e1e-9beb-2d15bcf2ac32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_f4a9070f-a53e-4386-b044-7fb7c14fe32f" xlink:href="dgx-20210630.xsd#dgx_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_ClientPayersMember_f4a9070f-a53e-4386-b044-7fb7c14fe32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_960ce8ce-e061-4bbb-96a8-8a7a2d98a64c" xlink:href="dgx-20210630.xsd#dgx_PatientsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_PatientsMember_960ce8ce-e061-4bbb-96a8-8a7a2d98a64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_044fb4c5-73d8-4f94-91c4-db80a40bbd7f" xlink:href="dgx-20210630.xsd#dgx_DSBusinessesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4f1e7306-a5e1-432e-b496-20d947e5e5b4" xlink:to="loc_dgx_DSBusinessesMember_044fb4c5-73d8-4f94-91c4-db80a40bbd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3c279b6e-17aa-4939-85c5-a3a3b3b699eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_srt_ProductOrServiceAxis_3c279b6e-17aa-4939-85c5-a3a3b3b699eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_99b14c37-ad71-4bf9-8e28-585d7550cacc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3c279b6e-17aa-4939-85c5-a3a3b3b699eb" xlink:to="loc_srt_ProductsAndServicesDomain_99b14c37-ad71-4bf9-8e28-585d7550cacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_6ac2af86-c1e1-451c-998a-67627224c24a" xlink:href="dgx-20210630.xsd#dgx_FeeforserviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_99b14c37-ad71-4bf9-8e28-585d7550cacc" xlink:to="loc_dgx_FeeforserviceMember_6ac2af86-c1e1-451c-998a-67627224c24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_d415a691-56fb-4cf5-bfed-fbef06deaf7f" xlink:href="dgx-20210630.xsd#dgx_CapitatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_99b14c37-ad71-4bf9-8e28-585d7550cacc" xlink:to="loc_dgx_CapitatedMember_d415a691-56fb-4cf5-bfed-fbef06deaf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_87b0e54f-6fa5-40a5-88b6-634fd3cf33c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8b9471e2-cc69-47db-9d31-d9a9cbcf7b7a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_87b0e54f-6fa5-40a5-88b6-634fd3cf33c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_0cfea775-bee6-4723-b449-52ae6c1d3c39" xlink:href="dgx-20210630.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87b0e54f-6fa5-40a5-88b6-634fd3cf33c3" xlink:to="loc_dgx_PercentageofNetRevenues_0cfea775-bee6-4723-b449-52ae6c1d3c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_fd9508b4-d28d-4014-8df9-1ac9a5299690" xlink:href="dgx-20210630.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_87b0e54f-6fa5-40a5-88b6-634fd3cf33c3" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_fd9508b4-d28d-4014-8df9-1ac9a5299690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="dgx-20210630.xsd#TAXESONINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_29960110-7c37-42b1-a92b-c57b64c0f9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_3febbd57-a356-4470-83d7-e8f555c1f050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29960110-7c37-42b1-a92b-c57b64c0f9ef" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_3febbd57-a356-4470-83d7-e8f555c1f050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20210630.xsd#TAXESONINCOMEDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4af073d1-6fa3-419a-91ef-04ac4b07c44b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4af073d1-6fa3-419a-91ef-04ac4b07c44b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_59732518-ecc5-4677-be39-8868baf723f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_59732518-ecc5-4677-be39-8868baf723f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_424d0200-e6fe-431b-be49-af5b2994d742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_59732518-ecc5-4677-be39-8868baf723f2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_424d0200-e6fe-431b-be49-af5b2994d742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_94d0d0b9-2dfa-452e-ad2b-b574fe290a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_424d0200-e6fe-431b-be49-af5b2994d742" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_94d0d0b9-2dfa-452e-ad2b-b574fe290a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_198f4cf9-4dbc-4f55-aaba-97ffb9559c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_198f4cf9-4dbc-4f55-aaba-97ffb9559c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_67e6e2c2-b271-4c0f-8ff0-8b900eaf1e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_198f4cf9-4dbc-4f55-aaba-97ffb9559c88" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_67e6e2c2-b271-4c0f-8ff0-8b900eaf1e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_575f652b-d4e0-4a8a-8d7f-a328b00fbb25" xlink:href="dgx-20210630.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_67e6e2c2-b271-4c0f-8ff0-8b900eaf1e72" xlink:to="loc_dgx_Q2SolutionsMember_575f652b-d4e0-4a8a-8d7f-a328b00fbb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5234f51b-9767-4fdf-a3e0-bffb2c60cb35" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e887b8cf-5b15-4175-90eb-8980641a8d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e887b8cf-5b15-4175-90eb-8980641a8d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_e12e39fd-62eb-495b-93c3-8d5e378cf28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_e12e39fd-62eb-495b-93c3-8d5e378cf28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_6a2d206b-8c84-46c4-a742-a5c1896fae4e" xlink:href="dgx-20210630.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_d4d5c80d-83e1-4257-a58e-8f1526ff2d85" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_6a2d206b-8c84-46c4-a742-a5c1896fae4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>dgx-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:dgx="http://questdiagnostics.com/20210630"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dgx-20210630.xsd" xlink:type="simple"/>
    <context id="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib645763448a14b6d8a210f113e155fd7_I20210715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-07-15</instant>
        </period>
    </context>
    <context id="i561420fa41374455918b2b347d38a86c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i99a551f639d34e26b6107af0da64abe6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3656967af97247b1bbcb74c67d929381_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3f1009ff18c488b8726927338c269af_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia74ca347035d47afab9af2863189a9af_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie409db7692b2496c84592ac0ae13ab4b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5cdf70fc1e32411f987859d4ba3a4b93_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1234b393ecf446beb2d12b0db437882a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i95131b6d75e44a49bc1fac55189ad1cc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1d562072f0674b3ab9fbfd9437b9b623_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if3f0b2f6f90d4e56a9e0c7eafef2d828_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94d95e47035740e2be82b0b81c67afed_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie0c0ed67c1eb40078423e9d062bb487f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2f8251b106654d1c98108056fb012db9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icfd6ba29f4e1492491f91836654d629f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iefc874b9d0dd40489c1a7dcf6860f5a0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9214e898766d4e348c518cc861e2a6d6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idadbab3594fd43348d9b825585c50f1e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0c07c80b26c24ce38628b41e10b0357e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibe18efd7ba104ac9a5aa32571d8c6166_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i562a2de976ae4600bcfccf456de6283f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i71c62f68e0b7484397a15c914fab24bc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3a4a7dcc35654302bd8e48f6068259be_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if708b3a322c142a896b74f2674affc33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0848c719bfa64a6997b49547abca2d7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if9a1846b30804708b76daaf8e7313d54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i926d05e6d1164bceb1d1e6ee02daa1c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5b79ec0ef2348fdae4dc4f7e23a8c61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id2775145b5b44ba595f9fd2c6019fffa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i127f391cad8f454e934f06617f28068b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iab17e5ada04d4e3f8418321f4fed5170_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45e6e7f9cf924fcfba4006108d77d2d7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i120d2d9a75ae49a78ce64d7e98309352_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if2d14897dec64b1f93d805966f667a67_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2c64b417754a41bf9cb5d032e7c7f1d2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i292f044a2a694be987cf1e050fc32158_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibe0f2af904df4308974d0cfadbf6c95f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9f22713e20cc4bba8a7d9e37885165ac_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id0cdf7d6ee7c436a9d9d7ab4fe709a5e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ida27930c41dd4f5a9e90d48ebfc0c9c4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3f21b83c03584dc6924263f55d606a78_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic29fec842eda4d01b395c9c45167a267_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib46a16fab53a4ae68476a2fb7593280f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if819fd1fb51043378a435a56ad7b4b3c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id2f9ac74121f49239c7f3983ae7bae36_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6e4e7a78200d43478e75bd5cdd2d9c12_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic61245d5d6bf4ec6ac96d7e5d11d0de6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i74a92cff8b5f4b7585d55a6b13176562_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i26783a3b7dd249be9c28f89f9ffb93c8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id6f8598006da47daaf4f264d1f79a720_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5fa0525d2dc0497f928c8d6ab3456eb5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5e56b1b204974d05a0f5e2c43eea7cbd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i546e403b15214524b8519bba76c4d0da_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3d014e770945452f897511320c1c2b70_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d38a260d94c443d8eea143672b2cd72_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50aeb63e5efe48d99c044cfb52e07b48_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6df3ecb6e73749a49030a463355f0fba_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7500943b3564489290004ac65ed7fccf_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3cc55a2801094ec0bc9f846effac87da_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i62149b0b25564ab180137047be530824_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i533de8c040f5497f94c63d60c5e38efa_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i32ceb997147b42ebafa6e46d4f452d31_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="iede8a4b7d31f4a908594d37d2d356dce_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="ic80123e8686446ea809da2ddaa1ffaea_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="i18670a49a70d49f8aeb8c2046b450952_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MercyHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ie3af8b0558d7461c9027eaf168d159f3_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic3be2c0db58246b7ba37ca73d78f5af0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i04611b3c394b4101bd96d6e4b765e44c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ieb4f5b2e63164cf29143b9d989289909_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i859aca831b984d80a0b94d96fc615aa2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id2e3fa85839f4364b166f6fd6333403f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib638d54663d141b3b55a392010b4133c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4153cd4b719540d983239e906877df0e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51a3f19649844f0b9777994eb7530457_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbe6cc9023dd4f6b925f3e4b803adba0_I20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="icfcc6d7cb7ac4f62b3b2a88f27e08e14_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7c021b8753de48c7949085222e7a6139_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia41845b250794af096b47fe4b8dcfef7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0928297813dc4017bf49f241cc643448_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i062d7e387e63446587683b565e79cc7c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i62c6b6c329864ab3b58435cdeddd4726_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i243d7693a5f1415e850da25a647196b6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i080fe75a1bab496783d14dbde41a0ab7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6b349580952a42daa37b46b6272cf25b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6867e614c34049c1a7f3aced88b5b8bc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5398a8c43e6c402d94b6baa7dbf0d6ee_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5f627c6887ae40ecafd69b4688c9cc51_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i240c440483ce414d8bd8a947d07168e4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i77a870ab4b284d47b78555d636f33091_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6261831038be4db5bd54afa80dbf7bd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4d571b8f74b4b3393f62cdbd449a4fa_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia38bbfcf307146078c97c1184f858dcd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i56c902ee777e4bfc97e2db0e0d3526be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i388db605d7fa414f925f9483e847602e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i158831a555d7459cbe9af1e66382b1d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11b6b69b0dc94269aeb47d2aa8b322c0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if8d9f93c589f4849bf27e56a6e0c38c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04635c8c75144bd8a8ba0318721159e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e506a9924014d9bb1c2cfc78ca49c38_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia9062ff9a1ae48d79906ea44e302c2e7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifef13a5c7cd74ff2af0e1affd9841703_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbac0da433664c12b78532c13c77e330_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id28577727d1648e484a07b8110249cb4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5227393e6940467e8dee71a1b9b51664_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7a3fbebc3bfe4304ba9e9eb9b1bba88c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7aa5e0abeaed4700bdad18c66e5e59b9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i662c45865225464399b955e53cc70538_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibd95473cf34947db9595e10c6d055373_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1fa06c6f3bf140899d194e149d257ba9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic627ecff5fda4835a645a85a28ace8c5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i03e1d81e938740ac958144ec1c77ded0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i20d06c07440d4f66b5778443f9d59b7a_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib08b3d9b382f42539d1313a3fc3d9152_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic1daf0363ce34e388d9a621878fbf6c0_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i326c009316994d11a6801f243ae0c3c5_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ib5a71b4b1c174929a891375f3de116e1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iea4626114bd94a1b8470c2ae9e6f26e2_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i3fbb220f78a341abb8f1709736881c15_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1b25ce7f6ff24ed7bbb7af00c1bd27a7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie4ea064d0de34ab9b6d853e2567d8e12_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">dgx:AcceleratedShareRepurchaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i44b2df1b377b46139f619a2f36e50ecf_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i02f8071b495d4e6690e62d4d392886da_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6a152b0fb1084caa902c4093da8d43db_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i556b98e351504ca9ab3b40b06f30f294_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib82b7d6590d24533bdb4d454c3f65409_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if6477236048c4c93b9a5e798f19e3fcc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5be56e298c3542a08d1a42235055721a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icab7ab47a0de43f7bab61f509c638937_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ie7d0fd1d47784fd697f3c49dd3ee9148_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5fb24d8255674ea29c12a58a75a31c7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29a251826fef44b7a2f0a3c45547f1cf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i383af7e535cb4e1b91b38301026c3942_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i90505fcb3b254cc1854ef977088118fc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5bb4af20d3554d7c929c5923a8579af2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3010233763bd4c139f2be9e14d283953_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib6397d097e9541cd93b37f7f3793e996_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaf9bb291bfed42dd8d3e3f6e51487a32_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieb0cbdde947349c2a36c2d246eb753b3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0889a4285c0e4785b648e20f63f330f9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9c3b5a5d28a4bd8ad953fad99e01101_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i15a526c3a9c94237af3d47054f8b6d88_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifcc4b8411f1549df9adea0e982455905_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i97dbe548aae446e5b0a2d3af9581d04d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ief4ea7051e25417fbffc0d616878520f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i624857d463ea42cba64821f6526c8f30_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9487c77290544536af9132f251d1f6ea_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7cc8267b895c4a3f960332826d5a02a4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibebaf9b7d93d4b928c763156787f0e12_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if7302c53e8d34d6f90c6b6355b0f4289_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ide03df6794ec4f319643260a062544e3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2b44cf9ddb7649a4b78b908d8d56915d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id2434d7efd8540e98be5af167e3ed184_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3fb502a9bf254ed190f3f05d0c743c9f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i60bb75a4ffe942ad8f8ee7cc12887a86_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib040e682f6cd49fa8fcaeab6c9d181d8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic0da175e34d54ca9bc607ec32504bb8c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9b11f69b1f65429992a961faaccd7fd2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i33bfedc0555f4b54a3fb6ed997bac076_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i74d1e8f63991474d991b6164216d4e30_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i25ee037b0e524fc29dea8a393cc05548_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i69f9d9630be94d08b53f303e6841bda8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibcc42e2ae9df4d33a04a0b7b4ad4f4a5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia152bf35c30347d8873598f3162479e9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2bdcdaca428a4c798866885a7bf83056_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ide868a83c608446793a82a3dd54fa369_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idd0e727fc05c4c8995fdb6239cf65e8b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iffe84216348445a59b369c286ef7ea93_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78df85d445ba4c0db260659c0ff4938d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3415e92f142e4b66b223b653c1a52387_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8c5637dc35e141ba997c638460a77408_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id0a7aade517b46ed8b5a72c6df38f8aa_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i71015133b38c46c58c9f22d76e9138bf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i61e91a1c6442413ea75e76e2d1d3dfba_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9d45b95ebfa54455b7a8148902aef07e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8d1ae3e3c083422987b0fb7513f90028_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i86c6e680c2644742bae6cf23bce0251e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib3fd720e863c4f78bafdeb62b08b7f4f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9dd965423d424e19a504a6a42bb048c0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i247d47c1463a483386454a9395684d29_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i25cda7d1389e444ea61b767b89bced02_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i53e1743ac9e84f96b59d2add6ce6e13d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iba66174bf50b4b8e989cb690f4f40491_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4d8f167638d849ea9481c99bc9392ad0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5541bed47cc341dfbed89f1ffbc4662d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3656dc776fa3408393224dc1faa34145_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i70684da285074a80b27a51d58ae0bb69_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib54ce13b5fa748fca4142752ebed0ace_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3456017b640b4ec79039ff09ce94613a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i12c508b86ea2424cb0fd8f135fe41718_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i29d70c753e104f2e9381d4c4d680e64e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i351bd30e85e24fbbb3960dc16939ff04_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifb969f883d7f4514bce846057de29d5d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0fb23c7e2fab487ba4834d786dea4bf7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia3845502e9c3418fa7afe7f9e6d923f7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic74a4e69eaf749ee870747305583176f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i17eefeebe6ed4e218bc255b2a54bc938_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52eab006215b4f08859dc4a709d65fa5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i67c88c4d2eab4a3e92f6026392a577d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i673f602d80e04697ad707632c81bedc9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9ec294bc9c1544d1b91cea9e983a73d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie91fe1b790d2497fa2a96a583468755b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie2fac1abae04410ca5aa5c55ced1c0d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7308d78e16804acdb197a6fe7389240b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icbc053e1f6804e8bad318c14a1840e34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5efcf88fa11e4c91a8d160f946aa751a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i498cb94f65974aa2812f578184595178_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0267b05c8fa74b65aae925e3bb8946a3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>dgx:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV8xLTEtMS0xLTA_6dd5fdfe-6e6e-49bc-af01-abf94b196322">0001022079</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV8yLTEtMS0xLTA_ccdc6109-b322-485f-8c00-f5154c590401">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV8zLTEtMS0xLTA_d40ffea9-379a-4d8e-abba-f667b8803fe7">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV80LTEtMS0xLTA_8473c0b0-684c-49b7-9489-ff30dece4d94">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80L2ZyYWc6NDY2ZWMxN2U1ZmNhNDk4MTg2OTMxZGRiNTlkOGQwOGIvdGFibGU6NWVjNTE3YjdhYTA2NDEwMmE1M2E4ZDg4MmYyZWFkYTEvdGFibGVyYW5nZTo1ZWM1MTdiN2FhMDY0MTAyYTUzYThkODgyZjJlYWRhMV81LTEtMS0xLTA_ef0303af-d8ee-419e-a350-9ca7e5d4f751">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTI4_f27e2b8e-9616-4a02-abb1-a74c1b0058b6">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTI5_02fbac45-eb7c-4615-b32b-7c6e982d80cf">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8yNzQ4Nzc5MDcxNDM2_6ab62e98-8600-4d6a-83a8-9acbcd7a6c9d">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTMw_fa899390-2b1b-4927-9dd8-5221f5ea234a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTMx_2516b97e-2ef2-4085-9627-05156af276fe">001-12215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTMy_d91fa084-2536-4502-b45a-7054d1862706">Quest Diagnostics Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8wLTAtMS0xLTA_d699fee2-e0ae-4ea8-9ae4-12b8b84991b2">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8wLTUtMS0xLTA_cc2dda37-e105-473c-bf2d-37cd98598063">16-1387862</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8yLTAtMS0xLTA_2e6fb709-7ee6-43bd-9f1c-5128668d64e2">500 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8zLTAtMS0xLTA_3ead50fb-d0ed-43f0-a78f-8feabcb6ac89">Secaucus,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8zLTEtMS0xLTA_82a66928-31df-49e8-8752-861fa90256ef">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF8zLTItMS0xLTA_32731fd7-8366-4837-ac0f-82d6fea92d52">07094</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF80LTAtMS0xLTA_73856ab9-c732-4357-87c8-808a9dac5827">(973)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MTY1OGE5NjZjMzcxNDNlODgzZmNhN2M3MmIwMWVkNjQvdGFibGVyYW5nZToxNjU4YTk2NmMzNzE0M2U4ODNmY2E3YzcyYjAxZWQ2NF80LTEtMS0xLTA_2d17dd37-4dbb-41b2-9847-e84ab68ddef0">520-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6N2RhOGI0ZDQ5MmU0NDM4ODkzZjc5Zjc4YWFkNDNkZGYvdGFibGVyYW5nZTo3ZGE4YjRkNDkyZTQ0Mzg4OTNmNzlmNzhhYWQ0M2RkZl8xLTAtMS0xLTA_d90748ce-b5c0-4746-af28-88a7f2456eea">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6N2RhOGI0ZDQ5MmU0NDM4ODkzZjc5Zjc4YWFkNDNkZGYvdGFibGVyYW5nZTo3ZGE4YjRkNDkyZTQ0Mzg4OTNmNzlmNzhhYWQ0M2RkZl8xLTEtMS0xLTA_03eb22b6-9399-4d12-90bd-091c551802ad">DGX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6N2RhOGI0ZDQ5MmU0NDM4ODkzZjc5Zjc4YWFkNDNkZGYvdGFibGVyYW5nZTo3ZGE4YjRkNDkyZTQ0Mzg4OTNmNzlmNzhhYWQ0M2RkZl8xLTItMS0xLTA_e3d02ed3-3a62-4acc-aa6e-00191f44f523">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTMz_ba6b8674-d630-47ad-99ea-cbb8706d6e89">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTI2_15fb8e6b-4ec2-4b0b-b98c-dc48e3bc03c9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MGMxNDk2OWI4ODUzNDRlNjg5NmE3M2I5ZDUzMDdlNmMvdGFibGVyYW5nZTowYzE0OTY5Yjg4NTM0NGU2ODk2YTczYjlkNTMwN2U2Y18wLTAtMS0xLTA_bb45b0a4-942a-464d-9e45-a1e6680a6e07">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MGMxNDk2OWI4ODUzNDRlNjg5NmE3M2I5ZDUzMDdlNmMvdGFibGVyYW5nZTowYzE0OTY5Yjg4NTM0NGU2ODk2YTczYjlkNTMwN2U2Y18xLTMtMS0xLTA_4ab78706-ec18-45b4-a531-8c27cf2104b8">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGFibGU6MGMxNDk2OWI4ODUzNDRlNjg5NmE3M2I5ZDUzMDdlNmMvdGFibGVyYW5nZTowYzE0OTY5Yjg4NTM0NGU2ODk2YTczYjlkNTMwN2U2Y18yLTMtMS0xLTA_58d4a011-316e-4470-850c-f00b3dbdb0fe">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xOTI3_3d4582ca-4337-4172-aa9c-cf870cb4f7cb">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib645763448a14b6d8a210f113e155fd7_I20210715"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xL2ZyYWc6ZGY2NzcyMGU1MDM4NDY3ZThkNDNjZDg2NTMxOTU3ODQvdGV4dHJlZ2lvbjpkZjY3NzIwZTUwMzg0NjdlOGQ0M2NkODY1MzE5NTc4NF8xODY3_203e3ccc-4e81-40f3-8e79-77d986c9b49c"
      unitRef="shares">122180759</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMi0xLTEtMS0w_fc1a95b9-5b36-446b-a520-35540da939d7"
      unitRef="usd">2550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMi0zLTEtMS0w_cd00fb5a-b1b6-4649-ab6f-94483fd194b1"
      unitRef="usd">1827000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMi01LTEtMS0w_bcc7d142-047b-488d-b70a-03e150aa0001"
      unitRef="usd">5270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMi03LTEtMS0w_119fac11-51cb-4fd0-bf88-67b5c546cb40"
      unitRef="usd">3649000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNS0xLTEtMS0w_831efc5a-e08c-48ea-87b5-c39666bc8d40"
      unitRef="usd">1565000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNS0zLTEtMS0w_26a5b6b8-6c3e-4efd-a5be-0556396591a2"
      unitRef="usd">1221000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNS01LTEtMS0w_618eeece-56f7-45ca-ab4f-d35296a692e6"
      unitRef="usd">3191000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNS03LTEtMS0w_fe8ac189-f1f7-4e18-897b-2963db5024dd"
      unitRef="usd">2491000000</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNi0xLTEtMS0w_aa2d429b-335e-44a1-b324-72d3688102af"
      unitRef="usd">429000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNi0zLTEtMS0w_02fdc74a-ac2f-4098-99a0-4d8634b3f552"
      unitRef="usd">360000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNi01LTEtMS0w_9b434130-3811-48d7-b34b-043a1373a557"
      unitRef="usd">836000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNi03LTEtMS0w_17cbd86b-3c1b-412c-a0c7-d3b8ec7c1b30"
      unitRef="usd">707000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNy0xLTEtMS0w_6a0e6c95-0f93-471e-b9ba-fadec14c3fc7"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNy0zLTEtMS0w_e108fc8e-1b65-4b0c-a825-cecd3a3e5719"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNy01LTEtMS0w_92bad958-ecb0-4de4-907c-5609465bf3aa"
      unitRef="usd">52000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNy03LTEtMS0w_c69d877b-5c7d-4a09-a523-4981df2bc2b2"
      unitRef="usd">50000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfOS0xLTEtMS0w_dee132ac-1d3b-4a2f-89ba-278cd6a8888b"
      unitRef="usd">2000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfOS0zLTEtMS0w_20eefe42-7c86-4708-a540-46a79110a780"
      unitRef="usd">62000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfOS01LTEtMS0w_83e8cbaa-1e12-44fe-bd9f-07b276bd0579"
      unitRef="usd">2000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfOS03LTEtMS0w_74994036-27b5-42fc-8853-0e55077f8bcc"
      unitRef="usd">57000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTAtMS0xLTEtMA_2e1e1fa8-fe4b-4016-8910-17e89865cc61"
      unitRef="usd">2017000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTAtMy0xLTEtMA_c996a5e0-4ed2-4ce6-b4d0-ef5445fdd87b"
      unitRef="usd">1544000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTAtNS0xLTEtMA_b3391794-b15c-49d6-b42d-917146c17300"
      unitRef="usd">4077000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTAtNy0xLTEtMA_9ea69cf1-c9d7-4a5a-ad6d-a9f29a26fe2a"
      unitRef="usd">3191000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTItMS0xLTEtMA_11d585e7-58c7-44bc-877d-336fa2cc849b"
      unitRef="usd">533000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTItMy0xLTEtMA_603367a3-7dda-4ba3-b82c-484e30ef32b6"
      unitRef="usd">283000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTItNS0xLTEtMA_e31eea8d-39ec-4cbc-8051-b82928873497"
      unitRef="usd">1193000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTItNy0xLTEtMA_6e4e6b85-6f7a-4267-9554-834cee776c44"
      unitRef="usd">458000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTUtMS0xLTEtMA_99c391fb-6817-47d7-b920-e331da94b1a3"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTUtMy0xLTEtMA_7e9828a4-a695-4881-bf87-879f836d9aa4"
      unitRef="usd">-41000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTUtNS0xLTEtMA_da3de060-e546-4363-bb49-c13b94b0505b"
      unitRef="usd">-76000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTUtNy0xLTEtMA_a379d696-e044-4dbf-90e9-5c87a2170389"
      unitRef="usd">-82000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTYtMS0xLTEtMA_05c69018-16ba-45e7-8e55-0bf5823533bb"
      unitRef="usd">322000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTYtMy0xLTEtMA_62fcc405-cbee-49ba-bb09-89f4fba19611"
      unitRef="usd">13000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTYtNS0xLTEtMA_6c0ee8fc-006d-4a23-9571-2764d9dfedc9"
      unitRef="usd">326000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTYtNy0xLTEtMA_16e49fba-4c78-4adb-bd3f-c7422731dc24"
      unitRef="usd">-3000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTctMS0xLTEtMA_8640f65c-f044-4249-bc80-28c5d41aa6ff"
      unitRef="usd">284000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTctMy0xLTEtMA_3093e26f-c667-4b16-ac86-f1deb1475a45"
      unitRef="usd">-28000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTctNS0xLTEtMA_7374c04c-486e-4abf-af2e-f02274bdf588"
      unitRef="usd">250000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTctNy0xLTEtMA_69fce8ec-6a42-4b2a-9e9b-8671f8363e0a"
      unitRef="usd">-85000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTktMS0xLTEtMA_7e749051-d36f-45ad-b726-01b3c4aeee1d"
      unitRef="usd">817000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTktMy0xLTEtMA_2107968c-f893-4137-8360-9e0cef22aad9"
      unitRef="usd">255000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTktNS0xLTEtMA_ce247608-152b-47a9-86af-c38f1a3e027a"
      unitRef="usd">1443000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMTktNy0xLTEtMA_8a866003-720f-4075-8b63-61db9c932e47"
      unitRef="usd">373000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjAtMS0xLTEtMA_68d4c507-6b50-4be3-9eed-988541251782"
      unitRef="usd">177000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjAtMy0xLTEtMA_e4976c99-b41f-4c99-89a6-8d196fe9c5d2"
      unitRef="usd">66000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjAtNS0xLTEtMA_a630ee36-57ab-481a-bfdf-8b3dffda8529"
      unitRef="usd">330000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjAtNy0xLTEtMA_295f0589-ff63-486e-85ec-e3e05bcfb00c"
      unitRef="usd">92000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtMS0xLTEtMA_b4a2d493-1de0-40a1-9c9a-483338a82029"
      unitRef="usd">10000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtMy0xLTEtMA_5edaa6f7-40a2-4a22-83fd-58329718ccda"
      unitRef="usd">4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtNS0xLTEtMTMwMw_26775f79-a83e-4a65-a3d6-e78ca2531c13"
      unitRef="usd">27000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtNS0xLTEtMTMwMw_4b9b3006-bb2c-4b86-a969-bfb3041b1996"
      unitRef="usd">27000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtNS0xLTEtMTMwMw_6e888c36-402f-4100-91ed-93b703198ee0"
      unitRef="usd">27000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjEtNy0xLTEtMA_5e1a2882-3725-457b-a133-5d41150c2f6b"
      unitRef="usd">18000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjQtMS0xLTEtMA_a738bfbc-6c8e-4dd8-a301-dbcc051d4740"
      unitRef="usd">650000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjQtMy0xLTEtMA_0c2e4dfe-6198-47c9-ad46-789083e8e45e"
      unitRef="usd">193000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjQtNS0xLTEtMA_f3a85723-3609-44e8-8548-e532bbbac80c"
      unitRef="usd">1140000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjQtNy0xLTEtMA_a494afc5-4bf0-4d2a-84a1-03edf69627a3"
      unitRef="usd">299000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjUtMS0xLTEtMA_ffe6f478-14ab-446f-9954-f6f4c0eae840"
      unitRef="usd">19000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjUtMy0xLTEtMA_2ad09ab2-879a-4382-9a1e-00e802b83535"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjUtNS0xLTEtMA_64f505bb-0ee4-488b-bb5c-be6ca8906851"
      unitRef="usd">40000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjUtNy0xLTEtMA_aabe4b27-36b4-4019-a032-e484f58c8aad"
      unitRef="usd">15000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjYtMS0xLTEtMA_02f6de2d-6a97-493b-bfb2-a53fb0526788"
      unitRef="usd">631000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjYtMy0xLTEtMA_064f0c87-2760-4057-8133-3312f5969fd5"
      unitRef="usd">185000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjYtNS0xLTEtMA_549be23e-8a12-4e87-a0b7-90c67573cc5f"
      unitRef="usd">1100000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMjYtNy0xLTEtMA_ac8f0836-20e2-4513-8528-77bc9f0c53a8"
      unitRef="usd">284000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMzYtMS0xLTEtMA_54510063-af48-4395-8246-7ffae0e10eeb"
      unitRef="usdPerShare">5.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMzYtMy0xLTEtMA_dd17af99-1810-4263-9494-b9ac1f6d8eb0"
      unitRef="usdPerShare">1.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMzYtNS0xLTEtMA_199f61ae-3ccd-4549-ac0a-6c64f7ef8bda"
      unitRef="usdPerShare">8.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfMzYtNy0xLTEtMA_5bc44d1e-e8e7-48cd-9dd1-be9d1299cefc"
      unitRef="usdPerShare">2.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDEtMS0xLTEtMA_c8d18fee-b4ac-43d6-8214-cfa21e433cd7"
      unitRef="usdPerShare">4.96</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDEtMy0xLTEtMA_ab52cefc-82d5-495a-881b-ac49e1632b21"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDEtNS0xLTEtMA_0e310ed0-435a-4c8f-b82f-13965dad1d2b"
      unitRef="usdPerShare">8.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDEtNy0xLTEtMA_4431b110-ffeb-4d65-9c0c-6f269fd0abee"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDQtMS0xLTEtMA_e59068b8-f6e4-4557-83f9-dcd46e65a6d6"
      unitRef="shares">125000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDQtMy0xLTEtMA_2571cb85-722a-42f3-b2c6-b7a9010dc47a"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDQtNS0xLTEtMA_414dbc7d-8aed-4768-976d-580e985cbf31"
      unitRef="shares">129000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDQtNy0xLTEtMA_1db536a0-0eb0-4d01-8549-dd6636661f52"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDYtMS0xLTEtMA_3addd579-c31f-4d02-a00d-bb5350c80b3d"
      unitRef="shares">127000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDYtMy0xLTEtMA_f5026ffd-8425-4838-a8b4-af969b048430"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDYtNS0xLTEtMA_6415670a-df5d-4f03-ad19-f6a3cdf1831c"
      unitRef="shares">131000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMy9mcmFnOjg3MDIzNDY1MjVjMDRiNmJhN2VhY2FmZGEyZTYxMTA1L3RhYmxlOmUxN2Y3YmZlY2E1ZTRiOGRiMzZhY2M5ZGUwYzk4Y2YxL3RhYmxlcmFuZ2U6ZTE3ZjdiZmVjYTVlNGI4ZGIzNmFjYzlkZTBjOThjZjFfNDYtNy0xLTEtMA_e08a7b44-ca28-455e-89f1-d125fe0b0980"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMi0xLTEtMS0w_a738bfbc-6c8e-4dd8-a301-dbcc051d4740"
      unitRef="usd">650000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMi0zLTEtMS0w_0c2e4dfe-6198-47c9-ad46-789083e8e45e"
      unitRef="usd">193000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMi01LTEtMS0w_f3a85723-3609-44e8-8548-e532bbbac80c"
      unitRef="usd">1140000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMi03LTEtMS0w_a494afc5-4bf0-4d2a-84a1-03edf69627a3"
      unitRef="usd">299000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNS0xLTEtMS0w_6c307b55-fcbb-44c6-9771-85d73f2bea94"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNS0zLTEtMS0w_49a3ecfb-146d-48d7-9022-528bf14e0768"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNS01LTEtMS0w_1f8e72dc-a255-455a-9f31-273425772864"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNS03LTEtMS0w_3b8e6356-58b3-48cd-9ca7-62ac72ce05cd"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNi0xLTEtMS0w_acee0d32-3f70-40aa-800d-00ee8695e246"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNi0zLTEtMS0w_95ca5f28-9a0c-4db5-b32c-3c27c7639d87"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNi01LTEtMS0w_18363e45-3156-4496-896e-87490c2b04e5"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfNi03LTEtMS0w_5f7ff597-8595-447a-bfb4-30a4a3c97a04"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfOS0xLTEtMS0w_f945583a-efc1-4bcf-ae5a-748e99ba07b0"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfOS0zLTEtMS0w_f3097aed-e76e-40d8-8d20-2ebada036c3f"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfOS01LTEtMS0w_fba526ec-b2d7-47c5-86bd-36d09cb5c65f"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfOS03LTEtMS0w_d0c92554-9d48-4566-b169-710f4b9c48e0"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTEtMS0xLTEtMA_5620b33c-4267-465e-b3f0-7558aae01c21"
      unitRef="usd">671000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTEtMy0xLTEtMA_3dc1f49e-9b63-4d93-b714-4c896fb2aab5"
      unitRef="usd">196000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTEtNS0xLTEtMA_5e0d45b1-50db-4b73-aecd-13d97542c443"
      unitRef="usd">1151000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTEtNy0xLTEtMA_d3b0111e-6fe7-4223-95e4-4217c60e1657"
      unitRef="usd">283000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTItMS0xLTEtMA_2633e01d-abbb-47d1-a021-7d8147fd640f"
      unitRef="usd">19000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTItMy0xLTEtMA_9ad6eb9e-6939-4951-b539-bb7f361bf125"
      unitRef="usd">8000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTItNS0xLTEtMA_0bd66f73-fd8a-400d-ac37-e9196219e019"
      unitRef="usd">40000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTItNy0xLTEtMA_429a80e6-39f6-4e6a-88a6-8dd28a2106c9"
      unitRef="usd">15000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTMtMS0xLTEtMA_5820f051-5240-400a-9568-76c402bed1e7"
      unitRef="usd">652000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTMtMy0xLTEtMA_49f95b2c-47b0-48f9-9b23-10b91a09238f"
      unitRef="usd">188000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTMtNS0xLTEtMA_1ceacde0-290a-46ad-b195-a6e77c166647"
      unitRef="usd">1111000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xNi9mcmFnOmRhZTlmNzFjMjk0OTQyYzA5YjJmOThkOGJhMmQwZDgyL3RhYmxlOjE5ZTYyNGMyNTRkOTQ0MzdiZTg1NDVkN2M5MzA2NTA0L3RhYmxlcmFuZ2U6MTllNjI0YzI1NGQ5NDQzN2JlODU0NWQ3YzkzMDY1MDRfMTMtNy0xLTEtMA_909f2484-7e9e-48d5-a17d-c6d2ca98abb3"
      unitRef="usd">268000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMy0xLTEtMS0w_1bafc3c0-f580-40ba-baa4-31f8fa128cf6"
      unitRef="usd">560000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMy0zLTEtMS0w_d5144588-2d0f-4bdc-80a9-6b684d896e68"
      unitRef="usd">1158000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNC0wLTEtMS0wL3RleHRyZWdpb246Y2I2YTM2NTBkNzVjNGI1N2I2OTlhYmRmNTYzZjRhNmZfNjM_661430d6-d57a-4012-83d0-34b61a71bfc9"
      unitRef="usd">29000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNC0wLTEtMS0wL3RleHRyZWdpb246Y2I2YTM2NTBkNzVjNGI1N2I2OTlhYmRmNTYzZjRhNmZfNzA_9cf61022-8c28-4c4f-9e4d-ee705e547aa9"
      unitRef="usd">28000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNC0xLTEtMS0w_882e0050-5043-4fdb-bd61-a80fdb7998a8"
      unitRef="usd">1255000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNC0zLTEtMS0w_3db0d1af-e527-4a18-9da9-2bd94d7c6198"
      unitRef="usd">1520000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNS0xLTEtMS0w_3382b614-3254-4d94-84f7-18f32f87a82f"
      unitRef="usd">199000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNS0zLTEtMS0w_1735cb35-8666-42b7-b1d7-7aecaa1ead06"
      unitRef="usd">223000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNi0xLTEtMS0w_9c4c2987-2435-447a-b3c5-a3232727cc95"
      unitRef="usd">132000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNi0zLTEtMS0w_ac5da6a5-ad06-4bd2-be9e-954ed5d8a06a"
      unitRef="usd">157000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfOC0xLTEtMS0w_e68dc20e-9da5-4fdb-81ad-4b2d9c22820b"
      unitRef="usd">2146000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfOC0zLTEtMS0w_f5a941b5-3151-40df-ae69-c658c5b00aef"
      unitRef="usd">3058000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfOS0xLTEtMS0w_7f8afb4d-5e91-43c2-a2fe-f9a843c1fe35"
      unitRef="usd">1622000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfOS0zLTEtMS0w_6ae5e412-747c-4036-bce7-ef3ec9200ed4"
      unitRef="usd">1627000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTAtMS0xLTEtMA_f90ef775-c449-4fd1-936f-4a4600fc707c"
      unitRef="usd">589000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTAtMy0xLTEtMA_fd5c1549-dfb4-4542-b39c-ff21b6713ea2"
      unitRef="usd">604000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTEtMS0xLTEtMA_192e71f9-a935-4879-ae0f-df8b2aa4d7d6"
      unitRef="usd">7045000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTEtMy0xLTEtMA_c4d3bd82-4d6f-4186-bb8b-6d15ddf53468"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTItMS0xLTEtMA_40750c3c-aee8-4952-b476-4c61f9dff947"
      unitRef="usd">1172000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTItMy0xLTEtMA_c62a77df-df87-4a7f-af85-dde507c77589"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTMtMS0xLTEtMA_53ac6749-76a5-4dad-a2b7-3114721e94bd"
      unitRef="usd">111000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTMtMy0xLTEtMA_24c19ecd-c0b3-42a8-ab63-52f2f5242ec4"
      unitRef="usd">521000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTQtMS0xLTEtMA_ce4c35b4-f17a-481b-8bac-560f77a2529e"
      unitRef="usd">176000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTQtMy0xLTEtMA_b4d3ae3d-5c96-4cb7-952d-0ba61cd88b57"
      unitRef="usd">176000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTYtMS0xLTEtMA_c4af5866-9388-4bf7-9886-9e6a5559319e"
      unitRef="usd">12861000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMTYtMy0xLTEtMA_350e5a8d-b4cd-4c77-b67a-1d3c9417ea25"
      unitRef="usd">14026000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjAtMS0xLTEtMA_23ae5740-3647-4aef-bb69-7213b7c0c3da"
      unitRef="usd">1404000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjAtMy0xLTEtMA_82ab840a-d919-4f86-a265-a86a284e83da"
      unitRef="usd">1633000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjEtMS0xLTEtMA_18ad9e6e-d29d-4ca4-b535-fdff7059a5c2"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjEtMy0xLTEtMA_95778e92-1e61-4dd1-854f-d1846292494a"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjItMS0xLTEtMA_be9d579f-9371-4d9b-9dff-83c840586bd0"
      unitRef="usd">145000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjItMy0xLTEtMA_14c74121-877a-4f32-aed5-bd0d51a82846"
      unitRef="usd">141000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjQtMS0xLTEtMA_e2214045-9581-4bba-af1f-771f95bb06dd"
      unitRef="usd">1551000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjQtMy0xLTEtMA_a27445d5-8dd6-4095-a4c4-7c88c027dfb5"
      unitRef="usd">1776000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjUtMS0xLTEtMA_f784d46c-12e3-4445-b5fd-f095eb9e1345"
      unitRef="usd">4008000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjUtMy0xLTEtMA_aefafa56-7d4b-452a-8925-fbaa9381cbe0"
      unitRef="usd">4013000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjYtMS0xLTEtMA_3edc94d6-8f72-4443-b981-99450407acb9"
      unitRef="usd">492000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjYtMy0xLTEtMA_4161b66c-be79-466f-aac8-9e924c6c9db2"
      unitRef="usd">499000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjctMS0xLTEtMA_81f73ce4-7eab-444f-a909-037604ca475a"
      unitRef="usd">792000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjctMy0xLTEtMA_73985cd2-50fb-48a2-be5c-6c90f174d69d"
      unitRef="usd">847000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjktMS0xLTEtMA_01d04dad-9148-4697-9feb-5825712cbea5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMjktMy0xLTEtMA_468605b0-37d6-4cd2-beaf-7208ffb71805"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzAtMS0xLTEtMA_5eee4f02-c24e-48d9-8b83-5ef8cec75079"
      unitRef="usd">78000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzAtMy0xLTEtMA_c6a35229-2901-43d3-abc3-012c528d9830"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzI4_68daf4be-8993-4569-82de-aa0ce39ba0db"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzI4_c10cf4ab-41f3-4236-b8ef-72893ba4be21"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzQy_add94852-7dbb-470f-8e29-371ed5b39697"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzQy_e5ae28dc-1c61-4abb-ad5d-d759e03e80d6"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzExMg_b0e8edc1-685e-41f7-b16a-3e596cd9189b"
      unitRef="shares">217000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjIyOTM1ZWVhNzI5MjQxNTU4YTA4NDJiYWRjNGU0ZWIyXzExMg_c9535d48-7c1f-48e0-8682-4b4c8877caa3"
      unitRef="shares">217000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMS0xLTEtMA_7a3de849-5c72-4ed5-81d0-8cd3d1556a0f"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzMtMy0xLTEtMA_0bae6181-a665-40bb-aaa8-fb7ce5913958"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzQtMS0xLTEtMA_ed9db5be-4836-40ed-9c22-ad39d6c3f0e9"
      unitRef="usd">2555000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzQtMy0xLTEtMA_8fb34189-0c30-4af6-b519-6db52c7c75eb"
      unitRef="usd">2841000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzUtMS0xLTEtMA_e8ac7042-8695-479e-9488-7bf2b7ff997f"
      unitRef="usd">10246000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzUtMy0xLTEtMA_27fe70e1-854b-472d-9cb6-45682fbd6675"
      unitRef="usd">9303000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzYtMS0xLTEtMA_0702198a-800e-49bd-9562-02c187cf8e18"
      unitRef="usd">-10000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzYtMy0xLTEtMA_9eb6ad0a-50da-4ee9-95a7-71cb95e56680"
      unitRef="usd">-21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2ZGYzNmY0ZjRlMzQ0Yjc5NTJlNTE2OTA5MjNlYWMyXzI5_9591c0fe-02b5-4cd5-8690-c8c03954d585"
      unitRef="shares">95000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjI2ZGYzNmY0ZjRlMzQ0Yjc5NTJlNTE2OTA5MjNlYWMyXzM2_cef01f75-0acb-491f-a664-58fc8f03f2c1"
      unitRef="shares">84000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzctMS0xLTEtMA_557dcdaf-bf14-4678-aa4e-5568727c0c6b"
      unitRef="usd">6894000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzctMy0xLTEtMA_d7fa207f-4055-4fa4-8e99-e04f39e62414"
      unitRef="usd">5366000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzgtMS0xLTEtMA_8958cde1-275a-4fd6-8df9-8efdcadd2d3e"
      unitRef="usd">5899000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzgtMy0xLTEtMA_d30bf4b8-3811-4d16-ba5a-17cb1b45a40f"
      unitRef="usd">6759000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzktMS0xLTEtMA_88fb9af3-ce25-4af9-b96e-ff72be846c73"
      unitRef="usd">41000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfMzktMy0xLTEtMA_aa6ba480-a325-487a-8811-68eb06c6117f"
      unitRef="usd">50000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNDAtMS0xLTEtMA_50633860-cd1a-4642-99a6-7aa85ff04f80"
      unitRef="usd">5940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNDAtMy0xLTEtMA_a5a0fce3-391f-46c8-a322-af7d132e93c3"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNDEtMS0xLTEtMA_239af3c8-8975-4dca-ad35-7f9425aaf04b"
      unitRef="usd">12861000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xOS9mcmFnOmVhM2Y0ZWM0N2JlNTRjNzliNjc3NGIwMTY0ZWUzMGY3L3RhYmxlOjQ4MTI1NjJjM2MxZjQzNDZiYzg1Yzc4NDM3NDExZGE1L3RhYmxlcmFuZ2U6NDgxMjU2MmMzYzFmNDM0NmJjODVjNzg0Mzc0MTFkYTVfNDEtMy0xLTEtMA_36aaecb2-6d45-49cd-9013-3521e4e5aa36"
      unitRef="usd">14026000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMy0xLTEtMS0w_f3a85723-3609-44e8-8548-e532bbbac80c"
      unitRef="usd">1140000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMy0zLTEtMS0w_a494afc5-4bf0-4d2a-84a1-03edf69627a3"
      unitRef="usd">299000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNS0xLTEtMS0w_de30d6f6-7dee-4265-af40-835d9c87c642"
      unitRef="usd">201000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNS0zLTEtMS0w_751404aa-f639-4b9b-b855-2d21feef9039"
      unitRef="usd">174000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNi0xLTEtMS0w_afe305de-66df-4061-826c-7c934208ea5d"
      unitRef="usd">2000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNi0zLTEtMS0w_04c08113-9223-4b58-88e1-d3ade55f9a99"
      unitRef="usd">13000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNy0xLTEtMS0w_9d46c3a1-1472-46a7-9a34-b8192cfa5f27"
      unitRef="usd">-89000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNy0zLTEtMS0w_d0c76939-bc60-45df-a05e-c62be3556e33"
      unitRef="usd">23000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfOC0xLTEtMS0w_0535e561-e04f-4c0c-b809-57f9d56f4d3d"
      unitRef="usd">39000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfOC0zLTEtMS0w_0f573602-9b40-4911-81f5-eb953085d7e3"
      unitRef="usd">31000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTAtMS0xLTEtMA_ea081166-f2cc-445a-86ab-fa33629e423d"
      unitRef="usd">314000000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTAtMy0xLTEtMA_75e5560b-d3b4-4ebe-a824-08841c750301"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTEtMS0xLTEtMA_22a27fbe-25e0-4745-8327-487706dab316"
      unitRef="usd">-1000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTEtMy0xLTEtMA_2e129075-f8fc-4578-941a-800eb1a20be1"
      unitRef="usd">-3000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTMtMS0xLTEtMA_c7c53ee6-c7d5-447d-980e-835c43f160e7"
      unitRef="usd">-265000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTMtMy0xLTEtMA_3906363c-376a-4ca3-80eb-87a138e220fb"
      unitRef="usd">75000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTQtMS0xLTEtMA_f7ebb71a-e066-4094-8c4a-6bbc28e12e73"
      unitRef="usd">-199000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTQtMy0xLTEtMA_49befeb8-9b1f-4d12-ba9c-702cd13f2434"
      unitRef="usd">42000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTUtMS0xLTEtMA_9fba7dba-63c7-45aa-adff-99c9e3fce5cb"
      unitRef="usd">85000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTUtMy0xLTEtMA_bc62588a-c02c-473d-9033-820ad1eb0a80"
      unitRef="usd">51000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTYtMS0xLTEtMTgwOA_614ca486-2656-43c3-8d73-266aa653eb88"
      unitRef="usd">0</dgx:TerminationOfInterestRateSwapAgreements>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTYtMy0xLTEtMTgwNg_27ad8910-d36a-4d9a-8b4c-aa11eab14572"
      unitRef="usd">40000000</dgx:TerminationOfInterestRateSwapAgreements>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTctMS0xLTEtMA_664e766f-9a39-42df-801d-bffc2d86fc97"
      unitRef="usd">-60000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTctMy0xLTEtMA_8737768b-34ef-4611-9582-a96500b5b3eb"
      unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTgtMS0xLTEtMA_7a34ce59-df9f-4683-bf4c-dfba9510d2ec"
      unitRef="usd">1191000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMTgtMy0xLTEtMA_ef4d47bc-4855-4be7-9ffc-aa618eef9605"
      unitRef="usd">602000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjEtMS0xLTEtMA_4658db5c-57d5-4d4e-85b0-3defe1b2778c"
      unitRef="usd">231000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjEtMy0xLTEtMA_a1de82bb-066a-44e0-a910-59a3df732902"
      unitRef="usd">228000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjQtMS0xLTEtMA_6ef36a60-1feb-461a-98a7-2c9c9ecf2637"
      unitRef="usd">170000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjQtMy0xLTEtMA_7570436c-f408-4415-a981-b6546241060c"
      unitRef="usd">165000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjYtMS0xLTEtMzY3Ng_5d69de6c-9804-45af-bd41-193a265b2c12"
      unitRef="usd">755000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjYtMy0xLTEtMzY4MA_556e4077-e1d0-4920-b832-45d6d2d97a99"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjYtMS0xLTEtMA_74253d1f-a73e-4da2-8c99-adbcb89e9b3c"
      unitRef="usd">10000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjYtMy0xLTEtMA_a9ce8083-b9a0-49f9-9ff3-c14c8f5177eb"
      unitRef="usd">18000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjctMS0xLTEtMA_e718ce93-ad39-4b95-a721-d81e0f1c6b97"
      unitRef="usd">344000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMjctMy0xLTEtMA_f73c40b5-fb96-423c-b8a8-edaf0562b7bf"
      unitRef="usd">-411000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzAtMS0xLTEtMA_93e0e8c1-6790-45de-83d6-3e3ffe438f5e"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzAtMy0xLTEtMA_84daba70-1318-43b7-b112-b6337b646d11"
      unitRef="usd">749000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzEtMS0xLTEtMA_8f2675be-6e9f-4bab-bbd7-7db9e53f4923"
      unitRef="usd">1000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzEtMy0xLTEtMA_901dc5ef-d69a-4d6b-bd0d-36c09847b4f2"
      unitRef="usd">1001000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzItMS0xLTEtMA_afecf1d5-279a-46e9-b656-8eb27e7c6d4d"
      unitRef="usd">1910000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzItMy0xLTEtMA_0b9d7657-e6a4-4b3d-8be9-c5b9cb7dc5ef"
      unitRef="usd">75000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzMtMS0xLTEtMA_d6525ba6-4de8-452b-9538-6fb4dbac00f3"
      unitRef="usd">68000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzMtMy0xLTEtMA_b631664e-b21a-4ecc-93b7-ceb5f3f65ebd"
      unitRef="usd">117000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzQtMS0xLTEtMA_c81265ff-e158-4cee-9efb-c67d7594b87b"
      unitRef="usd">22000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzQtMy0xLTEtMA_e61813ed-08c0-45e0-8caf-4131c8029190"
      unitRef="usd">13000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzUtMS0xLTEtMA_e67515a4-f178-4987-9c48-0cab353e22e8"
      unitRef="usd">156000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzUtMy0xLTEtMA_b6bc443e-313e-4102-bd49-8eceb44372d6"
      unitRef="usd">146000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzYtMS0xLTEtMA_e0919b8d-c9a7-4899-8624-b9995559618d"
      unitRef="usd">53000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzYtMy0xLTEtMA_b5ce6ba4-64ee-45a5-8251-4186ca489bd3"
      unitRef="usd">10000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzktMS0xLTEtMA_0d27a50f-740e-45d9-ad93-2193f54758ab"
      unitRef="usd">-59000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfMzktMy0xLTEtMA_458f2d8d-2827-420b-a2fc-0dcb76289645"
      unitRef="usd">-16000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDAtMS0xLTEtMA_e0091a23-4dfa-46bf-ba5c-51419d219d08"
      unitRef="usd">-2133000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDAtMy0xLTEtMA_60de0676-98ce-446f-92a0-192db6c216a4"
      unitRef="usd">-395000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDItMS0xLTEtMA_05c21d62-8dee-4e2b-8b59-5072974802ab"
      unitRef="usd">-598000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDItMy0xLTEtMA_fcbf9935-f3ad-4512-a8e2-638df75bd445"
      unitRef="usd">-204000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDQtMS0xLTEtMA_ba1d86c3-c8de-4e78-9ff8-60792259dde3"
      unitRef="usd">1158000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib3f1009ff18c488b8726927338c269af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDQtMy0xLTEtMA_a5160884-b24f-4f6d-8643-f218e6a27a60"
      unitRef="usd">1192000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDUtMS0xLTEtMA_8d4926ee-4862-4927-94c5-575f8028ca6b"
      unitRef="usd">560000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia74ca347035d47afab9af2863189a9af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yMi9mcmFnOmVmZjI3ZjU5ZTMwNzRmMWRiYjdkODRiN2Y5NzA3OTRhL3RhYmxlOmRiYmJkMmJmNzI0MDQzY2FiZTEzNDIyYWMxZDNiNDY5L3RhYmxlcmFuZ2U6ZGJiYmQyYmY3MjQwNDNjYWJlMTM0MjJhYzFkM2I0NjlfNDUtMy0xLTEtMA_a25a9cea-eaa3-406d-b10d-7ef2c5f34f98"
      unitRef="usd">988000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie409db7692b2496c84592ac0ae13ab4b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xLTEtMS0w_9a59f597-8dd0-44c9-ae51-4ccb638c5877"
      unitRef="shares">131000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie409db7692b2496c84592ac0ae13ab4b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0zLTEtMS0w_81e9cce0-c0fe-4ef4-ad80-11b5a217e934"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5cdf70fc1e32411f987859d4ba3a4b93_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi01LTEtMS0w_00393dd5-c44a-4634-ba38-d3b2379d77d3"
      unitRef="usd">2824000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1234b393ecf446beb2d12b0db437882a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi03LTEtMS0w_68967a52-e4f0-4af6-9dfa-ea98ae51338c"
      unitRef="usd">9690000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95131b6d75e44a49bc1fac55189ad1cc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi05LTEtMS0w_2b89ab74-0534-4d91-9e2c-fdbcbb08bc0a"
      unitRef="usd">-31000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d562072f0674b3ab9fbfd9437b9b623_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xMS0xLTEtMA_ff46f18c-faec-48d7-94bb-dc9c3a900c5f"
      unitRef="usd">-5740000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3f0b2f6f90d4e56a9e0c7eafef2d828_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xMy0xLTEtMA_61a7e193-d851-4c7e-a822-4a201eb26b96"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i94d95e47035740e2be82b0b81c67afed_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xNS0xLTEtMA_f51eecd0-005f-4cd7-a8da-139a051069c3"
      unitRef="usd">6790000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i94d95e47035740e2be82b0b81c67afed_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMi0xOC0xLTEtMA_00ef9f5c-257b-4b08-b671-4bb3fc852527"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ie0c0ed67c1eb40078423e9d062bb487f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMy03LTEtMS0w_ccc10ab3-905e-47d2-b41a-81bee0faa632"
      unitRef="usd">631000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i2f8251b106654d1c98108056fb012db9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMy0xMy0xLTEtMA_4689bdda-8587-42a9-b01c-94edf41a214a"
      unitRef="usd">17000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMy0xNS0xLTEtMA_a27869fa-b744-42fe-8a36-c0f30af949a7"
      unitRef="usd">648000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMy0xOC0xLTEtMA_43276ac8-72c1-49fb-b275-91f0c8c7039b"
      unitRef="usd">2000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icfd6ba29f4e1492491f91836654d629f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNC05LTEtMS0w_7958637f-a90b-40f1-8d58-f7b554983455"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNC0xNS0xLTEtMA_cf90bd8d-61fe-47e3-88cb-41155f8542aa"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie0c0ed67c1eb40078423e9d062bb487f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNS03LTEtMS0w_9f4c638c-012c-4958-ab60-eb622a9c5653"
      unitRef="usd">75000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNS0xNS0xLTEtMA_79dce035-2050-4d61-849f-067343fc7a00"
      unitRef="usd">75000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2f8251b106654d1c98108056fb012db9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNi0xMy0xLTEtMA_35c92bbc-d68a-4a82-b6d2-20dadb32fc39"
      unitRef="usd">21000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNi0xNS0xLTEtMA_7ad4dccd-6d92-41c8-983c-2ef373a04705"
      unitRef="usd">21000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNi0xOC0xLTEtMA_1f8a8833-c6e3-4ed1-8a7c-a7aa4eff37f0"
      unitRef="usd">3000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNy01LTEtMS0w_fc669419-b829-48a2-aad0-92c23c06978b"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iefc874b9d0dd40489c1a7dcf6860f5a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNy0xMS0xLTEtMA_783ad149-e31a-4fd2-bf2e-940e0415cca8"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfNy0xNS0xLTEtMA_24a5e42a-4536-462d-8599-9ed30a25e1cf"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOC01LTEtMS0w_d2be3940-1b48-478f-9eda-8e2b6ff1bc30"
      unitRef="usd">21000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOC0xNS0xLTEtMA_48a1b146-64fd-412e-b9d2-779f9131fc3f"
      unitRef="usd">21000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOS01LTEtMS0w_20f43ad1-60fa-4481-8105-e78d29d92185"
      unitRef="usd">9000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iefc874b9d0dd40489c1a7dcf6860f5a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOS0xMS0xLTEtMA_31310a35-7b27-4b81-89a2-5889749c40f0"
      unitRef="usd">42000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfOS0xNS0xLTEtMA_9a15b0ab-69a7-4606-bb92-524294fa67a0"
      unitRef="usd">51000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTAtNS0xLTEtMA_a862eabe-293f-42e1-831d-30d6b5c461f9"
      unitRef="usd">1000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTAtMTUtMS0xLTA_cf024910-a1bc-44cb-8503-d66cb9e04434"
      unitRef="usd">1000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9214e898766d4e348c518cc861e2a6d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTEtMS0xLTEtMA_ee58d2e1-5235-4373-b902-b3098c278fdd"
      unitRef="shares">9000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0f5fde02cd3148989bbfe95982b715f5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTEtNS0xLTEtMzkwMQ_ce5a746d-733b-404b-ae2e-9d838bf5144a"
      unitRef="usd">300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iefc874b9d0dd40489c1a7dcf6860f5a0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTEtMTEtMS0xLTA_9344654a-cfc7-4a67-98b7-db0abe292241"
      unitRef="usd">1200000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTEtMTUtMS0xLTA_30290390-ae24-4e87-8fe1-a2b1c04cba91"
      unitRef="usd">1500000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idadbab3594fd43348d9b825585c50f1e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMS0xLTEtMA_7ecfef95-7caf-46e1-9759-853890e9b450"
      unitRef="shares">122000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idadbab3594fd43348d9b825585c50f1e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMy0xLTEtMA_fe26e38a-15ad-4223-aa17-4bc5441d65e6"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c07c80b26c24ce38628b41e10b0357e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItNS0xLTEtMA_2fa154b2-7568-4f71-8721-94797213bc38"
      unitRef="usd">2555000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe18efd7ba104ac9a5aa32571d8c6166_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItNy0xLTEtMA_2c6e6084-8165-4cc2-b632-8371083a4d76"
      unitRef="usd">10246000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i562a2de976ae4600bcfccf456de6283f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItOS0xLTEtMA_d189cbeb-0e73-47cd-a4d9-5aee61ea2576"
      unitRef="usd">-10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71c62f68e0b7484397a15c914fab24bc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMTEtMS0xLTA_5d617cf0-c3eb-4397-b91d-88230819a113"
      unitRef="usd">-6894000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a4a7dcc35654302bd8e48f6068259be_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMTMtMS0xLTA_9e117fb7-df28-475d-bde9-bf448b8edd18"
      unitRef="usd">41000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMTUtMS0xLTA_6be51167-423f-4ac7-9689-3ccc2d802846"
      unitRef="usd">5940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTItMTgtMS0xLTA_70b70375-e86a-41f7-b566-e94552713e30"
      unitRef="usd">78000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if708b3a322c142a896b74f2674affc33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMS0xLTEtMTE4_aa29e3cf-0932-4d01-9baa-92070c4aabe1"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if708b3a322c142a896b74f2674affc33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMy0xLTEtMTIx_55ebbfa3-7a35-4f7d-89d9-2ed66bad0bb0"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0848c719bfa64a6997b49547abca2d7c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtNS0xLTEtMTI0_64ab6abd-3328-4539-a255-82f1c32bbc12"
      unitRef="usd">2841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9a1846b30804708b76daaf8e7313d54_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtNy0xLTEtMTI3_43a9267f-f0e9-46e7-9fdf-107747cf6d0c"
      unitRef="usd">9303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i926d05e6d1164bceb1d1e6ee02daa1c8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtOS0xLTEtMTMx_9739aa70-0f50-4534-bd26-6f0a417ee773"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib5b79ec0ef2348fdae4dc4f7e23a8c61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMTEtMS0xLTEzNA_8cbd012d-a048-4fe5-a0cd-23e081e0d8cb"
      unitRef="usd">-5366000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2775145b5b44ba595f9fd2c6019fffa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMTMtMS0xLTEzNw_49db37a4-ad9f-42e1-bdcc-4a4d58aff799"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMTUtMS0xLTA_5c3af7cb-5374-40ba-b705-e343e54452b5"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTYtMTgtMS0xLTE0MA_d6624923-6fd6-4c06-b728-d7f95af05b8b"
      unitRef="usd">82000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i127f391cad8f454e934f06617f28068b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTctNy0xLTEtMA_30e0c9bf-b8a5-44b7-8dba-333521b8f5c5"
      unitRef="usd">1100000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="iab17e5ada04d4e3f8418321f4fed5170_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTctMTMtMS0xLTA_1248dd70-81cb-4636-b4c1-285c8339fe13"
      unitRef="usd">34000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTctMTUtMS0xLTA_aff36f45-b119-45c3-a1ea-08ec153df45e"
      unitRef="usd">1134000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTctMTgtMS0xLTA_c329f1cc-d31a-4fc5-b90e-778d569fbfc3"
      unitRef="usd">6000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i45e6e7f9cf924fcfba4006108d77d2d7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTgtOS0xLTEtMA_ad08ea95-e7f5-426e-b848-e48fdbb91457"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTgtMTUtMS0xLTA_dc50c8e0-6aaf-478b-b966-b199fd071ed9"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i127f391cad8f454e934f06617f28068b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTktNy0xLTEtMA_42b27a2f-0f65-48d1-9412-cb4157a5f228"
      unitRef="usd">157000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMTktMTUtMS0xLTA_801a3bba-6772-426e-a064-2378c1fb2ea3"
      unitRef="usd">157000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iab17e5ada04d4e3f8418321f4fed5170_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjAtMTMtMS0xLTA_93bde61d-64ad-42ba-ab3f-2d15042ba63d"
      unitRef="usd">43000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjAtMTUtMS0xLTA_cc85da1e-41fa-41bf-a20f-12f03d47c044"
      unitRef="usd">43000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjAtMTgtMS0xLTA_edc51626-43cd-4e2d-a034-718144046c0a"
      unitRef="usd">10000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjEtNS0xLTEtMA_de05cad7-6540-4341-b48e-963f658b1bd2"
      unitRef="usd">-27000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjEtMTEtMS0xLTA_10b89308-8f63-4c28-966f-5a69c8c3feea"
      unitRef="usd">38000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjEtMTUtMS0xLTA_db060163-d2b4-4a9a-adb5-3b602fa11d52"
      unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjItNS0xLTEtMA_8379d958-b9db-4bf3-bf38-67e1f31a1833"
      unitRef="usd">39000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjItMTUtMS0xLTA_1946d161-28d3-475e-a10b-f39e7e0b5374"
      unitRef="usd">39000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i120d2d9a75ae49a78ce64d7e98309352_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjMtMS0xLTEtMA_35d11b05-4a00-4289-9948-b422726a3b28"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjMtNS0xLTEtMA_3080b4ef-c7d8-4b69-8b1d-cd2a0a102e06"
      unitRef="usd">12000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjMtMTEtMS0xLTA_7ba38fb0-595f-4668-b886-a9a9e71ce749"
      unitRef="usd">56000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjMtMTUtMS0xLTA_af2d2180-7297-4ed3-b71d-ba8f749a10e6"
      unitRef="usd">68000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjQtNS0xLTEtMA_3db35d1c-2b04-4620-925c-a09277866658"
      unitRef="usd">10000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjQtMTEtMS0xLTM5OTk_336ee658-f01b-4588-95eb-249c5a0aaa8c"
      unitRef="usd">12000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjQtMTUtMS0xLTA_dabdf271-b08e-420e-a3c7-43bfd1b420b8"
      unitRef="usd">22000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i120d2d9a75ae49a78ce64d7e98309352_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjUtMS0xLTEtMA_294fd0a4-66fb-408f-91f5-78f0e379449c"
      unitRef="shares">12000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5a8553462e28448b887e7f7980ea7379_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjUtNS0xLTEtMzg4Nw_10f046b4-287d-4654-b10c-46a1eda26e09"
      unitRef="usd">300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjUtMTEtMS0xLTA_8cec6b95-3609-4697-a17f-11ca49980fa0"
      unitRef="usd">1610000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjUtMTUtMS0xLTA_2dabe043-9ff6-4814-bcc4-67807c6bf9d3"
      unitRef="usd">1910000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idadbab3594fd43348d9b825585c50f1e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMS0xLTEtMA_e8a8419c-e0f1-484b-b100-d48d5e89ba2b"
      unitRef="shares">122000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idadbab3594fd43348d9b825585c50f1e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMy0xLTEtMA_60b0f660-47ba-4ae0-93a7-398ee1b9d122"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c07c80b26c24ce38628b41e10b0357e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtNS0xLTEtMA_c7ecf512-c50b-45cd-a8ae-a25e2d8dd86c"
      unitRef="usd">2555000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe18efd7ba104ac9a5aa32571d8c6166_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtNy0xLTEtMA_1defe77c-620c-4823-b4df-03cae7b9b99e"
      unitRef="usd">10246000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i562a2de976ae4600bcfccf456de6283f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtOS0xLTEtMA_0d0f4f55-96b5-4e3c-a5cd-631a405a6836"
      unitRef="usd">-10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71c62f68e0b7484397a15c914fab24bc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMTEtMS0xLTA_1bd40254-b343-4494-a740-8a2cb0faed31"
      unitRef="usd">-6894000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a4a7dcc35654302bd8e48f6068259be_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMTMtMS0xLTA_cb0516b3-6547-4426-9acc-84abf906cd09"
      unitRef="usd">41000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMTUtMS0xLTA_c1b305fd-02b1-4897-827f-37abd3393364"
      unitRef="usd">5940000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOmE0NjBiOTM0YmU1ODQyZjNhNzNhMGFmNDZjZDNhM2JmL3RhYmxlcmFuZ2U6YTQ2MGI5MzRiZTU4NDJmM2E3M2EwYWY0NmNkM2EzYmZfMjYtMTgtMS0xLTA_7dec7f28-7060-4f80-8349-0b474056414e"
      unitRef="usd">78000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if2d14897dec64b1f93d805966f667a67_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xLTEtMS0w_aa711460-39fc-4002-ae65-0bd6095037ca"
      unitRef="shares">134000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if2d14897dec64b1f93d805966f667a67_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0zLTEtMS0w_04617174-e25e-4431-bf41-2cb7e6bca0b6"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c64b417754a41bf9cb5d032e7c7f1d2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi01LTEtMS0w_c4f0dfa2-6c27-4281-817c-38ebcf68b7cf"
      unitRef="usd">2738000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i292f044a2a694be987cf1e050fc32158_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi03LTEtMS0w_9b18e19c-b0b3-4165-acc6-270247fbd73f"
      unitRef="usd">8197000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe0f2af904df4308974d0cfadbf6c95f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi05LTEtMS0w_2281ee99-db25-4c21-ad03-ecf8280fc72f"
      unitRef="usd">-58000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f22713e20cc4bba8a7d9e37885165ac_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xMS0xLTEtMA_d783c31e-f4a6-4993-bcd1-1a89a4c8f458"
      unitRef="usd">-5222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0cdf7d6ee7c436a9d9d7ab4fe709a5e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xMy0xLTEtMA_24dad66b-3926-4e3a-96c9-62ea7d8b1777"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida27930c41dd4f5a9e90d48ebfc0c9c4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xNS0xLTEtMA_6caf3637-163b-408d-8dab-4fadfb7d57b4"
      unitRef="usd">5703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ida27930c41dd4f5a9e90d48ebfc0c9c4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMi0xOC0xLTEtMA_66187ecf-f442-469c-a44a-84b48fc6487c"
      unitRef="usd">76000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i3f21b83c03584dc6924263f55d606a78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMy03LTEtMS0w_3d4455a3-d52e-436e-918b-2b9e914b35ee"
      unitRef="usd">185000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ic29fec842eda4d01b395c9c45167a267_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMy0xMy0xLTEtMA_fb7975bb-7566-49fe-9c05-02033ad70c5f"
      unitRef="usd">7000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMy0xNS0xLTEtMA_8a400c0b-0278-46cf-8a69-fe67cf68fa8b"
      unitRef="usd">192000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMy0xOC0xLTEtMA_07e569f9-08a5-498b-a206-1fa3f4f3f238"
      unitRef="usd">1000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib46a16fab53a4ae68476a2fb7593280f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNC05LTEtMS0w_fb92577e-8217-4795-bec6-24230b5223c4"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNC0xNS0xLTEtMA_19a1caa3-0fa2-40d5-8d13-ca89149db327"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3f21b83c03584dc6924263f55d606a78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNS03LTEtMS0w_6f828269-a434-4a78-9e70-898f36938c77"
      unitRef="usd">75000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNS0xNS0xLTEtMA_277c46c8-8360-41eb-80db-fc95017dddd4"
      unitRef="usd">75000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic29fec842eda4d01b395c9c45167a267_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNi0xMy0xLTEtMA_1ed118a6-636d-4ca3-82a2-b70f5cfe53a7"
      unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNi0xNS0xLTEtMA_1dc5e8b7-95bc-493d-8429-4aaa1adfd261"
      unitRef="usd">3000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if819fd1fb51043378a435a56ad7b4b3c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNy01LTEtMS0w_dbc4403b-11e4-4d83-877d-6f7d0430e0f0"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id2f9ac74121f49239c7f3983ae7bae36_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNy0xMS0xLTEtMA_40337f01-cb5b-44de-8f86-2e0e8b0da7ba"
      unitRef="usd">4000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfNy0xNS0xLTEtMA_0b5273a9-0da9-4c56-96db-d513bf51776f"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if819fd1fb51043378a435a56ad7b4b3c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOC01LTEtMS0w_805543f5-2b84-4886-a2f0-cb88fd1ac6b3"
      unitRef="usd">17000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOC0xNS0xLTEtMA_31a4dad0-5131-423b-8d01-eabdbc3ef8d5"
      unitRef="usd">17000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if819fd1fb51043378a435a56ad7b4b3c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOS01LTEtMS0w_cc6c32e8-2540-42c2-8a93-72a6a04a6bd0"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id2f9ac74121f49239c7f3983ae7bae36_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOS0xMS0xLTEtMA_10b83915-63ad-47a2-8bab-f93870814258"
      unitRef="usd">31000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfOS0xNS0xLTEtMA_8659d49d-c50b-40dd-a1e1-22c4676d34a5"
      unitRef="usd">37000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMS0xLTEtMA_5be198f0-f918-401a-95ea-2c86a1d27f39"
      unitRef="shares">134000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMy0xLTEtMA_9dfca37d-488c-479d-a6fd-eae5f59a1651"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e4e7a78200d43478e75bd5cdd2d9c12_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItNS0xLTEtMA_20d2c764-0ab6-4e3a-bacc-b706f977dec7"
      unitRef="usd">2764000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic61245d5d6bf4ec6ac96d7e5d11d0de6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItNy0xLTEtMA_5e461e65-ecf0-42f1-bb43-1410164e25c3"
      unitRef="usd">8307000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i74a92cff8b5f4b7585d55a6b13176562_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItOS0xLTEtMA_3dfb3a29-b654-4ff6-b890-6e6a2c9f3409"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26783a3b7dd249be9c28f89f9ffb93c8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMTEtMS0xLTA_01751891-5e3b-413d-a633-8bfa209f979c"
      unitRef="usd">-5187000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6f8598006da47daaf4f264d1f79a720_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMTMtMS0xLTA_c78368af-ab4d-4789-a3bd-8beb6879c636"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia74ca347035d47afab9af2863189a9af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMTUtMS0xLTA_4c3c248b-0cee-4865-ab2b-2f22a79028be"
      unitRef="usd">5881000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ia74ca347035d47afab9af2863189a9af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTItMTgtMS0xLTA_78d66a33-46ee-4290-b950-b03676b7daf8"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5fa0525d2dc0497f928c8d6ab3456eb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMS0xLTEtMA_5ec9fd8e-33a6-4b71-b468-9ecc1d574b36"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5fa0525d2dc0497f928c8d6ab3456eb5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMy0xLTEtMA_3fd256ca-dcb8-4afa-9562-340481c82612"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e56b1b204974d05a0f5e2c43eea7cbd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtNS0xLTEtMA_d719b3d1-8973-41ad-a195-1898ae1ed945"
      unitRef="usd">2722000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i546e403b15214524b8519bba76c4d0da_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtNy0xLTEtMA_91666225-62c9-4f7f-a1d0-ba0cf3640095"
      unitRef="usd">8174000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d014e770945452f897511320c1c2b70_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtOS0xLTEtMA_520930dd-e27e-4c44-b5e8-4e5a76eefff1"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8d38a260d94c443d8eea143672b2cd72_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMTEtMS0xLTA_85d0fbd8-4be5-4695-81c1-7a596cf7af66"
      unitRef="usd">-5218000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i50aeb63e5efe48d99c044cfb52e07b48_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMTMtMS0xLTA_86c50a7b-c240-44df-ba5c-6fc963975a72"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib3f1009ff18c488b8726927338c269af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMTUtMS0xLTA_004b1a31-66c0-4000-a380-5c51d3a59433"
      unitRef="usd">5687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ib3f1009ff18c488b8726927338c269af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTYtMTgtMS0xLTA_71518a51-7963-4104-b873-01f9bb425b31"
      unitRef="usd">76000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i6df3ecb6e73749a49030a463355f0fba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTctNy0xLTEtMA_5b50b1b8-d760-4ef5-bdd7-48ff51f74027"
      unitRef="usd">284000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i7500943b3564489290004ac65ed7fccf_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTctMTMtMS0xLTA_68da65cb-6887-4274-ac92-12dd8dcba427"
      unitRef="usd">13000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTctMTUtMS0xLTA_ca13e325-bfbb-4248-9036-77ca9e0da19b"
      unitRef="usd">297000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTctMTgtMS0xLTA_65a85509-4257-4441-98d5-00687d686990"
      unitRef="usd">2000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3cc55a2801094ec0bc9f846effac87da_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTgtOS0xLTEtMA_a03fd4fc-9692-4429-aeea-6c2c6b696efe"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTgtMTUtMS0xLTA_ebd3999b-78a2-46a4-99b0-b1a3513910f7"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6df3ecb6e73749a49030a463355f0fba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTktNy0xLTEtMA_d2588ad6-14cf-4c10-a63c-3e81310c1847"
      unitRef="usd">151000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMTktMTUtMS0xLTA_b727faae-7f86-49ee-8f56-c318cff7ab9f"
      unitRef="usd">151000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i7500943b3564489290004ac65ed7fccf_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjAtMTMtMS0xLTA_9e645ad3-5e0f-4133-9771-38fca1e40fcb"
      unitRef="usd">9000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjAtMTUtMS0xLTA_adf680bf-aaef-4963-96d8-d25d51fdbbf4"
      unitRef="usd">9000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjAtMTgtMS0xLTA_7bf84ecb-364d-4cc1-9d30-a3ed23c54bea"
      unitRef="usd">1000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjEtNS0xLTEtMA_7dfb8627-ba42-4969-967d-df75f492c067"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjEtMTEtMS0xLTA_27080d96-907c-42df-8687-a170ad3e5e3e"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjEtMTUtMS0xLTA_29070776-9a09-4c30-84e5-98a09a9fafbb"
      unitRef="usd">13000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjItNS0xLTEtMA_450f0343-5068-48b4-be91-98fc145180dc"
      unitRef="usd">31000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjItMTUtMS0xLTA_1ac1251c-e215-4b2c-8c52-38d063c5f999"
      unitRef="usd">31000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i62149b0b25564ab180137047be530824_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjMtMS0xLTEtMA_2fb5b9bf-30a5-4712-ae28-e7ab2176b58d"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjMtNS0xLTEtMA_00496f94-7a19-457b-a426-bb15fbf714e9"
      unitRef="usd">18000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjMtMTEtMS0xLTA_3dfbda7b-e6e8-4ddd-b105-672f110c74c1"
      unitRef="usd">99000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjMtMTUtMS0xLTA_be9b67ef-86e3-418e-91c8-d40b8bf0d107"
      unitRef="usd">117000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i89b50f0269d84a58b54615b1f06cf977_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjQtNS0xLTEtMA_ab00ff95-eb06-46e6-b429-286b79275f81"
      unitRef="usd">13000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjQtMTUtMS0xLTA_0e6b41ee-da2f-48cd-a7f1-fcf4b1c7a50e"
      unitRef="usd">13000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i62149b0b25564ab180137047be530824_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjUtMS0xLTEtMA_3411cf7f-2e12-4f59-87b6-8da97997317f"
      unitRef="shares">1000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjUtMTEtMS0xLTA_b54896e9-6a6b-4154-8ab5-46f2abc160b3"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjUtMTUtMS0xLTA_fd51fa5c-bb1d-424e-a0ea-ce50497377bb"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMS0xLTEtMA_5ce77a33-bc70-45cb-ae4c-d4c0fb9277a2"
      unitRef="shares">134000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31b1e248e2c94cdab2a726dbccc9ab5d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMy0xLTEtMA_abb9f7ca-6d74-4540-8e78-9768999712c8"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e4e7a78200d43478e75bd5cdd2d9c12_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtNS0xLTEtMA_6529aece-95fa-404a-864c-6efa5e84f8a1"
      unitRef="usd">2764000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic61245d5d6bf4ec6ac96d7e5d11d0de6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtNy0xLTEtMA_b57246a3-9e73-4ddc-b743-7bfbf1814888"
      unitRef="usd">8307000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i74a92cff8b5f4b7585d55a6b13176562_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtOS0xLTEtMA_33fab46e-321a-4e57-9dd9-8212f472ec38"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26783a3b7dd249be9c28f89f9ffb93c8_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMTEtMS0xLTA_5ec7814d-ac98-428f-a657-f3219d5362d7"
      unitRef="usd">-5187000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6f8598006da47daaf4f264d1f79a720_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMTMtMS0xLTA_4989b749-e98f-4c98-895b-bbb4f927bc5a"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia74ca347035d47afab9af2863189a9af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMTUtMS0xLTA_b33e138a-1be9-4318-a52c-20c6950468c0"
      unitRef="usd">5881000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ia74ca347035d47afab9af2863189a9af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8yNS9mcmFnOjM2MjJlMjgxMzBhMTQ1NzY4NDU0ZTQ4MTY3NzRmNDgzL3RhYmxlOjg3ZDY4ZTcxNTBhZjQ3NjdiYThlMzA3NjhhY2E0MGI1L3RhYmxlcmFuZ2U6ODdkNjhlNzE1MGFmNDc2N2JhOGUzMDc2OGFjYTQwYjVfMjYtMTgtMS0xLTA_5a54150d-374c-4b4c-a3d2-fc6e7059dc3e"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NatureOfOperations
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zMS9mcmFnOmZiNmQ0NmMzNGE3NzQwNzlhOWE5ZmMxMWI4NGQ1ZDBjL3RleHRyZWdpb246ZmI2ZDQ2YzM0YTc3NDA3OWE5YTlmYzExYjg0ZDVkMGNfMTY5OQ_442cb7b6-20c8-4db4-900d-921e1b32c428">DESCRIPTION OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI3NQ_bb3b9bd2-f2d4-48eb-9277-05762c2c0e6f">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#x201c;COVID-19&#x201d;) continues to impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three and six months ended June&#160;30, 2021 may not be indicative of the results that may be expected for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI4Ng_af2a153e-e6ab-48db-bdaf-7b0e9bfd45d0">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI2Ng_1be41e31-e021-4acb-91be-2d01cdc29f40">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI4Mg_3d668b8b-5498-4f03-9cfc-92edff2d0e0c">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNC9mcmFnOjk2M2YzN2I1Yzc5NzQ1YzI5Nzg2NTRkMzg3YTZmN2UwL3RleHRyZWdpb246OTYzZjM3YjVjNzk3NDVjMjk3ODY1NGQzODdhNmY3ZTBfNDI4NA_d793f3e1-39e2-4967-a1d7-aec4ebb21999">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RleHRyZWdpb246ZWU2OWFkMDA2OWFmNDE5NjhmZWZmODQ5NGYyNTQwZTVfMjk1_c6d826cb-4b5a-461d-a6b3-24dc5e56b53c">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program.  See Note 9 for further details.  The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first two quarters of 2021 did not equal the total for the six months ended June 30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of the ASRs.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RleHRyZWdpb246ZWU2OWFkMDA2OWFmNDE5NjhmZWZmODQ5NGYyNTQwZTVfMzAx_98ae7bde-5787-4cd6-9347-1dfa48323c80">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfNy0xLTEtMS0w_bac1ef35-4eee-4306-877b-f895c69a44d3"
      unitRef="usd">631000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfNy0zLTEtMS0w_8f7adcbf-7b93-42e2-8485-64f966fbe6c5"
      unitRef="usd">185000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfNy01LTEtMS0w_3bd8ae88-585d-4823-88ff-d1c863d1477b"
      unitRef="usd">1100000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfNy03LTEtMS0w_1bc497c8-89b3-4c4f-aa5b-43a9ab95cdfd"
      unitRef="usd">284000000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOC0xLTEtMS0w_7d57ad91-602d-49c9-bbda-7eb1812a45a2"
      unitRef="usd">3000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOC0zLTEtMS0w_a25c747b-c7cd-4021-a984-c424eaee7607"
      unitRef="usd">1000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOC01LTEtMS0w_ce8bb739-ee64-46fb-8a2c-f9578c65ae84"
      unitRef="usd">4000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOC03LTEtMS0w_405a3d90-ec8f-4ee7-9b0f-b46b31676062"
      unitRef="usd">1000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOS0xLTEtMS0w_b07b24e4-6862-4b46-a8e2-e12eddd7c52a"
      unitRef="usd">628000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOS0zLTEtMS0w_3ce586f9-0a20-4d8a-aca9-113eb0294f6e"
      unitRef="usd">184000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOS01LTEtMS0w_0497162a-ea3e-44b5-a021-569ce85eab0e"
      unitRef="usd">1096000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfOS03LTEtMS0w_581675dc-1b1b-4191-b742-8daf29b328dd"
      unitRef="usd">283000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTEtMS0xLTEtMA_e59068b8-f6e4-4557-83f9-dcd46e65a6d6"
      unitRef="shares">125000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTEtMy0xLTEtMA_2571cb85-722a-42f3-b2c6-b7a9010dc47a"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTEtNS0xLTEtMA_414dbc7d-8aed-4768-976d-580e985cbf31"
      unitRef="shares">129000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTEtNy0xLTEtMA_1db536a0-0eb0-4d01-8549-dd6636661f52"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTMtMS0xLTEtMA_9c487cb6-8610-468a-9ee7-555a6342830a"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTMtMy0xLTEtMA_fd2825cb-3716-429a-8520-e7c8f21e57a5"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTMtNS0xLTEtMA_a1caa044-d76e-4c1b-ab62-5919ffe9e137"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTMtNy0xLTEtMA_2ef4dc0c-2225-4e1c-9b3d-f12b929f211d"
      unitRef="shares">1000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTQtMS0xLTEtMA_3addd579-c31f-4d02-a00d-bb5350c80b3d"
      unitRef="shares">127000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTQtMy0xLTEtMA_f5026ffd-8425-4838-a8b4-af969b048430"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTQtNS0xLTEtMA_6415670a-df5d-4f03-ad19-f6a3cdf1831c"
      unitRef="shares">131000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTQtNy0xLTEtMA_e08a7b44-ca28-455e-89f1-d125fe0b0980"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTctMS0xLTEtMA_6e9086ac-19f2-46e5-9376-b6c931b67def"
      unitRef="usdPerShare">5.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTctMy0xLTEtMA_37ac15aa-3347-40f4-9dce-716aabde4edb"
      unitRef="usdPerShare">1.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTctNS0xLTEtMA_e056e47b-8f48-48b4-adc3-5d635457a335"
      unitRef="usdPerShare">8.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMTctNy0xLTEtMA_2c2df394-d513-430d-b7fa-1db41880b5bf"
      unitRef="usdPerShare">2.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMjItMS0xLTEtMA_ea240ddb-67f7-4ff4-b8f6-04eae1f9bf98"
      unitRef="usdPerShare">4.96</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMjItMy0xLTEtMA_56fb31a3-7395-41f8-8937-ed750fb254ac"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMjItNS0xLTEtMA_69e810ad-532e-412b-bd77-a0d9c1b8553d"
      unitRef="usdPerShare">8.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmFjZDQ5NmY0MmQ0OTQ2MThiYTYxZDlkM2Q5NGYzYzlhL3RhYmxlcmFuZ2U6YWNkNDk2ZjQyZDQ5NDYxOGJhNjFkOWQzZDk0ZjNjOWFfMjItNy0xLTEtMA_0c2958a7-0cdd-4fcd-8033-9b9482a8301f"
      unitRef="usdPerShare">2.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RleHRyZWdpb246ZWU2OWFkMDA2OWFmNDE5NjhmZWZmODQ5NGYyNTQwZTVfMjkx_d171ffc5-1bd2-4308-a860-c07d7d0d51bf">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmI5ZjMxNThjN2UwNjRjNWQ4ZGY0N2I5YWJjOWY2MWY4L3RhYmxlcmFuZ2U6YjlmMzE1OGM3ZTA2NGM1ZDhkZjQ3YjlhYmM5ZjYxZjhfMi0xLTEtMS0w_d2cf3dd1-90b4-4cd6-b15f-12eec6df9681"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmI5ZjMxNThjN2UwNjRjNWQ4ZGY0N2I5YWJjOWY2MWY4L3RhYmxlcmFuZ2U6YjlmMzE1OGM3ZTA2NGM1ZDhkZjQ3YjlhYmM5ZjYxZjhfMi0zLTEtMS0w_797feedf-ed36-45a5-bb5d-583fb66fa266"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmI5ZjMxNThjN2UwNjRjNWQ4ZGY0N2I5YWJjOWY2MWY4L3RhYmxlcmFuZ2U6YjlmMzE1OGM3ZTA2NGM1ZDhkZjQ3YjlhYmM5ZjYxZjhfMi01LTEtMS0w_5b4292c8-e2c3-4256-b68a-7bdf2063b141"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RhYmxlOmI5ZjMxNThjN2UwNjRjNWQ4ZGY0N2I5YWJjOWY2MWY4L3RhYmxlcmFuZ2U6YjlmMzE1OGM3ZTA2NGM1ZDhkZjQ3YjlhYmM5ZjYxZjhfMi03LTEtMS0w_28873f78-67c1-43cb-b59f-a6b87ae95179"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <dgx:AcceleratedShareRepurchasesInitialPricePaid
      contextRef="i533de8c040f5497f94c63d60c5e38efa_D20210401-20210430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8zNy9mcmFnOmVlNjlhZDAwNjlhZjQxOTY4ZmVmZjg0OTRmMjU0MGU1L3RleHRyZWdpb246ZWU2OWFkMDA2OWFmNDE5NjhmZWZmODQ5NGYyNTQwZTVfNDk0NzgwMjMyNTc1Mg_aabed288-d76c-47cb-be99-af3a0b89a94c"
      unitRef="usd">1500000000</dgx:AcceleratedShareRepurchasesInitialPricePaid>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfNTE5_c160c080-5a41-45cb-b12c-7550d3070e3d">BUSINESS ACQUISITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $54&#160;million of customer-related intangible assets and $171&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i32ceb997147b42ebafa6e46d4f452d31_D20210601-20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTc1NA_bd6bd55d-452a-4a3c-9f16-33cb3a6373db"
      unitRef="usd">225000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iede8a4b7d31f4a908594d37d2d356dce_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTc0MQ_7cca1f65-d295-49a7-ad47-39c68face5f5"
      unitRef="usd">54000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="ic80123e8686446ea809da2ddaa1ffaea_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTcyNw_3b7b00c0-e36c-472e-b98f-dca03c8d88b4"
      unitRef="usd">171000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:Goodwill
      contextRef="ic80123e8686446ea809da2ddaa1ffaea_I20210601"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTcyNw_7773d110-6cce-4c8a-843a-a3d0c3f83b48"
      unitRef="usd">171000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i18670a49a70d49f8aeb8c2046b450952_D20210601-20210601"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80MC9mcmFnOmM3OTg0NTQ3ZjFmYzQ4N2Y5YmIzMjRkMDNiNGE2YzcxL3RleHRyZWdpb246Yzc5ODQ1NDdmMWZjNDg3ZjliYjMyNGQwM2I0YTZjNzFfMjE5OTAyMzI1OTcxMg_59cb3314-4877-4edd-bb03-a16e0a2fbb35">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfODA0_660f54e7-67f0-41ba-a4c1-f3a6c53ba076">DISPOSITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; ("Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the three months ended June 30, 2021, the Company recorded a $314&#160;million pre-tax gain in other income (expense), net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the three months ended June 30, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Solutions' clients, providing a range of lab testing capabilities to augment Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Solutions' core offerings and extend its industry leading suite of services.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNjc_9be9f08b-c0e2-4190-876f-41ea1227c269"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="ie3af8b0558d7461c9027eaf168d159f3_D20210401-20210401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfMjUy_b501c5af-c8fe-4c51-a664-7f5cbb4a92f7"
      unitRef="usd">760000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMyNjczMA_c1dcc054-2461-45ed-ba62-69f8cf577e31"
      unitRef="usd">-314000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic3be2c0db58246b7ba37ca73d78f5af0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMzMDEzNw_104c3026-e817-4c06-beb4-40f4dfcd4568"
      unitRef="usd">20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMyODM3MA_cb661b76-73ee-4e23-a945-813fdedbb774"
      unitRef="usd">55000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMzMDUwNQ_679bf563-473b-467d-814a-619892509e16"
      unitRef="usd">127000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl83MC9mcmFnOjI0ZTI3NmNjZTgzZjQyYWM4MmUxYjhiYTRjZmJiZjg5L3RleHRyZWdpb246MjRlMjc2Y2NlODNmNDJhYzgyZTFiOGJhNGNmYmJmODlfNDk0NzgwMjMzMDQ5Mw_16abbc19-12f6-4d96-abaa-1fb15eb45782"
      unitRef="usd">72000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfNDg0NA_ef579edc-2eb5-4b5d-b880-f01a67e370a6">FAIR VALUE MEASUREMENTS  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed investment options that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of June&#160;30, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the six months ended June&#160;30, 2021, the Company recorded an $8&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of June&#160;30, 2021 and December&#160;31, 2020, the fair value of the Company&#x2019;s debt was estimated at $4.5&#160;billion and $4.6 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfNDg0Nw_3f010716-f79e-4c52-bd8a-9e3194c4221a">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:TradingSecurities
      contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNi0xLTEtMS0w_888e9283-3998-4eb6-acda-e3155bf4f5d5"
      unitRef="usd">75000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNi0zLTEtMS0w_11bdc377-4cc2-4bf6-aa72-978eacceb9e7"
      unitRef="usd">75000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNi01LTEtMS0w_b95586e2-0767-47c5-861a-434603dc555b"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNi03LTEtMS0w_3f561656-c47d-4272-afc3-30e56bf262dd"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNy0xLTEtMS0w_6f8846bf-7037-4aef-8a7f-5b10fc0cb048"
      unitRef="usd">55000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNy0zLTEtMS0w_99bc23c9-5562-413d-9c30-13a8e6e2b1d3"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNy01LTEtMS0w_64f1ba13-4a1f-42f4-aed2-c29bb40ea15f"
      unitRef="usd">55000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfNy03LTEtMS0w_954cc373-0659-45fd-be41-f8cb330b8e7c"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfOS0xLTEtMS0w_0a113f7b-686e-4647-864e-5df0e773c112"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfOS0zLTEtMS0w_a9f10f55-898e-49e0-8bd1-f8f32d6bb168"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfOS01LTEtMS0w_2003ad84-856a-477f-8506-db9242a89439"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfOS03LTEtMS0w_d764caaa-33de-41e2-ae11-5d2650394151"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTItMS0xLTEtMA_7989f8e0-ad6e-4adb-8bf1-46525d0e83d9"
      unitRef="usd">131000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTItMy0xLTEtMA_0d6fce71-f9b3-483c-9b84-e8675a63ecf5"
      unitRef="usd">75000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTItNS0xLTEtMA_56af5a95-2aa1-4a7e-b332-105448dc5efd"
      unitRef="usd">55000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTItNy0xLTEtMA_d3d83b82-bbf8-4201-9503-a02d6bd80329"
      unitRef="usd">1000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTUtMS0xLTEtMA_7318f8d9-8e50-4cd4-a578-2a7ab30bb6e7"
      unitRef="usd">140000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTUtMy0xLTEtMA_cf400cf0-3d4b-430f-8957-1fb85aa4bb2c"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i2f9e4ae4e2234472ba1d3739c30ca49f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTUtNS0xLTEtMA_e8efff42-a179-4e26-b2ea-f0ec2369f35f"
      unitRef="usd">140000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMTUtNy0xLTEtMA_a3846ba9-0243-4d94-a847-939d408f32d0"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i04611b3c394b4101bd96d6e4b765e44c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMjItMS0xLTEtMA_bba55f78-cb94-4fd3-8c32-b38aadafa61e"
      unitRef="usd">78000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ieb4f5b2e63164cf29143b9d989289909_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMjItMy0xLTEtMA_757a63fc-40e4-4485-b986-2f3343cf8185"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i859aca831b984d80a0b94d96fc615aa2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOjJjMDFjZTNmNDA2YTQ0NTZiY2FhODRjNjZlMjQ4YmVkL3RhYmxlcmFuZ2U6MmMwMWNlM2Y0MDZhNDQ1NmJjYWE4NGM2NmUyNDhiZWRfMjItNy0xLTEtMA_4512afa1-35b8-42f0-a8fa-ebea7324095c"
      unitRef="usd">78000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:TradingSecurities
      contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMy0xLTEtMS0w_5b7e9327-0c20-4014-a2df-96d8dc3ea7d5"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ib638d54663d141b3b55a392010b4133c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMy0zLTEtMS0w_81b6fa36-2e62-4257-aa09-4999352500b2"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i4153cd4b719540d983239e906877df0e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMy01LTEtMS0w_d7a2476d-c839-456c-8376-740fa56e7b30"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i51a3f19649844f0b9777994eb7530457_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMy03LTEtMS0w_6f20826e-2854-45a6-aa13-b615d3dee57d"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNC0xLTEtMS0w_2980f97f-4808-41c6-bd8e-95f00e76ce7a"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ib638d54663d141b3b55a392010b4133c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNC0zLTEtMS0w_3549eb69-55ac-4b8a-8cda-b22b8aee067d"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i4153cd4b719540d983239e906877df0e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNC01LTEtMS0w_a0725de5-eff1-43c6-bd4e-4962e5c50aaf"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i51a3f19649844f0b9777994eb7530457_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNC03LTEtMS0w_05a329f9-6ce6-4d1c-bd38-818df60de18e"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNS0xLTEtMS0w_e3a5a6fb-268b-425a-aaa4-9018c789edf4"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib638d54663d141b3b55a392010b4133c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNS0zLTEtMS0w_82007153-f09c-4009-a2ff-951f3781542c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4153cd4b719540d983239e906877df0e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNS01LTEtMS0w_f31e76a5-3c92-4c87-92be-de6addb1231f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i51a3f19649844f0b9777994eb7530457_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfNS03LTEtMS0w_21481957-48d4-404a-908f-f5bd902e6c7c"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTAtMS0xLTEtMA_099b87a7-490b-4587-9fb0-58e31733f57c"
      unitRef="usd">129000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib638d54663d141b3b55a392010b4133c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTAtMy0xLTEtMA_62e5d214-873a-44ba-8032-820111cf84ad"
      unitRef="usd">67000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4153cd4b719540d983239e906877df0e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTAtNS0xLTEtMA_6e04feee-2c8d-4f2b-86b3-358644deb6cd"
      unitRef="usd">50000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i51a3f19649844f0b9777994eb7530457_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTAtNy0xLTEtMA_03570f07-737d-4efe-acc2-5a19a15d32bc"
      unitRef="usd">12000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTMtMS0xLTEtMA_646e722e-5d97-4c92-9475-0811fe1851df"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ib638d54663d141b3b55a392010b4133c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTMtMy0xLTEtMA_1e8cf0dd-7bf1-4b0f-abad-2d271a86bc8a"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i4153cd4b719540d983239e906877df0e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTMtNS0xLTEtMA_040d5cb6-8c6e-484f-8c80-2433618777a1"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i51a3f19649844f0b9777994eb7530457_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMTMtNy0xLTEtMA_d8f97bab-81b8-4623-a4b5-aa176d60844f"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="id2e3fa85839f4364b166f6fd6333403f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMjEtMS0xLTEtMA_ca43cdbd-7e43-4541-bead-82ea97524c65"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ib638d54663d141b3b55a392010b4133c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMjEtMy0xLTEtMA_14e3e63b-73b4-4343-8516-6937daae41ec"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i51a3f19649844f0b9777994eb7530457_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RhYmxlOmJiZGIxMTc1NWM1NzQ5MjViMjlhMGQ2YzNlMDQyZmI1L3RhYmxlcmFuZ2U6YmJkYjExNzU1YzU3NDkyNWIyOWEwZDZjM2UwNDJmYjVfMjEtNy0xLTEtMA_196dce9f-77d7-4821-99fa-e4167cdbef9d"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="idbe6cc9023dd4f6b925f3e4b803adba0_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfMjk2MA_42b8a66f-c3fe-4efc-a6a1-022af6180347"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="icfcc6d7cb7ac4f62b3b2a88f27e08e14_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfMzcyOQ_ed3d0710-f0a3-44c6-af1a-cd953c6705b6"
      unitRef="usd">8000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfNDQ3NQ_a90bb97f-d679-4114-a53e-1779b9feaa09"
      unitRef="usd">4500000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80My9mcmFnOjIwY2E0NTBjYmNiOTQxOTdhZWY4MDIzMTNiNDRhNzU0L3RleHRyZWdpb246MjBjYTQ1MGNiY2I5NDE5N2FlZjgwMjMxM2I0NGE3NTRfNDQ4Mg_375a8ef1-c189-47ed-aa10-48b3e8d37719"
      unitRef="usd">4600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfMTEwNw_f511f074-923b-4daa-ae7e-9db9b8e22f33">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in goodwill for the six months ended June&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Principally all of the Company&#x2019;s goodwill as of June&#160;30, 2021 and December&#160;31, 2020 was associated with its DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, goodwill acquired was principally associated with the acquisition of the outreach laboratory services business of Mercy Health, and adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy; Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining 56% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets as of June&#160;30, 2021 and December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(682)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(853)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(853)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of June&#160;30, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfMTA5OQ_37ce0fbd-d4f6-4664-ac37-217ba062ee7c">The changes in goodwill for the six months ended June&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMS0xLTEtMS0w_32ec0c5a-ccdd-4b4d-94c3-52f0da20ec7f"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib3f1009ff18c488b8726927338c269af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMS0zLTEtMS0w_947680ab-69f1-4658-afac-b29903fffa12"
      unitRef="usd">6619000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMi0xLTEtMS0w_5a029cca-80e9-4b69-88d7-ced6fa35e0ce"
      unitRef="usd">174000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7c021b8753de48c7949085222e7a6139_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMi0zLTEtMS0w_00fadea1-eb67-4339-98db-7c759a619657"
      unitRef="usd">247000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMy0xLTEtMS0w_8fa65bef-d6b7-4be1-969e-eb36a72914ff"
      unitRef="usd">-2000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i7c021b8753de48c7949085222e7a6139_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfMy0zLTEtMS0w_b02bab4f-1466-4c02-b807-ef946d50618d"
      unitRef="usd">7000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfNy0xLTEtMS0w_20e1373f-43bf-4ebb-89de-10ab215446f5"
      unitRef="usd">7045000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOmE4MjQ0NWZhNWVhYTRlZmFiMjYxZmMzYjRkNGUzOWE4L3RhYmxlcmFuZ2U6YTgyNDQ1ZmE1ZWFhNGVmYWIyNjFmYzNiNGQ0ZTM5YThfNy0zLTEtMS0w_7abf42ab-0c73-4a0f-aaa4-fb03e9bdcd5d"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ia41845b250794af096b47fe4b8dcfef7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfNTg3_38b42b5f-92af-40fc-aac5-bffa1af70010"
      unitRef="number">0.56</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfMTA4Ng_464e39cc-e658-4134-b163-b1abf66fc3ce">Intangible assets as of June&#160;30, 2021 and December&#160;31, 2020 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(682)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(853)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(853)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0928297813dc4017bf49f241cc643448_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy0xLTEtMS0w_778c7c4c-6749-4fc1-8a3f-c930f64acf1e">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i062d7e387e63446587683b565e79cc7c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy0zLTEtMS0w_3673ed92-75d7-47c4-b1f0-15b224c78130"
      unitRef="usd">1535000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i062d7e387e63446587683b565e79cc7c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy01LTEtMS0w_7879779e-f3f0-429d-b882-04d8a8cd0d0d"
      unitRef="usd">682000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i062d7e387e63446587683b565e79cc7c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy03LTEtMS0w_d59bc5b5-ee44-4b62-84d7-f0d8db827e25"
      unitRef="usd">853000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i62c6b6c329864ab3b58435cdeddd4726_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy05LTEtMS0w_6577599c-a1e0-4b1c-bca8-efdcccd346b4"
      unitRef="usd">1479000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i62c6b6c329864ab3b58435cdeddd4726_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy0xMS0xLTEtMA_eea5fba6-68c1-4bd1-a201-403175c05b0a"
      unitRef="usd">638000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i62c6b6c329864ab3b58435cdeddd4726_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMy0xMy0xLTEtMA_d6ce3a1e-6992-4b7d-b67d-31ee7ac798f2"
      unitRef="usd">841000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i243d7693a5f1415e850da25a647196b6_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC0xLTEtMS0w_7dde5663-565b-4766-92d3-ffd703d39ec4">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i080fe75a1bab496783d14dbde41a0ab7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC0zLTEtMS0w_815c46e3-cd20-46eb-aba7-3f16a6c57157"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i080fe75a1bab496783d14dbde41a0ab7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC01LTEtMS0w_b389b7c1-df21-434e-b155-e4d09055ae6e"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i080fe75a1bab496783d14dbde41a0ab7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC03LTEtMS0w_238a2491-eb43-4105-823d-047cdec23b5f"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6b349580952a42daa37b46b6272cf25b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC05LTEtMS0w_fe5e2f16-c1b4-478e-9295-a3452fe95090"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6b349580952a42daa37b46b6272cf25b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC0xMS0xLTEtMA_f813147b-17d5-451f-b0d3-f95c8e9db875"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6b349580952a42daa37b46b6272cf25b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNC0xMy0xLTEtMA_e9743179-335d-4235-8bf9-ac361caf75be"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6867e614c34049c1a7f3aced88b5b8bc_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS0xLTEtMS0w_e0722f67-18cf-4bc1-b3bb-101dbbddaf30">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i5398a8c43e6c402d94b6baa7dbf0d6ee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS0zLTEtMS0w_b5ac9748-38ff-45f1-a51d-c5e7f99bd987"
      unitRef="usd">143000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5398a8c43e6c402d94b6baa7dbf0d6ee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS01LTEtMS0w_40ef738d-5f1a-45b1-bb71-a348ad897784"
      unitRef="usd">70000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5398a8c43e6c402d94b6baa7dbf0d6ee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS03LTEtMS0w_de34ba3e-44b0-4dd2-9444-0a3d96629ce4"
      unitRef="usd">73000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i5f627c6887ae40ecafd69b4688c9cc51_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS05LTEtMS0w_a2990c86-6230-449b-96a6-909c887e0a40"
      unitRef="usd">141000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5f627c6887ae40ecafd69b4688c9cc51_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS0xMS0xLTEtMA_94b5ff0f-0b1b-4e95-822a-d83ad0cf15f1"
      unitRef="usd">65000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5f627c6887ae40ecafd69b4688c9cc51_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNS0xMy0xLTEtMA_6807aebf-3368-4967-9fb8-434cb64075d4"
      unitRef="usd">76000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i240c440483ce414d8bd8a947d07168e4_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi0xLTEtMS0w_9005489b-c5ba-468e-b8d0-db311f876746">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i77a870ab4b284d47b78555d636f33091_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi0zLTEtMS0w_9bb369aa-892c-4a58-a97e-d67456e4352a"
      unitRef="usd">108000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i77a870ab4b284d47b78555d636f33091_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi01LTEtMS0w_0653b0d4-62b6-4cc7-b647-8d762be8e482"
      unitRef="usd">99000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i77a870ab4b284d47b78555d636f33091_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi03LTEtMS0w_b2bde92a-95dd-4ffa-80d6-5ae156628a2d"
      unitRef="usd">9000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6261831038be4db5bd54afa80dbf7bd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi05LTEtMS0w_ddb44c35-a1a8-4224-8078-23ea44a40207"
      unitRef="usd">108000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6261831038be4db5bd54afa80dbf7bd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi0xMS0xLTEtMA_eaea0d27-c4ce-4b09-8d9a-ba715b8ed344"
      unitRef="usd">95000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6261831038be4db5bd54afa80dbf7bd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNi0xMy0xLTEtMA_2ab53dd6-359f-4014-a793-d2956acfb208"
      unitRef="usd">13000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie4d571b8f74b4b3393f62cdbd449a4fa_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy0xLTEtMS0w_e1eddd92-4b4c-447d-89bb-f1202635a300">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia38bbfcf307146078c97c1184f858dcd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy0zLTEtMS0w_275b187f-898e-4e7a-aebb-6cf2958f59c5"
      unitRef="usd">1789000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia38bbfcf307146078c97c1184f858dcd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy01LTEtMS0w_29f4b572-d054-4d19-a447-c9cfa6c8f5ef"
      unitRef="usd">853000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia38bbfcf307146078c97c1184f858dcd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy03LTEtMS0w_06617bf2-4bc2-4508-87fe-dff088177746"
      unitRef="usd">936000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i56c902ee777e4bfc97e2db0e0d3526be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy05LTEtMS0w_ec1f2a68-d5c7-4272-a325-4b58fc8f163e"
      unitRef="usd">1731000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i56c902ee777e4bfc97e2db0e0d3526be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy0xMS0xLTEtMA_16a6d778-335f-42e5-8291-28819c9b4042"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i56c902ee777e4bfc97e2db0e0d3526be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfNy0xMy0xLTEtMA_f150259a-1295-4907-ae22-7fb86526ac52"
      unitRef="usd">931000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i388db605d7fa414f925f9483e847602e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTAtMy0xLTEtMA_0bbf5164-0d7c-43ec-b22b-a98db428ec7c"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i388db605d7fa414f925f9483e847602e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTAtNy0xLTEtMA_4137ba92-37e5-45ea-ba5f-db442df46bd5"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i158831a555d7459cbe9af1e66382b1d1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTAtOS0xLTEtMA_5549e260-0ebf-4ae5-b814-d5aed88856e6"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i158831a555d7459cbe9af1e66382b1d1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTAtMTMtMS0xLTA_89afbcd9-2b37-468d-b8dd-9bc4f3f8f750"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i11b6b69b0dc94269aeb47d2aa8b322c0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTItMy0xLTEtMA_b969cf0a-22d6-4695-9fb8-4e74a4061f92"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i11b6b69b0dc94269aeb47d2aa8b322c0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTItNy0xLTEtMA_5270afff-9d32-4b06-88f1-f3ae3c86cdad"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if8d9f93c589f4849bf27e56a6e0c38c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTItOS0xLTEtMA_6a7b80eb-b398-408e-80dc-36c774b46325"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if8d9f93c589f4849bf27e56a6e0c38c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTItMTMtMS0xLTA_cfd0d35c-e48f-4913-8381-b6ab31c36260"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtMy0xLTEtMA_773f40c8-9cae-4e09-9578-a4a800252f7b"
      unitRef="usd">2025000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtNS0xLTEtMA_08ac0b92-b3be-48b9-bf57-c3ce18eb6e52"
      unitRef="usd">853000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtNy0xLTEtMA_6df4909f-bca4-4ae5-94e1-5945de98a475"
      unitRef="usd">1172000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtOS0xLTEtMA_eaa6f8b2-f0f6-4fa7-bfc5-dabc73f15142"
      unitRef="usd">1967000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtMTEtMS0xLTA_84d3931f-73ca-491e-9e48-7c0335aeb4ce"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjFjN2M2N2I0MDEwNzQ1NDA4NDMwZjE1OGNmMzEyZmExL3RhYmxlcmFuZ2U6MWM3YzY3YjQwMTA3NDU0MDg0MzBmMTU4Y2YzMTJmYTFfMTMtMTMtMS0xLTA_5412831b-0c32-4be9-bb52-6d3a6030065c"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RleHRyZWdpb246YzkwMWQyZjQyMDE3NGMwM2FhODNiMDU2YmIwY2FlMjFfMTExMw_65bb4842-6709-43eb-9ac8-154946e4f306">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of June&#160;30, 2021 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfMS0xLTEtMS0w_6ff70f1a-10b6-4787-bb8d-fcd791729ed3"
      unitRef="usd">52000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfMi0xLTEtMS0w_3663b0ba-044b-4246-99ad-5a4f3555f50d"
      unitRef="usd">102000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfMy0xLTEtMS0w_f8a0900e-97f6-48af-9b4c-aae6e79e7131"
      unitRef="usd">101000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfNC0xLTEtMS0w_395f3e67-262a-431b-b4c4-a449fdb1ba4a"
      unitRef="usd">98000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfNS0xLTEtMS0w_50a10baf-7181-46b6-96e7-fffb31fd9ed9"
      unitRef="usd">96000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfNi0xLTEtMS0w_4732ba12-06b6-41a9-ab1f-1fe04d0dd56f"
      unitRef="usd">91000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfNy0xLTEtMS0w_cadc5fc1-c19e-46a3-a6ff-6f1ee78fe1e6"
      unitRef="usd">396000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80Ni9mcmFnOmM5MDFkMmY0MjAxNzRjMDNhYTgzYjA1NmJiMGNhZTIxL3RhYmxlOjQ0MzUzNmIyMGEyMjRiNDRiZjM0MTVlN2JhNDJiZThiL3RhYmxlcmFuZ2U6NDQzNTM2YjIwYTIyNGI0NGJmMzQxNWU3YmE0MmJlOGJfOC0xLTEtMS0w_148a26b3-8d32-4afe-a676-5686a210631e"
      unitRef="usd">936000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMzgzOQ_573ef7bb-2042-4f5a-9399-bb81091f96f5">FINANCIAL INSTRUMENTS &#160;&#160;&#160;&#160;The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $1&#160;million as of both June&#160;30, 2021 and December&#160;31, 2020.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Fair Value Hedges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of June&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both June&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMzgzMQ_312c7f90-4231-435c-a013-16665e22284c">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i04635c8c75144bd8a8ba0318721159e8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMjMyOQ_5dfa429c-2825-494e-8286-ccff4aa1fd08"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5e506a9924014d9bb1c2cfc78ca49c38_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMjMyOQ_fedaf100-b017-45b0-be35-490e8eae3731"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMjU0Nw_6d5b2bb0-05f6-43a8-9b81-f0a1af9ee7cc"
      unitRef="usd">1000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMzgyMA_9e2af33d-5d72-4c15-9998-2a07ac20f581">As of June&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both June&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;</dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ia9062ff9a1ae48d79906ea44e302c2e7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjljNDA0NTgzNTAxYTQ4YWViNTdlYTQ1MWM5ZWYzY2U4L3RhYmxlcmFuZ2U6OWM0MDQ1ODM1MDFhNDhhZWI1N2VhNDUxYzllZjNjZThfMi01LTEtMS0w_0326fcd8-f91a-4bc5-b6db-687df2d25b49"
      unitRef="usd">45000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ifef13a5c7cd74ff2af0e1affd9841703_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjljNDA0NTgzNTAxYTQ4YWViNTdlYTQ1MWM5ZWYzY2U4L3RhYmxlcmFuZ2U6OWM0MDQ1ODM1MDFhNDhhZWI1N2VhNDUxYzllZjNjZThfMi05LTEtMS0w_4652ea48-a32e-4b63-b629-084fba8307b1"
      unitRef="usd">51000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RleHRyZWdpb246NGIyMTY1YjMzZWI3NGQzZDgyZjVhNTRlMzI2MmRmMmRfMzgyMg_5d6de609-6f20-48b6-9acb-3a404c256c19">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and six months ended June&#160;30, 2021 and 2020:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfMy0zLTEtMS0w_05c69018-16ba-45e7-8e55-0bf5823533bb"
      unitRef="usd">322000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfMy01LTEtMS0w_62fcc405-cbee-49ba-bb09-89f4fba19611"
      unitRef="usd">13000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfMy03LTEtMS0w_6c0ee8fc-006d-4a23-9571-2764d9dfedc9"
      unitRef="usd">326000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfMy05LTEtMS0w_16e49fba-4c78-4adb-bd3f-c7422731dc24"
      unitRef="usd">-3000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="ibbac0da433664c12b78532c13c77e330_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNi0zLTEtMS0w_46b2ad7e-7a1f-4450-9f04-b5b723bf2763"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="id28577727d1648e484a07b8110249cb4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNi01LTEtMS0w_deb9492f-4c9b-4830-b004-396ed26e6417"
      unitRef="usd">1000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i5227393e6940467e8dee71a1b9b51664_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNi03LTEtMS0w_9b3faa44-2bdc-410c-9a6f-401128ed90f5"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i7a3fbebc3bfe4304ba9e9eb9b1bba88c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNi05LTEtMS0w_499e7085-9ce0-44c7-987b-fb8a2bff044a"
      unitRef="usd">-68000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i7aa5e0abeaed4700bdad18c66e5e59b9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNy0zLTEtMS0w_783cd94b-fab6-4d5e-a0c5-768ad630aeb3"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i662c45865225464399b955e53cc70538_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNy01LTEtMS0w_20115e15-43ff-4dd5-b823-d2f880e814cd"
      unitRef="usd">-1000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ibd95473cf34947db9595e10c6d055373_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNy03LTEtMS0w_4361f9cd-55c1-4c72-a94f-5f58398f4d09"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1fa06c6f3bf140899d194e149d257ba9_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl80OS9mcmFnOjRiMjE2NWIzM2ViNzRkM2Q4MmY1YTU0ZTMyNjJkZjJkL3RhYmxlOjMxNzdmMjZlMjQ0ZTQ3NGJhN2Q4ZTVmMjEzZjgwOTViL3RhYmxlcmFuZ2U6MzE3N2YyNmUyNDRlNDc0YmE3ZDhlNWYyMTNmODA5NWJfNy05LTEtMS0w_899cc365-2f8e-486d-8f0b-b4f8ea10308d"
      unitRef="usd">68000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMzMyMg_8b1e1c3f-f5b0-4e00-b21f-db6f78e45c17">STOCKHOLDERS&#x2019; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Changes in Accumulated Other Comprehensive Loss by Component&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three and six months ended June&#160;30, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the three months ended June 30, 2021, $20&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income (expense), net.  See Note 5 for further details. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the first and second quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of June&#160;30, 2021, $1.3 billion remained available under the Company&#x2019;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, the Company repurchased 12.5&#160;million shares of its common stock for $1.6&#160;billion, including 9.1&#160;million shares repurchased under ASRs as follows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract. For the three months ended June 30, 2021, the Company paid $1.5&#160;billion to the financial institutions and received 9.1&#160;million shares of its common stock, at an initial price of $132.27 per share for a value of $1.2&#160;billion, which represents 80% of the total value of shares to be repurchased under the ASRs. The ASR contracts will settle the remaining shares, based on the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, upon the completion of the ASRs over the third and fourth quarters of 2021. The Company recorded the transactions as an increase to treasury stock of $1.2&#160;billion and it recorded the remaining $300&#160;million as a decrease to additional paid-in capital in the Company&#x2019;s consolidated balance sheet.  The $300&#160;million recorded in additional paid-in capital will be included in treasury stock upon completion of the ASRs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2020, the Company repurchased 0.7 million shares of its common stock for $75 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shares Reissued from Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the six months ended June&#160;30, 2021 and 2020, the Company reissued 1.2 million shares and 1.7 million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of June&#160;30, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 6.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTA5OTUxMTYzMTM4NA_9be9f08b-c0e2-4190-876f-41ea1227c269"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic3be2c0db58246b7ba37ca73d78f5af0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNjI4MQ_af65aa34-7a8f-4ad2-8b00-7ef8f1d61628"
      unitRef="usd">20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic627ecff5fda4835a645a85a28ace8c5_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTA5OQ_cd0e91a5-aeee-46bd-8938-9e57657f1a2f"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTA5OQ_f0560210-b954-4e1d-bed7-5ab64df8cfd7"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i03e1d81e938740ac958144ec1c77ded0_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTIzMg_1afb92fe-01f2-4579-9ff4-05b3db2e74be"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTIzMg_714de203-12ce-4477-943b-9830f9647768"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i20d06c07440d4f66b5778443f9d59b7a_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTIzMg_9c688e68-ae49-4dbe-9c2c-5305fd8928c4"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib08b3d9b382f42539d1313a3fc3d9152_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTIzMg_c2efa9bf-bb67-45fb-90e3-5534dec19c69"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="ic1daf0363ce34e388d9a621878fbf6c0_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTQwOA_4e84ebc2-67ef-4742-b98f-5c0689b690c6"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i326c009316994d11a6801f243ae0c3c5_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTQwOA_57b96286-327f-49be-bb0b-5322fc6c4d20"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTQyMg_f0538db8-f73d-48b4-a0aa-87cb1d55deeb"
      unitRef="usd">1300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNjU5NzA2OTc3ODE1MA_ae8f7274-3706-4e60-b890-2f239c07af96"
      unitRef="shares">12500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ibf8a964aa07b49748a723e0a8762805d_D20210101-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNjU5NzA2OTc3ODE1Nw_a92e9c9b-8de5-4ea8-8330-c01580d58edb"
      unitRef="usd">1600000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib5a71b4b1c174929a891375f3de116e1_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNjQ3Mg_6b52ecfa-e917-4700-8989-fa943e45b944"
      unitRef="shares">9100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="iea4626114bd94a1b8470c2ae9e6f26e2_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTUzMQ_5b07554d-388f-49d6-afd8-8cac66827974"
      unitRef="usd">1500000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="iea4626114bd94a1b8470c2ae9e6f26e2_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNjcxNQ_5b07554d-388f-49d6-afd8-8cac66827974"
      unitRef="usd">1500000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3fbb220f78a341abb8f1709736881c15_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTU0Nw_005ef932-493b-48d0-9a8a-32dcf5f18ced"
      unitRef="shares">9100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTU2MA_e25d9067-b6f5-423b-ace3-708f535e9c65"
      unitRef="usdPerShare">132.27</us-gaap:AcceleratedShareRepurchasesInitialPricePaidPerShare>
    <dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution
      contextRef="i1b25ce7f6ff24ed7bbb7af00c1bd27a7_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTU3MQ_efc8660e-ad06-4c59-a74b-df0f5cb37302"
      unitRef="usd">1200000000</dgx:ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution>
    <dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements
      contextRef="i1b25ce7f6ff24ed7bbb7af00c1bd27a7_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTYzOA_6d830b3e-a39d-4b08-8b1a-5325883c8903"
      unitRef="number">0.80</dgx:PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="i3fbb220f78a341abb8f1709736881c15_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTU4Nw_4609b796-aca1-497e-936a-02ea8552e64e"
      unitRef="usd">1200000000</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease
      contextRef="ie4ea064d0de34ab9b6d853e2567d8e12_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTYwMQ_d16c09ee-9bbc-43b2-8298-5f883053252a"
      unitRef="usd">-300000000</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <dgx:AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements
      contextRef="ie4ea064d0de34ab9b6d853e2567d8e12_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfNDk0NzgwMjMzNTYxNQ_00852f80-4e68-44b7-9b79-a5fcade68dc0"
      unitRef="usd">300000000</dgx:AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTc0Mw_a6553c4d-775f-4eeb-a450-b8a00da52360"
      unitRef="shares">700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i37d363006bf1424ea9d44197b89324c7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMTc3Nw_f60df190-1b4a-4b3b-b8cb-9ec4ae4bda6b"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMjI2Nw_38ebf3b7-96b7-4866-851b-4169e012b9f6"
      unitRef="shares">1200000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMjI4MQ_c4739abc-89a5-461d-8919-f9061ae9f0a5"
      unitRef="shares">1700000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="idbe6cc9023dd4f6b925f3e4b803adba0_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81Mi9mcmFnOjE3ZDJhZmRiMmViMzRiMzU4YTJjY2U3NTIyOTliMGZhL3RleHRyZWdpb246MTdkMmFmZGIyZWIzNGIzNThhMmNjZTc1MjI5OWIwZmFfMjU4Ng_42b8a66f-c3fe-4efc-a6a1-022af6180347"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfMTUy_e0b47c86-b56c-47e5-a378-4060e816ee6d">SUPPLEMENTAL CASH FLOW AND OTHER DATA&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three and six months ended June&#160;30, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law.  In April 2020, the Company received approximately $65&#160;million of funds that were distributed to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic under the CARES Act.  The Company accounted for the receipt of the funds under a gain contingency model. Accordingly, the amount was recognized when the funds were received and the Company had determined that it satisfied the associated terms and conditions. During the three months ended June 30, 2020, based on the terms and conditions that were in effect at such time, the Company concluded that it had satisfied such terms and conditions for the $65&#160;million of funds that were received in April 2020 and, therefore, the Company recognized such amount in other operating income, net during the second quarter of 2020.  During the three months ended September 30, 2020, the Company reversed the $65&#160;million of funds that had previously been recognized and, during the three months ended December 31, 2020, the Company returned the funds.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfMTU4_0e6e0457-854d-4338-a68e-ae22f34fcb09">Supplemental cash flow and other data for the three and six months ended June&#160;30, 2021 and 2020 was as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:Depreciation
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMi0xLTEtMS0w_66f7d99b-ca33-4043-b11a-11e43b4a32ad"
      unitRef="usd">75000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMi0zLTEtMS0w_7a9706bc-3f39-406d-9bf6-8ea312b55712"
      unitRef="usd">64000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMi01LTEtMS0w_0674bb4a-4b30-4893-86d4-36a20dcfe502"
      unitRef="usd">149000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMi03LTEtMS0w_99d2f804-bae8-4231-a224-0b9673c34237"
      unitRef="usd">124000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMy0xLTEtMS0w_6a0e6c95-0f93-471e-b9ba-fadec14c3fc7"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMy0zLTEtMS0w_b4b8b46e-7cfb-47c8-b68c-a26aeaa8b241"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMy01LTEtMS0w_92bad958-ecb0-4de4-907c-5609465bf3aa"
      unitRef="usd">52000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMy03LTEtMS0w_ce1b2e2d-778a-4e09-b2e4-c31c26a40645"
      unitRef="usd">50000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNC0xLTEtMS0w_a7cfe5cb-6536-4528-b811-b20e86fdf781"
      unitRef="usd">100000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNC0zLTEtMS0w_62a49b9e-c640-48ca-84f3-f4bdcd14c220"
      unitRef="usd">89000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNC01LTEtMS0w_a0f9989e-1577-4521-ac53-301bc9af8f7f"
      unitRef="usd">201000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNC03LTEtMS0w_23b0b6a2-c104-4a30-8486-77ebb23e3888"
      unitRef="usd">174000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpense
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNi0xLTEtMS0w_bca08391-db58-4d70-9a3a-1202999505c5"
      unitRef="usd">38000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNi0zLTEtMS0w_1712b02c-8f4d-4fa8-8ceb-8340c4d242a5"
      unitRef="usd">42000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNi01LTEtMS0w_e0c0c446-14a2-4dd2-be04-72f8588aa33e"
      unitRef="usd">76000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNi03LTEtMS0w_f65f5780-6970-4a4c-915c-44749b2c6487"
      unitRef="usd">84000000</us-gaap:InterestExpense>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNy0xLTEtMS0w_0da8c90f-98aa-48bd-acf2-366746e74425"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNy0zLTEtMS0w_4055456e-a1c8-47ac-b9d7-483eb1d024e5"
      unitRef="usd">1000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNy01LTEtMS0w_d2826aef-9a9d-40d1-b175-ae9dee444640"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfNy03LTEtMS0w_8d353115-adce-428f-937a-37c0a5e615d4"
      unitRef="usd">2000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfOC0xLTEtMS0w_4bf9f41d-e10d-4ba8-9936-65870f21cb05"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfOC0zLTEtMS0w_eb9c91a6-8e8a-4825-baab-c79fa58248e8"
      unitRef="usd">-41000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfOC01LTEtMS0w_701f8867-6019-428f-85c7-aa08e74ba4b6"
      unitRef="usd">-76000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfOC03LTEtMS0w_d72a54ab-4c12-47c2-8a39-e2f0a6d6b787"
      unitRef="usd">-82000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestPaid
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTAtMS0xLTEtMA_57e32fd2-b254-41e9-a192-799f1d28b407"
      unitRef="usd">46000000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTAtMy0xLTEtMA_8b53b49b-983d-4ebc-8cc9-0e4e7615ddec"
      unitRef="usd">55000000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTAtNS0xLTEtMA_4bccc6a3-a487-4941-91cf-1fa500ae1d10"
      unitRef="usd">78000000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTAtNy0xLTEtMA_c8c9fbb6-b63f-4dfc-8d3a-a14a46d1f146"
      unitRef="usd">103000000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTEtMS0xLTEtMA_4d31bc51-14ae-4eaf-b258-01ec0932c1f8"
      unitRef="usd">328000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTEtMy0xLTEtMA_bd93cfeb-57d5-4682-b84d-bbcbfe2f5077"
      unitRef="usd">2000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTEtNS0xLTEtMA_c39e4af3-7361-47ec-9892-c6c51984275a"
      unitRef="usd">335000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTEtNy0xLTEtMA_3b844ccf-d302-42c9-b483-d5994d5d34aa"
      unitRef="usd">20000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTMtMS0xLTEtMA_2c34b2b2-4ea6-4d19-b894-393c052930c6"
      unitRef="usd">20000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTMtMy0xLTEtMA_28a3b73e-f5ff-4d25-94b3-6eaffb5726b5"
      unitRef="usd">48000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTMtNS0xLTEtMA_4f8a3a01-e0e4-4755-9a8d-585f153f9ac5"
      unitRef="usd">20000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTMtNy0xLTEtMA_d582f015-6d69-45b2-bb1f-59567cbb93f1"
      unitRef="usd">48000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTUtMS0xLTEtMA_906058ad-32ec-40cd-be70-4c95c3a3d3da"
      unitRef="usd">77000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ia74ca347035d47afab9af2863189a9af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTUtMy0xLTEtMA_4bee37bc-77c2-4297-ac04-bb2eca6f0f0f"
      unitRef="usd">75000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTUtNS0xLTEtMA_b09c3c85-e4f2-4237-80c8-bb258c0f6de6"
      unitRef="usd">77000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ia74ca347035d47afab9af2863189a9af_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTUtNy0xLTEtMA_f1234ff6-6075-4fdd-be2f-e14fae600281"
      unitRef="usd">75000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTgtMS0xLTEtMA_61f4d57c-0d4d-4061-b203-9683f2d8961b"
      unitRef="usd">234000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTgtMy0xLTEtMA_f278e946-5a0e-4450-93d2-318a51b702c5"
      unitRef="usd">120000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTgtNS0xLTEtMA_e97c4832-1ee3-49bd-a50f-30c6ae2e6e92"
      unitRef="usd">234000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTgtNy0xLTEtMA_95bf2d30-d687-4402-ba9f-1aec867dbe94"
      unitRef="usd">251000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTktMS0xLTEtMA_44c16f3b-352e-47e8-ac99-69276163987a"
      unitRef="usd">3000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTktMy0xLTEtMA_fbe58c9d-949a-48c4-845a-95a6ba3523e8"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTktNS0xLTEtMA_a2b58402-3e88-4fcd-99dd-f5b3b2817ab0"
      unitRef="usd">3000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMTktNy0xLTEtMA_b67092d8-a12c-4e7b-b3c1-c7bc6e4d265d"
      unitRef="usd">20000000</us-gaap:LiabilitiesAssumed1>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjAtMS0xLTEtMA_9fc70dbf-b0a8-4e26-a587-bad16d3146fd"
      unitRef="usd">231000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjAtMy0xLTEtMA_22d538c3-47df-4d7a-a093-4bccf82c7f36"
      unitRef="usd">120000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjAtNS0xLTEtMA_0b0c9a1e-8cbc-4969-9c60-28461e1566e3"
      unitRef="usd">231000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjAtNy0xLTEtMA_e7ff742a-260a-4bb5-9d18-7ee88f74a1fc"
      unitRef="usd">231000000</dgx:FairValueOfNetAssetsAcquired>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjMtMS0xLTEtMA_1f0d9cc2-e6cf-49e5-a6ff-b06fd27deb96"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjMtMy0xLTEtMA_89962adb-2aff-43ac-a5e8-b66e90b8925e"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjMtNS0xLTEtMA_18cf45a1-8fec-47ed-bd1d-d1514f5b019c"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjMtNy0xLTEtMA_9a2e54ee-f4a2-4237-a11d-67fa16cafe0d"
      unitRef="usd">3000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjQtMS0xLTEtMA_de70fc4b-c0e7-46eb-880a-f045b7e7d0c9"
      unitRef="usd">231000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjQtMy0xLTEtMA_cc73d5eb-6f1d-45e6-8702-0f79d6e1f108"
      unitRef="usd">120000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjQtNS0xLTEtMA_0aaf0746-ab26-432b-a917-321a133952b0"
      unitRef="usd">231000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMjQtNy0xLTEtMA_a6758561-bada-4490-9f32-b199b01f8c96"
      unitRef="usd">228000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMzEtMS0xLTEtMA_a7da8b4b-67b3-4a35-8dcb-464664efd353"
      unitRef="usd">33000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMzEtMy0xLTEtMA_41cbefab-8939-46aa-8c01-e13f5af3e540"
      unitRef="usd">47000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMzEtNS0xLTEtMA_cecb2d7b-eb9d-4c94-8b59-0c963a179d48"
      unitRef="usd">69000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RhYmxlOjQyMzY1MWI2ODdhYTQ4MTRhMzJkNGUxZjlkZDY0NzQ1L3RhYmxlcmFuZ2U6NDIzNjUxYjY4N2FhNDgxNGEzMmQ0ZTFmOWRkNjQ3NDVfMzEtNy0xLTEtMA_5ee1179a-7b76-49f8-98e3-7beefba27168"
      unitRef="usd">79000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche
      contextRef="i44b2df1b377b46139f619a2f36e50ecf_D20200401-20200430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfNjA0NzMxMzk2MDQ4OA_e62f0cea-66b2-4ad2-8a34-cc4d7c3f3851"
      unitRef="usd">65000000</dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche>
    <dgx:CARESActProceedsRecognizedInTheStatementOfOperations
      contextRef="i02f8071b495d4e6690e62d4d392886da_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfNjA0NzMxMzk2MDkzNw_3e0fc895-7095-4aeb-b577-dac44077dd45"
      unitRef="usd">65000000</dgx:CARESActProceedsRecognizedInTheStatementOfOperations>
    <dgx:ReversalOfRecognitionOfCARESActProceeds
      contextRef="i6a152b0fb1084caa902c4093da8d43db_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81NS9mcmFnOmUyMjExMDRiNzE3NTQxYmI5NzMwMWU2MGY5MmQ3OWI2L3RleHRyZWdpb246ZTIyMTEwNGI3MTc1NDFiYjk3MzAxZTYwZjkyZDc5YjZfNjA0NzMxMzk2MTA1MA_1595ddf5-92fd-4edf-b3cc-949faab6f549"
      unitRef="usd">65000000</dgx:ReversalOfRecognitionOfCARESActProceeds>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfODkyNA_ac2c3316-9a75-4b2d-b3a7-e4b862799bf7">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  See Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of June&#160;30, 2021, providing collateral for current and future automobile liability and workers&#x2019; compensation loss payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Lease Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#x2019;s 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#x2019;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re: Quest Diagnostics ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;AMCA Data Security Incident&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#x201c;AMCA&#x201d;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018 and March 30, 2019 (the &#x201c;AMCA Data Security Incident&#x201d;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#x2019;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#x2019;s nor the Company&#x2019;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#x2019; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of June&#160;30, 2021, the Company does not believe that material losses related to legal matters are probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for legal matters totaled $6 million and $1 million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reserves for General and Professional Liability Claims&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $151 million and $138 million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i556b98e351504ca9ab3b40b06f30f294_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMTEx_07a3e32f-247c-4728-972d-800ce1d56807"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib82b7d6590d24533bdb4d454c3f65409_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMTI0_f7cce64e-9e2f-4895-8d69-4d668d659849"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if6477236048c4c93b9a5e798f19e3fcc_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMTY3_65b45033-d729-44f6-a35c-a52d5e6ee525"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5be56e298c3542a08d1a42235055721a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMTgw_5f272bf7-058b-49f6-b903-cd08a1efccfd"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ib82b7d6590d24533bdb4d454c3f65409_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfNTc5_1c840460-2aec-497d-9289-05ebbe04424c"
      unitRef="usd">70000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMjE0MQ_aef3edc6-c113-4bc1-a09f-a1f0996f4673"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="icab7ab47a0de43f7bab61f509c638937_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfMjY4OQ_667dce09-ba6c-4551-bbe6-47a20e2b578a"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationReserve
      contextRef="ie7d0fd1d47784fd697f3c49dd3ee9148_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfNzYyOA_61c9f60d-8276-4d6c-9904-2986d0cc4691"
      unitRef="usd">6000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i5fb24d8255674ea29c12a58a75a31c7c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfNzYzNQ_4c1927ed-7b7e-46b6-a4ed-fcd8181f8955"
      unitRef="usd">1000000</us-gaap:LitigationReserve>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfODc0Mw_5cef7c4d-db65-4738-b9d6-51b87df7862e"
      unitRef="usd">151000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl81OC9mcmFnOjIzNDk5MjE5YmIxYTRjMGRhNTM2YjI1YTQ4NWU4ODY3L3RleHRyZWdpb246MjM0OTkyMTliYjFhNGMwZGE1MzZiMjVhNDg1ZTg4NjdfODc1MA_14b18d71-5e82-45b1-9bf8-3178f9be172d"
      unitRef="usd">138000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfMjQxNQ_219d2c44-fc3a-4e37-b238-8c2f8e3e4471">BUSINESS SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of June&#160;30, 2021, substantially all of the Company&#x2019;s services were provided within the United States, and substantially all of the Company&#x2019;s assets were located within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three and six months ended June&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i29a251826fef44b7a2f0a3c45547f1cf_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfODA3_81c79ce3-6587-4e94-82e3-5bb55d44b44f"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i383af7e535cb4e1b91b38301026c3942_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfODA3_a74abeb3-1bdf-469d-929c-ed7672be57cc"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfMjQxOA_cd10f9d7-d9fa-4c1b-821c-2c4e77a7265e">The following table is a summary of segment information for the three and six months ended June&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(330)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90505fcb3b254cc1854ef977088118fc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMy0xLTEtMS0w_3d30141b-eff6-4018-8d4a-8e6187a95cbd"
      unitRef="usd">2474000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bb4af20d3554d7c929c5923a8579af2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMy0zLTEtMS0w_75ea7535-7cf9-4547-9755-46330b0a22aa"
      unitRef="usd">1764000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3010233763bd4c139f2be9e14d283953_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMy01LTEtMS0w_fb48cfd6-5245-4c39-9b9e-d708fac842a2"
      unitRef="usd">5117000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6397d097e9541cd93b37f7f3793e996_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMy03LTEtMS0w_30420a93-b50d-4980-9abf-2f4fe4b5c8a2"
      unitRef="usd">3508000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf9bb291bfed42dd8d3e3f6e51487a32_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNC0xLTEtMS0w_e4eb7ba7-43de-48df-86d1-b246b4d1532c"
      unitRef="usd">76000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb0cbdde947349c2a36c2d246eb753b3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNC0zLTEtMS0w_25082193-9425-4f44-b2df-a4615bba6e43"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0889a4285c0e4785b648e20f63f330f9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNC01LTEtMS0w_73df5fb6-4e28-40d0-85d5-e351945556a5"
      unitRef="usd">153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9c3b5a5d28a4bd8ad953fad99e01101_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNC03LTEtMS0w_3df7489b-1765-41d2-ae5f-5532cf90218c"
      unitRef="usd">141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNS0xLTEtMS0w_6e331d9e-b58f-4f8c-a5cd-e6881c9c5e2c"
      unitRef="usd">2550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNS0zLTEtMS0w_4433f0e0-8512-4bad-87c6-762913b2ac69"
      unitRef="usd">1827000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNS01LTEtMS0w_925903e5-a258-472f-8654-8a2bce154a0c"
      unitRef="usd">5270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfNS03LTEtMS0w_7277701e-2745-40a0-8e69-fa24abd36b7b"
      unitRef="usd">3649000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i90505fcb3b254cc1854ef977088118fc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOC0xLTEtMS0w_36a902e3-fce5-457c-83bd-28a94c904fed"
      unitRef="usd">601000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bb4af20d3554d7c929c5923a8579af2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOC0zLTEtMS0w_e354c316-041f-4e19-897e-291bc6fe3387"
      unitRef="usd">280000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3010233763bd4c139f2be9e14d283953_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOC01LTEtMS0w_911d185b-bcea-4a38-9bf9-fc71be6a9caf"
      unitRef="usd">1313000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib6397d097e9541cd93b37f7f3793e996_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOC03LTEtMS0w_67c1d2ad-55b0-4f6a-bfca-78abbe777c33"
      unitRef="usd">485000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaf9bb291bfed42dd8d3e3f6e51487a32_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOS0xLTEtMS0w_ea0b83fb-b93e-4088-a780-ebb5b74c71ca"
      unitRef="usd">9000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieb0cbdde947349c2a36c2d246eb753b3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOS0zLTEtMS0w_d749f0c1-333c-4e1a-b459-cb45cca10ce4"
      unitRef="usd">4000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0889a4285c0e4785b648e20f63f330f9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOS01LTEtMS0w_d33d8285-9ee8-4b85-a3b5-128511a8c982"
      unitRef="usd">18000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie9c3b5a5d28a4bd8ad953fad99e01101_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfOS03LTEtMS0w_494c068d-54bb-4e26-ac6e-9f9d098f43a4"
      unitRef="usd">13000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i15a526c3a9c94237af3d47054f8b6d88_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTAtMS0xLTEtMA_5e73d491-914b-4d8c-bdc8-77e96686ecff"
      unitRef="usd">-77000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifcc4b8411f1549df9adea0e982455905_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTAtMy0xLTEtMA_41dfcf08-fbef-4ded-ba42-6c76b09da318"
      unitRef="usd">-1000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i97dbe548aae446e5b0a2d3af9581d04d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTAtNS0xLTEtMA_f3a97219-e85a-42f3-8366-63c12c8e0531"
      unitRef="usd">-138000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ief4ea7051e25417fbffc0d616878520f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTAtNy0xLTEtMA_76e1c6d4-4b0c-4dee-a71c-89da34466200"
      unitRef="usd">-40000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTEtMS0xLTEtMA_4aadee24-72b7-48bd-904f-3093e20408da"
      unitRef="usd">533000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTEtMy0xLTEtMA_614d8736-ada5-4785-97a2-0f3a9714c375"
      unitRef="usd">283000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTEtNS0xLTEtMA_93af02b9-6484-4101-aab1-d2bb84f8dfc7"
      unitRef="usd">1193000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTEtNy0xLTEtMA_d5901606-23a1-49a7-bcce-644219984bc1"
      unitRef="usd">458000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTItMS0xLTEtMA_8640f65c-f044-4249-bc80-28c5d41aa6ff"
      unitRef="usd">284000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTItMy0xLTEtMA_3093e26f-c667-4b16-ac86-f1deb1475a45"
      unitRef="usd">-28000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTItNS0xLTEtMA_7374c04c-486e-4abf-af2e-f02274bdf588"
      unitRef="usd">250000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTItNy0xLTEtMA_69fce8ec-6a42-4b2a-9e9b-8671f8363e0a"
      unitRef="usd">-85000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTMtMS0xLTEtMA_7e749051-d36f-45ad-b726-01b3c4aeee1d"
      unitRef="usd">817000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTMtMy0xLTEtMA_2107968c-f893-4137-8360-9e0cef22aad9"
      unitRef="usd">255000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTMtNS0xLTEtMA_ce247608-152b-47a9-86af-c38f1a3e027a"
      unitRef="usd">1443000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTMtNy0xLTEtMA_8a866003-720f-4075-8b63-61db9c932e47"
      unitRef="usd">373000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTQtMS0xLTEtMA_68d4c507-6b50-4be3-9eed-988541251782"
      unitRef="usd">177000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTQtMy0xLTEtMA_e4976c99-b41f-4c99-89a6-8d196fe9c5d2"
      unitRef="usd">66000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTQtNS0xLTEtMA_a630ee36-57ab-481a-bfdf-8b3dffda8529"
      unitRef="usd">330000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTQtNy0xLTEtMA_295f0589-ff63-486e-85ec-e3e05bcfb00c"
      unitRef="usd">92000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtMS0xLTEtMA_b4a2d493-1de0-40a1-9c9a-483338a82029"
      unitRef="usd">10000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtMy0xLTEtMA_5edaa6f7-40a2-4a22-83fd-58329718ccda"
      unitRef="usd">4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtNS0xLTEtMTMwNw_26775f79-a83e-4a65-a3d6-e78ca2531c13"
      unitRef="usd">27000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtNS0xLTEtMTMwNw_4b9b3006-bb2c-4b86-a969-bfb3041b1996"
      unitRef="usd">27000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtNS0xLTEtMTMwNw_6e888c36-402f-4100-91ed-93b703198ee0"
      unitRef="usd">27000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTUtNy0xLTEtMA_5e1a2882-3725-457b-a133-5d41150c2f6b"
      unitRef="usd">18000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTgtMS0xLTEtMA_a738bfbc-6c8e-4dd8-a301-dbcc051d4740"
      unitRef="usd">650000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTgtMy0xLTEtMA_0c2e4dfe-6198-47c9-ad46-789083e8e45e"
      unitRef="usd">193000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTgtNS0xLTEtMA_f3a85723-3609-44e8-8548-e532bbbac80c"
      unitRef="usd">1140000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTgtNy0xLTEtMA_a494afc5-4bf0-4d2a-84a1-03edf69627a3"
      unitRef="usd">299000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTktMS0xLTEtMA_ffe6f478-14ab-446f-9954-f6f4c0eae840"
      unitRef="usd">19000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTktMy0xLTEtMA_2ad09ab2-879a-4382-9a1e-00e802b83535"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTktNS0xLTEtMA_64f505bb-0ee4-488b-bb5c-be6ca8906851"
      unitRef="usd">40000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMTktNy0xLTEtMA_aabe4b27-36b4-4019-a032-e484f58c8aad"
      unitRef="usd">15000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMjAtMS0xLTEtMA_02f6de2d-6a97-493b-bfb2-a53fb0526788"
      unitRef="usd">631000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMjAtMy0xLTEtMA_064f0c87-2760-4057-8133-3312f5969fd5"
      unitRef="usd">185000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMjAtNS0xLTEtMA_549be23e-8a12-4e87-a0b7-90c67573cc5f"
      unitRef="usd">1100000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmFlZDEzNjI1M2VmYzQ4YTZiN2JmMWQxODk1NTRkODdiL3RhYmxlcmFuZ2U6YWVkMTM2MjUzZWZjNDhhNmI3YmYxZDE4OTU1NGQ4N2JfMjAtNy0xLTEtMA_ac8f0836-20e2-4513-8528-77bc9f0c53a8"
      unitRef="usd">284000000</us-gaap:NetIncomeLoss>
    <dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RleHRyZWdpb246NTU0MGY1ODU4ZDFjNDQyOGE1Yzc1YTYzOWQzNDQ0MWFfMjQyMA_e55d5177-d8ed-45b8-af8c-c329d8df2e76">Net revenues by major service were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.330%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i624857d463ea42cba64821f6526c8f30_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfMy0xLTEtMS0w_0479f099-7ec7-4ce5-80ce-05778c769a5a"
      unitRef="usd">1150000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9487c77290544536af9132f251d1f6ea_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfMy0zLTEtMS0w_0b058b33-2a8f-4a1d-a16f-c69e5d303ea6"
      unitRef="usd">812000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cc8267b895c4a3f960332826d5a02a4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfMy01LTEtMS0zODI_83932470-2c4c-4846-a005-ac81dee5d32f"
      unitRef="usd">2182000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibebaf9b7d93d4b928c763156787f0e12_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfMy03LTEtMS0zODU_06142437-869b-4c17-a401-963899cd8ff8"
      unitRef="usd">1757000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7302c53e8d34d6f90c6b6355b0f4289_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNC0xLTEtMS0w_8df7baec-9896-4b47-9cef-7716f6e9f989"
      unitRef="usd">511000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide03df6794ec4f319643260a062544e3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNC0zLTEtMS0w_a79ad8f5-8c87-4ce7-863e-5d971d1ae9ec"
      unitRef="usd">582000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b44cf9ddb7649a4b78b908d8d56915d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNC01LTEtMS0zODI_d4749370-f630-467c-9148-39e94d47e456"
      unitRef="usd">1339000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2434d7efd8540e98be5af167e3ed184_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNC03LTEtMS0zODU_34cffa89-e461-4465-bc4b-c0d8e53b380d"
      unitRef="usd">606000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fb502a9bf254ed190f3f05d0c743c9f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNS0xLTEtMS0w_44a72536-c8c8-4442-9e43-fd617e79b07e"
      unitRef="usd">673000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60bb75a4ffe942ad8f8ee7cc12887a86_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNS0zLTEtMS0w_5d7446f1-cd0d-4eaf-9f96-5c2afc8038d9"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib040e682f6cd49fa8fcaeab6c9d181d8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNS01LTEtMS0zODI_af00edb4-dea0-4fae-a926-5f90b891f694"
      unitRef="usd">1326000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0da175e34d54ca9bc607ec32504bb8c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNS03LTEtMS0zODU_0ff459cf-24a7-43ff-afab-8ba3ef9ab6c0"
      unitRef="usd">935000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b11f69b1f65429992a961faaccd7fd2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNi0xLTEtMS0w_3641355b-201d-4d34-9071-ca254b1bfcc3"
      unitRef="usd">140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33bfedc0555f4b54a3fb6ed997bac076_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNi0zLTEtMS0w_fc5b56a6-172b-4646-b8c3-2963d4279214"
      unitRef="usd">76000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74d1e8f63991474d991b6164216d4e30_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNi01LTEtMS0zODI_5c94d82b-be18-470f-ab6a-db6ab03ec74b"
      unitRef="usd">270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25ee037b0e524fc29dea8a393cc05548_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNi03LTEtMS0zODU_959d010e-50f5-4e3b-8853-e0d859e044d3"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69f9d9630be94d08b53f303e6841bda8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNy0xLTEtMS0w_59263974-0f97-4607-b05a-4ac1756dc2de"
      unitRef="usd">76000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcc42e2ae9df4d33a04a0b7b4ad4f4a5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNy0zLTEtMS0w_b0fc7932-481e-4105-baab-5736b06e54f4"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia152bf35c30347d8873598f3162479e9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNy01LTEtMS0zODI_2f6ebe97-bfe6-4efe-b755-c4a5a3313ae5"
      unitRef="usd">153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bdcdaca428a4c798866885a7bf83056_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfNy03LTEtMS0zODU_36e6811d-439e-407d-ab99-b50446da5cf2"
      unitRef="usd">141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfOC0xLTEtMS0w_9fd8c50b-06fa-427f-8b56-3f0e9fb87c83"
      unitRef="usd">2550000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfOC0zLTEtMS0w_d9d6e96d-834e-4f35-a49a-d9d25dc8ce6a"
      unitRef="usd">1827000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfOC01LTEtMS0zODI_0c762a78-5aa5-49e8-90f6-958acab4e624"
      unitRef="usd">5270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82MS9mcmFnOjU1NDBmNTg1OGQxYzQ0MjhhNWM3NWE2MzlkMzQ0NDFhL3RhYmxlOmM5MTA2OWMzMDUyOTRkMzVhYzk3MTllNDYxOWM5MjExL3RhYmxlcmFuZ2U6YzkxMDY5YzMwNTI5NGQzNWFjOTcxOWU0NjE5YzkyMTFfOC03LTEtMS0zODU_7c5ba0d4-90fe-4ebc-8c61-352bdf2def1e"
      unitRef="usd">3649000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTU0OQ_bfb33d9c-985c-4b44-a739-faed89c21552">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DIS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues in the Company&#x2019;s DIS business accounted for over 95% of the Company&#x2019;s total net revenues for the three and six months ended June&#160;30, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="ide868a83c608446793a82a3dd54fa369_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTA5OTUxMTYyOTM2Mg_71037b66-bbad-402c-b528-6ff16ebd8075"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i383af7e535cb4e1b91b38301026c3942_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTA5OTUxMTYyOTM2Mg_b11d5b5b-19a9-4102-958d-12fefbfe0057"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i29a251826fef44b7a2f0a3c45547f1cf_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTA5OTUxMTYyOTM2Mg_fb073dd2-6f32-4d66-a803-61bc5f55cf47"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="idd0e727fc05c4c8995fdb6239cf65e8b_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTA5OTUxMTYyOTM2Mg_fdd5dca3-d106-4832-9a47-fbd884b4e7c9"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTU1Mw_1baddeb8-1355-4ab3-81ab-3cc4eb1dc5fc">The approximate percentage of net revenue by type of customer was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="iffe84216348445a59b369c286ef7ea93_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMy0xLTEtMS0w_06ba8d48-9cdf-4ed6-84f8-37f97bf06a17"
      unitRef="number">0.38</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i78df85d445ba4c0db260659c0ff4938d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMy0zLTEtMS0w_e578ac1a-617d-4a55-9491-53341cdb60f9"
      unitRef="number">0.32</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3415e92f142e4b66b223b653c1a52387_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMy01LTEtMS0w_3b8bb8da-a9bf-4a1f-806a-3b72c6336a4a"
      unitRef="number">0.38</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i8c5637dc35e141ba997c638460a77408_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMy03LTEtMS0w_b04b6592-4cfb-4eeb-92f4-0fe72ad2a30b"
      unitRef="number">0.32</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="id0a7aade517b46ed8b5a72c6df38f8aa_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNC0xLTEtMS0w_fbbff670-91aa-4f94-84b8-ac7a294cd50f"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i71015133b38c46c58c9f22d76e9138bf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNC0zLTEtMS0w_b49b5e9c-5a0b-437c-952a-e532bacad563"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i61e91a1c6442413ea75e76e2d1d3dfba_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNC01LTEtMS0w_de4f3033-5bdb-4db3-bc90-1959f0ea41ce"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9d45b95ebfa54455b7a8148902aef07e_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNC03LTEtMS0w_3d7edbc6-b0bf-43c6-8060-587e4a53b0b9"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i8d1ae3e3c083422987b0fb7513f90028_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNS0xLTEtMS0w_a65e0310-dc8f-45d1-a45e-bdb2f9bcdf1a"
      unitRef="number">0.41</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i86c6e680c2644742bae6cf23bce0251e_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNS0zLTEtMS0w_b7a47eb7-d81d-496c-833a-75e7a789dbca"
      unitRef="number">0.35</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib3fd720e863c4f78bafdeb62b08b7f4f_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNS01LTEtMS0w_ee07e8c0-eaa0-420c-baa3-d4db4d283fc0"
      unitRef="number">0.41</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9dd965423d424e19a504a6a42bb048c0_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNS03LTEtMS0w_23b2297f-08b0-44a0-bf7b-9806ba27431f"
      unitRef="number">0.35</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i247d47c1463a483386454a9395684d29_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNi0xLTEtMS0w_e5649cba-ef9d-4d31-983d-cadaddf7d799"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i25cda7d1389e444ea61b767b89bced02_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNi0zLTEtMS0w_40516614-cfdb-49b9-9270-eba9852bde8c"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i53e1743ac9e84f96b59d2add6ce6e13d_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNi01LTEtMS0w_8ae38fae-a866-4d0c-acd7-7bd506d3420c"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iba66174bf50b4b8e989cb690f4f40491_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNi03LTEtMS0w_e14b86e8-1923-4e63-8516-48eb7c786e8c"
      unitRef="number">0.13</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i4d8f167638d849ea9481c99bc9392ad0_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNy0xLTEtMS0w_5b29aa9a-5772-4776-a2b1-efb783c916cd"
      unitRef="number">0.34</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i5541bed47cc341dfbed89f1ffbc4662d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNy0zLTEtMS0w_92837c50-6f4a-486c-beac-0848fb2c89df"
      unitRef="number">0.39</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3656dc776fa3408393224dc1faa34145_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNy01LTEtMS0w_d1bbd67e-fed5-4ed3-b49a-ac4dab3823fa"
      unitRef="number">0.34</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i70684da285074a80b27a51d58ae0bb69_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfNy03LTEtMS0w_b161a895-e8e0-4cd2-be0d-7204cb2a1a35"
      unitRef="number">0.36</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib54ce13b5fa748fca4142752ebed0ace_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOC0xLTEtMS0w_ec2f8e6d-622c-4692-bcfa-91c2804eb6c1"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3456017b640b4ec79039ff09ce94613a_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOC0zLTEtMS0w_1a8fca1e-ec42-41f1-b80f-833f474e29c8"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i12c508b86ea2424cb0fd8f135fe41718_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOC01LTEtMS0w_35e61e64-6841-49d8-a48b-9a7b697c3a19"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i29d70c753e104f2e9381d4c4d680e64e_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOC03LTEtMS0w_02db8bac-fe6a-4851-b4a8-2a751e48936d"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i90505fcb3b254cc1854ef977088118fc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOS0xLTEtMS0w_be3558d8-eccf-443d-b0e4-f4c04b5e238f"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i5bb4af20d3554d7c929c5923a8579af2_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOS0zLTEtMS0w_8f82c174-bc7e-4070-ad2d-2bd8f5b1e844"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3010233763bd4c139f2be9e14d283953_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOS01LTEtMS0w_382b31e0-2fa4-4d09-b10d-8d41071da73e"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib6397d097e9541cd93b37f7f3793e996_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfOS03LTEtMS0w_e3a5d983-9c30-4358-a765-4b5be323708b"
      unitRef="number">0.96</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i351bd30e85e24fbbb3960dc16939ff04_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTAtMS0xLTEtMA_1ac2d3b9-3b8a-4e93-9cff-b83013aeec09"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ifb969f883d7f4514bce846057de29d5d_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTAtMy0xLTEtMA_cc1462dd-4d45-4048-b274-823f1717c02c"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0fb23c7e2fab487ba4834d786dea4bf7_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTAtNS0xLTEtMA_e2ede340-d155-4ee7-8ba2-a48d64a21360"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia3845502e9c3418fa7afe7f9e6d923f7_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTAtNy0xLTEtMA_ea8bfea9-cd74-4687-a265-12a1d67add21"
      unitRef="number">0.04</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTEtMS0xLTEtMA_770ca5b8-5a0c-4009-863e-697fbffed913"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTEtMy0xLTEtMA_d109c80a-3b3f-4912-968e-a1279adef9c9"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTEtNS0xLTEtMA_178e27a5-a79e-4424-8e8a-553dfd4ab751"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE0ODFlYjQwMTZkYTQ4ZTNhZjA5YWYxZjdmOTVjYTBhL3RhYmxlcmFuZ2U6MTQ4MWViNDAxNmRhNDhlM2FmMDlhZjFmN2Y5NWNhMGFfMTEtNy0xLTEtMA_b8828957-2715-48c6-970f-3c22b96b7e50"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:AccountsReceivableDisaggregationTableTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RleHRyZWdpb246YTNhZGUwNzI2ZDQ3NDNmYTljZTQ2ZTRkMmEzNWY4YTRfMTU1NQ_37aeb8c1-624a-4f69-be98-dfe4cdaddf0f">The approximate percentage of net accounts receivable by type of customer was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:AccountsReceivableDisaggregationTableTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ic74a4e69eaf749ee870747305583176f_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfMi0xLTEtMS0w_a43f7681-ab7e-4372-bbab-83685416b23d"
      unitRef="number">0.31</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i17eefeebe6ed4e218bc255b2a54bc938_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfMi0zLTEtMS0w_cad61725-d2dd-40fc-b7ae-dd33d22d6f1c"
      unitRef="number">0.34</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i52eab006215b4f08859dc4a709d65fa5_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfMy0xLTEtMS0w_7800c93c-669f-47df-9782-fd48ca9f0c41"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i67c88c4d2eab4a3e92f6026392a577d6_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfMy0zLTEtMS0w_b97fe5f1-3b63-48a6-ac2b-df0d1c293072"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i673f602d80e04697ad707632c81bedc9_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNC0xLTEtMS0w_202c2d91-6e6f-4859-8194-422fc6cadf51"
      unitRef="number">0.42</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i9ec294bc9c1544d1b91cea9e983a73d2_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNC0zLTEtMS0w_469f95d4-0f47-43e8-bf83-5f80c8420e6d"
      unitRef="number">0.46</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ie91fe1b790d2497fa2a96a583468755b_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNS0xLTEtMS0w_3c57fa9d-6fb0-4e33-8d64-b257afdb2015"
      unitRef="number">0.17</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ie2fac1abae04410ca5aa5c55ced1c0d7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNS0zLTEtMS0w_b5c2618c-c28a-4529-ab0b-14c1aff92ba0"
      unitRef="number">0.11</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i7308d78e16804acdb197a6fe7389240b_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNi0xLTEtMS0w_46d557a4-0e5c-4e7a-970d-f03f6c4e8758"
      unitRef="number">0.96</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="icbc053e1f6804e8bad318c14a1840e34_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNi0zLTEtMS0w_6ccc0722-43e5-49e0-b701-019b52c1098b"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i5efcf88fa11e4c91a8d160f946aa751a_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNy0xLTEtMS0w_bdfdf32b-620a-4639-9859-466e1812ef5b"
      unitRef="number">0.04</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i498cb94f65974aa2812f578184595178_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfNy0zLTEtMS0w_2ac32ae2-389b-43b1-8a54-b451c872cd62"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i99a551f639d34e26b6107af0da64abe6_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfOC0xLTEtMS0w_75e62f07-5ef4-4d9a-9ca8-309aef7b673e"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i3656967af97247b1bbcb74c67d929381_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl82Ny9mcmFnOmEzYWRlMDcyNmQ0NzQzZmE5Y2U0NmU0ZDJhMzVmOGE0L3RhYmxlOjE3YzhiZmFjM2EzMjQxYzk4YzQyYTY4YTczYzNhNGYzL3RhYmxlcmFuZ2U6MTdjOGJmYWMzYTMyNDFjOThjNDJhNjhhNzNjM2E0ZjNfOC0zLTEtMS0w_ff5d7238-dfc5-4b0b-a143-7c755f58c306"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjU5OTUz_833f42c0-817d-4a01-863e-3e87bbfa2362">TAXES ON INCOME&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended June&#160;30, 2021 and 2020, the effective income tax rate was 21.6% and 25.5%, respectively.  For the three months ended June&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions (see Note 5).  In addition, the effective income tax rate benefited from $5 million and $4 million of excess tax benefits associated with stock-based compensation arrangements for the three months ended June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021 and 2020, the effective income tax rate was 22.9% and 24.4%, respectively.  For the six months ended June&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions (see Note 5). In addition, the effective income tax rate benefited from $9 million and $12 million of excess tax benefits associated with stock-based compensation arrangements for the six months ended June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxMTc5_f5e997bc-8507-4778-a311-48a2b5505bd6"
      unitRef="number">0.216</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxMTg3_1a889d8d-25a5-4172-8172-6632895e0152"
      unitRef="number">0.255</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie5be2a64222740cbb7881beb82d26db6_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjYyNTY1_cecc5e6f-f8d5-48fd-8d54-cd0d5cfb85d3"
      unitRef="number">0.176</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjYyNTcy_47746927-873e-4e2c-a5cf-7af53c1e7267"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i561420fa41374455918b2b347d38a86c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxNDU0_a05821b1-711b-4469-9ae7-5095b22dc261"
      unitRef="usd">5000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i4a9cd45826854ee5a823fdf6dfcaca31_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxNDYy_36bc4055-2b2f-4dda-b594-a9d0828f3354"
      unitRef="usd">4000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxOTc2_bfc33700-acf3-41f9-ad81-f05d446e4f24"
      unitRef="number">0.229</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcxOTg0_90b0587c-e37f-4eb6-a372-e457ffd97c26"
      unitRef="number">0.244</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0267b05c8fa74b65aae925e3bb8946a3_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjYyNTc3_d632741c-66bb-437d-a81d-d544c443d638"
      unitRef="number">0.176</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="iaa93de6de2ab4e9caf402cb0a7f5a405_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV8yMTk5MDIzMjYyNTg0_faa87407-e798-4ce9-9e5e-bb20929426ce"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcyMjUw_6747f884-2c23-4402-b9c9-0b9c7acb4d45"
      unitRef="usd">9000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="if242eb9f3c88481d9e48db59531aded1_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg4MmJiZmVmM2Q4ZDRmNWU4M2M2NWFlOTc4NWI3MzRmL3NlYzo4ODJiYmZlZjNkOGQ0ZjVlODNjNjVhZTk3ODViNzM0Zl8xMjA2L2ZyYWc6NGE2YTZiYTcxOTgyNGU1NThkNzk4NjVhMTIxZmU5NWUvdGV4dHJlZ2lvbjo0YTZhNmJhNzE5ODI0ZTU1OGQ3OTg2NWExMjFmZTk1ZV82NTk3MDY5NzcyMjU4_7a543607-b533-47b5-bf6d-49f7674ca935"
      unitRef="usd">12000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624751576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 15, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Quest Diagnostics Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1387862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Secaucus,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,180,759<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945628407016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 2,550<span></span>
</td>
<td class="nump">$ 1,827<span></span>
</td>
<td class="nump">$ 5,270<span></span>
</td>
<td class="nump">$ 3,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating costs and expenses and other operating income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of services</a></td>
<td class="nump">1,565<span></span>
</td>
<td class="nump">1,221<span></span>
</td>
<td class="nump">3,191<span></span>
</td>
<td class="nump">2,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">429<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">836<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating income, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses, net</a></td>
<td class="nump">2,017<span></span>
</td>
<td class="nump">1,544<span></span>
</td>
<td class="nump">4,077<span></span>
</td>
<td class="nump">3,191<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating income (expense), net</a></td>
<td class="nump">284<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">817<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(177)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="num">(330)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">650<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 631<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic(in dollars per share)</a></td>
<td class="nump">$ 5.05<span></span>
</td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="nump">$ 8.52<span></span>
</td>
<td class="nump">$ 2.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 4.96<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 8.38<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in Shares)</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in Shares)</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945625552888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 1,140<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in available-for-sale debt securities, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">671<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 1,111<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624340712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 560<span></span>
</td>
<td class="nump">$ 1,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $29 and $28 as of June 30, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">1,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,146<span></span>
</td>
<td class="nump">3,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,622<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,045<span></span>
</td>
<td class="nump">6,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity method investees</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">12,861<span></span>
</td>
<td class="nump">14,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,404<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of long-term operating lease liabilities</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,551<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">4,008<span></span>
</td>
<td class="nump">4,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">792<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Quest Diagnostics stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 600 shares authorized as of both June 30, 2021 and December 31, 2020; 217 shares issued as of both June 30, 2021 and December 31, 2020</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,555<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">10,246<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 95 and 84 shares as of June 30, 2021 and December 31, 2020, respectively</a></td>
<td class="num">(6,894)<span></span>
</td>
<td class="num">(5,366)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Quest Diagnostics stockholders' equity</a></td>
<td class="nump">5,899<span></span>
</td>
<td class="nump">6,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">5,940<span></span>
</td>
<td class="nump">6,809<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 12,861<span></span>
</td>
<td class="nump">$ 14,026<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945629239256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945628515912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,140<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Provision for credit losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="num">(89)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain on disposition of investment</a></td>
<td class="num">(314)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">265<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(199)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TerminationOfInterestRateSwapAgreements', window );">Termination of interest rate swap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities, net</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,191<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(231)<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(170)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from disposition of investment</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Increase in investments and other assets</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">344<span></span>
</td>
<td class="num">(411)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1,001)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(1,910)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(156)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(2,133)<span></span>
</td>
<td class="num">(395)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents and restricted cash</a></td>
<td class="num">(598)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of period</a></td>
<td class="nump">$ 560<span></span>
</td>
<td class="nump">$ 988<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TerminationOfInterestRateSwapAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination of interest rate swap agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TerminationOfInterestRateSwapAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624548552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock, at Cost</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 5,687<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,722<span></span>
</td>
<td class="nump">$ 8,174<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="num">$ (5,218)<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(151)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Jun. 30, 2020</a></td>
<td class="nump">5,881<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,764<span></span>
</td>
<td class="nump">8,307<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(5,187)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2019</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Jun. 30, 2020</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Mar. 31, 2020</a></td>
<td class="nump">5,703<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,738<span></span>
</td>
<td class="nump">8,197<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(5,222)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Jun. 30, 2020</a></td>
<td class="nump">5,881<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,764<span></span>
</td>
<td class="nump">8,307<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(5,187)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Mar. 31, 2020</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Jun. 30, 2020</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2020</a></td>
<td class="nump">6,809<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(5,366)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(1,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Jun. 30, 2021</a></td>
<td class="nump">5,940<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,555<span></span>
</td>
<td class="nump">10,246<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(6,894)<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2020</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Jun. 30, 2021</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Mar. 31, 2021</a></td>
<td class="nump">6,790<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,824<span></span>
</td>
<td class="nump">9,690<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(5,740)<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Jun. 30, 2021</a></td>
<td class="nump">5,940<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,555<span></span>
</td>
<td class="nump">$ 10,246<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">$ (6,894)<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Mar. 31, 2021</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Jun. 30, 2021</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945623545128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DescriptionOfBusinessAbstract', window );"><strong>Description of Business (Abstract)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of Business (Abstract)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945718516392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#8220;COVID-19&#8221;) continues to impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three and six months ended June&#160;30, 2021 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624172728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS (LOSS) PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.96&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.38&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program.  See Note 9 for further details.  The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the first two quarters of 2021 did not equal the total for the six months ended June 30, 2021 due to both quarterly fluctuations in the Company's earnings and in the weighted average common shares outstanding throughout the period as a result of the impact of the ASRs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945622273816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2021, the Company completed the acquisition of the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma, in an all-cash transaction for $225&#160;million.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $54&#160;million of customer-related intangible assets and $171&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The acquisition was accounted for under the acquisition method of accounting. As such, the assets acquired and liabilities assumed were recorded based on their estimated fair values as of the closing date. Supplemental pro forma combined financial information has not been presented as the impact of the acquisition is not material to the Company's consolidated financial statements. The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entity with those of the Company and the value associated with an assembled workforce and other intangible assets that do not qualify for separate recognition. All of the goodwill acquired in connection with the acquisition has been allocated to the Company's DIS business. For further details regarding business segment information, see Note 12.</span></div>&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945623538792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISPOSITION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISPOSITION</a></td>
<td class="text">DISPOSITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner, for $760&#160;million in an all-cash transaction.  The sales price is subject to customary post-closing adjustments.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, during the three months ended June 30, 2021, the Company recorded a $314&#160;million pre-tax gain in other income (expense), net in the consolidated statement of operations based on the difference between the net sales proceeds and the carrying value of the investment, including $20&#160;million of cumulative translation losses which were previously recorded in accumulated other comprehensive loss.  During the three months ended June 30, 2021, the Company also recorded $55&#160;million of income tax expense related to the gain, consisting of $127&#160;million of current income tax expense, partially offset by $72&#160;million of deferred income tax benefit.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945718391624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed investment options that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of June&#160;30, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the six months ended June&#160;30, 2021, the Company recorded an $8&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of June&#160;30, 2021 and December&#160;31, 2020, the fair value of the Company&#8217;s debt was estimated at $4.5&#160;billion and $4.6 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945620736568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in goodwill for the six months ended June&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,045&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of June&#160;30, 2021 and December&#160;31, 2020 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, goodwill acquired was principally associated with the acquisition of the outreach laboratory services business of Mercy Health, and adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy; Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining 56% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets as of June&#160;30, 2021 and December&#160;31, 2020 consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(853)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(853)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of June&#160;30, 2021 is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624304872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS &#160;&#160;&#160;&#160;The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $1&#160;million as of both June&#160;30, 2021 and December&#160;31, 2020.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $1&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of June&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both June&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945621949944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three and six months ended June&#160;30, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, its clinical trials central laboratory services joint venture, to IQVIA, its joint venture partner.  As a result of the transaction, during the three months ended June 30, 2021, $20&#160;million of cumulative translation losses were reclassified from accumulated other comprehensive loss to other income (expense), net.  See Note 5 for further details. </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first and second quarters of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February 2021 and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of June&#160;30, 2021, $1.3 billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021, the Company repurchased 12.5&#160;million shares of its common stock for $1.6&#160;billion, including 9.1&#160;million shares repurchased under ASRs as follows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;In April 2021, the Company entered into ASRs with several financial institutions to repurchase $1.5&#160;billion of the Company's common stock as part of the Company's share repurchase program.  Each of the ASRs was structured to permit the Company to purchase shares immediately with the final purchase price of those shares determined by the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount and was accounted for as two transactions: (1) a treasury stock repurchase and (2) a forward contract. For the three months ended June 30, 2021, the Company paid $1.5&#160;billion to the financial institutions and received 9.1&#160;million shares of its common stock, at an initial price of $132.27 per share for a value of $1.2&#160;billion, which represents 80% of the total value of shares to be repurchased under the ASRs. The ASR contracts will settle the remaining shares, based on the volume-weighted average price of the Company's common stock during the repurchase period, less a fixed discount, upon the completion of the ASRs over the third and fourth quarters of 2021. The Company recorded the transactions as an increase to treasury stock of $1.2&#160;billion and it recorded the remaining $300&#160;million as a decrease to additional paid-in capital in the Company&#8217;s consolidated balance sheet.  The $300&#160;million recorded in additional paid-in capital will be included in treasury stock upon completion of the ASRs.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2020, the Company repurchased 0.7 million shares of its common stock for $75 million.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the six months ended June&#160;30, 2021 and 2020, the Company reissued 1.2 million shares and 1.7 million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of June&#160;30, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 6.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624287960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW AND OTHER DATA<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three and six months ended June&#160;30, 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:56.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was signed into law.  In April 2020, the Company received approximately $65&#160;million of funds that were distributed to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic under the CARES Act.  The Company accounted for the receipt of the funds under a gain contingency model. Accordingly, the amount was recognized when the funds were received and the Company had determined that it satisfied the associated terms and conditions. During the three months ended June 30, 2020, based on the terms and conditions that were in effect at such time, the Company concluded that it had satisfied such terms and conditions for the $65&#160;million of funds that were received in April 2020 and, therefore, the Company recognized such amount in other operating income, net during the second quarter of 2020.  During the three months ended September 30, 2020, the Company reversed the $65&#160;million of funds that had previously been recognized and, during the three months ended December 31, 2020, the Company returned the funds.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945622266456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  See Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of June&#160;30, 2021, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of June&#160;30, 2021, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $6 million and $1 million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div>&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $151 million and $138 million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945717568248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of June&#160;30, 2021, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three and six months ended June&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.788%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945623523032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over 95% of the Company&#8217;s total net revenues for the three and six months ended June&#160;30, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945623503240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text">TAXES ON INCOME<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended June&#160;30, 2021 and 2020, the effective income tax rate was 21.6% and 25.5%, respectively.  For the three months ended June&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions (see Note 5).  In addition, the effective income tax rate benefited from $5 million and $4 million of excess tax benefits associated with stock-based compensation arrangements for the three months ended June&#160;30, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the six months ended June&#160;30, 2021 and 2020, the effective income tax rate was 22.9% and 24.4%, respectively.  For the six months ended June&#160;30, 2021, the effective income tax rate benefited from a lower effective income tax rate, 17.6%, on the gain on the sale of the Company's 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions (see Note 5). In addition, the effective income tax rate benefited from $9 million and $12 million of excess tax benefits associated with stock-based compensation arrangements for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945622167944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements ("ASRs").  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards to be Adopted</a></td>
<td class="text">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945622222248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.96&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.38&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.09&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624107480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value, Measurement Inputs</a></td>
<td class="text">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">June 30, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945738252216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill, Net</a></td>
<td class="text">The changes in goodwill for the six months ended June&#160;30, 2021 and for the year ended December&#160;31, 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,045&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Excluding Goodwill</a></td>
<td class="text">Intangible assets as of June&#160;30, 2021 and December&#160;31, 2020 consisted of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(853)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(853)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense Intangible Assets</a></td>
<td class="text">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of June&#160;30, 2021 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945622113064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock', window );">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</a></td>
<td class="text">As of June&#160;30, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both June&#160;30, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Fair Value Hedge Accounting on the Statement of Operations</a></td>
<td class="text">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three and six months ended June&#160;30, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945623532056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow and Other Data</a></td>
<td class="text">Supplemental cash flow and other data for the three and six months ended June&#160;30, 2021 and 2020 was as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:56.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945623471464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Segment Reporting Information by Segment</a></td>
<td class="text">The following table is a summary of segment information for the three and six months ended June&#160;30, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,140&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock', window );">Schedule of Revenues by Major Service</a></td>
<td class="text">Net revenues by major service were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.788%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,270&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Revenues by Major Service</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945623501880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The approximate percentage of net revenue by type of customer was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AccountsReceivableDisaggregationTableTextBlock', window );">Accounts Receivable Disaggregation</a></td>
<td class="text">The approximate percentage of net accounts receivable by type of customer was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableDisaggregationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disaggregation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableDisaggregationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945628305048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 631<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Less: Earnings allocated to participating securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 628<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 1,096<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic(in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.05<span></span>
</td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="nump">$ 8.52<span></span>
</td>
<td class="nump">$ 2.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.96<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 8.38<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options and performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember', window );">ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AcceleratedShareRepurchasesInitialPricePaid', window );">Accelerated share repurchases price paid</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AcceleratedShareRepurchasesInitialPricePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Initial Price Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AcceleratedShareRepurchasesInitialPricePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945625385752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,045<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
<td class="nump">$ 6,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember', window );">Mercy Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="nump">$ 225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember', window );">Mercy Health | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MercyHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945625662104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISPOSITION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from disposition of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 755<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (89)<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from disposition of investment</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on sale of investment, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945628151048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details) - Recurring Basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other Observable Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945625891304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of equity method investment</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=124268079&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945718472152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at beginning of period</a></td>
<td class="nump">$ 6,873<span></span>
</td>
<td class="nump">$ 6,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Adjustments to goodwill</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at end of period</a></td>
<td class="nump">$ 7,045<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">MACL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945629103336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Intangible Assets Not Subject to Amortization - Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Intangible Assets Not Subject to Amortization - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer-related intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(682)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(682)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(638)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(99)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember', window );">Total Amortizing Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945622144040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945623464584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Balance Sheets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Hedge Accounting Basis Adjustment</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945628716632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Income Statement) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items (Long-term debt)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624549768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized', window );">Additional amount authorized</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase authorization remaining available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,910,000,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare', window );">Accelerated share repurchase, initial purchase price, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Reissuance of shares for employee benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember', window );">ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution', window );">Value of shares to be received under accelerated share repurchase agreements at execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements', window );">Accelerated share repurchase, percent of total value to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,610,000,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost | ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stockholders' equity, period Increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital | ASRs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Stockholders' equity, period Increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements', window );">Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on sale of investment, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Q2 Solutions | Disposed of by Sale | Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_StockRepurchaseProgramAdditionalAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=dgx_AcceleratedShareRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945628128920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable associated with capital expenditures</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FairValueOfNetAssetsAcquired', window );">Fair value of net assets acquired</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: Cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945624319928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche', window );">CARES Act, amount received from initial tranche</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other expense (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_CARESActProceedsRecognizedInTheStatementOfOperations', window );">CARES Act proceeds recognized in the statement of operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ReversalOfRecognitionOfCARESActProceeds', window );">Reversal of recognition of CARES Act proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_CARESActProceedsRecognizedInTheStatementOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act proceeds recognized in the statement of operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_CARESActProceedsRecognizedInTheStatementOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ReversalOfRecognitionOfCARESActProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reversal of recognition of CARES Act proceeds</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ReversalOfRecognitionOfCARESActProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalCashFlowAndOtherDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Supplemental Cash Flow and Other Data [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalCashFlowAndOtherDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945625383256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted', window );">Self-insurance reserves</a></td>
<td class="nump">$ 151,000,000<span></span>
</td>
<td class="nump">$ 138,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Class action lawsuits | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember', window );">Excludes general and professional liability claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserves</a></td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945625578360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,550<span></span>
</td>
<td class="nump">$ 1,827<span></span>
</td>
<td class="nump">$ 5,270<span></span>
</td>
<td class="nump">$ 3,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating income (expense), net</a></td>
<td class="nump">284<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">817<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">1,443<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(177)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="num">(330)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">650<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">631<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember', window );">Routine clinical testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">812<span></span>
</td>
<td class="nump">2,182<span></span>
</td>
<td class="nump">1,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember', window );">COVID-19 Testing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="nump">1,339<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember', window );">Gene-based and esoteric testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="nump">1,326<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember', window );">Anatomic pathology testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember', window );">All other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,474<span></span>
</td>
<td class="nump">$ 1,764<span></span>
</td>
<td class="nump">$ 5,117<span></span>
</td>
<td class="nump">$ 3,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">$ 601<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 1,313<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">General corporate activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="num">$ (77)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (138)<span></span>
</td>
<td class="num">$ (40)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AllotherservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945711729016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Fee-for-service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Capitated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Client Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments | DS Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_FeeforserviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_FeeforserviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_CapitatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_CapitatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139945718765224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">21.60%<span></span>
</td>
<td class="nump">25.50%<span></span>
</td>
<td class="nump">22.90%<span></span>
</td>
<td class="nump">24.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share-based compensation, excess tax benefit, amount</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by Sale | Q2 Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">17.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>60
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#5RL[A:X6,UT9*4M,^]_4>T\XS@7+O? ,:K2V1GNS1> %.18D5A6<N "==[
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M]R4(@4R02V*,I>7S1I8_BT44D<O4P&U3/9JX3MUZR"N=WFOD]->QU$M78)]
MP:[ 6N.U2"K35R-8BU8:O8?[]#Y9*PG)PH!PF5J@TNX]W*GWL_*-,\ZR'2+R
M-;70(A-G:%6[,SOE7J;L-A)?QN[[<D@'/?A2>CG$ZAQL7;E1R7;T#/'=RC3?
MQ2JN%KN&%]E>6:=\/-]R_"+<H!H2R06$TM,!_+[.=_'R$ZO6V4;87%FKXNQP
M)44@M7L [B^4LOL3]P/%7NKX/U!+ P04    " ")@/=2FH_\Z5(&  #P&@
M&    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;*59VW+;-A#]%8R:Z20SMD2
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MNGB+ %0X-+9N (H,<4]))ITR(W9E%B7I3K(8_0!USYB(-YP$.G43I:CKS0A
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M8PH_*41H +S?<*Y>&CI!^=LS^0=02P,$%     @ B8#W4OC5 $!P!@  #AH
M !@   !X;"]W;W)K<VAE971S+W-H965T-"YX;6RMF6U3XS80Q[^*)F5Z[0P0
M6WZ(PT-F.*"]ZW '!:Y]+1R1:,ZV?)(,1S]]5[:Q$TM6:.?>@!]6Z[]6TOZT
MRLDS%U_EFE*%ON=9(4\G:Z7*H^E4IFN:$WG(2UK FT<N<J+@5JRFLA24+.M&
M>3;%GA=/<\**R>*D?G8C%B>\4ADKZ(U LLIS(E[>TXP_GT[\R>N#6[9:*_U@
MNC@IR8K>4?6EO!%P-^V\+%E."\EX@01]/)V<^4?G0:@;U!9_,?HL-ZZ1[LH#
MYU_US<?EZ<33BFA&4Z5=$/CW1,]IEFE/H.-;ZW32?5,WW+Q^]?Y;W7GHS .1
M])QG?[.E6I].D@E:TD=29>J6/W^@;8<B[2_EF:S_HN?6UIN@M)**YVUC4)"S
MHOE/OK>!V&C@AR,-<-L O[5!T#8(ZHXVRNIN71!%%B>"/R.AK<&;OJAC4[>&
MWK!"#^.=$O"603NU.+_^?'=]]?'B[/[R KT_NSK[?'Z)[CY<7M[?H0/TY>X"
M_;+W*]I#K$"?6)9!Y.7)5,&'=?-IVG[D??,1//*1/ZKB$ 7>/L(>]BW-S]W-
M+V@*S?VZN;?=? K=[?J,NS[CVE\PXN],2JJDPU'0.0IJ1^%8\(A<(U(L4:HO
MZ+>*/9&,%D/?38@:5W'M2B^NIT440V^>-N-@VOA^E'1&6R+#3F3H%'F6IKP"
M3;#H4@H"'S*ZCPI($/P1D0R6,2E2BB AH%30)5,HXQ ?J5_OX7G=O3V<(%(_
M@9&DW4C6[V!P:/Y 13= ^_ A6=)Z>68OMD@T>J/-7N(H&H3"8A1ASQZ*J M%
MY S%Q^()1H<+1JTC%)F?G,\'LDP;C .[JKA3%3M5W0A:$K9$]#OD9AUY'5:N
MUA#3M!("%$/PS1G;:(Y-S0$>:+;81#.[YEFG>>;4?,\5R=X@;V:&RP_C@3[3
M*/#&9GW2"4QV!!5()]3+/BHSHB5"3/4"+0%!JI[_-KF)&:D8#\-I-1J)Y[R3
M.W?*O0:Q1+%BA3(*4$)"T^> /QY4<#,>WKDA)4J&,]:TB;W0KM;W>FIX3KV_
M<[Y\!AY86> 97YQYX7!]6ZSB9#:RE/P-G/D[EK@BQ8I!DFO#-CK6K:.M<?1G
MP\&V6L4CH^WW!/+QSDPDE9Z+4J-5STSU@G*JUGP)#_1+:D]2K>-M0?Y0M6D4
M87]$=$\[WXV[ZSHGC<_&MOF6M-EPL>\PVI;6,\YW0Z[)1PYI-N8DL1$WBUGH
MX3%Y/7?\R+GCN&+D@65,L3:[WRF>?EWS;$F%?(<NZ]%W[$?\'B6^FR4=[$OR
M0NI% %\C:2HJV@/&&B +),*-/-'&QV(5!V.+MH>)[Z;)><N1DHMZ;P\;C8P7
MJP-%10Y[\@?[^K6P92C79;*MM>>*[P:+4RL?I/&L'W=K%RPH,1.ES6AL+?>\
M\=W V0;X+ITF0_PH,A:/Q6HVMK1QCQKL1LW5SIF 392$GI<,Y%FM_)&YBWO@
M8#=PKO[OX&.3+.%\.(.M1O,1S1OUCYL^32+?I<]DR,S49QHEX0@=<0\:O*.N
MXGG.6CK6Y14O=%QID8YI=?K31R%'LB0I/9V44)Q0\40G"V0K1'^ H^T^]P3#
M;H+=TB6E>9VS"U[H'@L.]3;,)E; ]((-@;7C)K!FQL0W;9*1-(A[HF$WT?ZL
M0!&Z8&15<*E8*I'<8-K//R78GQVW^YHC5X!ZM&$WVO2D@'Q;?P9V]40@*+8K
MBO:\0\]'L/:07!-!CU'L><TE3)X*-E2"_0/P:^K7!ZBKWE+$'B/0_^J%25G]
M9P_6T3+Q:2PHE\EVY'J\8C=>SY90U@.K(.'K0O, -IPI*1D P"K2 LW(*,]M
M5LD8EG!/5^RFZRU5!![!7H6( B:_?;5;B.AAHZRTF,T#;RSA]^3$;G+"%JO*
MJXPHVE7I/(=LL-9GFT^T/CZQJC;Q>. /#X!L1F,;]Z!':.!&Z+T (%7BY77Q
M$ 6:I3I&\ZB>O$G8+9@?=\H3F+P]B)/Y<$MI,XN">&3;$/1<#MQ<;C8X[C3U
MKDU05ODF>:&V'A;7%JMX%HT .N@!';@!_=E. /NYHHG@<+@UL]A$(V=IP<;A
MIYO2383?'$^S[HOFH7$ :EK%B3<6SQZNP5O*PVQ0A;U9>F@>RUJ*1YN9I7B<
M;AS6ZU]*/A&Q8H6$3>,CM/,.9]!YT?SXT-PH7M;G]T >Q?/Z<DT)B-8&\/Z1
M<_5ZHW\2Z'X"6OP+4$L#!!0    ( (F ]U(!"?)AQ (  %\'   8    >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&ULE97;3N,P$(9?911Q 1+;I.DA@-I*I2V"
M%8>*PN[%:B_<Q&TLG#AK.RWLT^_8"5%:VK+<)#[,/_/-9&+WUD*^J)A2#:\)
M3U7?B;7.+EQ7A3%-B&J(C*:XLQ R(1JG<NFJ3%(265'"7=_SNFY"6.H,>G9M
M*@<]D6O.4CJ5H/(D(?+MDG*Q[CM-YWWAD2UC;1;<02\C2SJC^CF;2IRYE9>(
M)3153*0@Z:+O#)L7H\#86X,?C*Y5;0PFD[D0+V9R$_4=SP!13D-M/!!\K>B(
M<FX<(<:?TJ=3A33"^OC=^Y7-'7.9$T5'@O]DD8[[SID#$5V0G.M'L;ZF93X=
MXR\47-DGK$M;SX$P5UHDI1@)$I86;_):UJ$F:+;W"/Q2X/^OH%4*6C;1@LRF
M-2::#'I2K$$::_1F!K8V5HW9L-1\Q9F6N,M0IP>CA_O9P^W->/@T&</E\'9X
M/YK ['HR>9K!\91(FNJ8:A82?@+?X'DVAN.C$U Q[BA@*=PQSO%SJ%,XJD][
MKD8X$\(-2Y#+ L3? _(]3QO0\D[!]_SF#OGHL'Q,0Y0WK=S;E+M8DJHN?E47
MW_IK[?$WTT13[%8-8@%7+"5IR B'J5#,MM^OX5QIB4WX^T"P5A6L98.U]P0;
M<OR9, (%_"TA$OE<+W*.+1Z*/-4[BUDX[%J'YD]=#?SSGKNJ%VR'R5EELL'9
MKCC;!SE'(DDP=VS*\.44,B)A17A.X1B_?"0X)U)!1F71'B>[L O_08W):WC-
M+?!/C#;0.Q5ZYPOH9?^27,="LK\TLBD4JSNY"^>=&E+7\[:P#]ML4'<KZN[7
MJ9E2^>?$W0\T?C/8(CYLLT$<5,3!0>(GO$I4+M\*YL\@@P\ YYTMQH\F9^TM
M1+=V_)FKYX[()4L5<+I D=<(4"V+X[R8:)'9$W$N-)ZO=ACC#4BE,<#]A1#Z
M?6(.V>I.'?P#4$L#!!0    ( (F ]U(V>T'YJ 8  " ;   8    >&PO=V]R
M:W-H965T<R]S:&5E=#8N>&ULE9E;4]LZ$,>_BB;3AW:F-):4:P>8@4!/>Z9<
MIJ&GSXZM)#JUK512")Q/?U9RL(-U 5[ =E;27ROM_E;V\4[(WVK-F$8/95&I
MD]Y:Z\WG?E]E:U:FZI/8L I^60I9IAINY:JO-I*EN6U4%GV2)*-^F?*J=WIL
MG]W*TV.QU06OV*U$:EN6J7P\9X78G?1P[^G!#[Y::_.@?WJ\25=LSO3/S:V$
MNW[32\Y+5BDN*B39\J1WAC_/Z-@TL!;_<+93!]?(3&4AQ&]S\RT_Z25&$2M8
MIDT7*?R[9S-6%*8GT/%GWVFO&=,T/+Q^ZOV+G3Q,9I$J-A/%+Y[K]4EOTD,Y
M6Z;;0O\0NZ]L/Z&AZ2\3A;)_T6YOF_10ME5:E/O&H*#D5?T_?=@[XJ !].-O
M0/8-2+?!(-" [AM0.]%:F9W61:K3TV,I=D@::^C-7%C?V-8P&UZ999QK";]R
M:*=/9S?7\YOOWR[.[BXOT/P._EU=7M_-T<T7-#N;?T5?OM_\FJ,C]'-^@=Z_
M^X#>(5ZA*UX4L ;JN*]!@NFHG^V'.Z^'(X'A1NA*5'JMT&65L_QY^SY(;_23
M)_WG)-KAW]OJ$Z+)1T02@CUZ9J]OGD3DT,:=U/9'0^Y,U1HM(3846DI1(@@W
MF6I>K>K]RC5GZG-DG$$SSL".,PB,<PT!SJM,E,RW!G7;D6UKXOC^%.,!3._^
MT#&N$9E.&YMGJH:-JF%T]F?YO[!C(<BU0EI E&>BRGC!4-7(-<_-768<M9'B
MGL,^0(O'-WMJU&@:13UUP2"]93RMDT:5H[044O/_[ .?\^KNAH=^27#'=ZX-
M'@_\OALW.L=1G;?&%S8Y0FY&F60YUZ@02C%OF(U=E1V-K@6F?HF31N+D!5<N
MF01AS5*F#^C]@E5LR?6'>C%5P*D31\S19-H1[-J0@.!I(W@:%3S7(OM]9+)\
MCD QH$_5^X ]F&MO[$P=%;0KU&."_4)QTJ;A)"KU+R N F4Y5QNAN%4IEN#I
M>U9'E#?7)JY;*1YTY'JLDH#< VK@J-P;O6;RHXEDKR[L[KVN*-<DL-B8M*)(
M//FNTVK%E"'403:!"()T9"*_X.F"%R]F%MPF>TRC7CC+,K$UR0XR#./WZ:+P
M;JE]+\]V]FC8=8AK=#0>!ES28@+'.=$HW*2/1EZ= ;-,;B$D]E'@Q_C E8.G
MW4CP6 U(0',+$3R,:O[69!?6Z/9*'#J#3QRONC;#4*RV1,%QI-PQ"958VL:H
M9A*B%,&.8TCMT@U*5Y(QRT&O<!<?73A[3 :AH&T)@^.(L4$;"(AP++L<&3EJ
M/:P)B&U9@^.PN7YMD> 5[;($XZF3@URK41+:OBUS\/1-)6"=PE]?V)"6&23.
MC/.M@B<*UC+[L^4U-.J%--O2.L_^(KN5]KZP]M"#T*Z3O%9DXO<2:0%"X@"9
MI1NNTZ+.05#J;*5_)8G+B2,\[FY K]4HD#U)"Q1"7JK),L;R_4*^"<W[G@\5
MC8?=[.0Q"@0Y:9E$XDR"[ G'><4,!5N)=;R+@P3@%>UA$'9\[3,*[8<65.3E
M XT3[N^WRE:;'[Q!Y)V!"R0ZZ!9$'J.C 0YD+-)RB\1//]W 7P(CX/CS^L!O
M 43B 'J^+Q="0@\PCM\C+\/&8S(>!(Z"I*4-B=/F!P-VUWL/HB5G"W^<N.@X
M<E*0SR9)0@O6(H;$$7.[E=D:0L4*U"9JMO(1*7-H\$KU'&( *HXW/6:A0HZT
M5"'QH\SE Y,9A[ &J58AL%"'WL$0]X0RFG1ENC88C_TR:8LD&D?29;DIQ"-C
MIFZ3HBCL&7'']7HMBMQL47/&J?5SI4P1NJURR$DJ=%+;%*E_CM3+I<XD?4:A
M4S!MV47C[+K@)D-5N:E.N1>MU,>CX:BKSF<U& 7DM=2B<6I=<*4E7VSM]K#O
M6P14U)4VZV&R45.O;E*I*R;][G71=#2DW0EXC'" 8/3@%5J<8'69ZLN>P2*5
M>I@T[!Y6?$8XY.T67/25X-JSRBO<J]E#(8*IXV./&9T&\@EM847CARPKVYZ7
MC>:Z5H0*P5XPJ!GOTZ(I&\QFD3S3K/[=.QGWG 4+T,TY/BN2!%Z<T1:'-([#
MV5O4?T0+MN)5918(<BD<*+CPQ[#G)1\>.E/R64T#APC:PI/&X?G&*3%3W$4G
M,W;>]@Z=8YS':#KI5G;]@V\-)9,K^PE&(?N:H7YMWSQM/O.<V8\;G>?G^/.L
M_EC3=E-_.[I*):R00@5;0I?)IS%X5]:?8^H;+3;VB\9":"U*>[EF*7#$&,#O
M2R'TTXT9H/DH=OH_4$L#!!0    ( (F ]U*CTT-;+ H   P^   8    >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&ULS9MO3^,Z%L:_BH6NM#,2I8T=V^D5( UM
MH=R=&5A@9K6ZVA>A-32:-.E-4OY\^W724#?VL5.@R^X;:.&Q>^S8YW<>)SU\
M3+-?^4R( CW-XR0_VIL5Q>+W;C>?S,0\S _2A4CD?^[2;!X6\FUVW\T7F0BG
M5:-YW,6]'NO.PRC9.SZL_G:9'1^FRR*.$G&9H7PYGX?9\XF(T\>C/6_OY0]7
MT?VL*/_0/3Y<A/?B6A0_%I>9?-==]S*-YB+)HS1!F;@[VOOB_3[F_;)!I?@9
MB<=\XS4JAW*;IK_*-^?3H[U>&9&(Q:0HNPCEKP<Q$'%<]B3C^*ON=&_]F67#
MS=<OO9]6@Y>#N0US,4CC?T;38G:T%^RAJ;@+EW%QE3Z.13T@6O8W2>.\^HD>
M:VUO#TV6>9'.Z\8R@GF4K'Z'3_5$;#3PB*4!KAO@;1N0N@'1&F!N:>#7#7S]
M$P)+ UHWH%H#8OL$5C=@>DB^I0&O&W"] ;,T".H&075U5Y>CNI;#L B/#[/T
M$66E6O96OJ@61-5:7L(H*=?N=9')_T:R77$\N/A^??'U?/CE9C1$US?RU[?1
M]YMK='$JWUT,_CZ^^#H<75W_#8W^\>/\YE^H@WY<#]&GWSZC?!9F(D=1@KY%
M<2S78;Z/?MM\>]@M9(#EQW0G=3 GJV"P)9B;M ACH-G W6R0SN=R&UP7Z>07
MT'KH;OUE.HW*;13&Z#*,IIWS! W"101',G+W=24*F2[$%(W"+(F2>V@.3EO"
MF4R6\V4<%K*7BV(F,B2')]/2K,P7#P)]37.HU[.6F95Y+5]FSZM)VD=A(;O-
M"Z"CL;NC[VG2F:1)D:7R(B?WZ#PIA%P&A1935R[#]5K$Z[6(J[Y]2]\G81PF
M$['_LK1DD$,Q.4#$VT>XY_6AE;'JD58]EGGZX=@CY+#[ (1!UF&0[<)X"..E
MV":*DU6';",*R@*^#F,5JBG"3<404'"LB4:F*/"XWQ2=FJ(.Z3<U9X"&8B]H
MJL:FRF?P_/KK^?6K-L0RO^?)I%R- GV2\UJ]^ERFC6IESM)X*K)<IIN_EE'Q
MC/Z\DNL,24H]AMGTWXXU1M<?3IT7][LL!Z)DDLX%=!VIL9IP7[N,(T 3:-,_
M-C6>95&R==S,&?<J%4P:J6 U#O0IEBGA\SY*Y-#2.U2$3P+,O<P(JN,Q;=VX
M-8W(^3IR[HQ\&#U$4Y%,<UE23&*YL:=0<!SX8.II4]\B:H07K,,+6L++BRRZ
M798(R%&1HB1--A-<5"<XM BS(I%K$XH^, /3=MO8*6E$WE]'WG=&?I[GRS)1
ME1=]LD)@7NXAM$SD'D*W(A%WD8Q;9C,PZ+YKD:X2DBG1%LR9J>#PJ+R>JDAZ
MSG%5B:!3%J33:L'+U1Y6=:YX*E^#&[?N<C,.HJV>H5O3#':C?/*<P8Z>1#:)
M\NHBK&8_712K8FA%,;"<\<P<8@E$L=-SP],:"#A= #8]KL\7(-+H<%9K-O'0
MMRQK3_'7<P/X>H5_N1<GZ8-<R6*^B--G(>06?"ZW99GB9)E<S$I:E%466B_]
M2.X)N6Q6.R"W+23KEJ@#:V88?5.TB)J#5E#T?.>@+Y?99"9#S:L<_E*NY:MR
MS;&4?" 8_2*M-,&FIG=@VZ>*I)X;I8Z(P;DUH=CA5 ^5FD7)AJ@9J6*GYX8G
M4%C^L4QD2=<K2SK< R?61*%'?$LDBH6>&X9F;=D6R(EG4H\&@7:-![7*55T"
M'6'.M-)E!*@"TM-RPRF@ZE#C8D(B3Z^+Q]  >Y:)5E3WW%A?3_3/K8MXST0T
MM]0^GF*TUW<6NU=B*L0\O(T%LEDG].>76UF#A)/"5>!BQ4_LYJ>[Q,4F!2WL
MP0J"V W!G=10V(1BQX)GO.$HM[24/[?>;]C$'K?D2JR0AK?TE"H#?0NSE_4(
M9R!L<L::@;#B#'9SQLQ ;8&<8),QE/<T+ YJE2L# 1UA3K2:8@2H D^W8:>
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MWZ5I\?*F_&[L^@O@Q_\!4$L#!!0    ( (F ]U++]V<C!0(  (D$   8
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&ULI53!CILP$/T5RZ=6J@*!;%I%@!2R
M6365=C<*W?;LP !6C$UMLVS_?FU#:"HUN?0"'GO>FS?PQE$OY$G5 !J]-8RK
M&-=:MRO/4WD-#5$ST0(W)Z60#=$FE)6G6@FD<*"&>8'O+[V&4(Z3R.WM91*)
M3C/*82^1ZIJ&R-\I,-''>([/&P=:U=IN>$G4D@HRT"_M7IK(FU@*V@!75' D
MH8SQ>KY*%S;?)?R@T*N+-;*='(4XV6!7Q-BW@H!!KBT#,:]7V !CELC(^#5R
MXJFD!5ZNS^P/KG?3RY$HV CVDQ:ZCO$7C HH2<?T0?1?8>SGSO+E@BGW1/V0
M&]YAE'=*BV8$&P4-Y<.;O(W?X1*PO ((1D#@= ^%G,I[HDD22=$C:;,-FUVX
M5AW:B*/<_I1,2W-*#4XG]]ML<]CMO^^>G]#S TI?LMW3-LLB3QMRF^+E(U$Z
M$ 57B);H47!=*[3E!11_XSTC:E(6G)6EP4W";QV?H=#_A (_F-_@"Z=.0\<7
M7NL45"YIZ[P@2I1VRB0HA3ZLCTI+XXZ/-XHLIB(+5V3Q_Y_S)I&=Q95J20XQ
M-L.F0+X"OL:.4I*?*BDZ7J!_]>!=V*,!6;DA4"@W #TX9=J=YFP]V.M/^C"D
MCT16E"O$H#10?_;9V%H.QA\"+5IGMJ/0QKIN69N[ J1-,.>E$/H<V +3[9.\
M U!+ P04    " ")@/=28UM]8VD(  "!%0  &    'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;-U8;5,CQQ'^*U-*E7U7!0@$MB\^H$K W5G)'2AP.)5*Y<-H
MMZ4=LSNSGIE%\._]=,_N:L'H8B?.EWP!K=33+T]W/]VSQVOG[T)!%-5#5=IP
M,BIBK+\?CT-64*7#GJO)XI>E\Y6.>/2K<:@]Z5P.5>5XLK__[;C2QHY.C^6[
MN3\]=DTLC:6Y5Z&I*NT?SZATZY/1P:C[XMJLBLA?C$^/:[VB&XJW]=SC:=QK
MR4U%-AAGE:?ER6AZ\/W9$<N+P(^&UF'P67$D"^?N^&&6GXSVV2$J*8NL0>/?
M/9U36;(BN/%SJW/4F^2#P\^=]O<2.V)9Z$#GKOR[R6-Q,GHS4CDM=5/&:[?^
M@=IXOF%]F2N#_%7K)'MT.%)9$Z*KVL/PH#(V_=</+0Z# V_VMQR8M <FXG<R
M)%Y>Z*A/C[U;*\_2T,8?)%0Y#>>,Y:3<1(]?#<[%TYO;3Y^FU_]05^_5S>S#
MY>S]['QZ^5E-S\^O;B\_SRX_J/G5Q]GY[-W-\3C"'I\:9ZWNLZ1[LD7WM^J3
ML[$(ZIW-*7]Z?@P_>V<GG;-GDR\J_$MC]]3A_HZ:[$\.OJ#OL _^4/0=;M$W
MS3+7V&CL2LU=:3)#0?USN@C1HUC^]04#1[V!(S%P]#]!]X_2K<YT,$&YI9I[
M"F2CEH;X7) R-I(WE6JL;G(3*5>9LP%8Y)H?EL9JFQE=JH!#A&:,@5N1>TKI
MLE0Z_PDUFKY?%R8KH%%%*':UL6P$1BMMT=XLH[0G92FC$$  "I2BM%IJXS?J
M^0"<1$^)PR ?+]Z&'7A6@7<*)H1[]AS/M#-P$9XC!,A"5(="+4$X06F;0[O+
M[@I7YN3#UXI^;DQ,UME36# N#ZI.V%"^I]X]9%3#6[@ ";\V@51N0E:Z0/F.
M!!X:Q#J,GD.#PUI9)HL2062-]UQ:5L?&TYZZ2K'@FR[ SH4N"YTK I.+/52F
M?(1,;C+-%,9F^%2G)18Z N1'M2!%#S52PYEK52\;./M(VN]QOL-_EO%0N*;,
M63_S/J<89WYJ;"+6M8F%V/KM"I&\L@$G=-5RCM1J^_C5G]Y,#KY[&[B_]]74
MV@;'KJEV'G5A%=.P.MC?_:O$(E'M$M*[T"5,D$I3#&:U6B-WR#;0@@?>5;_3
M/RW%=P'XJP5Y=7@@E /B630PX$ 3G)XV"JD'UM^6")+-38(J\]"_>,3DZ6FF
M1D5DIBXAL2*+>BA+^1WEMD'CUHJ;-^Q/4*\8E<G^VP_3Z5P^'KQ]G0 8ZNWH
MJZV-%E"I)'X.NB*.*A8H814 $PHD2K=>NDAJHJ+[G1A!(F+H_Q=)G +%>V*E
M'HK8]<QY9_6]\<TF[O.K'V<7NP=_[F(7P\8V"!8^&]@$%[%]P@^N>NP@>(HB
MTX TLQ+,/&.E/3[F(HS5H<P3JFT87T,]!0'WWI4-PP=93_<DI@N-1EP0670>
M-Y0D,CF3DBZ(M*XK*,RI,ME.6S.2LK;9X6Y.&;.[ /G4YE-HX1-O(*C" /$
MC!+GTH,48M@8;-6\%M+47(? JC @0@\6*9$;")4(IDS0#)P)9F7-$E(@8SC-
MOS*9/%>-].%H2T(['5&_0&ZQ\)3 "^9!56DC(-X(%.8Y]?-<*(S;:D%_ -G=
M!CGZ#KY64@"<6E \P$C3#S]NH28N,-YV>4@(MW'G=0T=AN,,F%;Z#H[T5CA,
M';#AUC*TDKMZN:2V1KWT 5S6%9>A  YYBNEH:?3"E!ABK:H-HZ3ND&:70;KE
M3++"7=L!]S*_M67_DCM]B;,00VP#'O)&9MGFT*:$40E9;&3DI1QE,BUR@[!]
MQ[Y,.SU,F+#:6V@(:@Z1FX)IZFGO-?8>XL0=!WHPDF89X_C%='704A"JQNXB
M8TLR42]*>,BKN-!#;NY-CF)+,Q7)CZ#).A5JX G=8[W#L6&U<1Y+!0L_GU'4
MN8Q6=UDJ(BF6JFY$7R\ 6#"+6 ?W:0(MKMUN5B)MJB*@ =!X*<N>'H(N]$=[
M%AL;.C5K2MTRBL0B"P7%=OU!P@$.AI*$C7C_AL1%=6'TRCJ@G6%M2DM*VR7/
M@TC$L V7G8[(UG*YX3JY1YNOL)TT,ABE*#<^HWZ:B#*SN1#$A2D;/O3_&R-:
M&^2O5O":"Z#M<R<;08VYBGZ5P9 S$LQFVS4-&JQKJ_F_U]"M(&G]:$5:/WA]
M'AA(W>-:8FI)7V[U:7>2>I7>6GG->S">L$(]FS_3*E$WG[\FH91<O:OJTCV"
MY3\ZN]K]3)CP,RBUXLT<RYF(L^H7CU^B?7L5%R#9#&-JJZX=WF/6Q)>/L"UN
MWJA*'DC,&A(92*OQ6<'34Z\PD!(/OAI-;Z[#Z/6 D%+1M*6VE3"&N L;IHFR
MH1L>Z3)WGSD[$ :\)J32'C;)KPKAM[FTIRYIK08WVAM.O/:Y\""FY31WLF3.
MK/JD 46[T;*=]_V,>/'\F<,_]&IH.!ZTYGJX>H96KKW_U=XQ!KP]50B6[WFI
MYJ!]U6"AY&J#1\2I2(BT58ZUQ@,\)M6!>NYHT#*HF0]R2I6P= 6@J-M:O0EW
MTJA\7>KPY1]01#F>9GSI66A[IZYX*"&,:U;T:O1Q=G9U/>KV:2[.=D#6-9K.
M6?R!"9XS_$H 9%%0ODI;3IGNI86IF8#Z]1*"-NAL,/XWWHLUQ;=>FX2?!=8O
M-"EC//W;79<O7YENTE+S(AQ[[8:#'1@7L[2?@%Y33\B%N:HH-SC -PZXBP6/
MC7"DADT6V(97Q:\N/9,6FSQE,0$+Q7W:3;H,#7V7Y5CWFW&WI+N7[PE/KAI;
M[OZ;+:9VP21'_.":O_?2RYKQX+5817XE+_]"N@"D-V3]M_W[Q6EZK;813R\G
MT3%(>\#*O,31_;WOOAFE+:-[B*Z6EVP+%Z.KY&.!NS)Y%L#O2X<R;Q_80/_6
M]?074$L#!!0    ( (F ]U*D(Y\B@00  #D+   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;*U6;6_;-A#^*P<M6%L@T)M?XJ2. 2=-UPQMEEG;^F'8
M!UHZ640I4B6I./GW.U*RXFQ)&G2#+8D4[QX^]T;=?*OT%U,A6KBMA32G065M
M<Q)%)J^P9B94#4I:*96NF:6IWD2FT<@*KU2+*(WC:50S+H/%W+^[UHNY:JW@
M$J\UF+:NF;X[0Z&VIT$2[%ZL^*:R[D6TF#=L@QG:WYMK3;-H0"EXC=)P)4%C
M>1HLDY.SL9/W G]PW)J],3A+UDI]<9/+XC2('2$4F%N'P.AQ@^<HA ,B&E][
MS&#8TBGNCW?H[[WM9,N:&3Q7XC,O;'4:S (HL&2ML"NU_8"]/1.'ERMA_!VV
MG>SX.("\-5;5O3(QJ+GLGNRV]\.>PBQ^0B'M%5+/N]O(LWS'+%O,M=J"=M*$
MY@;>5*]-Y+AT0<FLIE5.>G9QL5Q=75[]E,'UQ0JR#\O5Q3RRA.M6H[S'..LP
MTB<PIO!)25L9N) %%@_U(^(SD$IWI,[29P%_;F4(H_@0TCA-GL$;#4:./-[H
M*2.9EEQN#%RCAJQB&@_AC!F> Y,%O..BM5C G\NUL9K2Y*]GMAP/6X[]EN-O
M^?7UQU^R[,WS[GTAU( !OU4(N:J;UC*?VZITJ=G;4_3VX,[JAJPFZ9H$C3,>
MMLP _4LEJ"8-O.:24DL(0C*'@+<Y-M8K==(%Y=6;$]I3(SZ(-%"<T,<IX[=/
MK+@(NEN\-UK6JI66*%BK^9IL6 L$J^#7%HVE<+"-5,;RW/SXPRQ-CMX.Y*W*
MOU1*%*C-"5S1B<4E+>&W@>  IJ.$[LELXNZ'21S3,YV-X2,: ALRA)%+<N;<
M1S@-TZ3-&W*RW(#!O-7<<C0P@@3&=-VKW3 NOL<.\&O)VT?B1YS3F><\]ISC
MXZGG/(+/_JPA$7:#FH[.!]$U0&>OL83D2#^$3]())"-BGA[[YT59TNGHTL=O
M2N?CGI4GD#FBH!J78\9SHZSP'P*98Y\=K>04RM3_DN]AMC,W28^(TY2NA*[)
MO6_O,_&_)4Q7\0<P"6.?!.'(>7<63E+GUC!)AY/@ ,:A=S;)3+V,%TW#^-B7
M7E<X_\B)+1)#J7Q2BM85 965=87*1-Z*H5 ?+<^^TEIO%BEQ3>ZV?(@*^D#]
MGT7X\M@F_I?"I81EH[GP((?>M',Z@YB\ Y26K'<6$_UEMB)O<%N1=UP6""BY
M)%1.(RXI3K;M-B59C4VK\XH^JW"0A!-8=\>0\],>_BOS(*+N['*E^6^ICO8>
M:*/51K,ZA(S<=J4LPC%%3T/9:M+4]/VV5+@F]&&EQN0%)^D+4_'5H]7N]G:4
M2ZY)W&X5?&W)$K=$._OH%+SP:82T(KRP5=8YL5<U%.:Z"S,^$N8^A]:*_-]C
MBSLH19O;EG5^[_/RWFV#?<[H?G7[\DJVE5;MIJ)77I.<Q%7A@L0H%(;:HUV@
M.&V8#S.7)^%CG]IHKYVI46]\T^92@+X:76<SO!WZPF77#MV+=TWE)Z8WE',@
ML"35.#R:!*"[1JV;6-7XYHC\1:V6'U;4VZ)V K1>*DJ:?N(V&+KEQ=]02P,$
M%     @ B8#W4@>%7SVE!   "PH  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&ULI5;;;ALW$/V5@6"@+[9NMI,@L U(3HJXA2^-XO:AZ .U.](2YI)K
MDBM9_?J>X5ZLI+8?6D#0+LFYG#ESX9YMG7\(!7.DI]+8<#XH8JP^CD8A*[A4
M8>@JMCA9.5^JB*5?CT+E6>5)J32CZ7C\;E0J;0<79VGOSE^<N3H:;?G.4ZC+
M4OG=G(W;G@\F@V[CJUX7439&%V>56O."XWUUY[$:]59R7;(-VEGRO#H?S"8?
MYR<BGP1^U[P->^\DD2R=>Y#%57X^& L@-IQ%L:#PV/ E&R.& ..QM3GH78KB
M_GMG_><4.V)9JL"7SORA\UB<#SX,*.>5JDW\ZK9?N(WG5.QESH3T3]M&]OAX
M0%D=HBM;92 HM6V>ZJGE84_AP_@5A6FK,$VX&T<)Y2<5U<69=UOR(@UK\I)"
M3=H IZTD91$]3C7TXL7\?G%U\WFQH-GE;_=7BZMO5[<WB[-1A&D1&&6MF7EC
M9OJ*F7=T[6PL GVV.>??ZX\ J<<U[7#-IV\:_*6V0SH>'])T/)V\8>^XC_,X
MV3M^+<XZ8"<$NG3E4ELE)1'HS]DR1(_*^.L-%R>]BY/DXN3_4OD?S-"M)5#"
M-&D8.:18L,12*;NC#$_#D?.TJ[+'6@>=BMZMTA:Z$1V;%634TGD5G=]18+_1
M&0=:=M1 ^)I]MJ,OK$PL#FE;:.B((,0J[S8Z9Q](V9PJ,,@V!M*69OY!V:#"
M(?W:/J]U"*[V.HG>/AA5N%(=BJS"SYBC3(6"P#S$F^[$>*&#Z?04-6X,-H8T
M1Z_EA",)  /':)0_Y@95M<\*'&(3^,6<RU(^.\"EVM&2,3(V6DPH(,[SQ(<R
MP-!,,G&Z9#"'T-1&:3!CF'* MNODLF05:L\80)$J]MKE#>DJ!$;<B64/\T"!
M<::-I &S*D3A\>#TI(M$EDTCLS]"&$KRI&U4=JW%96</3!U,WD_VU:)Z.D([
MU:!()-?.Y5N<#ND;<+Q@PC-"$ORJ=#[JOX6_#7M25 =>U8:,7K$8GIS2CI4/
MC:7]@MD*6UGF:BLP)2LU.MK_J[!*CH7+Q58K#;=#F@5,]ZQXF2B)T&BUU 8F
MA/6 FP#[6_:2K,QYQ)I&;)=V[8E#!+T)B\)RHTR=5+O*SHP+$G$.F2$MZ@J-
M("E#IE&PE'(M_8&>%QNH()OI'\H Q43617#'5BHM< H>N^)!H\>RV/G;YT W
M:@+/B\WH]KORIY *PAF=-_A[WR%B0T"V_'=Y?2;AN::TS4R=<P.%GRI<9C@/
M.\M^+20"+>X?86#E7=E&VI4PKF[?3KI]^)(,>-=QA\LFH@\+%[B3Z&:*9$O6
MB7')E0-V\9U4I(V1WA+5EZ=[%VQ*+T+)0<N_4)VQ4)%RERA[K!5*<9?J*W"E
M@+(I@;5-U**20$>+J*>G!X\Y FIM>[&W,7R?&\EIRF<['F0V_IB>3U>+?O@-
M"9<\K6J?T.<<,1&$W;7RN=#9#\G ZS02]@KH$)M,-PXQ3*;#EVZ2T=X%C3&P
M3I\A4A]HG.:N[G?[+YU9<\$_BS>?2=<*B4="#:^@.AZ^/QV0;SX]FD5T5;KN
MERYBYJ37 E]K[$4 YRL'H.U"'/3??Q?_ %!+ P04    " ")@/=28P&EGGX$
M  # "0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6R=5MMN&S<0_96!
MZK8I(.MFV0Y268#LM(T*I';B)'TH^D#MCK1TN.2&Y$K6W_<,5]>F-HH AK4D
MYW+FS(4<K9S_' KF2(^EL>&J5<18O>IV0U9PJ4+'56QQ,G>^5!%+O^B&RK/*
MDU)INH->[Z);*FU;XU':N_/CD:NCT9;O/(6Z+)5?7[-QJZM6O[7=>*\7192-
M[GA4J07?<_Q8W7FLNCLKN2[9!NTL>9Y?M2;]5]=#D4\"GS2OPL$W220SYS[+
M8II?M7H"B UG42PH_"SYAHT10X#Q96.SM7,IBH??6^N_IM@1RTP%OG'F3YW'
MXJKULD4YSU5MXGNW>L.;>,[%7N9,2/]IU<B>G[<HJT-TY489"$IMFU_UN.'A
M0.%E[PF%P49AD' WCA+*URJJ\<B[%7F1AC7Y2*$F;8#35I)R'SU.-?3B^/7T
M_N[V?OIA>OO'J!MA4+:[V4;YNE$>/*%\06^=C46@7VS.^;%^%T!V: 9;-->#
M9PW^7ML.G?7:-.@-^L_8.]M%=Y;LG3T5G0X9$&I;<TZW%7LEI1!(V9QP5KF@
M#/WF75T%^FLR"]&C2OY^QO%PYWB8' ^_C=;_K4RWEB:5UX;Z#2EMB@73C2LK
M9=<4G,E)QT##WO?D5I9]*'1%VD;V'"(^Z!T-Z-Z9N@G\A^_ZE\.?Z47K:+OU
M4SM9R8!$9Z D>JT,UFS!B"&C9@[4.0^/[)<ZXT /#EYH"8G:,U YFK[[-)W0
M&T#2=A':-+59!Y[2]M;#D195RD=@;A.&"YU<7O10X<9(LP*XPI\QIYD*!? H
M&U3JXPY]  '(&S" F(Q)!XR4V0/:7% T/8/Y0LAN/,V,"X!#*G_  :8)1AC=
M>0V'$!8N#VP?DZNRS-5@,D_P!#WZSWD=UWN"E=02\9=:=DN.A4,^[)(;5QV:
MX!RS*V!&D)M_[2^OO:!+^X5GIK)I*):&(K0#[]KA&)SGS'F1471RUA_NB,-D
M/HWJD1:8Q\*B@Q+ V\R53"_X$<,\,))A.56'F$2'H(YTKB34$/$CV 6NVW>,
M3+Z<7*.1Z_D<\5N0/^.X8FZVQ>8V,2YCSIM&2SZ4]VN)=*E,S5LJ]DRU!:*I
MI7+H9+"O PAF=5D;);.[H<XD1(2\!GA:%3HK:,5239Z7VM7!'+ C=91M+ C^
MQ :X@&PA-PN,BJ$.O?[61*!/W-[?R?GY(?8-[Y*0#?40;:!LJD_RU$XIT"$*
M FB=] >7QPQX+QGYVEH[M1!Z%3&[^3P@ ;,U.FEPJ(X[BF$@/]2?L>6Y1H%^
M1'P>102&HCY=L\)B@?B;I!P&NH)%H)>+/NW+L(R\T)D0O_%P,"A0 DLMMJ5Y
MCJ;-CS)GI!';&Z'4GX3<+E)EP A%;MC(5*5FVNBHD6M0INI%*LY_&W1>5(%"
M1D^J.GZ,R%UJ6VUS]#XP&;Q:Q&I NR97VVG6^:^1WSVX54OVB_1VP%"4H=!<
ML+O=W?-DTMS*>_'F;?-6^85&%QF>0[77N<1KP#?OA681797NZ)F+F%[ILP!8
M]B* \[ES<;L0![M'V_@?4$L#!!0    ( (F ]U)JIS!?"0D  "\;   9
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M^QW5;DX]R.ML5@1$O1S2&HA84]F#2_T@OSE]/!?D2RZ3-@B*D6,'>L@"L(Q
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M=.:_+@1'UF@!GL\T["PN2$'U@\_I?P%02P,$%     @ B8#W4ALK3X*7!0
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MZ$=)!S"J#;P9].D85(H[EA*[*)EZ+A4.UM0;D$C:L^6\9"*3D12%<FDL:(5
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MVM&]VP]I!Z&&9 %:7VCM=A]LH/KI=/$O4$L#!!0    ( (F ]U*?QVG$VPP
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MY"68085NQN85$IH,YLW@7%_*,%=)&@)\8VODU(HCLTJ:%G[>J:)()FD\!)4
MA92;2Q)=I553Y#[824L-,CF16HY /X8-\T/&;O#(.FH4\!U95O?'G-SJJD+I
M^\OD0SVIRJ8O&;H BX6M:;$M?G5ML9QT)$':BG?DH>>4C(B1HV;#GC0TC&L-
M.#HE*43%$6)RK]U,*M0;T)%9XE(0AAUD;A.W]^PD"K!KI58X%V8UZE0TA[.H
M=_8/;^B^<,1 &%FRE?K-:I!SB):[,VM#QPF(^NT53U2O87/WM$.&\_VF]4<6
MM]-ABFO4'@[HVF]'T1#7I-WOC8[WI.& #1(6]?&?1NRSQJRQ3SQ"[_=['GT4
M#SUZ/.QY]$$Z/DSM#UH.>A&AC0)6$B6XIJ/^<?W&+&71B&'S49Z>#(>G["2B
M_V2$S[1W6AGS@1_])($2L+<=C1.6]D<(M#K[6"XJ#IT&#L6CE)W$@([ABY-1
M_Y0]A'U3@6P5]2G'WZJN+'Y:$:N0?UN_4*T+3TN!]*?D?,74(G!BA'C%_3Z4
M2M.$)<.DA@=@S6;8YJT<#/"1)+#P9!R?LOO_1="V( 1%HQ[<BZ#"PT^^"7B9
M YA(OH&'4N3@>,Q^0 3/=[=PYXR<KD(Y!$,POA'G#%I8\"'((JB>1&,V8D")
M^L>._Q.9YMC==E[SZ9)0ND1($$J7J-?SR9/N,8&:4,G_BY)>-?/0;[FMFBF4
M_OTH^%*-IQ\FTNT@X17U7!E%L6=.-(H#+_M#=,H?'^[.X) /Y_I1Q/K8"58D
M8_!DX)/]+$S0/IFLINJ3L9/F!\-V0F[&7+2W#]@#Y%(\3@D['K!Q KX=')Z;
M4Q1XE 8B>HPD:2CZ?]>+;_T*[NZ\7\#OHKE_BT)5'$TEO&K8/MV^J+D.[R>:
M[>$MSR,W<PRAF!=F.-KK#/LMC*[^S4GXXO32OZV8:@<O^%O,I1AR:0/69YI<
M';Z0@.WKJZM? %!+ P04    " ")@/=2I^",5UH%  ">#   &0   'AL+W=O
M<FMS:&5E=',O<VAE970R,"YX;6R55VE3W$80_2M=FW(25P%[<I@ 58"Q35+&
M%&#G0RH?9J7>U90EC3(S8B&_/J];VEUA#CL%-8Q&?;Q^?6@X6#C_-63,D>Z*
MO R'O2S&:K_?#TG&A0E;KN(2;V;.%R;BT<_[H?)L4E4J\OYH,-CI%\:6O:,#
M/;OT1P>NCKDM^=)3J(O"^/L3SMWBL#?L+0^N[#R+<M _.JC,G*\Y?JXN/9[Z
M*RNI+;@,UI7D>7;8.Q[NGTQ$7@6^6%Z$SIXDDJES7^7A/#WL#000YYQ$L6#P
MYY9/.<_%$&#\T]KLK5R*8G>_M/Y.8T<L4Q/XU.5_VC1FA[V]'J4\,W4>K]SB
M [?Q;(N]Q.5!5UHTLI/='B5UB*YHE8&@L&7SU]RU/'04]@;/*(Q:A9'B;API
MRK<FFJ,#[Q;D11K69*.AJC; V5*2<AT]WEKHQ:.KLR]G%Y_/Z.KL]-/[B_.;
M\T\7!_T(P_*ZG[1&3AHCHV>,[-!'5\8LT%F9<OI0OP] *U2C):J3T8L&?Z_+
M+1H/-F@T& U?L#=>13E6>^/GHN1;+FNFF7<%G0*K1S6 Z9C1J7+,GOXZG@8]
M__L%AY.5PXDZG/P(K<^R^C]L-*FAM^?7=(%6]4U @6Q),6/$5%2FO/_YI[W1
M</>WH'+3.L!B"*C\Q-5EY)30Q.1N$>R;[5?D9D^J1A=-3F77B:B):,P\,YDR
MI6#OJ&ARSI)S0L9XE3$5P6:@&^.9*F_1\S:_IP3NO U0@7]#&;J&;EU>%RP'
MGG,C;0I!C(O-U.6Y@6]ORF"TC<,6W0!)-[X-6F0VR>##W=H4<!,P:1,$$3E$
M6\XIL+^U"=X('(=(_.IH@P(<AID5+F.@BKU.NC(!GFENYT:]JJ;GQ,U+^R]$
M5]2L ZLK#!F)+F>=-RV]2PQ ET@R?EUD+.,L8&P$Y<9SY3RR\YI L[Y=X<W,
M+=.450$T>TZ;\-N<D=C&9(*DN#*%I%D<)X ,*KR"1US$=Q7&H"07YI"R:&..
M%. 103$(;UHC63;#W+NZTNKBNR0SY9RU"!J*'U J29BK>XEBYG+KR%00-$FF
M8 -W8-HRR>N45=XBAF0)5SNO1LY,CL0+_:"JD5;VS#U0I5Q:DX?7&YJ."M$A
M$DD!D@4;PN^Z1%9P O0B>PQ/1/P2W(:V$)>IPUM@$?F6#H':,A3V*6.3QRR1
M%-HRU!Z'&S27]BH+Q268$<5'3JU*">CFP:9"Y=R;0H)!O7;D.Z$A$GQZ:%9[
MK5F$86PNQ3<W7FEIRW!9F4VV'TR$7\(WO1+0P1<NHEDE^UHVH%B&@T0//E*C
MD\*62 +8IA!Q( %].VQ@6GO\N"PE<5=:Q@0$\KFDX6#SCRUZ>]VMU_5X6B-Z
MT$--+]Z+%^M_K!?7K:BMDW*.:O;W:!WD*TEJ[V74^._WE%;!G=:I>$X0,6XE
MDO/.+*0IP-U7W"T%6L"5"6VYH#!N=$QV/XGK\7B-P?GT&QV<2NAZ]^%QB>W3
M.^9-\++91D3C/7I%XY$LJ]VIJ6S41([;GQL=ZT_4+$V&--YNU_>/RG<XH.%(
MUS&=/BC4\83&;W3=H<NV8%5VJ.NH=2GE]V9W^;LCN6\031Y^R8:# 8 _7K^?
MF_;[%MI99J;YC^7I(?5OH5Q,(38>;CQB_WQ)UG@H%$^P=*BZ; C9P4]+47LR
M&=&D0TYGH"5.^=?:EGI&*=3XP ET?!LJ&413FZ.C.;RFX:Z0VJ%S1[@$D>!>
M27R*@0Z'3UUH^IT[(\B9Z\T8WTZQTUP?5Z>KR_=Q<^=<BS<W]X_&SQ$-Y3R#
MZF!K=[M'OKD--P_157H#G;J(3.@6A8C>$P&\GSD,I/9!'*S^)3GZ#U!+ P04
M    " ")@/=2C+LYZ?("  "U"   &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6SE5FUOTS 0_BNGB F02M*F[=[45MJZ(8JT%];Q(B$^N,FEL>;8P79)
M]^\Y.UGHI'5L"#[QH<TYON>Y%Y_O,JJ4OC$YHH5U(:09![FUY6$4F23'@IE0
ME2AI)U.Z8):6>AF94B-+/:@04=SM[D8%XS*8C/R[2ST9J9457.*E!K,J"J9O
MCU&H:AST@KL75WR96_<BFHQ*ML0YVH_EI:95U+*DO$!IN)*@,1L'1[W#XX'3
M]PJ?.%9F0P87R4*I&[>8I>.@ZQQ"@8EU#(P>/W"*0C@B<N-[PQFT)AUP4[YC
M?^MCIU@6S.!4B<\\M?DXV \@Q8RMA+U2U3MLXADZOD0)X_^AJG7[_0"2E;&J
M:,#D0<%E_63K)@\;@/WN%D#< &+O=VW(>WG"+)N,M*I .VUB<X(/U:/).2[=
MH<RMIEU..#NY/OIR.H>+<YB=3R_.3D>1)5*W%24-P7%-$&\AV(4S)6UNX%2F
MF-['1^1,ZU%\Y]%Q_"CA^Y4,H=_M0-R->X_P]=L(^YZOOX5O)A-5(%RS-9QP
MDPAE5AKAZ]'"6$TU\>T1$X/6Q,";&/QY$I]% %1P8'.DGT:$HDXPN@0#I0?;
M] "3J1-HZ=0QR]!7.? Z:$M!:V81*F8@[H6[.S5B& YW.G2G3%GKB]OPR39_
M9VJ!$C-N"99I50 #NO>HMP,ZT-LCQSI =]0Q+ZF3W,F&"025>7FJBI+)VY<&
M!MT=4)5$;7)>$IU%BL22 !\@AKD2*W?A#;PR%,BY(I^&KT.840M(4^ZVGAG"
MBR'=/"%\$Z'LO1BT2W(-UPD:X[$-S  S1B6<.8**VQSH%B<W;USS2($L44,U
MK.Y)6C.Y1&IRA,J>?^@/GZ#AZ[]6,W%XT-3,(!QLK9G'+?Z'%7-POV)Z\;\M
MF2>?^+WC>ZCS11NCI$"]] /3D LK:>NITKYM9_)1/8I^J=<#_8SI):>D"LP(
MV@WWA@'H>DC6"ZM*/Y@6RM*8\V).WQ6HG0+M9XI.HEDX ^V7RN0G4$L#!!0
M   ( (F ]U+2N >/50H  "(;   9    >&PO=V]R:W-H965T<R]S:&5E=#(R
M+GAM;-U977/;NA']*QC=F9MD1K9DY\MSXWA&_DBJ-K%][:2=3J</$ F)B$F
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M]]^^'L0;B/8AV)I_!9G9$&S%'PLEX2%:@/=SBUXT/9""[F>QDS\!4$L#!!0
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M3*.3(?4ZTW;#=N%T[3O00COJ9U[,Z0\$&E:@\Z76;KM@@NXOR>Q?4$L#!!0
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M'0Y18;;Y)&ENO%F&SX"I\8A"6"[P%2<M"^#YS'"HFQLVT'T7GOX-4$L#!!0
M   ( (F ]U*=@G3$2P,  -D'   9    >&PO=V]R:W-H965T<R]S:&5E=#(Y
M+GAM;(U56V_:2A#^*R-+1VJE-KZ&I!$@)4!;*C5%0'L>JCXL]H!7M7=]=M>0
M_/O.KHWC*($>@<9[F?GF\LWN#@]2_=8YHH&'LA!ZY.7&5#>^K],<2Z8O9(6"
M=K92E<S05.U\72EDF3,J"S\*@H%?,BZ\\="M+=1X*&M3<($+!;HN2Z8>[["0
MAY$7>L>%)=_EQB[XXV'%=KA"\[U:*)KY'4K&2Q2:2P$*MR/O-KRYN[3Z3N$'
MQX/NC<%FLI'RMYW,LY$7V("PP-18!$:?/4ZP*"P0A?%?B^EU+JUA?WQ$_^AR
MIUPV3.-$%O_RS.0C[]J##+>L+LQ2'CYCFX\+,)6%=A(.C6YRY4%::R/+UI@B
M*+EHONRAK4//X#HX81"U!I&+NW'DHIPRP\9#)0^@K#:AV8%+U5E3<%Q84E9&
MT2XG.S->SG[,[K_/8#F;?/MT/U_/O]W#FS7;%*C?#GU#'JR>G[9H=PU:= )M
M %^E,+F&F<@P>V[O4V1=>-$QO+OH+."76EQ '+R#*(C",WAQEV[L\.)3Z>(>
M18VP5;*$"<6JJ"VHY":'B2LV*OAYN]%N_=<9ATGG,'$.DQ,.IURSW4[ACKDF
ME%MH0WBMN.>AUCD"JRHE'SAU(T*%*D5AZ.A86$$'6+79;1[!/%9N.3UF=6 :
MZ+^5!9U#?0/K7"$^HPNHV.B*O>(/)W8L#58$O=%G9(7)4Z80N-"U0D7P'Q'?
MTY7Q7J/:\Y2,K^$?B",KNM&$5=Q0)AG$[6\M#2L@?PD(20CQ92L_R3TJ03>#
M@8H]VMTP@#!R,H9)P7L[<0+Q!R<'L" .:$L[W=#)J'4YG:_@P]7Q/X#IJHTH
M@?NGPEI' 07^0IYIE,NN42[/LGN;IK*VP2TQ1;ZW)Q">-\]K'7,>\^\=PXY>
MU9/7_],]SQMB2L;EAM3B\-V+GI@?*8Q#2WQ"HD?@HJ%I0+^6N'8EB2#I4?:&
MB[2H,RYVD$K7%4Q06S&1T1V<U72WV] 5ZDK2@['A!2=#_1;"*TMUC^2!99CH
MI8YPU+Y6@;\PZ_>N6RK.SCTJ&AQ.<_-VJ]V[==M<UT_JS:/WE:D=90,%;LDT
MN+@B0E7SD#03(RMW>6^D(2;<D(Y'ALHJT/Y62G.<6 ?=:S[^ U!+ P04
M" ")@/=2!%S2X8T$   3$0  &0   'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6RU6%USXC84_2L:FNDD,[OX"X/)$F9(,-UT-ID4)MV'3A\46P%-;,LKR6'[
M[WLE.\888=)MRP-8\CE7]YZKCRLF6\9?Q(80B;ZG22:N>ALI\TO+$M&&I%CT
M64XR>//,>(HE-/G:$CDG.-:D-+%<VQY:*:99;SK1?0]\.F&%3&A&'C@219IB
M_M<U2=CVJN?TWCJ6=+V1JL.:3G*\)BLB'_,'#BVKMA+3E&2"L@QQ\GS5FSF7
M"\=7!(WXG9*M:#PC%<H38R^J<1M?]6SE$4E())4)##^OY(8DB;($?GRKC/;J
M,16Q^?QF?:&#AV">L" W+/E*8[FYZ@4]%)-G7"1RR;:?2160=C!BB=#?:%MA
M[1Z*"B%96I'!@Y1FY2_^7@G1(( =,\&M".Y["5Y%\-J$P1'"H"(,WCN"7Q'\
M]XXPK A#K7TIEE9ZCB6>3CC;(J[08$T]Z'1I-@A,,S6S5I+#6PH\.0UGR_O;
M^U]6Z"%<HM7GV3)$YW,B,4W$!?J('E=S='YV@<Z0A<0&<R(0S=!C1J7XT.BX
MHTD"\P3ZSIK-B27!1360%57N7)?NN$?<<= =R^1&H#"+26S@WW3SO5/\L)L_
M[.!;(&VMK_NF[[7;:7"6\S[R[ _(M5W'%$\W_=<BZZ3/WT^W36K\N]$7/SSZ
MGI9>/5<];<\[IF7*BDP*A*7D]*F0^"DA2#+T6T&$1'.*UQD3DD;BYY\"UQE]
M0A%+4]B]8!%%+QN6Q(2+RPX_!K4? ^W'X(@?][#ATPR,D].NF%)>6A]JZVKG
M?YT./9#WM9G70XP3^/N8T(!Q;'L?M#@$N<&@QNS%[]?Q^YWQ?R%"7*(0\XQF
M:TA'DK (2Q(K 7+,(6R:8PGOD"!1P:FDQ*A#.8K?<,UKJ7"(:.D4'B(&+0&Z
M;.R%/ZS#'W:&OPO\%;;)'YF$2+]S/JDSD48(9S&*:5)(\XXW/)PN;M 2ZA#C
M!"TA0@/&'@];:AV"W, SZS6J]1IUZO55G^XP/? KX5"MU(J4QP>4.T*"!&J^
M?"P5,:DP.DRCVUH0<P/&:ZM@LC-NB=!M9T^$H!8AZ!1AI=*/6*[**:$SGA.N
M"\,L(J44J%#'JBGVX, ?MQ7Y241X$K$X1!Q9*.,ZYO%_E_B.!3 VI&S4$L"
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M] RUW#RI-ATM"O=FF MM-M@U4_,,16DGF.]+(?1#QSY#ZH?M\!=02P,$%
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M-E$_:5<;-VKC3K63[&\ZOW3E&0U&PJ86WZ8P/O'^/GHA\-3D%7E)(R_Y_Q6
M(NO.?7*2UB3H#UYH/35Z5B#/Y%XV<B\[Y=Y.9LN.NK]J:*XZ3]2TU#2C-4QL
M"6GN>LG7)<W!PF"AN\Y6&/R\5(-.L?>H4LH[]4$;32X,*M14!H>Z;;WJNBD'
M\440O&U3YQ_=_@6JC6N*&E)9"E,U@F:V:;P3UV[\G^95U[YEBFX #3FN"1I<
M)%1OJFJ$U<#(G>LEC])09W*?6_IY0&4-:'TMI3D,K(/F=V3\+U!+ P04
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MV@70_E(I^^ZX(6_?M.P/4$L#!!0    ( (F ]U*3RKG;* ,  !D*   9
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;*U66T\B,13^*R<3'R 1YP9X"9 H
M8&2CK!%U'S;[4)D#TSC3LFT1-]D?OVUG'&X#FM67F5[.]YU;>WI:"RZ>98RH
MX#5-F&P[L5*S,]>5XQA3(H_X#)G>F7"1$J6G8NK*F4 265":N('G-=V44.9T
M6G;M5G1:?*X2RO!6@)RG*1%_+C#AB[;C.V\+=W0:*[/@=EHS,L41JH?9K= S
MMV"):(I,4LY X*3MG/MG?=\S "OQ2'$A5\9@7'GB_-E,!E';\8Q%F.!8&0JB
M?R_8Q20Q3-J.WSFI4^@TP-7Q&_NE=5X[\T0D=GGR@T8J;CLG#D0X(?-$W?'%
M%>8.-0S?F"?2?F&1R1XW'!C/I>)I#M86I)1E?_*:!V(%X.\"!#D@V 34=P#"
M'!!^5$,]!]0_JJ&1 ZSK;N:[#5R/*-)I";X 8:0UFQG8Z%NTCA=EYJ",E-"[
M5.-4YW(P/!]V!^?7,!B.[N\>;OK#^Q%4!FS,4X21(@KUL5!5J/10$9K(*M3@
M8=2#RD$5#H RN*%)HE,N6Z[2]AA6=YSKOLAT!SMTAW##F8HE]%F$40F^MQ_?
MW(-W=1R*8 1OP;@(]A)^F[,C"+U#"+S +[&G^W&X5^;.Y[3W_UO[6C#"XF2$
MEB_<P==#05^(N<;P\UKOP4 ?!?EK#W.]8*Y;YOH.YN\J1J&/CCUB%7S514]B
M]1 8JK)#E)$U+9FI>R^=, A:[LMJ8K9E_'!=I%=&TUR7Z6_+U)8T:[XV"E\;
M'_!UR)DN[4)'DTTAOUN5?N[XGH@V"RW-+\[5<<%\O-?^*XRF& $U?%"YYFQ:
M4RA278N?5+4L6QE=8R6$WD:NMB7\C52]R]'?EJ@U3\HS=5)X>O+93,%?N"14
MP"-)Y@@F-%IJ3Y!/"]6G7YP^WUO6=V^O6TMNJ9,FZ93IDAX!D1!G]NN+*)68
MFRI?7L.]K4NQF=$2D=IF3M^GZ9>(;"7577GJ4A13VV-(&/,Y4UEM*U:+/N;<
MOMX;ZQ?^6=<O6>^9OL<^K4OZK&FZ(4+'2T*"$ZW*.S)=ALCZD&RB^,P^M$]<
MZ6?;#F/=NZ$P GI_PKEZFQ@%13?8^0=02P,$%     @ B8#W4FY$,;L_!P
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MRY^6EW?+7P><9^](W]R_P,=#;+@_PL<3T_TK?'R=_R:@&C;_B<(M39XY9$S
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M>LH S>,89C^7*"*'VX$U^!AXQKL]$P/&?);"'5HC]IH^9?S-J%E"'*.$8I*
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M:IE3/D*K;%(L&F-:M!PBV\%9[9KV1\VSIL]2\]R#R=>![+::W31<UK3S:/F
M($7TINO$WO0T=G=/4W"%'Y\(V3#( :&XF$#OP1XF.P2V)./Q/0"2HHP?1)(=
MB(31<4'1A;IR?'P$=.1"HL&XTH;@:3 C^;2IP8RG4IB-H_N>&&6[XJ*-@J(1
M*(_U]6A]F;<HKK"D\:5UL[(TXYYUXY=7=0U]>7/X"+,=3BB/VY:[,J_'?$%D
MY65<^<)(6MPV;0AC)"X>]PB&*!, _ON6$/;Q(AS45Z+S?P!02P,$%     @
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MY7TEGQB9N4K[) W5;3>,J16CL@=H?RFEV4ZL@[*Y#WX!4$L#!!0    ( (F
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M\*L%M O ZXE2]GGBVMSJ.VCT/U!+ P04    " ")@/=23T2=A\$&  #0(@
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MMN?@T7D4=>=4M/MK8?X;4$L#!!0    ( (F ]U*7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ B8#W4E^6/Y(M!
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M;W!S+V%P<"YX;6Q02P$"% ,4    " ")@/=2%OWYJ>X    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " ")@/=2
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( (F ]U)*CS)3+ 4  %<5   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " ")@/=2
MFH_\Z5(&  #P&@  &               @(%O#0  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ B8#W4C\]MUW/ P   @T  !@
M     ("!]Q,  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M (F ]U+XU0! < 8   X:   8              " @?P7  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    " ")@/=2 0GR8<0"  !?!P  &
M            @(&B'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ B8#W4C9[0?FH!@  (!L  !@              ("!G"$  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( (F ]U*CTT-;+ H   P^
M   8              " @7HH  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    " ")@/=2R_=G(P4"  ")!   &               @('<,@
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ B8#W4F-;?6-I
M"   @14  !@              ("!%S4  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( (F ]U*D(Y\B@00  #D+   9              "
M@;8]  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ B8#W
M4@>%7SVE!   "PH  !D              ("!;D(  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    " ")@/=28P&EGGX$  # "0  &0
M        @(%*1P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( (F ]U)JIS!?"0D  "\;   9              " @?]+  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ B8#W4G^V;P1M!0  [PP
M !D              ("!/U4  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    " ")@/=2KZ7BFOD'   O%0  &0              @('C6@
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( (F ]U)2JB.B
M;PD  /P9   9              " @1-C  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ B8#W4ALK3X*7!0  1@T  !D
M ("!N6P  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " ")
M@/=2G\=IQ-L,  !5(0  &0              @(&'<@  >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( (F ]U+]M2WVE <  ,H2   9
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M970R,RYX;6Q02P$"% ,4    " ")@/=2@G4 49D#  #A"   &0
M    @(&XG@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M (F ]U*"T>OY=P0  *8*   9              " @8BB  !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ B8#W4M<_E\4>!   # H  !D
M             ("!-J<  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    " ")@/=2R(8<!=,#  ">"   &0              @(&+JP  >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( (F ]U*):L>)\ 4
M ",.   9              " @96O  !X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @ B8#W4IV"=,1+ P  V0<  !D              ("!
MO+4  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " ")@/=2
M!%S2X8T$   3$0  &0              @($^N0  >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    ( (F ]U)W$1@;' ,  .0*   9
M      " @0*^  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @ B8#W4F%[NS[[ P  (0X  !D              ("!5<$  'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " ")@/=2XNGW]=@$  !K%@
M&0              @(&'Q0  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    ( (F ]U)Z^#' #@,  *@(   9              " @9;*  !X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ B8#W4D2OS?@4
M P  F@@  !D              ("!V\T  'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    " ")@/=2+)0L3=<&  #H)P  &0
M@($FT0  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( (F
M]U)S,W\8T@(  #H'   9              " @338  !X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @ B8#W4L2Y)SU$ @  WP0  !D
M         ("!/=L  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
M    " ")@/=2D\JYVR@#   9"@  &0              @(&XW0  >&PO=V]R
M:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( (F ]U)N1#&[/P<  (<A
M   9              " @1?A  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL
M4$L! A0#%     @ B8#W4@2[6MD'!0  'A4  !D              ("!C>@
M 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " ")@/=28FMN
M?_$"  #H!P  &0              @('+[0  >&PO=V]R:W-H965T<R]S:&5E
M=#0R+GAM;%!+ 0(4 Q0    ( (F ]U*041*%F0,  !,-   9
M  " @?/P  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
MB8#W4D]$G8?!!@  T"(  !D              ("!P_0  'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    " ")@/=2\)I>7NP$   K(0  &0
M            @(&[^P  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    ( (F ]U).R=3@;@,  #0+   9              " @=X  0!X;"]W
M;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ B8#W4@2/X#L- P
M9Q    T              ( !@P0! 'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" ")@/=2EXJ[',     3 @  "P              @ &[!P$ 7W)E;',O+G)E
M;'-02P$"% ,4    " ")@/=27Y8_DBT$  #Z'@  #P              @ &D
M" $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ B8#W4OTLU:6N 0  P1L
M !H              ( !_@P! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ B8#W4B;ZAZ>U 0  W!L  !,              ( !Y X!
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #8 -@"Q#@  RA !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>220</ContextCount>
  <ElementCount>304</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>49</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107104 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2109105 - Disclosure - DISPOSITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISPOSITION</Role>
      <ShortName>DISPOSITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2111106 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2115107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2119108 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124109 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2126110 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2130111 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2132112 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2135113 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2138114 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOME</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - DISPOSITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISPOSITIONDetails</Role>
      <ShortName>DISPOSITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DISPOSITION</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2417406 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2422409 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Income Statement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2425411 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2428412 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2429413 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2434415 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2437416 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dgx-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2439417 - Disclosure - TAXES ON INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOMEDetails</Role>
      <ShortName>TAXES ON INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/TAXESONINCOME</ParentRole>
      <Position>46</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="dgx-20210630.htm">dgx-20210630.htm</File>
    <File>dgx-20210630.xsd</File>
    <File>dgx-20210630_cal.xml</File>
    <File>dgx-20210630_def.xml</File>
    <File>dgx-20210630_lab.xml</File>
    <File>dgx-20210630_pre.xml</File>
    <File>dgx06302021ex101.htm</File>
    <File>dgx06302021ex22.htm</File>
    <File>dgx06302021ex311.htm</File>
    <File>dgx06302021ex312.htm</File>
    <File>dgx06302021ex321.htm</File>
    <File>dgx06302021ex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>65
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dgx-20210630.htm": {
   "axisCustom": 0,
   "axisStandard": 20,
   "contextCount": 220,
   "dts": {
    "calculationLink": {
     "local": [
      "dgx-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dgx-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dgx-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dgx-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgx-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dgx-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 389,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 18,
   "keyStandard": 286,
   "memberCustom": 22,
   "memberStandard": 27,
   "nsprefix": "dgx",
   "nsuri": "http://questdiagnostics.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://questdiagnostics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - EARNINGS PER SHARE",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107104 - Disclosure - BUSINESS ACQUISITIONS",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109105 - Disclosure - DISPOSITION",
     "role": "http://questdiagnostics.com/role/DISPOSITION",
     "shortName": "DISPOSITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111106 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119108 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124109 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126110 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130111 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132112 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135113 - Disclosure - REVENUE RECOGNITION",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138114 - Disclosure - TAXES ON INCOME",
     "role": "http://questdiagnostics.com/role/TAXESONINCOME",
     "shortName": "TAXES ON INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - BUSINESS ACQUISITIONS (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i32ceb997147b42ebafa6e46d4f452d31_D20210601-20210601",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - DISPOSITION (Details)",
     "role": "http://questdiagnostics.com/role/DISPOSITIONDetails",
     "shortName": "DISPOSITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "ie3af8b0558d7461c9027eaf168d159f3_D20210401-20210401",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i04611b3c394b4101bd96d6e4b765e44c_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413404 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i04611b3c394b4101bd96d6e4b765e44c_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i3656967af97247b1bbcb74c67d929381_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417406 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i3656967af97247b1bbcb74c67d929381_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "ia9062ff9a1ae48d79906ea44e302c2e7_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422409 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "ia9062ff9a1ae48d79906ea44e302c2e7_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "ibbac0da433664c12b78532c13c77e330_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425411 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428412 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Schedule) (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i44b2df1b377b46139f619a2f36e50ecf_D20200401-20200430",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429413 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i44b2df1b377b46139f619a2f36e50ecf_D20200401-20200430",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434415 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i624857d463ea42cba64821f6526c8f30_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437416 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i3656967af97247b1bbcb74c67d929381_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dgx:PercentageofNetAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439417 - Disclosure - TAXES ON INCOME (Details)",
     "role": "http://questdiagnostics.com/role/TAXESONINCOMEDetails",
     "shortName": "TAXES ON INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i561420fa41374455918b2b347d38a86c_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i99a551f639d34e26b6107af0da64abe6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i5fa0525d2dc0497f928c8d6ab3456eb5_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i5fa0525d2dc0497f928c8d6ab3456eb5_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210630.htm",
      "contextRef": "i9c09ceeb88da4e69b594c0cab256f96a_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 49,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dgx_AcceleratedShareRepurchaseAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase Agreements",
        "label": "Accelerated Share Repurchase Agreements [Member]",
        "terseLabel": "ASRs"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseAgreementsMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AcceleratedShareRepurchasesInitialPricePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Initial Price Paid",
        "label": "Accelerated Share Repurchases, Initial Price Paid",
        "terseLabel": "Accelerated share repurchases price paid"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesInitialPricePaid",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_AccountsReceivableDisaggregationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Disaggregation [Table Text Block]",
        "label": "Accounts Receivable Disaggregation [Table Text Block]",
        "terseLabel": "Accounts Receivable Disaggregation"
       }
      }
     },
     "localname": "AccountsReceivableDisaggregationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AllotherservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other services [Member]",
        "label": "All other services [Member]",
        "terseLabel": "All other services"
       }
      }
     },
     "localname": "AllotherservicesMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements",
        "label": "Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements",
        "terseLabel": "Amount recorded in additional paid-in capital that will be included in treasury stock upon completion of the accelerated share repurchase agreements"
       }
      }
     },
     "localname": "AmountRecordedInAdditionalPaidInCapitalThatWillBeIncludedInTreasuryStockUponCompletionOfTheAcceleratedShareRepurchaseAgreements",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_AnatomicpathologytestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anatomic pathology testing services [Member]",
        "label": "Anatomic pathology testing services [Member]",
        "terseLabel": "Anatomic pathology testing services"
       }
      }
     },
     "localname": "AnatomicpathologytestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CARESActProceedsRecognizedInTheStatementOfOperations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act proceeds recognized in the statement of operations",
        "label": "CARES Act proceeds recognized in the statement of operations",
        "terseLabel": "CARES Act proceeds recognized in the statement of operations"
       }
      }
     },
     "localname": "CARESActProceedsRecognizedInTheStatementOfOperations",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche",
        "label": "CARES Act, Related Expenses or Lost Revenues, Amount Received from Initial Tranche",
        "terseLabel": "CARES Act, amount received from initial tranche"
       }
      }
     },
     "localname": "CARESActRelatedExpensesorLostRevenuesAmountReceivedfromInitialTranche",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_COVID19TestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing Services",
        "label": "COVID-19 Testing Services [Member]",
        "terseLabel": "COVID-19 Testing Services"
       }
      }
     },
     "localname": "COVID19TestingServicesMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapitatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitated [Member]",
        "label": "Capitated [Member]",
        "terseLabel": "Capitated"
       }
      }
     },
     "localname": "CapitatedMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ClientPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client Payers [Member]",
        "label": "Client Payers [Member]",
        "terseLabel": "Client Payers"
       }
      }
     },
     "localname": "ClientPayersMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DSBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Businesses [Member]",
        "label": "DS Businesses [Member]",
        "terseLabel": "DS Businesses"
       }
      }
     },
     "localname": "DSBusinessesMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DescriptionOfBusinessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business (Abstract)",
        "label": "Description of Business (Abstract)",
        "terseLabel": "Description of Business (Abstract)"
       }
      }
     },
     "localname": "DescriptionOfBusinessAbstract",
     "nsuri": "http://questdiagnostics.com/20210630",
     "xbrltype": "stringItemType"
    },
    "dgx_DiagnosticInformationServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Information Services Business [Member]",
        "label": "Diagnostic Information Services Business [Member]",
        "terseLabel": "DIS business"
       }
      }
     },
     "localname": "DiagnosticInformationServicesBusinessMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_EquityMethodInvestmentOwnershipPercentDisposedOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Ownership Percent Disposed Of",
        "label": "Equity Method Investment, Ownership Percent Disposed Of",
        "terseLabel": "Percent of ownership interest sold"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentDisposedOf",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_ExcludesgeneralandprofessionalliabilityclaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excludes general and professional liability claims [Member]",
        "label": "Excludes general and professional liability claims [Member]",
        "terseLabel": "Excludes general and professional liability claims"
       }
      }
     },
     "localname": "ExcludesgeneralandprofessionalliabilityclaimsMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired",
        "label": "Fair value of net assets acquired",
        "totalLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "FairValueOfNetAssetsAcquired",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FeeforserviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee-for-service [Member]",
        "label": "Fee-for-service [Member]",
        "terseLabel": "Fee-for-service"
       }
      }
     },
     "localname": "FeeforserviceMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ForeignCurrencyTranslationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation",
        "label": "Foreign Currency Translation [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GenebasedandesoterictestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gene-based and esoteric testing services [Member]",
        "label": "Gene-based and esoteric testing services [Member]",
        "terseLabel": "Gene-based and esoteric testing services"
       }
      }
     },
     "localname": "GenebasedandesoterictestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GovernmentPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Payers [Member]",
        "label": "Government Payers [Member]",
        "terseLabel": "Government Payers"
       }
      }
     },
     "localname": "GovernmentPayersMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HealthcareInsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurers [Member]",
        "label": "Healthcare Insurers [Member]",
        "terseLabel": "Healthcare Insurers"
       }
      }
     },
     "localname": "HealthcareInsurersMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MercyHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mercy Health",
        "label": "Mercy Health [Member]",
        "terseLabel": "Mercy Health"
       }
      }
     },
     "localname": "MercyHealthMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MidAmericaClinicalLaboratoriesLLCMACLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mid America Clinical Laboratories, LLC (MACL)",
        "label": "Mid America Clinical Laboratories, LLC (MACL) [Member]",
        "terseLabel": "MACL"
       }
      }
     },
     "localname": "MidAmericaClinicalLaboratoriesLLCMACLMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_PatientsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patients [Member]",
        "label": "Patients [Member]",
        "terseLabel": "Patients"
       }
      }
     },
     "localname": "PatientsMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements",
        "label": "Percent of Total Value of Shares Received at Execution of Accelerated Share Repurchase Agreements",
        "terseLabel": "Accelerated share repurchase, percent of total value to be repurchased"
       }
      }
     },
     "localname": "PercentOfTotalValueOfSharesReceivedAtExecutionOfAcceleratedShareRepurchaseAgreements",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Accounts Receivable",
        "label": "Percentage of Net Accounts Receivable",
        "terseLabel": "Net accounts receivable"
       }
      }
     },
     "localname": "PercentageofNetAccountsReceivable",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Revenues",
        "label": "Percentage of Net Revenues",
        "terseLabel": "Percentage of net revenues"
       }
      }
     },
     "localname": "PercentageofNetRevenues",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_Q2SolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 Solutions",
        "label": "Q2 Solutions [Member]",
        "terseLabel": "Q2 Solutions"
       }
      }
     },
     "localname": "Q2SolutionsMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ReversalOfRecognitionOfCARESActProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal of recognition of CARES Act proceeds",
        "label": "Reversal of recognition of CARES Act proceeds",
        "terseLabel": "Reversal of recognition of CARES Act proceeds"
       }
      }
     },
     "localname": "ReversalOfRecognitionOfCARESActProceeds",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_RoutineclinicaltestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Routine clinical testing services",
        "label": "Routine clinical testing services [Member]",
        "terseLabel": "Routine clinical testing services"
       }
      }
     },
     "localname": "RoutineclinicaltestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Revenues by Major Service",
        "label": "Schedule of Revenues by Major Service [Table Text Block]",
        "terseLabel": "Schedule of Revenues by Major Service"
       }
      }
     },
     "localname": "ScheduleOfRevenuesByMajorServiceTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "label": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt"
       }
      }
     },
     "localname": "ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SeniorunsecuredrevolvingcreditfacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving credit facility [Member]",
        "label": "Senior unsecured revolving credit facility [Member]",
        "terseLabel": "Senior Unsecured Revolving Credit Facility"
       }
      }
     },
     "localname": "SeniorunsecuredrevolvingcreditfacilityMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockRepurchaseProgramAdditionalAmountAuthorized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized",
        "label": "Stock Repurchase Program, Additional Amount Authorized",
        "terseLabel": "Additional amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorized",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Line Items]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Line Items]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataLineItems",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Table]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Table]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataTable",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TerminationOfInterestRateSwapAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of interest rate swap agreements",
        "label": "Termination of interest rate swap agreements",
        "terseLabel": "Termination of interest rate swap agreements"
       }
      }
     },
     "localname": "TerminationOfInterestRateSwapAgreements",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TotalAmortizingIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Amortizing Intangible Assets [Member]",
        "label": "Total Amortizing Intangible Assets [Member]",
        "terseLabel": "Total Amortizing Intangible Assets"
       }
      }
     },
     "localname": "TotalAmortizingIntangibleAssetsMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UMassJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UMass Joint Venture [Member]",
        "label": "UMass Joint Venture [Member]",
        "terseLabel": "UMass Joint Venture"
       }
      }
     },
     "localname": "UMassJointVentureMember",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution",
        "label": "Value of Shares to be Received Under Accelerated Share Repurchase Agreements at Execution",
        "terseLabel": "Value of shares to be received under accelerated share repurchase agreements at execution"
       }
      }
     },
     "localname": "ValueOfSharesToBeReceivedUnderAcceleratedShareRepurchaseAgreementsAtExecution",
     "nsuri": "http://questdiagnostics.com/20210630",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r270",
      "r294",
      "r341",
      "r343",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r515",
      "r517",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r194",
      "r327",
      "r329",
      "r474",
      "r514",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r194",
      "r327",
      "r329",
      "r474",
      "r514",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r270",
      "r294",
      "r331",
      "r341",
      "r343",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r515",
      "r517",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r270",
      "r294",
      "r331",
      "r341",
      "r343",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r515",
      "r517",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Initial Price Paid Per Share",
        "verboseLabel": "Accelerated share repurchase, initial purchase price, per share"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "terseLabel": "Accelerated share repurchases"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r18",
      "r28",
      "r199",
      "r200"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $29 and $28 as of June 30, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r31",
      "r57",
      "r58",
      "r59",
      "r500",
      "r522",
      "r523"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "negatedTerseLabel": "Accumulated other comprehensive loss",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r56",
      "r59",
      "r66",
      "r67",
      "r68",
      "r120",
      "r121",
      "r122",
      "r398",
      "r518",
      "r519",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r350",
      "r351",
      "r352",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r344",
      "r345",
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r164",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All other operating segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r35",
      "r201",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r101",
      "r218",
      "r225"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r113",
      "r176",
      "r183",
      "r190",
      "r207",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r393",
      "r399",
      "r442",
      "r461",
      "r463",
      "r478",
      "r498"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r19",
      "r20",
      "r52",
      "r113",
      "r207",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r393",
      "r399",
      "r442",
      "r461",
      "r463"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r203",
      "r204",
      "r211",
      "r482"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r411",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r340",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r340",
      "r342",
      "r377",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill, expected tax deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r379",
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable associated with capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "verboseLabel": "Less: Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r38",
      "r103"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r97",
      "r103",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r97",
      "r443"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW &amp; OTHER DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash surrender value of life insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "terseLabel": "Hedged items (Long-term debt)"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r46",
      "r244",
      "r483",
      "r505"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r252",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r27",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r27",
      "r463"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 600 shares authorized as of both June 30, 2021 and December 31, 2020; 217 shares issued as of both June 30, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r76",
      "r490",
      "r511"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r75",
      "r391",
      "r392",
      "r403",
      "r489",
      "r510"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r74",
      "r390",
      "r403",
      "r488",
      "r509"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r210",
      "r316",
      "r326"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "General corporate activities"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r81",
      "r113",
      "r207",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r442"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Operating costs and expenses and other operating income:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses, net"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r362",
      "r368",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current income tax expense (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer-related intangibles"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r276",
      "r285",
      "r286",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r44",
      "r112",
      "r118",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r307",
      "r308",
      "r309",
      "r310",
      "r452",
      "r453",
      "r455",
      "r456",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r101",
      "r114",
      "r363",
      "r368",
      "r369",
      "r370"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax (benefit) provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r101",
      "r231"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r101",
      "r171"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r425",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r409",
      "r412",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r409",
      "r410",
      "r415",
      "r417",
      "r419",
      "r421",
      "r423",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r404",
      "r405",
      "r409",
      "r410",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r230",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by Sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "netLabel": "DISPOSITION"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r340",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r23",
      "r25",
      "r479",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r77",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r133",
      "r135",
      "r145",
      "r146",
      "r147",
      "r151",
      "r152",
      "r427",
      "r428",
      "r491",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic(in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r77",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r135",
      "r145",
      "r146",
      "r147",
      "r151",
      "r152",
      "r427",
      "r428",
      "r491",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r356",
      "r358"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "terseLabel": "Share-based compensation, excess tax benefit, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r66",
      "r67",
      "r68",
      "r120",
      "r121",
      "r122",
      "r124",
      "r130",
      "r132",
      "r154",
      "r208",
      "r306",
      "r311",
      "r350",
      "r351",
      "r352",
      "r364",
      "r365",
      "r426",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r518",
      "r519",
      "r520",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r78",
      "r79",
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Loss on sale of investment, before tax",
        "verboseLabel": "Gain on sale of investment, before tax"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r39",
      "r177",
      "r206"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity method investees"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r430",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r276",
      "r285",
      "r286",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r431",
      "r464",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r430",
      "r431",
      "r432",
      "r433",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r276",
      "r332",
      "r333",
      "r338",
      "r339",
      "r431",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r276",
      "r285",
      "r286",
      "r332",
      "r333",
      "r338",
      "r339",
      "r431",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r276",
      "r285",
      "r286",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r431",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3",
        "verboseLabel": "Significant Unobservable Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value, Measurement Inputs"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r276",
      "r285",
      "r286",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r464",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r435",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets, useful life",
        "verboseLabel": "Weighted Average Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Intangible assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r219",
      "r221",
      "r224",
      "r228",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r219",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r224",
      "r475"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "negatedTerseLabel": "Gain on disposition of investment"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r212",
      "r213",
      "r463",
      "r477"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Balance at end of period",
        "periodStartLabel": "Goodwill, Balance at beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during the period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Hedge Accounting Basis Adjustment"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r176",
      "r182",
      "r186",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes and equity in earnings of equity method investees"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r71",
      "r101",
      "r173",
      "r206",
      "r485",
      "r506"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in earnings of equity method investees, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r340",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r14",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r233",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r359",
      "r360",
      "r361",
      "r366",
      "r371",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r116",
      "r131",
      "r132",
      "r174",
      "r357",
      "r367",
      "r372",
      "r513"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r98",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Non-controlling Interest [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r147"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r220",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r220",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets Excluding Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible assets, Cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r217",
      "r222"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Total intangible assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r492"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r70",
      "r170",
      "r451",
      "r454",
      "r494"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r17",
      "r51",
      "r463"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "verboseLabel": "Leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r34",
      "r113",
      "r207",
      "r442",
      "r463",
      "r481",
      "r503"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r105",
      "r106",
      "r107"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails": {
       "order": 2.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedTerseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r43",
      "r113",
      "r207",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r394",
      "r399",
      "r400",
      "r442",
      "r461",
      "r462",
      "r463"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r46",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r44",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "terseLabel": "Self-insurance reserves"
       }
      }
     },
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r50",
      "r113",
      "r207",
      "r256",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r442",
      "r480",
      "r502"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r155",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r97",
      "r99",
      "r102"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r14",
      "r60",
      "r63",
      "r68",
      "r72",
      "r102",
      "r113",
      "r123",
      "r125",
      "r126",
      "r127",
      "r128",
      "r131",
      "r132",
      "r143",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192",
      "r207",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r428",
      "r442",
      "r486",
      "r507"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Quest Diagnostics",
        "totalLabel": "Net income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r63",
      "r68",
      "r131",
      "r132",
      "r396",
      "r402"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r134",
      "r139",
      "r140",
      "r141",
      "r142",
      "r144",
      "r147"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings available to Quest Diagnostics\u2019 common stockholders \u2013 basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards to be Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r311",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating income (expense), net",
        "totalLabel": "Total non-operating income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r176",
      "r182",
      "r186",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Total operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r458"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r457"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r54",
      "r55",
      "r57"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net change in available-for-sale debt securities, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r66",
      "r67",
      "r69",
      "r73",
      "r306",
      "r444",
      "r449",
      "r450",
      "r487",
      "r508"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss), net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "verboseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "netLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATANarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating income, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "terseLabel": "Less: Earnings allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r86",
      "r89"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Increase in investments and other assets"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r87",
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid for business acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "terseLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r19",
      "r36",
      "r37"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r92",
      "r95"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from disposition of investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/DISPOSITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r90",
      "r349"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r14",
      "r60",
      "r63",
      "r68",
      "r96",
      "r113",
      "r123",
      "r131",
      "r132",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192",
      "r207",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r390",
      "r395",
      "r397",
      "r402",
      "r403",
      "r428",
      "r442",
      "r495"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r21",
      "r22",
      "r232",
      "r463",
      "r496",
      "r504"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r59",
      "r66",
      "r67",
      "r69",
      "r444",
      "r448",
      "r450"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r30",
      "r311",
      "r353",
      "r463",
      "r501",
      "r521",
      "r523"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r120",
      "r121",
      "r122",
      "r124",
      "r130",
      "r132",
      "r208",
      "r350",
      "r351",
      "r352",
      "r364",
      "r365",
      "r426",
      "r518",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r167",
      "r168",
      "r181",
      "r187",
      "r188",
      "r194",
      "r195",
      "r197",
      "r325",
      "r327",
      "r474"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Total net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r459",
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATAScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r377",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow and Other Data"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Hedge Accounting on the Statement of Operations"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill, Net"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r176",
      "r179",
      "r185",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r176",
      "r179",
      "r185",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Segment Reporting Information by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Receivables Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r164",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r197",
      "r239",
      "r240",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r176",
      "r180",
      "r186",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r110",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r164",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r197",
      "r215",
      "r234",
      "r239",
      "r240",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r49",
      "r66",
      "r67",
      "r68",
      "r120",
      "r121",
      "r122",
      "r124",
      "r130",
      "r132",
      "r154",
      "r208",
      "r306",
      "r311",
      "r350",
      "r351",
      "r352",
      "r364",
      "r365",
      "r426",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r518",
      "r519",
      "r520",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/DISPOSITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r154",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r26",
      "r27",
      "r306",
      "r311",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "auth_ref": [
      "r27",
      "r306",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Reissuance of shares for employee benefit plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r26",
      "r27",
      "r311",
      "r346",
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r49",
      "r306",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Share repurchase authorization remaining available"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r27",
      "r32",
      "r33",
      "r113",
      "r202",
      "r207",
      "r442",
      "r463"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Quest Diagnostics stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Quest Diagnostics stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r67",
      "r113",
      "r120",
      "r121",
      "r122",
      "r124",
      "r130",
      "r207",
      "r208",
      "r311",
      "r350",
      "r351",
      "r352",
      "r364",
      "r365",
      "r388",
      "r389",
      "r401",
      "r426",
      "r442",
      "r444",
      "r445",
      "r450",
      "r519",
      "r520",
      "r533"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r111",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r311",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r306",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Stockholders' equity, period Increase (decrease)"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r47",
      "r113",
      "r207",
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance, Value",
        "periodStartLabel": "Balance, Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Intangible Assets Not Subject to Amortization - Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r484"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r48",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock, at Cost"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r48",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r27",
      "r306",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock, shares",
        "terseLabel": "Purchases of treasury stock- shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r48",
      "r313",
      "r314"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 95 and 84 shares as of June 30, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r306",
      "r311",
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock, value"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-lived Intangible Assets [Member]",
        "terseLabel": "Intangible Assets Not Subject to Amortization - Other"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpatentedTechnologyMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based innovations or scientific advances that have not been patented.",
        "label": "Unpatented Technology [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "UnpatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r134",
      "r147"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in Shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r133",
      "r147"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in Shares)",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=124268079&loc=d3e32787-111569"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r527": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r528": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r529": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r531": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r532": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>66
<FILENAME>0001022079-21-000111-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001022079-21-000111-xbrl.zip
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M?*#7%E9+;IT_'X&Y@<H;.C I*T!@+@5#<@\"G(X6E!,^,H]<^@#A' ?DP^O
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M(U(A@R&H Q?016&S==GE')R\R&5= )%-=9)P0L)).EOE+ T_A>FFY("7C11
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MS3&1<PO9*IMB6C!0G8F4'X:HZK)4CFB,02 ).H,B!88L225TJ$.^3IT$-SF
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MV'].]S]Z]GKO0_?-_N[OK[=V#U_OOWZ6-SNE.=5Z:5+U[I\<N7<JN$H%J2L
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M&"$(Q(VP2&OBD/7< )&,.DIJ]W3AAL(-R^2>+MQP/VZ8<E!C8 1#P$EE2+3
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M&L9);]#)<OMU'X[LL/,%?O[:"</#"X5OZE/C"<.3CU@WZ&75Z]:/W'.%FK(
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M;QJTYN7S+]":*[0F-65C$)Z(A*J05&#$!:?(,>-1C)0XJ0@#2U?6).9%"C]
M"O_6ZX6OG:.C(FH?WTB^F.O""C.QPM:TP"6&@B+1(&OR(;M6Z3? ,9&$=M1:
M'E20*VMJ%?,26-XTB"W )"X0NR_$)H+7\\!<T!3QD#59HI,![+1#,A 10A2,
MYX19N:I5"7][B.C=[@YM]Z"32]J-S-WBK5Z0()[,_.@8K 7#K6_^Z#3/:F&0
M>S'(]K20YE@)[)E/HAET[HJ>5'>N)$I<GT1WB-&,^]NHXK=N&OP6(*0+_!X#
M?E,"7%*K5*B5XIP'IB*R40L4 @BLO%)"FQI^LGBP'R; O\!@6)=ZKSK=^M1Y
M>%8=P_"P%](+^4TH*6)S<V)OU?.[4T_OU-07IIB)*:YV$&8V,3LW2.7 6AYL
M0#8GNS!"N*($#'<A,<6L;>B*F&ZPF"Z@>A103<0OY9X8\ %Y[!CBU&IDG61(
MT$BCR!WM/%]9$_0)0/6,A&^=6E'.B>=\3CS)5VGUNKY$A]Z#"]Y-"U@/W#/A
M.(HD%Z32Q"'MK$="XJB4I8(:2 )6S1BW703LT@C8 JFY0&HB7AT/S (+2'B3
M74I)736"!H2=E<0'K9U03P2I9YX'UFA]8)3\=;,^,&M7@.4NQ/L"^T0O+)6M
M$/=,Q/WABB[$;11:2I3$IT;<Q43<6J<_0:;5$X:16A>BJUK>K^U],]O:%[IY
M=G2SL/R\0C>STLU$3V0"@[ Z(,=]2'JB4LBE-4,D,&\X49"LKT0W?!73>67-
MSCD][^+[+K:IJ%EFGLV1Z*W#GZ$7S:-\Y;/13'_4[.O/CG6=H\ZP,ZY]M#_L
M^;\/>T?I@L'_\R]-B?JY&CEH2VNDTAII23;\I*W7T61[E]Y>90,W<0/_0V^*
M$WM6MYS-Y&R][Y_"I%I=Z?/5G$=HF*M@O'W>CG;/>C>LC_;.E+POE3?NH>!_
MOI)[1YD%H3A&3/(<Y@01.2<-4I0PISSV+.2"8*O\*5*$2C.P9\@="ZR,7[CC
M$;ACXAS0U#K-L47!D)RWJR6R5 IDM;14<]!C[I"LY#@\J$OJV!0XZ?5K</5B
M==3K'J A](\31%Q)=YA7Z,:?:5K;:58WTZ06@K@/05S-,]0V&)"  C79>V@Y
M<H()%$.,"HNT:)ZNK)7TA:;!:5YA&P5.<X#31-X:H90&0Q$!21 /@2 M>$2!
M:"ZIH=QP^R1P>BFRMO==M9TIWUP1P8]29>="83\K]'$?^KB24.C !*%,1(:I
M3!_&H9Q&B#3S28L76KJ \UE>R?EO&K8>I\Q.P=9#L341S81[Q0E- EGE$.7(
M*+(0!$J0"H)8G<QAF;'5O'2%98^G7,ZZ^K-I#B^UA/<"CAF*1_"!-'@E4P,H
M)1QS@8S02<5PSB(;240J5QL2SF$90MT\4\PK.+'4V%].Q:0 =($ G>@IEBK.
M15),= @2<6P$LMQSI+S6'E,5HJN+8:M9,S]*J?T[QO7\63SWBQ;Q4U[(]6[8
ML">=I(K5)M"N2Y-51Q26*.'96.7]E0*^2O/ I4>$ D,\,0QR(@84$[^ ,T 8
M3ZS"5S&>L8%'(X3[\P;@(D1X >"C '!*K$.TT0J)5. .<4$MTH8*%)VU>1&]
M UP#D)23^/D([W(4\&1' 24#_)Z4<261D$'PAB<C0$=%L\QFR)EDM!O#!>9I
MO;PSB3),.9UO&KP>^32@P.O^\)I(9$XD<3*IQ Z405S*B*SU&ADP-*V5-\'1
M#*\GZ&GQC.3QJ'Y1D;V/5,1HRO=66.&>K."GA:XF43$/'"FP+@O=Q H&&X29
MDCC'QREA5]94$;J-P]5<*QD57,T%5Q-IJYC1P@>*!(X)5]KFMO;"HR1G<20J
MJ;DFK*QIWKQ2O<M^_-YH]6"C=WS<&=<6SMF'&=%I[-#U/U(5;F>_QQ'#WP:=
MU]W.T?^[,NR?PO=\,?4(V74V_0"%)NY $W]/BU], J[K\QK"=5+*C4(F@D-"
M4Z$(]0ZLR##XCB/FG)H\^VZ:1?B4W?2XNVG*Q)-:8N$P8BJ?I6;QDS901(IB
M':-31./;=],S8MD]" #'=8IW>LZ\<?N]HZ/L&NVD/=R'03GEG)=5-IGJUI69
MWAY/]*C.R8;M]\_2J^O'.0NRZ)6S0/S\2G:T   >,46><DAZ93!(.\V0@*@]
M>"6P,LE>*Z>:30/<O,RU KA% &ZZZXIE@E*#J,$$<188LLXSE);*"YKPIQ-%
MKNF2X_00@7U3A:Q1WY528:A4&&KB/K[YZ=Z=)@:N-COVH-L;I%$-T@#*SBX[
M>[X[.W2^?'<+E*]_3<14TDFG&Y)1_1J9>HZ?)'$UF?:][@@!J]6)[5=?[-$I
M5/_S(ZWI+?3W#VT?YF*N;+?>W.1OZ'5K>?/6]G?[^T,[A/#?/+#)5X^U)5RT
MI3MH2SO#G8VQMK1A\,?_/<3^^+]=^Y<YW?V\?;;;WB$?__KO8>M\6^Q\?O>M
MU7[//[37T_>G>?@K/<=O[]/8M\_^]WR;?Y(ZV,@=(&T,0SPIS$C3 ,A:[($9
M9W%P/U:Z;]D^]U.^R_99KNWC"?:1YV-,$G.')B:1TY#=7]HP9]/&HF1E#;_"
MUU-]KKU0G4"_&N3U_+FZ=</5[P\>R;,RM=7J?358/QT>]OJ)@$.QYYYDB[T[
M^Y3$K>%:4*2"2_M,X8@T)..0*0)!.&:D43]@J!LWS+P\ V7#-'##@+! =?"(
M^%PAQ:9=8X,(*"AA #/0.,B5-8GQ'2AIM'LJ>[FLE1WD<B!),3RL_CCM0L7P
M:I79I3Y;W 0/QR[1&"/UJWA6)GNTC;D]&)R63?E$FW+KV\[!)X=!0_ $22T@
MRTN%')$6,1!&^F"(-C_2M!8K^,IV>>KMXHU@(G"-E"<1<0T8::DIXHY[K97R
MUK*5-4JN1[/<RF*=>E%G9+!+ZSJ9P"_X+.$1D%:;, 5BLT)L<C"G+ N@N4'"
MY^R%7&I%DY!PX@,+1 AI<2R5!9N'I4=0<@J6[H6ER9D;=A8DT019*07B."O-
MUFH4G?))02',"+T$9067I1#0>AIUGC][5)W83D"=;N5'&;$E3&8!;04N9_]M
MFOSM[C@9>8I/"I7,1"57Z_\$$YQP.52&Y?(B$)#QE"8C/"VI]"QB,(E*5H4H
M10:;!KY%U.4OX)L[^*;*\4?'.-$&8<\PXC9*Y 0Q2"9(4J^\$N R^'0#JQ N
MJ2S?@Z%-+X8*;+^;QE_R#Q<@PB\F?6L\Y^O>GQZ?'N6CP4V('=\I$7BSL<B5
M6CZ@K5>84Z2E2=: ,H ,UQHI%ZE3,1JCDF5-\"KE3] <OLCPIY;A!7WS1]]$
MAE,506&H"_OG$T^:%6@G<W2&IM$%*95863.K##>^D,^RR/"I#5SUZGH"OG=\
MTH=#Z XZ7Z ZZ@V>J5C_]T+D^B ]9_KMAAY=%]->YT1O3$_Z=C>M ?R99KX%
MP]W8MM\*J<Q$*E=*_6"5EL9HBS3&R30W+I&*D!1AZHE6/FH@.HOT:XSRGR+)
MGPQP]Q?E!7!/ [BI1CW@I W8(I'X$7$ DP!G%5+$.R- 2*EQ/L!=*.!>=GAT
MNP]V<-H_NPB0ML,T"8/A4X4;7@QG*NZB &XFP/D?15S0C[]].&\=I_%]WCO:
M.7^'/WSVHM7.S[!%=]OK8N=SFI>_=G(DJ_ADA"$>1T@"T8F<R"VR\8N1UQXS
M(W@0.BO=UUW6==C$TT1YE0W4E VT0S]YB)A$)1"V/EEMAL1\ELJ1T-'KB%E,
MBE8N/W-[D&$=EW.'D)S5*EU^ NG37^#H[#D'Z"S&.+FSV^,*WDK(P;W@-I57
M+U3PP4;D(N&(2Z61M1R0$%(KFMN.2[>R)E>UN8Z98I0LHU%2@+9 H$TLD:"B
MI5A%Q+%(JDVT'&DP!@'FD1F0E!.^LB96F;SNS%]"8^1)+(NZL=<LN<@/Z?B%
MGWU/H04(\^D""*,*'H5C9N*8@RM%38W0/@!!5(G<^S#7% _1)**)P:>M2@.#
MS#%ZUF+'=P9!\_I^/7^8+D 5*#!].$RG5 &&7>1.H[0XN?TOD<C9!%BB?%H]
M+BS/(?-R58FFP?09*0NMFPOD/=,#QB=(LMGI='O]Q!07!;H*8\S$&%?*I6H=
MG;&1(0]4Y(!"@YR1@&)4U('FTBNVLO84T80OT4Y_@BR; J:'@FFJ19>5SG*-
MD6493%I9I+,@EAH<EEX2DN/JQ/5#^!+6\P"SO!CA2V2$;W?]T6F>U+>]?A[@
M^G#8[[C382Z_V>[=7("S4-(,E-3:O%K=-JT?TQ(C'T@RW"6G**V[1,I:+6+$
M/.8P!;%J^(RL5 SW!D/[20SW NU%0'M*VQ 61P\,L7P8G31UG?4.BFQ4@3 *
MAGE6'[#A8NP_6IW=D0HRU9VL/M._NTIR=<I'CY(>_/M9?QB7-4YQ^Y]'GX9G
M0^6+:)X^V;WKW5 \L@\DZ:UI_8NR[%U)U*R-2B9A\#8G2@NDHN%4V+20W*VL
M$;JJY8P^EKEA93$*6B&Z0G1/K;,6HILWT4VT42:M!>\HDH$GHC,^((-)4DX%
M)< A41V3B>CX*J8SYI0^.='5ZNI/M1US$8<Y%1$_=2\/V:P90VWM%]?_:>UJ
M^.;C?6R!P*:UWGL(E?4YB\YV<UN4JML;9N6WGU[NUF=>!_VZ^DU_F,->AX<P
M@#1&.X2Z,]FK6Q]P_"U4I6&<] 9U+8G7?3BR.1SVYZ^=,#R\X):I3XTW!YY\
MQ+JT$4Z'MW]DR1> ?Q<8//5O'FU-7UI3YR)$%G3@48!F7@H+1FGA%./Q$Z4K
M%Q\Z[$\D^ $@UP?[=S(ETP.^MD=?[=E@Y:<K\W#<Z5X,B-.1J_C[F;YU8F)\
MM(D903OQ?R_W/4_[X+2;R"%?E<9D&S.6ZK"?A=Z__GF)5,):W7<MH2@W\ZL;
M7?[RDUV[:?V?=)]>,Y#K?5J]>[^UWZXVM]=_:^WNM[<W]JOMUL;NWMO=O?7V
MUF:UWMJL]M__NK^=KMC;WMIO$/!N?J"-W=;^[I_;F_7H]]OIQ\Y6J[U?[;ZI
M-M;W?Z_>_+G[5_.?XLWN7M7^?:O:W_[?:F>WU?Y]O]I*$GVS^N-]:VLDCB^S
M%/(29=VK:OQ3_?NT:T]#9PCA/\T?:Z=;I=L>)6(8_&>VJ:U5D>_4HS3L(WLR
M@-<7O_Q\T?BWTZV_O/[0S\>V?Y"8>RPO,VM_I_K4WS=Z>T+HK_"(U,<^N_$W
MC]]^5;_UG=(V>D_Q5USS6]_&K\BM[_WHM@2_4IS>Z[8_?D^PV[_T08.]VQS<
MT2]ZZ]F'N8L+=;2+&N5$W>]\JW;258>#:BN)R'"9)76?WC]W:((TB\70\*G+
M!'V'#E%W>N(7-W/X/ONK66ZG6YJBV\%A%8]Z7P=5[/>.J]X)9!4TF6G9X/Y2
M>T#NTBWMOLN]#*W$GHQ%EF%REA(+MX3CPK#JU*4O[A!?M=Q>Y>?I&#8>&P_@
MM Z6@S1.&.ZQMXX*&8VTGS;K$[#T'WKP4=C;?B]VAKE&2E-\P6<[G4M?\/''
MS]OLX^?WXF-[YVLKW6_GK[W.A\_A[]W-O4Z+?A"M\W6VV]X[O/0%'Z?WC__X
M.XWON'6^C7<VWYU_H&\Z']M;YZW-[;,/?^U\^[C9ZK0V/XCO?<$??\MC?'?V
MX3@][>=W7UMI?!_^^N-HI[V#=S[_<?CA_,W?.W0;MSX?Q4L_\#[^^BDRJX6B
M##&)#>(<=*YTIA$(1IUSUFOL5];(*IDUY.C)#JT*0S2;(2+E%)S)YZR::Q(,
M<!T230A&;#(G2,T0^((A\#]G&!0:N"\-G%_2@.6&V^@%XBYBQ .U2'-+$&80
MHC22JKK#S:P)@R\V_NBV3@.?3P?#^DRE&O:J/B1@^,X15-U+M2>_GO_RV2@X
MZ?>^=+*)[<[N;14LN6Y;>B@_F]V_"2=IQW?JTY4Z\,X>Y]C3\_J%DF_W<,7Y
MJEB<GN[T^Q'48;[=L#XUZT5@SB P6_M3>G, AH.,$JD @#B5 MG(,=),!..U
M\I+3[+8JN7A- ]K<]<\"M/D#;:*9*I%,3VXMRE&U23TU#CDM!**!D@@0#68F
M&:CJ>EVJHIG>'3]OLZ8YR,B)O7[E^Q ZP[K0-I1,^+E+YAP9DK_WK\[P<",9
M!$GM[Z^GJ1YNU/.>+=FM;R?0'32FTM9RT$9G2C[;F 2T"("D#+G8EB1(4^F1
M\H9QBC58$4H_RN:!;>[2N8#ML< VD=$X\:$FA"%#*4LR6FBD-1 46%HS(:*Q
M)LOHQG?(:+2(WH0(_;1G+QU%]EOU;P==B)WA?T:NHL&S-:1G*C[[<'E]2\7^
MBR48%>=OVV]CYOAUM J%0&8AD.E3*!.X],P21'CN'BVM0L8RGC1]8JB/5D2J
M5M;T=>]SJ3W[?"1U0==<T341SP%[)4VRGIV7&'&1%&*+!2 OJ0,FA 26#W>*
M>'X(<NH$->3L $+=KRKMW)&G&T:[^'G*Y:<TH^LF"[_F"=^8FN]"$S/0Q.[&
ME!#&@N56.*2N18WRVB3YBPT2*IJ0UH@'EDQF]@1'P$42+U82%V3- UE3]G$4
MBDE,D7$<YW8D!&D2!4J+)AC6(BA( I@UKPOT159*&A/\&(R+NO(9:0R_V4ZW
M2LC.CSE.A,UY@YWN%Q@%B3Q/E6'!IOQ59LMSGEU^N]W]1&6[<?MRLDOPV$S!
M8^TKA>O 9O^?E"A2[Q'GPB(MK4L;B#%)DSRBM>I 2O.8YZ4V3(=JGT._%^S@
ML$#N$2$W*>&ADJXN)'8H,,<1!P?(:LH13HM)O!*889(CRC0E].?&*1;+)*?K
MYJRK.2KS>0KD1KC6ZTG.92<3@XP<@.54[CX<<;6>&;54Q<0,5$"R.Q072#.J
M<K%KA66PCI%<YJ<8] V#V1PD<X'98\-L(HHI$&JP$BCJF+1?H30RG(RZNSMB
M*7:01'%QKS\$/1N'MGN0;I=-YDDF1([C&!5QG2KJ6K(B2E;$4G9(6/>^=YIS
M@_K@H?,EEX I&N>C:9Q)_.7.IK )HY_;W8OYW[N<_B(59Y**.]/*IU=>, ")
MO H"<:X",AI#SI#PG,6$:5 K:U1>[^)>U,\G=KO._4"I8.TQL#95S]6D-9#,
M(Z:D1=Q;EI1/<$@K2Y@&2G%T*VOJ.M2:TU)XZ83TB3VK*[O5F8S>]T\A7,1Z
M/-.<B68$8=[.)6]'*Y)3KT;K,55"NK#+3.SR;EJ21P7.J630 I82<6PXTIY;
M))WS5"?C%W+;07)#<8!RNK/,/J2"NZ? W42J<^,@)@I%QN6>08%0Y*SQ2&'J
M V%IA1E?6>-/D,3T/$7[]F5B!5R*]^<IR9\R!.-&'LFL<1GW#1>,4LAC)O)X
M/RVT3716!9>D-/,*<6%S+YL8D3'> (L>A$\F@2[6=], MQC!70 W'\!-I+7S
MD@JM+?))/".N6.ZIPI(A3K$-!!RV=?/.Y@5Y+JFT;D/_N-.UD[#)49/*JF^'
M4 V^VI/*'O1AU,&D2/'YEN7\/M8K''Q[/;4>.<AKM!I[:3'VTUJL7RY%H9B9
M*.;#1*:W#[[NKG^2A'O+M414BF2,,Y\8)BB6_I362L'R&C]AW%<1[HL1[@5Q
MCXBXLPGB6@>?J+)!&X)18-FY'HQ%VG&/K"4$K"-<*)K,\">HC_L\!7L=HW1+
M;$<)PURT<[U>C=V+D)L->](9VJ,6E'3LV5C%3]OF4G)04L9<Y, @3D-$&I.
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M(ARV#DEC$Y8EEL@YD[!,.34\6JELPK(H%M426U2UMZ).?_&]-*P*CD^.>F<
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M5PII'BPB3#MN2F.,<C?&=IX-63P76#_D['*&]8/#>B:GT5@?B<3(EBH@1LJ
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MOOS:WCEXBUM?#EEK\UWY_N MVSDXI"UX1VOSZ,OO=*]]V#OM0MGH^\U#]O[
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M7#"F--%0,&:<X,'+Z%S,>%X\/,\&HH3R1G!GD5 *8$PD0\9I@C#Q7GEG#4N
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M1 NI:];OO*&BPT[UL3!)NNK-M'55Q EK=SLQ%: :#Q/TSXO2J#_UT5E&NPR
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MO6/=-B8)FM^<$YQ$P<Z=CIGU:R\>D)_K!+"E')$> 2M9.5DY/Z]R\C;V^7R
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M%'&/%('/*8):KTQ0"G'%/6) W$BI&)''3@GJ,0.[ 2AB%?I")HE,$O= $I'
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M5&2B*_ZN_2P]4)T^YK)^E<7Z#SLLA[<!M:79BP>"J]8L9W2C=S >+5_(Y>/
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M7Z^7?$\ZLQ4H^BG% 2PN$ 8L;A'W#[K]HPACR,O4/\@+DO'W*"_U@<W44Q[
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M/_,2="# IVQHK=( X/']L&C/E5^A>](S;9UT2VO)(AZ7J;2V-'Z46XIKDQ3
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M=Q/%?($C&RT.5"'/?43<80-2HK'(646$TS$PGHL6-'Z 7X"9-:+B7=#6S ]
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MMLB5)XV$F:.-JN8C !FP1<-A!1[5VMH?F9?/84]9L9UI%;A:P0"XVC\8Q%W
MG<P!ZR?,E>8XO4,G"USO(V IG)W_7< KCKEDPFNO!.'<!6VULY@1K8#HA(GZ
M\GI00]#2X+<%"D/-5;RKVO*^F9_I1B5HO8?I I9OIH[]L32N] =W-^RUCK(O
M+B3+J?&(:BH0-SPB3;5$WJ?$K26@T^F%(B!$%%A:8RC'A ?C'/'4)Z^TM]QX
MIB^/@&CV^I[W.L5@$\$8.4P4XL+!;Y'E7<=11QN9JK+9SH4^7!(+,;%=3*KM
M. "6BTKN9(8Q+6PRN42J2W@BFF?@JF6LV@N1XB#SI(Q)V1;?.P\_E5&_ULQ
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M@+P%/MPH^6I)P.'B/,3WIV31)8.#A4[<L\A[O6Z.SR:IU1HL:4K&$ANY#LK
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MF=# S-."F=\622.@G$9G$O-:<TV"R6E1 #:"$0NZ]U2@(5<(-"?%[AK N3_
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MAY\2K!/L8&XH=&)DJ3J5P0F;5[+SMS,9]"\OF@L4L#45QT7%HM-X4-U>^X6
M2R^]<609FXTM:#E;*[^7L(ZA^&O0WQG8_877?-F6=4EW?6V&YJD< (NN!/H(
MP!R*_XZ!*0 +S^1X3J#[Q[#XHV\'(5]<*X$4@?5DU1A(,DOO=OKM[E$MMX?I
MAL+]5W(% ->M77C&6>X@J8H^)9&"Y9H)*[FP6EBJK8_:B[->-W:Z._5&^^VY
MG*+^/K"NRJ0_/6W#Z<O7)O,XP7;\BV%[)0I^^.H#CH98@6S,M2ZE"T@;II&)
M0DFA$K$T71U==,EV_F1UY68[;[6="0N95Q,Y(SCBD03D8E!(6"=Y2-JGH%Z\
MQBOR?*WD<Q\4!S5[A44OAGF1@7-.T"1:OSN5'5-_/#B+)/A1D00SF+<F$<ZQ
MXMAZ(S3A/'KBE0(1%D\"W-0TP,TT1^_GCM[&<6OG*[')&9HBPB2!(BF4028E
MCK!P+#@:%7?Q5DCRDW63F^V\U78JPD.DF"%"/3 &KA0RG#ED-,/)2/A;ZEMM
M)\4!2X^!*># DY1.**4Y9\D$89RJHVN S4^VD]"&S]_!=AHOM8Y2 Y_G!O'@
M(C*>>B08!H%+&ZH]O]5V.JR!OHUCFB9.!3.!,,(L2QX^)8*>C29NQ+:[V$Y/
M8[+&)>2<5 "V"0@31X:$8$"VGL!VF\SGQ?G2P;?XX ))8!G4M2<7I/0,U/:*
M"G,8ZGC@=^TP-NK[_0YOHW<B;+^-;@""\M',W]:RL DWU=S+GA]$V+%0W9K'
MEJ]G0W%%TMDA.MW3@WI/<[320O9=$FS"3#(?&8],ZV"LI$0KG5P"EC]1^=A5
M&ORU!M[L\*EXP^P,3H[@:@B5[=]V5RO'_.IXM-L?9+_N";<POQRW^'"XN?J5
M1\VC\Q1)%1/BBE/0#W5"PF.IC9,&>[E0"A&CL)V@-Q%I# ^$6*FSU,^9C=BS
M$UL-G>XTI;K9Z8?8::&<D51+Q*A*N75)S*U+'(AYE"8O/0\47Y1Z?(FYWM7F
M^I7L,P*P.._V7\P!9(P5@B0)0B( !)5.$JP ,H*5W+HH)[[>LWX?O8#?Y^(#
M\S'NV[)7]G9F)V5V3WV&R*]\='),?LKU!(+3*"D6$->.(XNM15IY1X(0(48'
M1V?E?'7X8G),@(7LU_DO)T$:<!I"',PSITDH_@5<QT[VIO(#K11%)[.I*V\J
MX*.BUR^&L8JU*@?UISE^)0[VRU[]9\ZU.1^0\U3DDY_(6SM3.)]G'_AY!WG=
MVWZ213KWK3K=[Q6>?<6Z87957_Z5<VU:;Q:R>MG7'GH+B#BSJ',_=P>S$+T=
M %40I;XAFV"PKVSWT!X-7_SKU)S@]$T?KG/Z\]DENW2&*=U?!%VUT"&WQJP.
MR:N*..L0B'_;I1E+L3O(W.)_KD\Q4R]>=RJ4 =[T)C.:JI267::3=G%<[H=/
MZUN=8FUC]5U[<ZNS\6:KV&B_V?SXU^;'U<[Z6I6?M/7ICZT-N./CQOK6TL^G
MO=E9WRHZF\6;S?;6YON-M6H:;S?:J^TW&ZOOBZT.?-!:;W>VB@K_R>_YSLY&
M^]/ZVM)/[K=Q;Y*]^<_E'VO9*R8Q%L.7P'R[<3BL@R$.RV$.8PPY'N:BF=P@
MD.&BBU<DP]TLN6VYN.UR&UN&SS,P91IP?(,PX],AIS.Y,%P>=5J)D,.S5NND
MK0&E(]=.YT9Q;15E$5NM0'O"(EQ7.4<LH))TLMEE/#BJ5)-J2X>K_K_C<MZ,
M_<M%ENU]$NWC50KCAG&LD];J5QMU4H 5B"DL$8\2(Z<-1C119GS6$XT$&8VN
MB&MBR^H-GQJWIF;KO/A5M-<B"NO/'I-%--=3QZ0J<3L])6_ZPU$=W?S+ZJAG
MSTO[\*LU-)I<05^'*."\6(TT8QAY3(3&0>@8*GWULN:)$Z7UY205+X<U+(@A
MPBKBN".>*&ZHL=H0IL3_S]Z;-K659&NC?T7!>]Y[JB*<KIP'5U\B*(/KT+>
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M^JT3L:CX@:Y9LORJ2TO<(E-DE85;C/$KLQUMKS?5DYN#**0Y'X8==Y+M#NN
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M]2$Q,N4\4KG; :=&(>LQ!TT28,+*A.%_  MMVD0+"ZVV\,AAH>%_<MAXYK5
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M6Y#+D4IDA5;(V4!D8(3+E#&$+>F(6K/C>%O&O)5P<LN8JV;,1C<A&@33GB'
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MW,2@S& ?$Z76!I,MAB6;6+2\OL:\?I=QZ!8&UA<&&HX#'RE7$FM$!'6(*VO
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MJE;,0&);OFMQT(\-%G-E<#XPB_G836GEL94&W$MTS[)BW?%"8#%QRO30C*W
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M%X'0GIF&08>&WQITIA&0-QUQ\S746FY?F]!FW?FA.0FACB>RDD.U#%>J(;Y
MOBN.M').=?^W@A-7[;O-HF6EE;:H @I_=BTTDU1[9G6&9G5-JL:R>6Z^(!-E
MS*E^F"S.0USDJL":7,")&;G?*E2"R !!H#^WEM^;L"]%;7U@3>(%GBN+Y2&V
MX-ZT=7N[WOY5!)S4F7#ZQLJ0# ^.]QN5V:$[3!0>$H,[YDM3"H/4K1SP;0):
M7"**R%49, I6+IW9I "[91O/W5>C4C=]^]_T.>JFKQ]K.>F;/J7JK%O3O[H>
MHS4NFZ8"\J+QL%"YJ&QC-%H#>P=CM7%,@2R>"$.\<5>\7'1Y44W->=DX!=:N
M]=4:83#H6/*#NM@0<GY11FU5@E<W:."O=H93K?VO<^Y*3P(]EC><KYJ_SK()
M58^K8@ G_;716W)I:>SFS*D=&M5&QWJW&MMB9;J.+8.?+TH0A7CMALX+-JZH
M[E]7TUVLI7:SLU*CFKGH;Z7B6(33\MVZHEXL2J:*.Z9+,JJNA$.32T03.Q<5
MIMI*GN\0A5BUX;L+%\TH_YMYNK78A-58$/HF&=[<QM(3@Q7BA(6W8-%1[=\K
MON+<Z=Q(U"J(.$WZ?O<.D?Q9]T%7H@@7:8(%G FB;CD!0FCLUPF6[^Y<D)+R
MUM3*%629LKC=D+C&1D6\F$X!%; TH=15\0(]AV^0FMK.08[E\51C\:AF+EG9
MU4PQ(&#&+X6O3 )_];"ZV,::H+F8S;#^NC1E&I!)[^*2"MQ:SK)$64_LY*V1
M(*_;*Y2:@C[.L=!T/%I[<?&7&FUA\ =>QM?:7XGI]&NO^XG%C[FXY6L,L2O>
MV"32$;L*I:*&4A?55@IG+T&I=IOA0%XUA?!D%>2.)?*Z_ H;98"R_R?_^R&K
ML-AQ1D,_?AVS$0"$[DS09!N/=2)+\I++.N:(L\\L,-MDV1E1N5+LA<K4UHO$
M.J/$G,6]8[%4,;AG>+QRMJ:U:P@L1R=]):)/J6^74\LKJL.<3;1YSD!&47A-
MET&VG)#$(%W\K8)EP=[I3;7\#24#93? IO$></*';PJWOE7&[9K"/5YS#S (
M5NJ.'AAP]]A-#^C$=UX]4$N]#>![?J8P[K88=T:EL]__^L_WK[6_%F/4L('%
MO<_C(38;P#^?O3@25K6WV);.U8[<!IXM+K8<0W6\O.^.E^**HNW-@8%6%?5:
M*$7#DQ5%Z L&.FI@#LSF6"Z[1E0QT<+#6K\?"+W%]PQQRG7'NLV*CM1KL+]M
M)<J8HT93S:,O>/6%<91T=X^N=H#^3*\O\%GR92Z#8V&*?U#069W%TLXNHGI%
M2PY9>A[7#H:S\%(WF,50B],XM;?%^MZC(NG$W\(7*$A9F%JU$KGPG<[M[X8L
M&JWM$GW%*>JL3"CJ[9EM.HO@FI98%O>[Z ",2ITH#2\2GY^CK0CF^HL!77=*
M4V9!XVGTG$6CL.WO(@)SA5D=HV]G=L6EU8=SUJ=1Q)PG56-XQ:PLK^DRF(WG
M35WR%DQ=-\$S:PD%J"7+9"[H1L!.1F_ B:+S02C7%!U:N_''URV<,FI-(&;@
M;3SW!,:.9"<?G*B- =SY*,AR;+[SS'57%MYI 2N!WZT/7_=J%G9Y)NQ(O'0Q
M+7\-#"C\>LV4 R(B$1-;I&D%YQ!= RU9*W,D' ZN))@TD\@ND,>BU^XG+'Y#
MWS/&AP+U92+AK8GAHR,D7T3))ZSV*TFW08RH)('5X7!-#7-D",<H41[5?]Y(
ME/^67E)JMH 0%<D230LF;*+5O;V-LG'C$&+S2V)0"OIW@#ZYVII@5'(!8UNS
MA.Y&:T]64[F_ N%&Y]+X0$_7-^#>JV^@ARZ UW',Q^243C3JQ:Q]XM-Y&8\P
MXN!U&^#\_.SUYT_5&B/BB(ZZ&P(C1#9=1), A&/&#<J.QWB=0/'A]:EF.;"?
MF8R)IYC4!DC/S*&4]%$K6L6MU62"/;^P?3(JAG7R%SX3]9X[LU!@%YN VD&=
ME*1.))8$[P(!SN/97(:O@28VR3  @GZIIZ Y\4H(0U=%,A3M1L2F421'^[6L
M;@A3M&]B$A0F;[6Q-2):3T(;E4R$RV7G_95]=O37[NXH@V,@(SY@-=\Q=CNK
M2*$>-ND":^,=Q4E-,1YI%=1U+-_Z@Q)W.3'/,"XC')J+&I#<]9I=4(X6!1)F
ME$'7;/>9:5M#R^^4[*9 DE:1A15:"RM<Z<Q2:8'Q0Z/Z%WAQUKPM5R3:7+7@
M2T3KH@8C>M\I;%^&BQ=NK&RN!0GKZUY_+1@V'%7#J\.[\.J>@70]LVYBPSZ#
MA<E).044Z]?*]^YRU&7)Q 3F%=HQDI$V6ZZZ6^Y&'@MC6EIV6C5A=,M/5@PB
MQ+RYZ,7,U#J\<,ME_%(8W4+P=-N8#E:'K59%0&RS2/%=P"W1[A(YM]"DZ I)
M],JD-&.Z1[Y-(*V*^-H_XLM=7***^%(17\<1\;6]?$/^+;LL*)SD'T)Y[%>;
M\4T2M2^B9X]^9'U:MFREQ_-+=ED+O8X_2]H1U  9'K=(4HO,;&URG5"KJEEK
M:"ST#\?'G5:2HJ-?6P&"91ADEL_)YTAMSJGCM5:Q;^11 ")>*M+0Z3-<S8Z]
MIW"'$D<B@1J]MSP1/A)I2H[9)5U"R0-"[8!,S=:PHR;@>* 844+7)!2?V$"Q
M>R#=OIXL+@O9[K-.4)0F!56=$#<C8(2M+*$.^'BYT"21VA)AK%;,7VWJC-@=
M@NY]6#]I4=V_IQD?BP:^S:KJMM_=8>C<Z_[>[0K;Z%WM@,66CU+C;^WGJJVG
MD26B+39 ]BLG<W8B*VJ(/.=1<=4-[6NO'(@D1#Y=3G=;G;@<:0K"$<<BM;MZ
MU2FN=@F+^I.\]IU NU<:]9Q%^T8"F(J6S/$V"G\56\8<STD]H)L)*V-Q$$QU
M6_7N>A8[J==#!($N)&?C)#*RDK+YFC4)ZM[4 I,B2+%7U7_FV93.F()CL3TO
MW7>D!>70K,P.G.$2H"(6GV*-G+9];:=U+U8Z@9=D(";A+#8D7P9"S2SJ2\<4
M^X".,K0)(\#&?"0#)CN)K)2ZDH[Y]XS<Q=>PA<FTN"(?IW!Q-F\M4$X;08D)
M0C&^V^;]2,9&<:;BQHZ4E P('MB$P)2H&"-(ZN50RW8!,"#P&4+YALL5H3+C
MM6267K\ZYON6QJ^3?;^IAB#1+=#@G.Y8GME+-YE86TA>9@+YEAA&*GPB".(.
M_ZW%7QOCO7B7)O$9_PKG6-74B!Z#2QGO31)I*:-:7M@"+=*],]VT 0?"K/"A
MUN;OB8!=XN>R*!"M%,-*H\[N8)IT+JZ[R2]6B?(;-<>Z[B9?K43 UB&N370J
M26TA(C;9DGW!AYZX4=Z4&=W(:*_%C3Z>U3]D*KV"X%V61TW1.[6R\F(A>[F.
MVI>AZ'%]#JP]AZ8B!!6>$>YI=!2/BZH-3*44UM>D<.)U!0H0(-R?T;]C&OK_
M]<L.VNA:[,NA]80JVW*$.&&'-#]+5:5G[=SW:T__V-5;NE5$L)Q3A^1J51"$
M7@9J30ZJ$AJ)HE2P(#KRKUMW\J\?M85WL9"LU!2>:KE668C$>'%9FA<S[9K/
M.@G@ZQ+9UL&)*C&A7GW/X%=^Y'OP(WN;_<BXW"SYW[,=/)O>F7(^*^?SD3N?
M>U<H?4_EYFBD3EI@*1/R/R!*5AK&<Z*?9=1455F;N"D\#G5YP-K.E#$(/'FY
MD=N"V7P)? 8#V%SR-HC.2 W7IX;L,;8SGU;\9?W#J[IU0I;3_NBE5W(N*2K6
M!,,1M8K'+2L;&H*=R:8C\LOR\9 >U3T<%IY9QM!RW(V/L;G=IF?;I@V&ENO=
M:M;MSUQ[\S?56ONV5B^\'68]_%K]86 &:JT'P '3O-VLCP%7U]Z-MG9L[[2Q
M(Y!E]KXET(H&8PBC&%,Z/@BO]+N%E([[Z)1TM'#YG'W? 2IW19MVJ-0H4-_
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MW06ID4<QDA#U1[H$^4D6-Z=_!$.-RA]_6JQ\?J>'2[J48PU]%WC^M*BR65:
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M [+6KP3H^*;SG5$&!G*)R:_:&'8W;O96 2,&0OC/'# /_7TI*!;H3"FWP6
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M.J !]4[HM!H%/H+E?9=)@')>K"4[%EK&YNB(1ID_A S;Q-+[@B$]Z&]YS ;
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M7*Z2OW^#G>US[-X50*HHPJ4^95DB50M@>NN<J<=,4_VRW-]FZ!N#DY3*_I$
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M/R9CY9B,H;_S*?G-@?8%7"<9+R0; 'T0G8S>RW9$JXSD1)3HCVV;%]F\J>[
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MH(H"L6JIAM"[+(LK0<38.6RQ2]P ]1V@RRF%A-2< ";HLF)*HVLUKQF/1SG
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M\Y-A:+H!Q.X[GD4YALF80_.E48 ICP*D^,+PRREBJ3@>5D@;U6J-@_1=^6:
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M2'-FT%Q]9O!QX-LS]L\XFKB?_P]02P,$%     @ BH#W4C<W,,[X#0  HH4
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M3G$-_K]K1"SBNP?\J+8D_A*3P,%T,\)S@#G!TYL*Q/EJ'+Q^=]'D S0D+I'
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MSBJ2\1S79?$_EN$7WEXO,7%\V^1WOMDAX6VJ2#2$"IP@9)_NB!\N;RI1<2?
MBXH471'W<@/NM>TOD.-I\(X!K6^2W.W4R =$#UN@)G;E31 UE&;J7#;9 G2R
M[3KP<8B>,3G$5TK)(G1 &:F&8@4C[+)+I-6G)?8HIC[I0408X0?L08A0%G[H
MP2<+.P_89I=+:\P[D&L2Y%ESO-GG*7+INM.G0<^CI^C=)#IN<5.Q"+:=(*/Z
MHB<+WX,@19X/*Z_+@@3NL68KGJUYJ[ 1/=$@8'DS!YH=?>4"(@EFD'2?A1R+
M=G(KBIY $\'G#BM!_3-T@N<^#N8^M/(!7)6]UA\],/2YLQQB8K$C& Y=^BR
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M1C)]"7D\@>7W3OPGF/XV&(TG@]GG_=$,)CB<WBC=?LK>O^?XZ]]@=C;&WWS
MKY3I-^U["]DDYHD6/A*9J",V(@$D,)>,SM1'>5LA16I3%-N"0]E/PX)(E]A?
M%%6]@.%L>O63A?((99=\^OL3#'+)A\WU\78\&B]1C4Z7+]S[= &C*?19SM)I
M\,0)%HCT3!)G-: !<HJQB&:HD?0>A71[K#?8WYO$9^-)@@F:Y^?//D(QII>6
M>HG/3^*M:7'?3EQ^X\5T?GZ^>"89S.#\ZO\7L_U]\'@V;J'?)9M01MO2[? V
MEC+R?N;2>(H8N(L%2 )BC<TD9>-=DB! T29$>P#,*A3C_T^QJCJM1J['N0Y
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M_O;N:._7O;?'^[_O[;_%CWL52Q(?>GKKVL1OCJA2D>*K\?G%!,Y0U:CSI=U
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M+V7)6NBRM9MZ70MRTXW.Y31B9$09*+LKT1#+I"'<6F883@VJVUQ6O#K&BE>
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M77(%FW*DDGI6S%1<_KS\$?P4?O[;_P%02P,$%     @ BH#W4D!.7P7X0@
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M2/(J,8U(6*72.S,$KX@K:PFU0JA\P0 _W=AXD[/0O5[OIC?&#/'!MRN(I6Z
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MQ-/$93+9TUPGHZ QQ)^,7)J 547+U6H#S<,Z!=\K>3F_HTY*^\F3_DR&'>=
MQ&0EH3:5JU\^D: %(U$YP:63#D(=;V-5I#_)N8R<575>X13F%&(QMKNY.\W&
M*).J0=6$_>OA$,<U[2%SVT U6A_0NK,D<"^(%#J2D#D0JYTH^?]:R3KIIVV.
MXB>WEW%[9URID-(SA89 2MI1?P3OH(^:'G>H1)<R:4H<+06$K,HD. 8D!.M,
ML@JBJ'.[=0F@GVQ<QL8V-%@A]>>&[<O0 9HC %P2Y3U:R+;TN:>!DRQR0-B1
MJ9@J'0 ]ANLGS9:?'[6FSPH]H=]#!L27EL'S*AHM0B;):$\DT$BLBY8(GXS@
M'KA5O@K=G@#VDV_+^-:F1BLT=:XOQFD05+ 4#61+F"DI?DI(XHPLX8,2&V69
M&EDGFW9+ ]Q6'N5+H?USY-5SR>:L+YM)B(XYXZ4%]#_14$+1:$5"!+2>+'AA
M6/#>5^L(M87Q[2K_XUDR>^NS;V6&53B/6PGPO?!C$]A5,T_6!+Z;#)3GR*5Y
M&VN+1'A&/)9!4YT3$+"E=[ABD7CNT72D+J,AF2R'.I?DGA5_GTAJ><7T747_
M+><$_XV?#7K37DLWN1?!.Q-I<"3P<DR#O@L)Q@5"T66V2L5LYB-P"P.]#QZ\
M?<]R*^H8M"7+"F'7'P2P_\,1\83KR=%DE ^D].HF4FM'''7H)G#D/M4 O%(M
MCB> _;0(EUN$;>JT0MCJ$7@WLZL)P.T9;8L@[L8\:U6QS4FS@59J6U +@8+)
MC!IC2"J-123UDOB0 K$6YXW0-*9*<: =T>8)JVBWK%E%&;79<I?M].Y[R3XY
M'HP7K\&S>N*X-U/%$F%9(':0AH1,*7'>.45#\%K6R?C=!/6.C:C-2? 8Q6IJ
ML()U]7@C+>FCX:77"14B$!F0"B%G10R%)$6V.8M:+>^?83O"EV!9M:?/"FD1
MBYLM- 'UL\_ARNIKU-=N'=EOK<]A3D%9FC-AE)<>;%P1!TX0G;C&"<*MJ50G
M]Z7T.6R?#ZN(O.5#G ^#(72_]*<9$?'[^=#W1]-+-;-S"&&-TN5J5Q0E_=MY
M$GBY!>U28DYRC=9A@S.=I][S7'K0K*2*024Y;N]>TH>]P]._[QU]/OAXL'?V
M^13_.CX_NZLS.+V_Y7^H*>C''WQW^'??NX;UKS*U\]Z6;C]5$,+<A2G*'>,R
M<>J5E4Q(;_%K\& #FIHARDX[$#:\1SM[W'T3:V) H>7TH=O'GW5][W9MW/=7
M<[D"(BM?[&>2>"F2:G!A],((8KRV3F7I!:U33713Y)MW>O/%NCR#>#V<Z*83
MI.(XKPO222NKG(@U(I.0K.5!))5S'0_Q 90=W 3=)H\>-H3;1!457+U]/[HX
MF^P*^+R)6.ZF[:W'T@E:)R:X(RFS3"13GGAJ*8%@LO6:.9"54DB;P'MC'&I?
M936:7GS%);\XKFAYE!./.\:_AS"^QW^!0"1*@]BH2OO<DCLM@B!4LY0-[DQ<
MU(G4-$7XQMA517$U^MY.;(Y%S$=[E7-*#6&@.)%4..(9UP1H1K-&Z&+>U&'4
M,DAOC4*MJ*;"4=,LT;EX5>AK^ZD]/C59O\].@"&59IW3%/Q.!/2NDE=$E>"V
M!*N(!?2-7':9F<B\JI6_LBK4-\:QNJJL<$GG%!+ 95E8%_>"G?K[MS+M,#0'
M':6!1$T%NN$Z$<\Y$(<6(@?+A#=UKHNO"/2-\:ZF&BM<UKF3U?=%TIJ&%B*N
MO,FD1)3T#N41&+%>L-*"00CF?,Z\3A9V$W3;NK6P4U:UKJ;G<H_@WL ^3EJA
M3Q[_80C_NB[GD),#:R/*_4B*,F,6/>#@.0F.X^HLF&7&)"-2G7AB W"[BBJV
M3XCEC&M%,34*Y\T@+@)X<Q[>!&+="HU/@]Q15<:V%;R,0"UK9T=$"L$$:AT0
MEC1:ARX'@D@3<31:QS4PP^N86SLCT%.5%I\!?U91RI9X,SHM)R!#7(-O F?"
M4^JY\B3D4C(Y4Y2!1 ^7 J,F4^&#J[Q[/8)NA\9Y6VIM0)N-=%*CC/7=U+G]
M\J]=&.)++KX?P5?H36:/4-1*E@7)''#V*&F)2R82(TN10IL$Y96Z]S3"]Q9,
MG[;44Z-6]2*B/\1[,Z6:@-VZ';04[LXMHM;TWF1U:E5IV]KFEH*V4M($WA!F
M0SG"98ZXXNLRRV7$13>(2OE7SX!AS4VFYT&P5715DUB'_:OK\6@B 79[?\Q[
MJPTC.01-I$9]V^@IL89!I #&QSIAOT= /0]KJ25U+B/.AKJH:2[=@\9O$^&S
MC*QTK $M<,BNU' /C@B*/]!&6VWK)*H\ NJMT60=76QI-1$WT)2/B;ML21 J
ME]A.0M,_6&*,E!QH\#9NCR;B;=)D'5TLM9NWDTEZ[(?ECL77MC-%'SRW9B;H
MXX.8+XU?; RJ,O,TXF2FSG@JN3$&-2X%A<69G@]>L>-,SD !MR4!A$4OB12Q
M5#+(Y2Y[XBI2S4%!W>F^HTS.C]W^8-@=?Y]%&^?KHOLO:'O^&)B<?F2Z>(?D
M2*"4EG;&@3BF MJ@3BD6!3!>QVQ?&_(+#"ROPLOY)74[JJU@OBVIV%\J\YY?
M^/XY7%X-<./Y?GAYA?(MO^MP3;D)$0W.!+I4;0/BO?2X":DD5)"0V3:+CC^&
M]8VQL+(R:YJ%CQT79LNI,M0B)2:!BI2)=]X3IE F(3'@OG)TYS5D.&Q"K-;5
MM.L,A]%PW+E=HZ?=58U()J$;S;1"]$ZA0<VB(<8SGUPRKN')&#[Y'L'PNWER
M/7CULSZJ7TFI@S:$V^(J\P.065?D!E!6.6M?3=^[.$'?4!V+E+J!+"NK-T0>
M<2OS1*1<.K]Y02P7I="5=-8P#@$:E6%Y/FI=<FQ=3ZNKB+#E"\.?/_K1Z/\,
M4!I_Q\7]>@BSPROPB4<GB#<E).R%))ZQ2+(7V>+/DX*YRW\+[PDO>?SVK,2-
MQ3UH5U:["Y_C)F(CI8H =QE'G55I 1:)"E0%[@)Z0[4/ 5YL^'R=/;FB>G8>
M/F\"]F?XO'V];Q3=7$=I.P^?2X@F>^V)B<D0R:T@P=E A$W>6\4-U&I;OWN&
MM1,^WQ[!5M'5E@->PGINM5<D&MSH9322!$$S,4EQ'44"9BIG';Z\@-=*ZEPA
MX+6*+K97.N7WDY/W_S@\.MH[?G]X?+YW_/OANZ.#O;.S@_.SWP>#]$>WUUL_
MZK7"PUL*?:T[G+GXE]$);=AD;00CH\\V:Q Z9<B@T+3UG17>L]GL?G<]ZO9A
M--J+_[KNCF92F9VT,2F8]8X(XY&J'OGJ4Z)$::U4Y,)FSJM,[\=0;;J>+7CV
M76SC)/]],+YWCV[ZJ2&D#I=1JA@<,1+QRJA+MTHN)NGFPIJ<,ZN3)KL>WNVO
M@JTQ:7[1VX+":A2OC!>0KDN/W@7X1^^^W_ONQAD*P62* (47I;T5H\3;X$D(
MW/ALA)2N3D/U59%N*U!0C5!55;/K@, CTIO6*Q8.(%I)(*E0ZF4DXI)E)#/J
M.14V)KJU-7V7!Q1U2?#T$K:R,BJ8]HM@39?/6:>&)@"KGD@\"7$WIQ"M*+0!
M23;7QDYHHS05QNE(DL)I(E7F!,$E B)''<&S%+=F+&V#+D\<*>R&+:LHH>7P
MQ\=NVKN$83?Z??PU_M4[\F$P+/^B"Z.CH_V/>_M',[\5M)59*I*\U40F$8EG
MQA#J0>!3K4#D#4(B*[SR6=C&FRAK4%_2S^*$8+9'CZH<$3QX>OTS@L<'-'](
MD*7/.>@<I9>1":\A<!LXE39:R/#8(<&#%VU0^[@( HZZ7R'M]=-A_T8TTY^@
MV^7[7[IH'TVK;=T9Z!E43 & "(N>ETPTDN"")C1J8YSWRJI&%9'7>OO&9YY+
MW_%Y!/FZ=]1%\><D<)I:090#=#"E\\1[D4FB >=K!!8J%>5J@FY[:]R6./+@
M*+1M%54X Y@?^>_#P6AT\.VFS<+L(*\3-(U4"D=,Y+@NLTA+8VM:6@B;Y,#&
MG.IX_LWPO7HJ55!3C3C,<C'LQ7A]>=WS8Y39Y6 X[O[/I!!=1^,.HAUZJ]2
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M6X[+'$?N>F"""$V3U^"#M75.DAX!];IYTI8V6HQ1%V?T?##VO9O3LFEUBT4
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MQ 6.+@B-$4T=ZDG2F<><'->Y3J[4-JGPQ/G!MIBPBJPK,."L>*R0"JA9$1Z
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M>6(\&5^G#=<:8+>5\UR=-;45]5RNO]^6IWEW/4+!C48W([KI<YBTCA&M*^4
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M0E;_ *HL7L#?B_(?^1N%\)_KF]X7K]_+_.EY#J(@"G?_6OZ%!U)% F-(DUA
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M&R5K)8=IGG >%;^;)L?%#;MM<M;LO8V3\W=T/PYC_C?EB-[HU,R,>ZDGB=G
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M\T#/4M-@(L4R@2C+4HC3@,(D00HE*@T#Y-9';?OY8YNM&^IU2HG8A<]NZEX
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M1D7 !0S#V/3&-8?P&<H@$4)F2B:2!U8[.2=DC,U';=0$K9Y7P&BJ<01&5\L
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M(@I1' :0XHS"+")8RB!.8B8G\V).I]:DZ%,_)]I<:=GK3%Z;!_+:/F=>]#J
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ME"JG9B;G18YM_:)UJRI@_,)B!J;T:[7(7=M*6N!LQQ!^T>N9+HRR&WN2WZ]
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MCYT3V^,LZ/DMMXEPK3K8TGT5^Z\;-Z\J^FD;O";5=0'/=X*=DPY#)]MU >A
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MFQ,'^ M\&S_T>G)J'(UX)6_&#Z+C;HQG._[^RT<S[],OW^>S=0UZ+#/$.,'
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M:C9?U'HSC8;,[9\SL^B^5X^F6V&=YF_JS?-+N9GF(Y,R%S"WQWW"%AK%A9:
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M397PBG-SZ71L)-':G&R,3CI6)W_4[^7:<%\),)<)<*.0V+#V3"@1$/67!O.
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M/]>#KP[:M^>G7QN];U1NL"CV!)'&%\K!-S\<E>-"%,>)'\%5!]8AS%;QS56
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M=(>M@<(@*Y>NPIZ6[8 *1[Q7Z"0;\(*ZX%6H,V?T9=KZ/O&O JF.5=( R+[
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M?A/1-P":V]FQBYN1*+,CW#!FIY,O$/'[X6+NQ&W1U.ED4[$RFB&FZ(ER.I8
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M *!)3@P]%I9YH'7N2&]"99,%GYTAYF'!9RWU-;'!/^(.Q8H[Q/S'YY$?E_%
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M#=738P-^YYV!F*>3)\H@%IR&AYQ^ 13U;#B'$YA^&T98BJ;,T3P;+YZRD-+
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M6BV6-R6UWUMKO>*SKEH;V,:_0 *X*%M X6$RGN/S\;-G1V-\!\RN>G3=Z&#
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MIGZ<_SZ9W^E',[M.M RXC%)AE$.,I(M0.*$'B](LTWR$-3EGMK>=<@UZF[.
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M.1#T=*G0AFGCZ_0R^6G.YS9!T4OG<YMHHP%'\.XJOZZB6 30* XC.'@2O<8
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M;,#<GUC>2O#*<\%)2CP0F3'$"R 2095[D RD2+H%5'=][YNMAMT3%<V13#2
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M+S?32\./7T9YJX5E2\8Y5FH$@HFD-*XC,6>3HA7<Y#H!:QOI^F7L.ZK_ZL1
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M-AM*G"A%%BRC1\1T@HB4LU?."Q%:;5?B4W\!!'[:!,.CU_;L*(X4Z^ZOZ2'
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MP6=,67*=.OI7!!L"2 <&IJ>W_SNS[+"!NCZ"Y#)1?#4!G4L] *HM &;3/JN
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M,NMT]B!?.T/?Y[V_>[AS&)*K6[)^9<?J%^5+P&GV/__'_P-02P,$%     @
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MCXN@4&QORQ Z*VSG6B<TDS,E G0)F\LD5]<OKXI/Q4>QDK<<+/+EJ"N=I+J
MLLL0K !@UO$KGBH"*B- /*/@E/.= BAWF9= -X);Q"3D.G@*Q2KI2X,6>*^[
MJ?]7;"KA4YG 7/FWF7+X2D;DDBI0FL9;Z_SK96A7,ID&][O"7K8MK#,@Q5QF
M]Y%41=@MZ!#W4P*7NM(0--Q#>]-YUR5%+]^K5D3OK(*+))J !$#!4J>A QJ&
M*" N,!'1J>\P,TEV&KO((M$2NJ*Y:C(!_4\-(1U,P8:6S:IHOMCN:XV-^UHK
MCF%+XG>D9666J\[R7K6(0I;"!A41:H=FPD97U\HCEV(*L066ALXB<V[<@(P\
M&5L+S;W]O0C*SP2"5ME=FEAE?3 2Q0FZS.Z8FYC4HG&I$1,<-/D#=S'T9!H)
M24/$=L"93\X38)!<,0VNWP6F![X/7<%*!)CP/#=@YQEH'D1N#_+ AO-2^>U?
MD60\Q]&G*^"?'_6E]?9T;H-,B,->:)=[ID;Q^M7^VR-M_Y(V<WG(*7E?)9?N
M>R8$FV_R7)_[]^68ARV>;-22F'JX[U1"YJ?>[06L;CW1:[#X"KD8?1@^[R57
M^'K*OO],,>SI4<M52L@B;)&VJ5A(,1M?J5OFHR"B,3)JUA=#Z$3+$#:/SRUU
MIG\#M4!URBH3"*EN*M0')IHTG$$N4?K[RZM?J*:U/B!O#8?=?J?W"\1$P]85
M[#>]86N,1;GNY?!B\+%[-=J@$U^.T(85[S@/UZBM)9!N%(=RSI3.DCQ(+-)X
MK2VCV.:I,@U9;$1A<Q\-^J*K!)-)(BC2MH/6\BLD ]I+TP^;RTHUI8+_;IWW
M[OHZ5QZFIVO?TU)>7T8JY[%DRH!BZRLA)\>8V["%KBO8-RH@X)#&FC7S?XX\
MKN.0SIM<6#'904<155/0SLQ #D"FMPS3#AIF:F8U+FU>Z&VUGNJN 84U7KYR
MUERU337CK;;M'U8;!X<;F^M59V/;D]/^NWJPW_BD:6N6Y)1LD(P&S'\H[94>
M.>EF([XC3NZB4T&@WWXLG%0N?[D-UI^SP?K3*?LEP^PO*["P3 _;,*$"78!X
M^1WDI_&]'F4B^WJED0; *\8V9DI1%VBBY.*B378ZW=T'/!=&%< =1S#.!2=Q
MR3RDB5S0B;0U#<[ NSS(JE;D\%6SOP'[#[ Y8N&G7&3HTY0;+%S09>8MWM4B
MXGS%8$-.XU)RAG2%W,S7L7[9*BS>IV$"4N"P\#LF6%XT*23<HQC2*QH"Q"ON
M#/AM%Q?CA49#'N8S9>MI(Z9N(1%;Z'BG:'BONO%S!O 'Y/6KO<,C<LW"4#"]
M!3Z]>T>C@6#K^?SZV?M9\)!.("!-8Q+['&\+T+R6*O3(-?=8;L+#5M&@M8'H
MD(+-MKEPN1  ;\[MX'R+(,;<J_]CSGK_QP(#';);%E+A;0'.$(< S-D&=#DH
M$*B+-#(%50HM0^[9C!&XOH\ZSBX*#BX:[B#@LKA9U +E,U@0,"Y^0'7)/9+5
M2,!?<;&F1F)%T.OO?E]8M,^ECKD!QO-,8GOP3S.+-)L UR:8:S*F'V>17S^O
M]X!O\F %PK4/4WCDDFI-W2#1S)B-):"OG]F%)?>$QZF@,>S0P.^PVJY:UU54
ME)%G6&HZ)Z<)#^V+>?ANG&!*!SRVE9"EMP>*!O9[+&6[-_-<L=]_+"[0 1/2
M,OUP;QY:5WU=8(N^2"83Z=Z0@VK=V:&[#VLCXU\*B_AJR6]#>%;\8!PG_"C5
MS;9$8\N@=R1,C^7N<QGBF]L%+7PNP!ZS.YH_N-DJ\T: @7I=^&?22U@GKI8B
M=V&M_VP1VD4'N1TR"OSAT]BE9W9K"@M;9>,/42_><\K[BC=6%)0)Z60+4NWG
M8.Y_*!S,N [U\*AJGG]B63P)#9Y9S?/N]F"K(+?GGF4"(1O7>(ZLN)'Y@T<@
M'::B+:FIK4/=,"5H>A]*46-S1!CV[/C>UJ5/KKEV00LX!&\C:^S7O:V"_1:^
MPO-VNK"@GUW_O^22/0@9%P[<142^V,$?OT4W>+]M0/<NB@9T3P![)C'VT#5Y
M[,CS0.WQRU;%1[IXC\#>4QY2'9#3JKU4**)E<EGM5'-C?K=-$#]XZEE8P'D(
MAJRX>[/PX6C0+7RIKKU%:/>Y"]QC4);[N@*^NG )F=99@N<MM[%LM@)Q[M8^
M% [H?N)BY30]K@:M]F#L(DAK:2U=#HFWWC*?#CGGD FAY^$M%9P6MK8R<*,D
MG#)V?UYQ%7N^>&2R52IP92^$PK/9?^Q@5QUY+M9IYTWG>T\W/"K_7 '5[%'X
MS[R^8DLOHG@9\+\G]S]X"P/6I? M,)TF\YMN3[#7ZRW?HC8+))G9&]3BI6^S
M2Q:>?4<83--PE=XS.J*W]BEV>J6I6%W[_L(U]EL"\V07AQF)[]]F=\?AZ7P0
M$NAJ!'.ZR!#,9.]=6R(:[\9TWAYI<LH$L[>I9DQW*$8(>$46C$^07)-?-+:X
MS6(R?YXO:T5E$ [$'X1&,D%\<_)]CC5?W)Y=*=P0@K/TTM-LG<4]<W/8SRT,
MC\&!GNG4CSFS4( P\3YK;SV&FZ_B^F>87RV]?MM>!'[R/U!+ P04    " "*
M@/=2O&2(G%<&  #F80  $P   &1G># V,S R,#(Q97@R,BYH=&WMG6USVC@0
MQ]_?IU#I]/H&;)X2$J#,I"1MT\O3->EE^NI&V O6Q4@>28;03W\K8Y)<0]*$
M!.A<-IEAP))7J[]^6LE"V.U7N\?=LV\G>RRRPYB=?'U_L-]EA9+OG]>ZOK][
MMLL^G1T>L+I7KK SS:415BC)8]_?.RJP0F1MTO3]\7CLC6N>T@/_[(OO3-7]
M6"D#7FC#0J?MCN K\+#S6_M5J<1V59 .05H6:. 60I8:(0?L/ 1SP4JE/%=7
M)1,M!I%EU7*UPLZ5OA C/DVWPL;0F=EI^]//;3\KI-U3X:33#L6(B?!=030@
MZ#5X=:/,MX-ZN+G5VX1:/:A!+0BJ4.XU_J[5T$L?\T]/,G82P[O"4,A2!,Z!
M9J.:V-98A#9J5LKE-X4L7Z?=5])B:1I/GKZ=VKAER<*E+?%8#&0SJU K.R!D
MB+XW:YN)+4QMS?('*E:Z^;J<_;5<2JG/AR*>--^>B2$8=@1C]D4-N7Q;--@J
M)0-:]*<9C?@.S8KS-_LXSBN =F(A85:A2J7Z9NI%"('2W#5K,T6'M,M5Z.Q=
M1J(G4/GJ?ZNV0*7F"#3?2H G@O[EI#A->T:$@NL)^YAR[ 16:<-4GYU"D&KL
M$&!NU>ZYZU#YH0[U.74H='8RMSZG\815:\6LUQ29C8#U51RKL>MB9E89]-IE
M_C,%8]FNX .IC!6!8?L214B<#M@O$ZU&(H2PZ$[\!P++K,HL8D,-,P,F#2)F
M0 JEF5063)&E:$&&>:1@7(9,: TC%?!>#&PPU1"P_-S6S;-9+(PKN ?H,*9R
MR\:@@0EC4G=X\E./4VU2M.^,<XD>]E%+K+B&@;.L7;!Q;9N5?-V"; ?KAM6I
M;-=0.6X8Q[B"%?_]]<96ZX[FG0]VIVVS>N9MWU,:2RLA C%/##1G;UJA,$G,
M)TTALX;,3FH-N1Y@U.DI:]6PN8&M/@*-E>1QWD<R3J?)>3S:WO8V&]LN)%GT
MQH:S@O-HY671RK?A[;1JP]NH-.Y,+GN5.]/N,UNI>N6MVK.;K5>\K>KF\WM;
M]RJ-^H/,^IG 4Y&Q&4W"Y;M"K7#5TCRX&&B%=)7R#A_VW7\K1R"&/G;4!*."
MBD7(9N$@3[4JF9.8\#!$>IO5Y)*Y&' C6CISM^A026'%T;7\@.B*,?2.4#G3
MG.1\E)S[+AIJDO(YR)PSNJ](6#UUXX7J;G&X=B/NL1YP*;YGTZXYPN=!=^;>
MS$8]FU[^T"I:C?/WU<(/XV\^HMXI]B_44LMNC_ESQTUO>^,-3HBRJ=A1-A4+
M4\ Y9*VQ]-GMPSS<\!KS/:R7?]YAEX;&_Z'M[Y]2/SP:OA2]=H9X7H!7%X<0
M.J_8 >\YK92[JBHN4;P7$(=V(>9CKN&)0\&+1/*$VRC#SR/L"+N58L>Z2F85
MR19A,!X: G$A13]@,:@B<;@@A[E^179PT"7X* JNEKY/RB3"XHSP%/1(!%@$
M\4@\KH_'/T#:-+B8T&"\D) S^8B_!?ES!K\I?4'AC\+?&O [@TM.%R($WRKA
MLQ%(?G,QE?@C_E8HVQ5XS(5 +'4PN;H:(107TO3X(N81FB$4%T7Q"_1!@PR
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M4P%\7'?&^1-1DY!80H:;PU;SL3 6A+(E%%]ZO\'+Z@KZS-R9.]X^60"V=PZ
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M0;06'!>Z .2 BE8]8S! %TR> #P@2LZ9HN!L/++[JMG [FVQL.A'&O)*%6#
M72H$(+DC\P)Q55\S13I1<L*Q<*9T7)S\ZR)[\B23:L:A=1HKGS+I"IX!?Q^%
M5=0?_0ONA_T@^)EP\F,N9T_V@H/F2:M=]1<<WN?"PF#K=J-%ZPC6(=<U,%S2
MS/!N^>4$2EHFZ:PK4C>\ZW2R'HX)UD5@6$5H791]<W'?H1W4@XZ[\F ASI:5
M Q>W(>JNJ6'9AK9.O7W<>K"Y60\>[OH.M4?M>J=YM)7:AC/9FPV!,1E-GU?:
ME;)#L6"ZK>R.!&46\7' -70_-CXLGQXQ[L+)B]D<((777[A#3_8ZD!G<Y[U;
M RN.%E-86E>H:/N%\,X@-#$$E7?&JU@\N+1 EKBS2%*ZOE'/EHC:8NPO::[>
M/S__L8#T[WB8X[$*^16V$N2U!HJ&Y&.%U_QWP].+!8_(Y;R\7_L=UWID&JXL
M+16];6KZO6MYF?+W$KO^=X<)7[NHMUCNKNPU%UWH"-9\;A_N\@C6L?+I[R"Z
MVY!G?P-02P,$%     @ BH#W4KD'5 VO!   <1,  !0   !D9W@P-C,P,C R
M,65X,S(Q+FAT;>U86V_;-A1^WZ\X=;!> %LW2W5\:0!75A 769S:RMH^#;1$
M640D41.I.-ZOWR%E)VLN:[.F:S?4#X*I<_O.E11'3R8S/_QP&D J\PQ.SUX?
M3WUH=4SS7=<WS4DX@:/PEV-P#<N&L"*%8)+Q@F2F&9RTH)5*60Y,<[U>&^NN
MP:N5&<Y-I<HU,\X%-6(9MPY&Z@T^*8D/?AH]Z71@PJ,ZIX6$J*)$TAAJP8H5
MO(NI.(=.9\OE\W)3L54JP;$<&][QZIQ=D(8NF<SHP4[/R&S6(U,;&2UYO#D8
MQ>P"6/RJQ1R;1+;3[^^[[M*-EK0?>=1;TFX<NY;MV?%O-H(TD;V1$7*3T5>M
MG!6=E"K[ ]<Q>EXIAVL6RW1@6];/+<UZ,$IX(=%>A?+-WT;-+6627LH.R=BJ
M&&B76HWHCASQC%>#/4O_AHK224C.LLW@6<AR*N"$KF'.<U(\:PM,0T?0BB4-
MHV!_4,2$\/1RW4#NH9Z,%73G@NTHT,%ERI9,0M<Q[(\1WXTUPN#2ZJN#=>\$
MZP?S<'HX]<?A='8"LT/PCZ;!(03O _\LG/X:X"ND!G.LV_GB;'P20C@#>Q_.
MC(7A&_!TSW[9&X+=]:SV=^_K> 'CR>PT#"8?>;,(?.U\WWJI A >!; 8SU^/
M3X)%9_;^./@ 8S]4%,>RG <[>4?A_K7^2;7"%EAR*7D^4.6_?2-YJ9;?*%*G
M=25J@G8EOR?9(%,*=1'32J#+.%TB6DF6,,0@4R+;2E*Q+*F0P!/(-W!>\'5&
MXQ5MA-_6I,(P91N8TY)7R%7 (:]RL*W.6TAXI;E*=(#'0-%2#&_J@BH0UK"+
M"/3 0M5O:V5CPLBJX$*R2,"TB'B%.M78:P,1B$*-OH2A>5@SF6K5"QK5%<Y:
MA$R*&(++*"7%BN)(S',F!,Y@B'B!/!7F$V&FM*)*N U)G>$ZXGF9*>DKC17]
MO6855=-2*&1H08URC-AS\@+0(]M['K]0E!OVKVR/(QTMN]]UX;GMW8A\;S]7
M6GK['-6\T*A5L+4V5F#(<B*WL"5A*BNLN#O6"6%J5594*+!MQ4BR#% !!IQD
MZ(HH$;UH<I6P@A21>H^J8[T_:>O(56>-KQPSI:V+3^?$^%0_7%>_),N,[JA+
M7F'!=; +,E(*.MC]&<9,E!G9#%BA:UD+#6_WUH6JT8ADVS[5+=N0M[M.OV_T
MK)[:>"0VK8QWAK=[DJ'W)%/&MVF>T?7L>ZF6<3_M[[3:GF'WO,=7VS,<9__1
MU79MHVNYCZ[6\0S7=3Y+K:G3UJ0.BT.4I'C5ZK9V B6)8QP$ Z>\!!OKX>:!
MX6:!-+7Q[\]@??:9J$YYNN?M#Z^Z9>O^PSS+:/)].?:FQLGC=)L!_@#?+.59
MZW\3AJ=[;F\H]!,6DI8I+>#(@'DMHG.^%N?LGX9FVP0[GJW1;C-.'RO"C\NZ
M'>QJ[",O")ZQ&'8I^%*3GSD4OIGS_Z6B_1J%^B,QCY 8/\43'6II@Y\RFN")
M$D^7DEU0F"4)P\.Y/J_]R-2WS]0I'II9K"]4OB 9IC[C?O%WZ.=\H]ZXGREY
M<T$UJ&A&5(7=NK&YGNKZY&U=BY ECO9:WB_R /0?/9O+*'TM=O G4$L#!!0
M   ( (J ]U*SFM^]J@0  &@3   4    9&=X,#8S,#(P,C%E>#,R,BYH=&WM
M6%MSVD84?N^O.,'37&:,+B#,-9XA(-=D'+!!KINGSJ)=P8XEK;J[,J:_OF<E
ML!M?$CMQZ[03'C2LSNT[E_VT4N_%<#((/A[[L-1)#,>G[XY& ZA4;?NL/K#M
M83"$P^##$7B6XT(@2:JXYB(EL6W[XPI4EEIG'=M>K5;6JFX)N;"#J6U<>78L
MA&(6U;2RWS-W\,H(W?^I]Z):A:$(\X2E&D+)B&84<L73!9Q1ILZA6MUH#42V
MEGRQU%!S:BZ<"7G.+T@IUUS';'_KIV>7ZYY=!.G-!5WO]RB_ $[?5CB)]MPH
M]+SV/&IX\[!&6DVGW:#N7I-YK<:<_NXB2!O52QNEUS%[6TEX6ETR$[_CU:QF
M(]/=%:=ZV7$=Y^=*H;K?BT2J,9Y$^_)OZ>:6,\TN=97$?)%VBI0JI>E6'(I8
MR,Z.4_RZ1E*-2,+C=>=5P!.F8,Q6,!4)25_M*FQ#53')HU)1\3\98D)XQ7)5
M0FZBGYBG;)N"6S.@_<LEGW,-]9I5^Q3QW5A#+"Z3_SA8[TZP W\:C Y&@WXP
MFHQA<@"#PY%_  >C<7\\&/6/\!9*_2G.[71VVA\'$$S ;<&I-;,&%KS<P09W
MP:TWG-WO/M?^#/K#R7'@#S_)9N8/BN3;SIXI0'#HPZP_?=<?^[/JY+<C_R/T
M!X&1U!SG\0V]8W#_/O]$+G +S(76(NF8\=_<T2(SRV>JU'$N54XPKA;W-!OT
MDD&>4B85IHSL$C*I><01@UX2O6LLC<J<*0TB@F0-YZE8Q8PN6&E\DA.)98K7
M,&69D*B5PH&0";A.]00B(0NM#!,0%!A&HO ^3YD!X73KB* @+'1]DIL80TX6
MJ5":API&:2@D^C2TMPM$(0I#?1''\+#B>EFXGK$PE\BU")FD%/S+<$G2!4-*
M3!*N%'(PA")%'8G]1)A+)IDQWH4HCW$=BB2+C?651\G^R+EDABV50881#)5C
MQ5Z3-X 9N8W7](V1W(A_%;L?%M5RVW4/7KN-&Y5OMA+CI=D2Z.9-@=H4N_#&
M4RQ90O0&MB;<=(6G=]<Z(MRL,LF4 ;MK%$D< SK @I,84U$9HE=EKR*>DC0T
M]]$U+9Y/1734RN,R5X&=*J*K+_?$^M)^N)Y^3>8QVTKG0N+ 57$7Q"13K+/]
MTZ5<93%9=WA:S')AU+V]MR[,C(8DWNS38LN6XNNGCN643QZ-NU;3;>2-V"I$
MMJ:W90W+:3?OE3J6>Z_L<UY=SVK4ZT_NMN9:C>;>T[MM66WG?O%7N_6L>MM[
MD%N[:%O9.IP.E9'T;:5>V1IDA%)D@DXMNP07!^+FB>'FA)3#\>^3<%'$H=DJ
M+W<:K>[5=MFD_[C,8A9]7XF]SY%Z:O62P1^1FV,RJ_QORO!RQVMV57&%#T2>
MPWL+?LD-TWYM33;3O]791*N71/I4I7U:U0VE&\)'75 BYA2VM?_6D ]D@V=+
M_K\TK4\ZH3\Z\@0=\2_Q *GY!8-?><C@& ]CG)H7?CR9_>C/\_=GL.0L@H.K
MH_,DBK!/\IM:8Q='VX>\2'[V]?,AKZ8W/LMDHOPNU9$L)F;J;GVHN:;T H-S
M;4+FR.NYOM_D$2_/GUS+;U#%U[#]OP!02P$"% ,4    " "*@/=2(01QBH/W
M 0!I)QD $               @ $     9&=X+3(P,C$P-C,P+FAT;5!+ 0(4
M Q0    ( (J ]U(W-S#.^ T  **%   0              "  ;'W 0!D9W@M
M,C R,3 V,S N>'-D4$L! A0#%     @ BH#W4KR]5F/;&P  F0<! !0
M         ( !UP4" &1G>"TR,#(Q,#8S,%]C86PN>&UL4$L! A0#%     @
MBH#W4D!.7P7X0@  ^LL" !0              ( !Y"$" &1G>"TR,#(Q,#8S
M,%]D968N>&UL4$L! A0#%     @ BH#W4H+S-$QKM@  "F@' !0
M     ( !#F4" &1G>"TR,#(Q,#8S,%]L86(N>&UL4$L! A0#%     @ BH#W
M4A#4YL*E<@  004% !0              ( !JQL# &1G>"TR,#(Q,#8S,%]P
M<F4N>&UL4$L! A0#%     @ BH#W4IG[^%]G"P  8UP  !0
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M2P$"% ,4    " "*@/=2N0=4#:\$  !Q$P  %               @ &,L0,
M9&=X,#8S,#(P,C%E>#,R,2YH=&U02P$"% ,4    " "*@/=2LYK?O:H$  !H
M$P  %               @ %MM@, 9&=X,#8S,#(P,C%E>#,R,BYH=&U02P4&
2      P #  / P  2;L#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
